nlm	694	NBK1396|NBK1435|NBK1419|NBK1372|NBK1418|NBK1516|NBK1152|NBK1493|NBK1264|NBK299311|NBK1483|NBK355754|NBK84111|NBK263441|NBK1169|NBK355518|NBK43797|NBK1475|NBK1431|NBK1381|NBK1193|NBK1273|NBK1172|NBK24599|NBK1454|NBK26471|NBK1519|NBK1207|NBK1108|NBK268647|NBK1450|NBK1267|NBK1236|NBK1161|NBK1365|NBK333437|NBK1429|NBK1144|NBK1360|NBK114459|NBK1378|NBK1317|NBK1456|NBK1154|NBK5300|NBK208534|NBK100238|NBK1159|NBK51784|NBK1255|NBK253404|NBK2591|NBK1131|NBK26468|NBK1138|NBK1241|NBK1426|NBK390611|NBK327153|NBK247162|NBK1363|NBK1151|NBK1503|NBK32534|NBK1421|NBK169615|NBK1204|NBK1522|NBK91457|NBK1322|NBK1398|NBK55063|NBK1380|NBK424403|NBK1441|NBK1247|NBK1517|NBK1212|NBK373577|NBK1167|NBK1394|NBK284774|NBK1258|NBK1500|NBK99168|NBK1171|NBK1760|NBK1234|NBK246980|NBK32533|NBK1286|NBK169825|NBK22925|NBK1385|NBK1328|NBK326661|NBK1386|NBK1513|NBK25565|NBK1293|NBK1391|NBK62112|NBK5313|NBK1110|NBK1332|NBK1359|NBK1104|NBK1544|NBK84551|NBK154653|NBK47457|NBK1156|NBK1727|NBK154652|NBK1250|NBK1186|NBK1348|NBK1259|NBK99496|NBK1387|NBK1106|NBK1117|NBK304142|NBK333201|NBK5188|NBK1137|NBK84550|NBK1337|NBK5189|NBK52917|NBK1181|NBK1127|NBK396257|NBK1346|NBK1291|NBK1168|NBK1539|NBK45014|NBK1358|NBK1205|NBK1285|NBK1511|NBK201366|NBK1242|NBK1187|NBK1468|NBK1340|NBK153601|NBK169431|NBK1374|NBK1876|NBK1342|NBK131811|NBK1482|NBK7046|NBK410087|NBK1507|NBK1527|NBK1527|NBK1253|NBK1461|NBK1455|NBK3794|NBK2690|NBK1245|NBK1458|NBK1400|NBK1409|NBK5200|NBK1289|NBK1533|NBK1474|NBK1119|NBK1674|NBK1309|NBK1185|NBK1216|NBK1434|NBK11167|NBK1191|NBK1158|NBK99494|NBK385626|NBK100664|NBK269029|NBK1209|NBK1536|NBK1272|NBK1251|NBK57098|NBK7040|NBK7047|NBK1350|NBK22301|NBK220444|NBK1447|NBK1534|NBK84112|NBK1878|NBK1508|NBK1491|NBK1373|NBK1190|NBK258640|NBK367946|NBK344340|NBK327268|NBK3823|NBK333438|NBK1492|NBK25442|NBK1501|NBK1157|NBK1304|NBK1125|NBK1369|NBK1200|NBK1123|NBK1306|NBK1436|NBK1244|NBK1279|NBK1494|NBK1462|NBK453432|NBK54467|NBK1263|NBK190102|NBK1142|NBK100826|NBK121284|NBK1163|NBK236968|NBK1235|NBK1401|NBK1292|NBK1368|NBK56080|NBK1345|NBK5201|NBK425540|NBK1206|NBK1180|NBK7050|NBK1147|NBK1676|NBK1388|NBK114458|NBK2534|NBK1227|NBK1543|NBK1673|NBK368474|NBK1384|NBK1281|NBK1459|NBK1443|NBK1199|NBK1371|NBK1505|NBK1506|NBK285321|NBK253403|NBK1518|NBK51671|NBK1136|NBK1364|NBK1269|NBK1446|NBK1318|NBK11168|NBK1135|NBK1430|NBK164500|NBK1547|NBK1523|NBK1198|NBK1481|NBK385627|NBK1312|NBK1261|NBK26372|NBK115333|NBK1344|NBK5941|NBK55061|NBK349073|NBK114807|NBK1529|NBK100239|NBK1404|NBK1495|NBK1440|NBK169003|NBK2701|NBK1423|NBK333439|NBK390610|NBK1139|NBK1121|NBK97260|NBK1351|NBK1375|NBK25507|NBK1439|NBK1444|NBK1252|NBK100241|NBK185330|NBK1395|NBK1211|NBK1392|NBK1524|NBK1150|NBK1111|NBK1530|NBK1338|NBK1287|NBK3789|NBK49247|NBK1769|NBK1390|NBK1509|NBK1274|NBK1305|NBK1367|NBK1768|NBK53700|NBK1496|NBK174884|NBK1260|NBK2587|NBK1477|NBK1472|NBK1243|NBK1262|NBK1476|NBK258641|NBK190103|NBK1675|NBK97965|NBK1118|NBK453433|NBK1470|NBK1170|NBK1405|NBK1325|NBK1478|NBK1469|NBK62111|NBK114806|NBK425128|NBK201978|NBK1333|NBK349072|NBK47079|NBK1334|NBK390670|NBK1238|NBK1203|NBK1484|NBK338165|NBK1389|NBK305870|NBK43417|NBK1298|NBK1457|NBK47312|NBK320989|NBK1521|NBK1383|NBK184570|NBK1408|NBK1313|NBK1174|NBK1420|NBK1311|NBK338540|NBK368476|NBK1149|NBK1133|NBK1480|NBK1361|NBK1308|NBK1208|NBK343782|NBK1215|NBK5199|NBK1974|NBK107219|NBK1335|NBK390803|NBK1424|NBK274564|NBK153723|NBK1356|NBK1354|NBK97333|NBK50780|NBK84258|NBK274565|NBK401562|NBK24676|NBK52787|NBK385289|NBK61984|NBK9674|NBK1284|NBK195853|NBK1233|NBK1538|NBK1257|NBK1413|NBK1520|NBK214367|NBK1499|NBK1473|NBK1146|NBK174452|NBK9587|NBK7041|NBK1239|NBK279760|NBK1303|NBK1502|NBK1828|NBK1875|NBK24701|NBK1214|NBK1535|NBK1130|NBK1231|NBK1290|NBK1179|NBK373578|NBK45015|NBK1728|NBK1433|NBK1425|NBK396098|NBK1162|NBK148668|NBK92947|NBK1192|NBK1498|NBK1319|NBK1128|NBK1422|NBK185329|NBK1224|NBK1432|NBK1415|NBK1412|NBK2689|NBK425723|NBK1414|NBK5299|NBK1355|NBK1165|NBK1466|NBK1132|NBK1173|NBK121988|NBK321516|NBK1428|NBK1177|NBK1288|NBK368475|NBK1141|NBK1109|NBK1201|NBK1176|NBK1357|NBK185066|NBK1124|NBK1331|NBK1370|NBK1296|NBK51754|NBK1166|NBK1232|NBK1510|NBK1188|NBK1295|NBK1427|NBK1248|NBK1393|NBK1327|NBK1126|NBK154378|NBK447152|NBK190101|NBK1451|NBK1548|NBK1223|NBK1448|NBK9673|NBK1280|NBK1122|NBK6852|NBK1486|NBK1537|NBK1467|NBK242617|NBK47027|NBK1464|NBK1230|NBK395975|NBK1297|NBK1283|NBK2692|NBK316514|NBK65707|NBK1465|NBK1488|NBK153722|NBK26472|NBK100240|NBK1266|NBK1490|NBK1246|NBK1326|NBK1460|NBK1504|NBK1197|NBK1182|NBK1221|NBK247161|NBK99167|NBK1329|NBK174451|NBK143129|NBK121283|NBK447920|NBK196157|NBK1485|NBK327267|NBK1229|NBK299584|NBK1347|NBK92946|NBK99495|NBK1973|NBK84399|NBK1487|NBK1148|NBK426063|NBK1330|NBK1113|NBK1115|NBK52764|NBK1153|NBK1270|NBK1353|NBK1452|NBK1222|NBK1497|NBK299312|NBK83985|NBK268648|NBK1240|NBK114805|NBK1417|NBK195854|NBK1324|NBK1526|NBK1237|NBK1129|NBK83297|NBK435692|NBK3795|NBK1184|NBK1175|NBK1757|NBK1202|NBK1225|NBK1399|NBK1362|NBK1438|NBK1275|NBK1471|NBK54582|NBK1196|NBK231880|NBK1140|NBK1256|NBK1268|NBK63582|NBK1105|NBK379665|NBK1189|NBK1756|NBK1145|NBK1164|NBK1219|NBK1277|NBK201365|NBK1377|NBK1321|NBK1376|NBK431123|NBK442323|NBK1143|NBK2594|NBK1352|NBK1310|NBK144284|NBK1228|NBK1479|NBK1300|NBK1210|NBK1307|NBK1382|NBK45978|NBK1160|NBK1107|NBK1827|NBK8828|NBK304122|NBK1195|NBK1302|NBK131810|NBK396561|NBK6803|NBK425223|NBK1379|NBK1525|NBK1120|NBK23758|NBK5942|NBK1218|NBK274566|NBK1445|NBK1532|NBK1366|NBK5192|NBK1276|NBK1194|NBK1349|NBK26373|NBK1437|NBK1403|NBK114628|NBK425926|NBK1103|NBK447257|NBK1282|NBK395611|NBK1220|NBK350554|NBK1515|NBK1217|NBK1323|NBK453434|NBK154138|NBK1265|NBK1341|NBK1463|NBK6816|NBK1874|NBK1967|NBK1271|NBK7014|NBK447258|NBK1407|NBK3821|NBK1178|NBK148820|NBK1114|NBK1514|NBK4144|NBK1183|NBK1249|NBK1294|NBK1512|NBK1531|NBK378974|NBK1315|NBK55062|NBK1112|NBK1406|NBK1343|NBK1213|NBK1410|NBK1489|NBK3822|NBK1453|NBK1402|NBK1449|NBK1397|NBK349624|NBK1416|NBK1339|NBK20221	
nih	694	NBK1396|NBK1435|NBK1419|NBK1372|NBK1418|NBK1516|NBK1152|NBK1493|NBK1264|NBK299311|NBK1483|NBK355754|NBK84111|NBK263441|NBK1169|NBK355518|NBK43797|NBK1475|NBK1431|NBK1381|NBK1193|NBK1273|NBK1172|NBK24599|NBK1454|NBK26471|NBK1519|NBK1207|NBK1108|NBK268647|NBK1450|NBK1267|NBK1236|NBK1161|NBK1365|NBK333437|NBK1429|NBK1144|NBK1360|NBK114459|NBK1378|NBK1317|NBK1456|NBK1154|NBK5300|NBK208534|NBK100238|NBK1159|NBK51784|NBK1255|NBK253404|NBK2591|NBK1131|NBK26468|NBK1138|NBK1241|NBK1426|NBK390611|NBK327153|NBK247162|NBK1363|NBK1151|NBK1503|NBK32534|NBK1421|NBK169615|NBK1204|NBK1522|NBK91457|NBK1322|NBK1398|NBK55063|NBK1380|NBK424403|NBK1441|NBK1247|NBK1517|NBK1212|NBK373577|NBK1167|NBK1394|NBK284774|NBK1258|NBK1500|NBK99168|NBK1171|NBK1760|NBK1234|NBK246980|NBK32533|NBK1286|NBK169825|NBK22925|NBK1385|NBK1328|NBK326661|NBK1386|NBK1513|NBK25565|NBK1293|NBK1391|NBK62112|NBK5313|NBK1110|NBK1332|NBK1359|NBK1104|NBK1544|NBK84551|NBK154653|NBK47457|NBK1156|NBK1727|NBK154652|NBK1250|NBK1186|NBK1348|NBK1259|NBK99496|NBK1387|NBK1106|NBK1117|NBK304142|NBK333201|NBK5188|NBK1137|NBK84550|NBK1337|NBK5189|NBK52917|NBK1181|NBK1127|NBK396257|NBK1346|NBK1291|NBK1168|NBK1539|NBK45014|NBK1358|NBK1205|NBK1285|NBK1511|NBK201366|NBK1242|NBK1187|NBK1468|NBK1340|NBK153601|NBK169431|NBK1374|NBK1876|NBK1342|NBK131811|NBK1482|NBK7046|NBK410087|NBK1507|NBK1527|NBK1527|NBK1253|NBK1461|NBK1455|NBK3794|NBK2690|NBK1245|NBK1458|NBK1400|NBK1409|NBK5200|NBK1289|NBK1533|NBK1474|NBK1119|NBK1674|NBK1309|NBK1185|NBK1216|NBK1434|NBK11167|NBK1191|NBK1158|NBK99494|NBK385626|NBK100664|NBK269029|NBK1209|NBK1536|NBK1272|NBK1251|NBK57098|NBK7040|NBK7047|NBK1350|NBK22301|NBK220444|NBK1447|NBK1534|NBK84112|NBK1878|NBK1508|NBK1491|NBK1373|NBK1190|NBK258640|NBK367946|NBK344340|NBK327268|NBK3823|NBK333438|NBK1492|NBK25442|NBK1501|NBK1157|NBK1304|NBK1125|NBK1369|NBK1200|NBK1123|NBK1306|NBK1436|NBK1244|NBK1279|NBK1494|NBK1462|NBK453432|NBK54467|NBK1263|NBK190102|NBK1142|NBK100826|NBK121284|NBK1163|NBK236968|NBK1235|NBK1401|NBK1292|NBK1368|NBK56080|NBK1345|NBK5201|NBK425540|NBK1206|NBK1180|NBK7050|NBK1147|NBK1676|NBK1388|NBK114458|NBK2534|NBK1227|NBK1543|NBK1673|NBK368474|NBK1384|NBK1281|NBK1459|NBK1443|NBK1199|NBK1371|NBK1505|NBK1506|NBK285321|NBK253403|NBK1518|NBK51671|NBK1136|NBK1364|NBK1269|NBK1446|NBK1318|NBK11168|NBK1135|NBK1430|NBK164500|NBK1547|NBK1523|NBK1198|NBK1481|NBK385627|NBK1312|NBK1261|NBK26372|NBK115333|NBK1344|NBK5941|NBK55061|NBK349073|NBK114807|NBK1529|NBK100239|NBK1404|NBK1495|NBK1440|NBK169003|NBK2701|NBK1423|NBK333439|NBK390610|NBK1139|NBK1121|NBK97260|NBK1351|NBK1375|NBK25507|NBK1439|NBK1444|NBK1252|NBK100241|NBK185330|NBK1395|NBK1211|NBK1392|NBK1524|NBK1150|NBK1111|NBK1530|NBK1338|NBK1287|NBK3789|NBK49247|NBK1769|NBK1390|NBK1509|NBK1274|NBK1305|NBK1367|NBK1768|NBK53700|NBK1496|NBK174884|NBK1260|NBK2587|NBK1477|NBK1472|NBK1243|NBK1262|NBK1476|NBK258641|NBK190103|NBK1675|NBK97965|NBK1118|NBK453433|NBK1470|NBK1170|NBK1405|NBK1325|NBK1478|NBK1469|NBK62111|NBK114806|NBK425128|NBK201978|NBK1333|NBK349072|NBK47079|NBK1334|NBK390670|NBK1238|NBK1203|NBK1484|NBK338165|NBK1389|NBK305870|NBK43417|NBK1298|NBK1457|NBK47312|NBK320989|NBK1521|NBK1383|NBK184570|NBK1408|NBK1313|NBK1174|NBK1420|NBK1311|NBK338540|NBK368476|NBK1149|NBK1133|NBK1480|NBK1361|NBK1308|NBK1208|NBK343782|NBK1215|NBK5199|NBK1974|NBK107219|NBK1335|NBK390803|NBK1424|NBK274564|NBK153723|NBK1356|NBK1354|NBK97333|NBK50780|NBK84258|NBK274565|NBK401562|NBK24676|NBK52787|NBK385289|NBK61984|NBK9674|NBK1284|NBK195853|NBK1233|NBK1538|NBK1257|NBK1413|NBK1520|NBK214367|NBK1499|NBK1473|NBK1146|NBK174452|NBK9587|NBK7041|NBK1239|NBK279760|NBK1303|NBK1502|NBK1828|NBK1875|NBK24701|NBK1214|NBK1535|NBK1130|NBK1231|NBK1290|NBK1179|NBK373578|NBK45015|NBK1728|NBK1433|NBK1425|NBK396098|NBK1162|NBK148668|NBK92947|NBK1192|NBK1498|NBK1319|NBK1128|NBK1422|NBK185329|NBK1224|NBK1432|NBK1415|NBK1412|NBK2689|NBK425723|NBK1414|NBK5299|NBK1355|NBK1165|NBK1466|NBK1132|NBK1173|NBK121988|NBK321516|NBK1428|NBK1177|NBK1288|NBK368475|NBK1141|NBK1109|NBK1201|NBK1176|NBK1357|NBK185066|NBK1124|NBK1331|NBK1370|NBK1296|NBK51754|NBK1166|NBK1232|NBK1510|NBK1188|NBK1295|NBK1427|NBK1248|NBK1393|NBK1327|NBK1126|NBK154378|NBK447152|NBK190101|NBK1451|NBK1548|NBK1223|NBK1448|NBK9673|NBK1280|NBK1122|NBK6852|NBK1486|NBK1537|NBK1467|NBK242617|NBK47027|NBK1464|NBK1230|NBK395975|NBK1297|NBK1283|NBK2692|NBK316514|NBK65707|NBK1465|NBK1488|NBK153722|NBK26472|NBK100240|NBK1266|NBK1490|NBK1246|NBK1326|NBK1460|NBK1504|NBK1197|NBK1182|NBK1221|NBK247161|NBK99167|NBK1329|NBK174451|NBK143129|NBK121283|NBK447920|NBK196157|NBK1485|NBK327267|NBK1229|NBK299584|NBK1347|NBK92946|NBK99495|NBK1973|NBK84399|NBK1487|NBK1148|NBK426063|NBK1330|NBK1113|NBK1115|NBK52764|NBK1153|NBK1270|NBK1353|NBK1452|NBK1222|NBK1497|NBK299312|NBK83985|NBK268648|NBK1240|NBK114805|NBK1417|NBK195854|NBK1324|NBK1526|NBK1237|NBK1129|NBK83297|NBK435692|NBK3795|NBK1184|NBK1175|NBK1757|NBK1202|NBK1225|NBK1399|NBK1362|NBK1438|NBK1275|NBK1471|NBK54582|NBK1196|NBK231880|NBK1140|NBK1256|NBK1268|NBK63582|NBK1105|NBK379665|NBK1189|NBK1756|NBK1145|NBK1164|NBK1219|NBK1277|NBK201365|NBK1377|NBK1321|NBK1376|NBK431123|NBK442323|NBK1143|NBK2594|NBK1352|NBK1310|NBK144284|NBK1228|NBK1479|NBK1300|NBK1210|NBK1307|NBK1382|NBK45978|NBK1160|NBK1107|NBK1827|NBK8828|NBK304122|NBK1195|NBK1302|NBK131810|NBK396561|NBK6803|NBK425223|NBK1379|NBK1525|NBK1120|NBK23758|NBK5942|NBK1218|NBK274566|NBK1445|NBK1532|NBK1366|NBK5192|NBK1276|NBK1194|NBK1349|NBK26373|NBK1437|NBK1403|NBK114628|NBK425926|NBK1103|NBK447257|NBK1282|NBK395611|NBK1220|NBK350554|NBK1515|NBK1217|NBK1323|NBK453434|NBK154138|NBK1265|NBK1341|NBK1463|NBK6816|NBK1874|NBK1967|NBK1271|NBK7014|NBK447258|NBK1407|NBK3821|NBK1178|NBK148820|NBK1114|NBK1514|NBK4144|NBK1183|NBK1249|NBK1294|NBK1512|NBK1531|NBK378974|NBK1315|NBK55062|NBK1112|NBK1406|NBK1343|NBK1213|NBK1410|NBK1489|NBK3822|NBK1453|NBK1402|NBK1449|NBK1397|NBK349624|NBK1416|NBK1339|NBK20221	
http://www	693	NBK1396|NBK1435|NBK1419|NBK1372|NBK1418|NBK1516|NBK1152|NBK1493|NBK1264|NBK299311|NBK1483|NBK355754|NBK84111|NBK263441|NBK1169|NBK355518|NBK43797|NBK1475|NBK1431|NBK1381|NBK1193|NBK1273|NBK1172|NBK24599|NBK1454|NBK26471|NBK1519|NBK1207|NBK1108|NBK268647|NBK1450|NBK1267|NBK1236|NBK1161|NBK1365|NBK333437|NBK1429|NBK1144|NBK1360|NBK114459|NBK1378|NBK1317|NBK1456|NBK1154|NBK5300|NBK208534|NBK100238|NBK1159|NBK51784|NBK1255|NBK253404|NBK2591|NBK1131|NBK26468|NBK1138|NBK1241|NBK1426|NBK390611|NBK327153|NBK247162|NBK1363|NBK1151|NBK1503|NBK32534|NBK1421|NBK169615|NBK1204|NBK1522|NBK91457|NBK1322|NBK1398|NBK55063|NBK1380|NBK424403|NBK1441|NBK1247|NBK1517|NBK1212|NBK373577|NBK1167|NBK1394|NBK284774|NBK1258|NBK1500|NBK99168|NBK1171|NBK1760|NBK1234|NBK246980|NBK32533|NBK1286|NBK169825|NBK22925|NBK1385|NBK1328|NBK326661|NBK1386|NBK1513|NBK25565|NBK1293|NBK1391|NBK62112|NBK5313|NBK1110|NBK1332|NBK1359|NBK1104|NBK1544|NBK84551|NBK154653|NBK47457|NBK1156|NBK1727|NBK154652|NBK1250|NBK1186|NBK1348|NBK1259|NBK99496|NBK1387|NBK1106|NBK1117|NBK304142|NBK333201|NBK5188|NBK1137|NBK84550|NBK1337|NBK5189|NBK52917|NBK1181|NBK1127|NBK396257|NBK1346|NBK1291|NBK1168|NBK1539|NBK45014|NBK1358|NBK1205|NBK1285|NBK1511|NBK201366|NBK1242|NBK1187|NBK1468|NBK1340|NBK153601|NBK169431|NBK1374|NBK1876|NBK1342|NBK131811|NBK1482|NBK7046|NBK410087|NBK1507|NBK1527|NBK1253|NBK1461|NBK1455|NBK3794|NBK2690|NBK1245|NBK1458|NBK1400|NBK1409|NBK5200|NBK1289|NBK1533|NBK1474|NBK1119|NBK1674|NBK1309|NBK1185|NBK1216|NBK1434|NBK11167|NBK1191|NBK1158|NBK99494|NBK385626|NBK100664|NBK269029|NBK1209|NBK1536|NBK1272|NBK1251|NBK57098|NBK7040|NBK7047|NBK1350|NBK22301|NBK220444|NBK1447|NBK1534|NBK84112|NBK1878|NBK1508|NBK1491|NBK1373|NBK1190|NBK258640|NBK367946|NBK344340|NBK327268|NBK3823|NBK333438|NBK1492|NBK25442|NBK1501|NBK1157|NBK1304|NBK1125|NBK1369|NBK1200|NBK1123|NBK1306|NBK1436|NBK1244|NBK1279|NBK1494|NBK1462|NBK453432|NBK54467|NBK1263|NBK190102|NBK1142|NBK100826|NBK121284|NBK1163|NBK236968|NBK1235|NBK1401|NBK1292|NBK1368|NBK56080|NBK1345|NBK5201|NBK425540|NBK1206|NBK1180|NBK7050|NBK1147|NBK1676|NBK1388|NBK114458|NBK2534|NBK1227|NBK1543|NBK1673|NBK368474|NBK1384|NBK1281|NBK1459|NBK1443|NBK1199|NBK1371|NBK1505|NBK1506|NBK285321|NBK253403|NBK1518|NBK51671|NBK1136|NBK1364|NBK1269|NBK1446|NBK1318|NBK11168|NBK1135|NBK1430|NBK164500|NBK1547|NBK1523|NBK1198|NBK1481|NBK385627|NBK1312|NBK1261|NBK26372|NBK115333|NBK1344|NBK5941|NBK55061|NBK349073|NBK114807|NBK1529|NBK100239|NBK1404|NBK1495|NBK1440|NBK169003|NBK2701|NBK1423|NBK333439|NBK390610|NBK1139|NBK1121|NBK97260|NBK1351|NBK1375|NBK25507|NBK1439|NBK1444|NBK1252|NBK100241|NBK185330|NBK1395|NBK1211|NBK1392|NBK1524|NBK1150|NBK1111|NBK1530|NBK1338|NBK1287|NBK3789|NBK49247|NBK1769|NBK1390|NBK1509|NBK1274|NBK1305|NBK1367|NBK1768|NBK53700|NBK1496|NBK174884|NBK1260|NBK2587|NBK1477|NBK1472|NBK1243|NBK1262|NBK1476|NBK258641|NBK190103|NBK1675|NBK97965|NBK1118|NBK453433|NBK1470|NBK1170|NBK1405|NBK1325|NBK1478|NBK1469|NBK62111|NBK114806|NBK425128|NBK201978|NBK1333|NBK349072|NBK47079|NBK1334|NBK390670|NBK1238|NBK1203|NBK1484|NBK338165|NBK1389|NBK305870|NBK43417|NBK1298|NBK1457|NBK47312|NBK320989|NBK1521|NBK1383|NBK184570|NBK1408|NBK1313|NBK1174|NBK1420|NBK1311|NBK338540|NBK368476|NBK1149|NBK1133|NBK1480|NBK1361|NBK1308|NBK1208|NBK343782|NBK1215|NBK5199|NBK1974|NBK107219|NBK1335|NBK390803|NBK1424|NBK274564|NBK153723|NBK1356|NBK1354|NBK97333|NBK50780|NBK84258|NBK274565|NBK401562|NBK24676|NBK52787|NBK385289|NBK61984|NBK9674|NBK1284|NBK195853|NBK1233|NBK1538|NBK1257|NBK1413|NBK1520|NBK214367|NBK1499|NBK1473|NBK1146|NBK174452|NBK9587|NBK7041|NBK1239|NBK279760|NBK1303|NBK1502|NBK1828|NBK1875|NBK24701|NBK1214|NBK1535|NBK1130|NBK1231|NBK1290|NBK1179|NBK373578|NBK45015|NBK1728|NBK1433|NBK1425|NBK396098|NBK1162|NBK148668|NBK92947|NBK1192|NBK1498|NBK1319|NBK1128|NBK1422|NBK185329|NBK1224|NBK1432|NBK1415|NBK1412|NBK2689|NBK425723|NBK1414|NBK5299|NBK1355|NBK1165|NBK1466|NBK1132|NBK1173|NBK121988|NBK321516|NBK1428|NBK1177|NBK1288|NBK368475|NBK1141|NBK1109|NBK1201|NBK1176|NBK1357|NBK185066|NBK1124|NBK1331|NBK1370|NBK1296|NBK51754|NBK1166|NBK1232|NBK1510|NBK1188|NBK1295|NBK1427|NBK1248|NBK1393|NBK1327|NBK1126|NBK154378|NBK447152|NBK190101|NBK1451|NBK1548|NBK1223|NBK1448|NBK9673|NBK1280|NBK1122|NBK6852|NBK1486|NBK1537|NBK1467|NBK242617|NBK47027|NBK1464|NBK1230|NBK395975|NBK1297|NBK1283|NBK2692|NBK316514|NBK65707|NBK1465|NBK1488|NBK153722|NBK26472|NBK100240|NBK1266|NBK1490|NBK1246|NBK1326|NBK1460|NBK1504|NBK1197|NBK1182|NBK1221|NBK247161|NBK99167|NBK1329|NBK174451|NBK143129|NBK121283|NBK447920|NBK196157|NBK1485|NBK327267|NBK1229|NBK299584|NBK1347|NBK92946|NBK99495|NBK1973|NBK84399|NBK1487|NBK1148|NBK426063|NBK1330|NBK1113|NBK1115|NBK52764|NBK1153|NBK1270|NBK1353|NBK1452|NBK1222|NBK1497|NBK299312|NBK83985|NBK268648|NBK1240|NBK114805|NBK1417|NBK195854|NBK1324|NBK1526|NBK1237|NBK1129|NBK83297|NBK435692|NBK3795|NBK1184|NBK1175|NBK1757|NBK1202|NBK1225|NBK1399|NBK1362|NBK1438|NBK1275|NBK1471|NBK54582|NBK1196|NBK231880|NBK1140|NBK1256|NBK1268|NBK63582|NBK1105|NBK379665|NBK1189|NBK1756|NBK1145|NBK1164|NBK1219|NBK1277|NBK201365|NBK1377|NBK1321|NBK1376|NBK431123|NBK442323|NBK1143|NBK2594|NBK1352|NBK1310|NBK144284|NBK1228|NBK1479|NBK1300|NBK1210|NBK1307|NBK1382|NBK45978|NBK1160|NBK1107|NBK1827|NBK8828|NBK304122|NBK1195|NBK1302|NBK131810|NBK396561|NBK6803|NBK425223|NBK1379|NBK1525|NBK1120|NBK23758|NBK5942|NBK1218|NBK274566|NBK1445|NBK1532|NBK1366|NBK5192|NBK1276|NBK1194|NBK1349|NBK26373|NBK1437|NBK1403|NBK114628|NBK425926|NBK1103|NBK447257|NBK1282|NBK395611|NBK1220|NBK350554|NBK1515|NBK1217|NBK1323|NBK453434|NBK154138|NBK1265|NBK1341|NBK1463|NBK6816|NBK1874|NBK1967|NBK1271|NBK7014|NBK447258|NBK1407|NBK3821|NBK1178|NBK148820|NBK1114|NBK1514|NBK4144|NBK1183|NBK1249|NBK1294|NBK1512|NBK1531|NBK378974|NBK1315|NBK55062|NBK1112|NBK1406|NBK1343|NBK1213|NBK1410|NBK1489|NBK3822|NBK1453|NBK1402|NBK1449|NBK1397|NBK349624|NBK1416|NBK1339|NBK20221	
ncbi	693	NBK1396|NBK1435|NBK1419|NBK1372|NBK1418|NBK1516|NBK1152|NBK1493|NBK1264|NBK299311|NBK1483|NBK355754|NBK84111|NBK263441|NBK1169|NBK355518|NBK43797|NBK1475|NBK1431|NBK1381|NBK1193|NBK1273|NBK1172|NBK24599|NBK1454|NBK26471|NBK1519|NBK1207|NBK1108|NBK268647|NBK1450|NBK1267|NBK1236|NBK1161|NBK1365|NBK333437|NBK1429|NBK1144|NBK1360|NBK114459|NBK1378|NBK1317|NBK1456|NBK1154|NBK5300|NBK208534|NBK100238|NBK1159|NBK51784|NBK1255|NBK253404|NBK2591|NBK1131|NBK26468|NBK1138|NBK1241|NBK1426|NBK390611|NBK327153|NBK247162|NBK1363|NBK1151|NBK1503|NBK32534|NBK1421|NBK169615|NBK1204|NBK1522|NBK91457|NBK1322|NBK1398|NBK55063|NBK1380|NBK424403|NBK1441|NBK1247|NBK1517|NBK1212|NBK373577|NBK1167|NBK1394|NBK284774|NBK1258|NBK1500|NBK99168|NBK1171|NBK1760|NBK1234|NBK246980|NBK32533|NBK1286|NBK169825|NBK22925|NBK1385|NBK1328|NBK326661|NBK1386|NBK1513|NBK25565|NBK1293|NBK1391|NBK62112|NBK5313|NBK1110|NBK1332|NBK1359|NBK1104|NBK1544|NBK84551|NBK154653|NBK47457|NBK1156|NBK1727|NBK154652|NBK1250|NBK1186|NBK1348|NBK1259|NBK99496|NBK1387|NBK1106|NBK1117|NBK304142|NBK333201|NBK5188|NBK1137|NBK84550|NBK1337|NBK5189|NBK52917|NBK1181|NBK1127|NBK396257|NBK1346|NBK1291|NBK1168|NBK1539|NBK45014|NBK1358|NBK1205|NBK1285|NBK1511|NBK201366|NBK1242|NBK1187|NBK1468|NBK1340|NBK153601|NBK169431|NBK1374|NBK1876|NBK1342|NBK131811|NBK1482|NBK7046|NBK410087|NBK1507|NBK1527|NBK1253|NBK1461|NBK1455|NBK3794|NBK2690|NBK1245|NBK1458|NBK1400|NBK1409|NBK5200|NBK1289|NBK1533|NBK1474|NBK1119|NBK1674|NBK1309|NBK1185|NBK1216|NBK1434|NBK11167|NBK1191|NBK1158|NBK99494|NBK385626|NBK100664|NBK269029|NBK1209|NBK1536|NBK1272|NBK1251|NBK57098|NBK7040|NBK7047|NBK1350|NBK22301|NBK220444|NBK1447|NBK1534|NBK84112|NBK1878|NBK1508|NBK1491|NBK1373|NBK1190|NBK258640|NBK367946|NBK344340|NBK327268|NBK3823|NBK333438|NBK1492|NBK25442|NBK1501|NBK1157|NBK1304|NBK1125|NBK1369|NBK1200|NBK1123|NBK1306|NBK1436|NBK1244|NBK1279|NBK1494|NBK1462|NBK453432|NBK54467|NBK1263|NBK190102|NBK1142|NBK100826|NBK121284|NBK1163|NBK236968|NBK1235|NBK1401|NBK1292|NBK1368|NBK56080|NBK1345|NBK5201|NBK425540|NBK1206|NBK1180|NBK7050|NBK1147|NBK1676|NBK1388|NBK114458|NBK2534|NBK1227|NBK1543|NBK1673|NBK368474|NBK1384|NBK1281|NBK1459|NBK1443|NBK1199|NBK1371|NBK1505|NBK1506|NBK285321|NBK253403|NBK1518|NBK51671|NBK1136|NBK1364|NBK1269|NBK1446|NBK1318|NBK11168|NBK1135|NBK1430|NBK164500|NBK1547|NBK1523|NBK1198|NBK1481|NBK385627|NBK1312|NBK1261|NBK26372|NBK115333|NBK1344|NBK5941|NBK55061|NBK349073|NBK114807|NBK1529|NBK100239|NBK1404|NBK1495|NBK1440|NBK169003|NBK2701|NBK1423|NBK333439|NBK390610|NBK1139|NBK1121|NBK97260|NBK1351|NBK1375|NBK25507|NBK1439|NBK1444|NBK1252|NBK100241|NBK185330|NBK1395|NBK1211|NBK1392|NBK1524|NBK1150|NBK1111|NBK1530|NBK1338|NBK1287|NBK3789|NBK49247|NBK1769|NBK1390|NBK1509|NBK1274|NBK1305|NBK1367|NBK1768|NBK53700|NBK1496|NBK174884|NBK1260|NBK2587|NBK1477|NBK1472|NBK1243|NBK1262|NBK1476|NBK258641|NBK190103|NBK1675|NBK97965|NBK1118|NBK453433|NBK1470|NBK1170|NBK1405|NBK1325|NBK1478|NBK1469|NBK62111|NBK114806|NBK425128|NBK201978|NBK1333|NBK349072|NBK47079|NBK1334|NBK390670|NBK1238|NBK1203|NBK1484|NBK338165|NBK1389|NBK305870|NBK43417|NBK1298|NBK1457|NBK47312|NBK320989|NBK1521|NBK1383|NBK184570|NBK1408|NBK1313|NBK1174|NBK1420|NBK1311|NBK338540|NBK368476|NBK1149|NBK1133|NBK1480|NBK1361|NBK1308|NBK1208|NBK343782|NBK1215|NBK5199|NBK1974|NBK107219|NBK1335|NBK390803|NBK1424|NBK274564|NBK153723|NBK1356|NBK1354|NBK97333|NBK50780|NBK84258|NBK274565|NBK401562|NBK24676|NBK52787|NBK385289|NBK61984|NBK9674|NBK1284|NBK195853|NBK1233|NBK1538|NBK1257|NBK1413|NBK1520|NBK214367|NBK1499|NBK1473|NBK1146|NBK174452|NBK9587|NBK7041|NBK1239|NBK279760|NBK1303|NBK1502|NBK1828|NBK1875|NBK24701|NBK1214|NBK1535|NBK1130|NBK1231|NBK1290|NBK1179|NBK373578|NBK45015|NBK1728|NBK1433|NBK1425|NBK396098|NBK1162|NBK148668|NBK92947|NBK1192|NBK1498|NBK1319|NBK1128|NBK1422|NBK185329|NBK1224|NBK1432|NBK1415|NBK1412|NBK2689|NBK425723|NBK1414|NBK5299|NBK1355|NBK1165|NBK1466|NBK1132|NBK1173|NBK121988|NBK321516|NBK1428|NBK1177|NBK1288|NBK368475|NBK1141|NBK1109|NBK1201|NBK1176|NBK1357|NBK185066|NBK1124|NBK1331|NBK1370|NBK1296|NBK51754|NBK1166|NBK1232|NBK1510|NBK1188|NBK1295|NBK1427|NBK1248|NBK1393|NBK1327|NBK1126|NBK154378|NBK447152|NBK190101|NBK1451|NBK1548|NBK1223|NBK1448|NBK9673|NBK1280|NBK1122|NBK6852|NBK1486|NBK1537|NBK1467|NBK242617|NBK47027|NBK1464|NBK1230|NBK395975|NBK1297|NBK1283|NBK2692|NBK316514|NBK65707|NBK1465|NBK1488|NBK153722|NBK26472|NBK100240|NBK1266|NBK1490|NBK1246|NBK1326|NBK1460|NBK1504|NBK1197|NBK1182|NBK1221|NBK247161|NBK99167|NBK1329|NBK174451|NBK143129|NBK121283|NBK447920|NBK196157|NBK1485|NBK327267|NBK1229|NBK299584|NBK1347|NBK92946|NBK99495|NBK1973|NBK84399|NBK1487|NBK1148|NBK426063|NBK1330|NBK1113|NBK1115|NBK52764|NBK1153|NBK1270|NBK1353|NBK1452|NBK1222|NBK1497|NBK299312|NBK83985|NBK268648|NBK1240|NBK114805|NBK1417|NBK195854|NBK1324|NBK1526|NBK1237|NBK1129|NBK83297|NBK435692|NBK3795|NBK1184|NBK1175|NBK1757|NBK1202|NBK1225|NBK1399|NBK1362|NBK1438|NBK1275|NBK1471|NBK54582|NBK1196|NBK231880|NBK1140|NBK1256|NBK1268|NBK63582|NBK1105|NBK379665|NBK1189|NBK1756|NBK1145|NBK1164|NBK1219|NBK1277|NBK201365|NBK1377|NBK1321|NBK1376|NBK431123|NBK442323|NBK1143|NBK2594|NBK1352|NBK1310|NBK144284|NBK1228|NBK1479|NBK1300|NBK1210|NBK1307|NBK1382|NBK45978|NBK1160|NBK1107|NBK1827|NBK8828|NBK304122|NBK1195|NBK1302|NBK131810|NBK396561|NBK6803|NBK425223|NBK1379|NBK1525|NBK1120|NBK23758|NBK5942|NBK1218|NBK274566|NBK1445|NBK1532|NBK1366|NBK5192|NBK1276|NBK1194|NBK1349|NBK26373|NBK1437|NBK1403|NBK114628|NBK425926|NBK1103|NBK447257|NBK1282|NBK395611|NBK1220|NBK350554|NBK1515|NBK1217|NBK1323|NBK453434|NBK154138|NBK1265|NBK1341|NBK1463|NBK6816|NBK1874|NBK1967|NBK1271|NBK7014|NBK447258|NBK1407|NBK3821|NBK1178|NBK148820|NBK1114|NBK1514|NBK4144|NBK1183|NBK1249|NBK1294|NBK1512|NBK1531|NBK378974|NBK1315|NBK55062|NBK1112|NBK1406|NBK1343|NBK1213|NBK1410|NBK1489|NBK3822|NBK1453|NBK1402|NBK1449|NBK1397|NBK349624|NBK1416|NBK1339|NBK20221	
management	691	NBK1396|NBK1435|NBK1419|NBK1372|NBK1418|NBK1516|NBK1152|NBK1493|NBK1264|NBK299311|NBK1483|NBK355754|NBK84111|NBK263441|NBK1169|NBK355518|NBK43797|NBK1475|NBK1431|NBK1381|NBK1193|NBK1273|NBK1172|NBK24599|NBK1454|NBK26471|NBK1519|NBK1207|NBK1108|NBK268647|NBK1450|NBK1267|NBK1236|NBK1161|NBK1365|NBK333437|NBK1429|NBK1144|NBK1360|NBK114459|NBK1378|NBK1317|NBK1456|NBK1154|NBK5300|NBK208534|NBK100238|NBK1159|NBK51784|NBK1255|NBK253404|NBK2591|NBK1131|NBK26468|NBK1138|NBK1241|NBK1426|NBK390611|NBK327153|NBK247162|NBK1363|NBK1151|NBK1503|NBK32534|NBK1421|NBK169615|NBK1204|NBK1522|NBK91457|NBK1322|NBK1398|NBK55063|NBK1380|NBK424403|NBK1441|NBK1247|NBK1517|NBK1212|NBK373577|NBK1167|NBK1394|NBK284774|NBK1258|NBK1500|NBK99168|NBK1171|NBK1760|NBK1234|NBK246980|NBK32533|NBK1286|NBK169825|NBK22925|NBK1385|NBK1328|NBK326661|NBK1386|NBK1513|NBK25565|NBK1293|NBK1391|NBK62112|NBK5313|NBK1110|NBK1332|NBK1359|NBK1104|NBK1544|NBK84551|NBK154653|NBK47457|NBK1156|NBK1727|NBK154652|NBK1250|NBK1186|NBK1348|NBK1259|NBK99496|NBK1387|NBK1106|NBK1117|NBK304142|NBK333201|NBK5188|NBK1137|NBK84550|NBK1337|NBK5189|NBK52917|NBK1181|NBK1127|NBK396257|NBK1346|NBK1291|NBK1168|NBK1539|NBK45014|NBK1358|NBK1205|NBK1285|NBK1511|NBK201366|NBK1242|NBK1187|NBK1468|NBK1340|NBK153601|NBK169431|NBK1374|NBK1876|NBK1342|NBK131811|NBK1482|NBK7046|NBK410087|NBK1507|NBK1527|NBK1253|NBK1461|NBK1455|NBK3794|NBK2690|NBK1245|NBK1458|NBK1400|NBK1409|NBK5200|NBK1289|NBK1533|NBK1474|NBK1119|NBK1674|NBK1309|NBK1185|NBK1216|NBK1434|NBK11167|NBK1191|NBK1158|NBK99494|NBK385626|NBK100664|NBK269029|NBK1209|NBK1536|NBK1272|NBK1251|NBK57098|NBK7040|NBK7047|NBK1350|NBK22301|NBK220444|NBK1447|NBK1534|NBK84112|NBK1878|NBK1508|NBK1491|NBK1373|NBK1190|NBK258640|NBK367946|NBK344340|NBK327268|NBK3823|NBK333438|NBK1492|NBK25442|NBK1501|NBK1157|NBK1304|NBK1125|NBK1369|NBK1200|NBK1123|NBK1306|NBK1436|NBK1244|NBK1279|NBK1494|NBK1462|NBK453432|NBK54467|NBK1263|NBK190102|NBK1142|NBK100826|NBK121284|NBK1163|NBK236968|NBK1235|NBK1401|NBK1292|NBK1368|NBK56080|NBK1345|NBK5201|NBK425540|NBK1206|NBK1180|NBK7050|NBK1147|NBK1676|NBK1388|NBK114458|NBK2534|NBK1227|NBK1543|NBK1673|NBK368474|NBK1384|NBK1281|NBK1459|NBK1443|NBK1199|NBK1371|NBK1505|NBK1506|NBK285321|NBK253403|NBK1518|NBK51671|NBK1136|NBK1364|NBK1269|NBK1446|NBK1318|NBK11168|NBK1135|NBK1430|NBK164500|NBK1547|NBK1523|NBK1198|NBK1481|NBK385627|NBK1312|NBK1261|NBK26372|NBK115333|NBK1344|NBK5941|NBK55061|NBK349073|NBK114807|NBK1529|NBK100239|NBK1404|NBK1495|NBK1440|NBK169003|NBK2701|NBK1423|NBK333439|NBK390610|NBK1139|NBK1121|NBK97260|NBK1351|NBK1375|NBK25507|NBK1439|NBK1444|NBK1252|NBK100241|NBK185330|NBK1395|NBK1211|NBK1392|NBK1524|NBK1150|NBK1111|NBK1530|NBK1338|NBK1287|NBK3789|NBK49247|NBK1769|NBK1390|NBK1509|NBK1274|NBK1305|NBK1367|NBK1768|NBK53700|NBK1496|NBK174884|NBK1260|NBK2587|NBK1477|NBK1472|NBK1243|NBK1262|NBK1476|NBK258641|NBK190103|NBK1675|NBK97965|NBK1118|NBK453433|NBK1470|NBK1170|NBK1405|NBK1325|NBK1478|NBK1469|NBK62111|NBK114806|NBK425128|NBK201978|NBK1333|NBK349072|NBK47079|NBK1334|NBK390670|NBK1238|NBK1203|NBK1484|NBK338165|NBK1389|NBK305870|NBK43417|NBK1298|NBK1457|NBK47312|NBK320989|NBK1521|NBK1383|NBK184570|NBK1408|NBK1313|NBK1174|NBK1420|NBK1311|NBK338540|NBK368476|NBK1149|NBK1133|NBK1480|NBK1361|NBK1308|NBK1208|NBK343782|NBK1215|NBK5199|NBK1974|NBK107219|NBK1335|NBK390803|NBK1424|NBK274564|NBK153723|NBK1356|NBK1354|NBK97333|NBK50780|NBK84258|NBK274565|NBK401562|NBK24676|NBK52787|NBK385289|NBK61984|NBK9674|NBK1284|NBK195853|NBK1233|NBK1538|NBK1257|NBK1413|NBK1520|NBK214367|NBK1499|NBK1473|NBK1146|NBK174452|NBK9587|NBK7041|NBK1239|NBK279760|NBK1303|NBK1502|NBK1828|NBK1875|NBK24701|NBK1214|NBK1535|NBK1130|NBK1231|NBK1290|NBK1179|NBK373578|NBK45015|NBK1728|NBK1433|NBK1425|NBK396098|NBK1162|NBK148668|NBK92947|NBK1192|NBK1498|NBK1319|NBK1128|NBK1422|NBK185329|NBK1224|NBK1432|NBK1415|NBK1412|NBK2689|NBK425723|NBK1414|NBK5299|NBK1355|NBK1165|NBK1466|NBK1132|NBK1173|NBK121988|NBK321516|NBK1428|NBK1177|NBK1288|NBK368475|NBK1141|NBK1109|NBK1201|NBK1176|NBK1357|NBK185066|NBK1124|NBK1331|NBK1370|NBK1296|NBK51754|NBK1166|NBK1232|NBK1510|NBK1188|NBK1295|NBK1427|NBK1248|NBK1393|NBK1327|NBK1126|NBK154378|NBK447152|NBK190101|NBK1451|NBK1548|NBK1223|NBK1448|NBK9673|NBK1280|NBK1122|NBK6852|NBK1486|NBK1537|NBK1467|NBK242617|NBK47027|NBK1464|NBK1230|NBK395975|NBK1297|NBK1283|NBK2692|NBK316514|NBK65707|NBK1465|NBK1488|NBK153722|NBK26472|NBK100240|NBK1266|NBK1490|NBK1246|NBK1326|NBK1460|NBK1504|NBK1197|NBK1182|NBK1221|NBK247161|NBK99167|NBK1329|NBK174451|NBK143129|NBK121283|NBK447920|NBK196157|NBK1485|NBK327267|NBK1229|NBK299584|NBK1347|NBK92946|NBK99495|NBK1973|NBK84399|NBK1487|NBK1148|NBK426063|NBK1330|NBK1113|NBK1115|NBK52764|NBK1153|NBK1270|NBK1353|NBK1452|NBK1222|NBK1497|NBK299312|NBK83985|NBK268648|NBK1240|NBK114805|NBK195854|NBK1324|NBK1526|NBK1237|NBK1129|NBK83297|NBK435692|NBK3795|NBK1184|NBK1175|NBK1757|NBK1202|NBK1225|NBK1399|NBK1362|NBK1438|NBK1275|NBK1471|NBK54582|NBK1196|NBK231880|NBK1140|NBK1256|NBK1268|NBK63582|NBK1105|NBK379665|NBK1189|NBK1756|NBK1145|NBK1164|NBK1219|NBK1277|NBK201365|NBK1377|NBK1321|NBK1376|NBK431123|NBK442323|NBK1143|NBK2594|NBK1352|NBK1310|NBK144284|NBK1228|NBK1479|NBK1300|NBK1210|NBK1307|NBK1382|NBK45978|NBK1160|NBK1107|NBK1827|NBK8828|NBK304122|NBK1195|NBK1302|NBK131810|NBK396561|NBK6803|NBK425223|NBK1379|NBK1525|NBK1120|NBK23758|NBK5942|NBK1218|NBK274566|NBK1445|NBK1532|NBK1366|NBK5192|NBK1276|NBK1194|NBK1349|NBK26373|NBK1437|NBK1403|NBK114628|NBK425926|NBK1103|NBK447257|NBK1282|NBK395611|NBK1220|NBK350554|NBK1515|NBK1323|NBK453434|NBK154138|NBK1265|NBK1341|NBK1463|NBK6816|NBK1874|NBK1967|NBK1271|NBK7014|NBK447258|NBK1407|NBK3821|NBK1178|NBK148820|NBK1114|NBK1514|NBK4144|NBK1183|NBK1249|NBK1294|NBK1512|NBK1531|NBK378974|NBK1315|NBK55062|NBK1112|NBK1406|NBK1343|NBK1213|NBK1410|NBK1489|NBK3822|NBK1453|NBK1402|NBK1449|NBK1397|NBK349624|NBK1416|NBK1339|NBK20221	
treatment of manifestations	686	NBK1396|NBK1435|NBK1419|NBK1372|NBK1418|NBK1516|NBK1152|NBK1493|NBK1264|NBK299311|NBK1483|NBK355754|NBK84111|NBK263441|NBK1169|NBK355518|NBK43797|NBK1475|NBK1431|NBK1381|NBK1193|NBK1273|NBK1172|NBK24599|NBK1454|NBK26471|NBK1519|NBK1207|NBK1108|NBK268647|NBK1450|NBK1267|NBK1236|NBK1161|NBK1365|NBK333437|NBK1429|NBK1144|NBK1360|NBK114459|NBK1317|NBK1456|NBK1154|NBK5300|NBK208534|NBK100238|NBK1159|NBK51784|NBK1255|NBK253404|NBK2591|NBK1131|NBK26468|NBK1138|NBK1241|NBK1426|NBK390611|NBK327153|NBK247162|NBK1363|NBK1151|NBK1503|NBK32534|NBK1421|NBK169615|NBK1204|NBK1522|NBK91457|NBK1322|NBK1398|NBK55063|NBK1380|NBK424403|NBK1441|NBK1247|NBK1517|NBK1212|NBK373577|NBK1167|NBK1394|NBK284774|NBK1258|NBK1500|NBK99168|NBK1171|NBK1760|NBK1234|NBK246980|NBK32533|NBK1286|NBK169825|NBK22925|NBK1385|NBK1328|NBK326661|NBK1386|NBK1513|NBK25565|NBK1293|NBK1391|NBK62112|NBK5313|NBK1110|NBK1332|NBK1359|NBK1104|NBK1544|NBK84551|NBK154653|NBK47457|NBK1156|NBK1727|NBK154652|NBK1250|NBK1186|NBK1348|NBK1259|NBK99496|NBK1387|NBK1106|NBK1117|NBK304142|NBK333201|NBK5188|NBK1137|NBK84550|NBK1337|NBK5189|NBK52917|NBK1181|NBK1127|NBK396257|NBK1346|NBK1291|NBK1168|NBK1539|NBK45014|NBK1358|NBK1205|NBK1285|NBK1511|NBK201366|NBK1242|NBK1187|NBK1468|NBK1340|NBK153601|NBK169431|NBK1374|NBK1876|NBK1342|NBK131811|NBK1482|NBK7046|NBK410087|NBK1507|NBK1527|NBK1253|NBK1461|NBK1455|NBK3794|NBK2690|NBK1245|NBK1458|NBK1400|NBK1409|NBK5200|NBK1289|NBK1533|NBK1474|NBK1119|NBK1674|NBK1309|NBK1185|NBK1216|NBK1434|NBK11167|NBK1191|NBK1158|NBK99494|NBK385626|NBK100664|NBK269029|NBK1209|NBK1536|NBK1272|NBK1251|NBK57098|NBK7040|NBK7047|NBK1350|NBK22301|NBK220444|NBK1447|NBK1534|NBK84112|NBK1878|NBK1508|NBK1491|NBK1373|NBK1190|NBK258640|NBK367946|NBK344340|NBK327268|NBK3823|NBK333438|NBK1492|NBK25442|NBK1501|NBK1157|NBK1304|NBK1125|NBK1369|NBK1200|NBK1123|NBK1306|NBK1436|NBK1244|NBK1279|NBK1494|NBK1462|NBK453432|NBK54467|NBK1263|NBK190102|NBK1142|NBK100826|NBK121284|NBK1163|NBK236968|NBK1235|NBK1401|NBK1292|NBK1368|NBK1345|NBK5201|NBK425540|NBK1206|NBK1180|NBK7050|NBK1147|NBK1676|NBK1388|NBK114458|NBK2534|NBK1227|NBK1543|NBK1673|NBK368474|NBK1384|NBK1281|NBK1459|NBK1443|NBK1199|NBK1371|NBK1505|NBK1506|NBK285321|NBK253403|NBK51671|NBK1136|NBK1364|NBK1269|NBK1318|NBK11168|NBK1135|NBK1430|NBK164500|NBK1547|NBK1523|NBK1198|NBK1481|NBK385627|NBK1312|NBK1261|NBK26372|NBK115333|NBK1344|NBK5941|NBK55061|NBK349073|NBK114807|NBK1529|NBK100239|NBK1404|NBK1495|NBK1440|NBK169003|NBK2701|NBK1423|NBK333439|NBK390610|NBK1139|NBK1121|NBK97260|NBK1351|NBK1375|NBK25507|NBK1439|NBK1444|NBK1252|NBK100241|NBK185330|NBK1395|NBK1211|NBK1392|NBK1524|NBK1150|NBK1111|NBK1530|NBK1338|NBK1287|NBK3789|NBK49247|NBK1769|NBK1390|NBK1509|NBK1274|NBK1305|NBK1367|NBK1768|NBK53700|NBK1496|NBK174884|NBK1260|NBK2587|NBK1477|NBK1472|NBK1243|NBK1262|NBK1476|NBK258641|NBK190103|NBK1675|NBK97965|NBK1118|NBK453433|NBK1470|NBK1170|NBK1405|NBK1325|NBK1478|NBK1469|NBK62111|NBK114806|NBK425128|NBK201978|NBK1333|NBK349072|NBK47079|NBK1334|NBK390670|NBK1238|NBK1203|NBK1484|NBK338165|NBK1389|NBK305870|NBK43417|NBK1298|NBK1457|NBK47312|NBK320989|NBK1521|NBK1383|NBK184570|NBK1408|NBK1313|NBK1174|NBK1420|NBK1311|NBK338540|NBK368476|NBK1149|NBK1133|NBK1480|NBK1361|NBK1308|NBK1208|NBK343782|NBK1215|NBK5199|NBK1974|NBK107219|NBK1335|NBK390803|NBK1424|NBK274564|NBK153723|NBK1356|NBK1354|NBK97333|NBK50780|NBK84258|NBK274565|NBK401562|NBK24676|NBK52787|NBK385289|NBK61984|NBK9674|NBK1284|NBK195853|NBK1233|NBK1538|NBK1257|NBK1413|NBK1520|NBK214367|NBK1499|NBK1473|NBK1146|NBK174452|NBK9587|NBK7041|NBK1239|NBK279760|NBK1303|NBK1502|NBK1828|NBK1875|NBK24701|NBK1214|NBK1535|NBK1130|NBK1231|NBK1290|NBK1179|NBK373578|NBK45015|NBK1728|NBK1433|NBK1425|NBK396098|NBK1162|NBK148668|NBK92947|NBK1192|NBK1498|NBK1319|NBK1128|NBK1422|NBK185329|NBK1224|NBK1432|NBK1415|NBK1412|NBK2689|NBK425723|NBK1414|NBK5299|NBK1355|NBK1165|NBK1466|NBK1132|NBK1173|NBK121988|NBK321516|NBK1428|NBK1177|NBK1288|NBK368475|NBK1141|NBK1109|NBK1201|NBK1176|NBK1357|NBK185066|NBK1124|NBK1331|NBK1370|NBK1296|NBK51754|NBK1166|NBK1232|NBK1510|NBK1188|NBK1295|NBK1427|NBK1248|NBK1393|NBK1327|NBK1126|NBK154378|NBK447152|NBK190101|NBK1451|NBK1548|NBK1223|NBK1448|NBK9673|NBK1280|NBK1122|NBK6852|NBK1486|NBK1537|NBK1467|NBK242617|NBK47027|NBK1464|NBK1230|NBK395975|NBK1297|NBK1283|NBK2692|NBK316514|NBK65707|NBK1465|NBK1488|NBK153722|NBK26472|NBK100240|NBK1266|NBK1490|NBK1246|NBK1326|NBK1460|NBK1504|NBK1197|NBK1182|NBK1221|NBK247161|NBK99167|NBK1329|NBK174451|NBK143129|NBK121283|NBK447920|NBK196157|NBK1485|NBK327267|NBK1229|NBK299584|NBK1347|NBK92946|NBK99495|NBK1973|NBK84399|NBK1487|NBK1148|NBK426063|NBK1330|NBK1113|NBK1115|NBK52764|NBK1153|NBK1270|NBK1353|NBK1452|NBK1222|NBK1497|NBK299312|NBK83985|NBK268648|NBK1240|NBK114805|NBK1417|NBK195854|NBK1324|NBK1526|NBK1237|NBK1129|NBK83297|NBK435692|NBK3795|NBK1184|NBK1175|NBK1757|NBK1202|NBK1225|NBK1399|NBK1362|NBK1438|NBK1275|NBK1471|NBK54582|NBK1196|NBK231880|NBK1140|NBK1256|NBK1268|NBK63582|NBK1105|NBK379665|NBK1189|NBK1756|NBK1145|NBK1164|NBK1219|NBK1277|NBK201365|NBK1377|NBK1321|NBK1376|NBK431123|NBK442323|NBK1143|NBK2594|NBK1352|NBK1310|NBK144284|NBK1228|NBK1479|NBK1300|NBK1210|NBK1307|NBK1382|NBK45978|NBK1160|NBK1107|NBK1827|NBK8828|NBK304122|NBK1195|NBK1302|NBK131810|NBK396561|NBK6803|NBK425223|NBK1379|NBK1525|NBK23758|NBK5942|NBK1218|NBK274566|NBK1445|NBK1532|NBK1366|NBK5192|NBK1276|NBK1194|NBK1349|NBK26373|NBK1437|NBK1403|NBK114628|NBK425926|NBK1103|NBK447257|NBK1282|NBK395611|NBK1220|NBK350554|NBK1515|NBK1323|NBK453434|NBK154138|NBK1265|NBK1341|NBK1463|NBK6816|NBK1874|NBK1967|NBK1271|NBK7014|NBK447258|NBK1407|NBK3821|NBK1178|NBK148820|NBK1114|NBK1514|NBK4144|NBK1183|NBK1249|NBK1512|NBK1531|NBK378974|NBK1315|NBK55062|NBK1112|NBK1406|NBK1343|NBK1213|NBK1410|NBK1489|NBK3822|NBK1453|NBK1402|NBK1449|NBK1397|NBK349624|NBK1416|NBK1339|NBK20221	
therapies under investigation	683	NBK1396|NBK1435|NBK1419|NBK1372|NBK1418|NBK1516|NBK1152|NBK1493|NBK1264|NBK299311|NBK1483|NBK355754|NBK84111|NBK263441|NBK1169|NBK355518|NBK43797|NBK1475|NBK1431|NBK1381|NBK1193|NBK1273|NBK1172|NBK24599|NBK1454|NBK26471|NBK1519|NBK1207|NBK1108|NBK268647|NBK1450|NBK1267|NBK1236|NBK1161|NBK1365|NBK333437|NBK1429|NBK1144|NBK1360|NBK114459|NBK1317|NBK1456|NBK1154|NBK5300|NBK208534|NBK100238|NBK1159|NBK51784|NBK1255|NBK253404|NBK2591|NBK1131|NBK26468|NBK1241|NBK1426|NBK390611|NBK327153|NBK247162|NBK1363|NBK1151|NBK1503|NBK32534|NBK1421|NBK169615|NBK1204|NBK1522|NBK91457|NBK1322|NBK1398|NBK55063|NBK1380|NBK424403|NBK1441|NBK1247|NBK1517|NBK1212|NBK373577|NBK1167|NBK1394|NBK284774|NBK1258|NBK1500|NBK99168|NBK1171|NBK1760|NBK1234|NBK246980|NBK32533|NBK1286|NBK169825|NBK22925|NBK1385|NBK1328|NBK326661|NBK1386|NBK1513|NBK25565|NBK1293|NBK1391|NBK62112|NBK5313|NBK1110|NBK1332|NBK1359|NBK1104|NBK1544|NBK84551|NBK154653|NBK47457|NBK1156|NBK1727|NBK154652|NBK1250|NBK1186|NBK1348|NBK1259|NBK99496|NBK1387|NBK1106|NBK1117|NBK304142|NBK333201|NBK5188|NBK1137|NBK84550|NBK1337|NBK5189|NBK52917|NBK1181|NBK1127|NBK396257|NBK1346|NBK1291|NBK1168|NBK1539|NBK45014|NBK1358|NBK1205|NBK1285|NBK1511|NBK201366|NBK1242|NBK1187|NBK1468|NBK1340|NBK153601|NBK169431|NBK1374|NBK1876|NBK1342|NBK131811|NBK1482|NBK7046|NBK410087|NBK1507|NBK1527|NBK1253|NBK1461|NBK1455|NBK3794|NBK2690|NBK1245|NBK1458|NBK1400|NBK1409|NBK5200|NBK1289|NBK1533|NBK1474|NBK1119|NBK1674|NBK1309|NBK1185|NBK1216|NBK11167|NBK1191|NBK1158|NBK99494|NBK385626|NBK100664|NBK269029|NBK1209|NBK1536|NBK1272|NBK1251|NBK57098|NBK7040|NBK7047|NBK1350|NBK22301|NBK220444|NBK1447|NBK1534|NBK84112|NBK1878|NBK1508|NBK1491|NBK1373|NBK1190|NBK258640|NBK367946|NBK344340|NBK327268|NBK3823|NBK333438|NBK1492|NBK25442|NBK1501|NBK1157|NBK1304|NBK1125|NBK1369|NBK1200|NBK1123|NBK1306|NBK1436|NBK1244|NBK1279|NBK1494|NBK1462|NBK453432|NBK54467|NBK1263|NBK190102|NBK1142|NBK100826|NBK121284|NBK1163|NBK236968|NBK1235|NBK1401|NBK1292|NBK1368|NBK56080|NBK1345|NBK5201|NBK425540|NBK1206|NBK1180|NBK7050|NBK1147|NBK1676|NBK1388|NBK114458|NBK2534|NBK1227|NBK1543|NBK1673|NBK368474|NBK1384|NBK1281|NBK1459|NBK1443|NBK1199|NBK1371|NBK1505|NBK1506|NBK285321|NBK253403|NBK1518|NBK51671|NBK1136|NBK1364|NBK1269|NBK1446|NBK1318|NBK11168|NBK1135|NBK1430|NBK164500|NBK1547|NBK1523|NBK1198|NBK1481|NBK385627|NBK1312|NBK1261|NBK26372|NBK115333|NBK1344|NBK5941|NBK55061|NBK349073|NBK114807|NBK1529|NBK100239|NBK1404|NBK1495|NBK1440|NBK169003|NBK2701|NBK1423|NBK333439|NBK390610|NBK1139|NBK1121|NBK97260|NBK1351|NBK1375|NBK25507|NBK1444|NBK1252|NBK100241|NBK185330|NBK1395|NBK1211|NBK1392|NBK1524|NBK1150|NBK1111|NBK1530|NBK1338|NBK1287|NBK3789|NBK49247|NBK1769|NBK1390|NBK1509|NBK1274|NBK1305|NBK1367|NBK1768|NBK53700|NBK1496|NBK174884|NBK1260|NBK2587|NBK1477|NBK1472|NBK1243|NBK1262|NBK1476|NBK258641|NBK190103|NBK1675|NBK97965|NBK1118|NBK453433|NBK1470|NBK1170|NBK1405|NBK1325|NBK1478|NBK1469|NBK62111|NBK114806|NBK425128|NBK201978|NBK1333|NBK349072|NBK47079|NBK1334|NBK390670|NBK1238|NBK1203|NBK1484|NBK338165|NBK1389|NBK305870|NBK43417|NBK1298|NBK1457|NBK47312|NBK1521|NBK1383|NBK184570|NBK1408|NBK1313|NBK1174|NBK1420|NBK1311|NBK338540|NBK368476|NBK1149|NBK1133|NBK1480|NBK1361|NBK1308|NBK1208|NBK343782|NBK1215|NBK5199|NBK1974|NBK107219|NBK1335|NBK390803|NBK1424|NBK274564|NBK153723|NBK1356|NBK1354|NBK97333|NBK50780|NBK84258|NBK274565|NBK401562|NBK24676|NBK52787|NBK385289|NBK61984|NBK9674|NBK1284|NBK195853|NBK1233|NBK1538|NBK1257|NBK1413|NBK1520|NBK214367|NBK1499|NBK1473|NBK174452|NBK9587|NBK7041|NBK1239|NBK279760|NBK1303|NBK1502|NBK1828|NBK1875|NBK24701|NBK1214|NBK1535|NBK1130|NBK1231|NBK1290|NBK1179|NBK373578|NBK45015|NBK1728|NBK1433|NBK1425|NBK396098|NBK1162|NBK148668|NBK92947|NBK1192|NBK1498|NBK1319|NBK1128|NBK1422|NBK185329|NBK1432|NBK1415|NBK1412|NBK2689|NBK425723|NBK1414|NBK5299|NBK1355|NBK1165|NBK1466|NBK1132|NBK1173|NBK121988|NBK321516|NBK1428|NBK1177|NBK1288|NBK368475|NBK1141|NBK1109|NBK1201|NBK1176|NBK1357|NBK185066|NBK1124|NBK1331|NBK1370|NBK1296|NBK51754|NBK1166|NBK1232|NBK1510|NBK1188|NBK1295|NBK1427|NBK1248|NBK1393|NBK1327|NBK1126|NBK154378|NBK447152|NBK190101|NBK1451|NBK1548|NBK1223|NBK1448|NBK9673|NBK1280|NBK1122|NBK6852|NBK1486|NBK1537|NBK1467|NBK242617|NBK47027|NBK1464|NBK1230|NBK395975|NBK1297|NBK1283|NBK2692|NBK316514|NBK65707|NBK1465|NBK1488|NBK153722|NBK26472|NBK100240|NBK1266|NBK1490|NBK1246|NBK1326|NBK1460|NBK1504|NBK1197|NBK1182|NBK1221|NBK247161|NBK99167|NBK1329|NBK174451|NBK143129|NBK121283|NBK447920|NBK196157|NBK1485|NBK327267|NBK1229|NBK299584|NBK1347|NBK92946|NBK99495|NBK1973|NBK84399|NBK1487|NBK1148|NBK426063|NBK1330|NBK1113|NBK1115|NBK52764|NBK1153|NBK1270|NBK1353|NBK1452|NBK1222|NBK1497|NBK299312|NBK83985|NBK268648|NBK1240|NBK114805|NBK1417|NBK195854|NBK1324|NBK1526|NBK1237|NBK1129|NBK83297|NBK435692|NBK3795|NBK1184|NBK1175|NBK1757|NBK1202|NBK1225|NBK1399|NBK1362|NBK1438|NBK1275|NBK1471|NBK54582|NBK1196|NBK231880|NBK1140|NBK1256|NBK1268|NBK63582|NBK1105|NBK379665|NBK1189|NBK1756|NBK1145|NBK1164|NBK1219|NBK1277|NBK201365|NBK1377|NBK1321|NBK1376|NBK431123|NBK442323|NBK1143|NBK2594|NBK1352|NBK1310|NBK144284|NBK1228|NBK1479|NBK1300|NBK1210|NBK1307|NBK1382|NBK45978|NBK1160|NBK1107|NBK1827|NBK8828|NBK304122|NBK1195|NBK1302|NBK131810|NBK396561|NBK6803|NBK425223|NBK1379|NBK1525|NBK23758|NBK5942|NBK1218|NBK274566|NBK1445|NBK1532|NBK1366|NBK5192|NBK1276|NBK1194|NBK1349|NBK26373|NBK1437|NBK1403|NBK114628|NBK425926|NBK1103|NBK447257|NBK1282|NBK395611|NBK1220|NBK350554|NBK1515|NBK1323|NBK453434|NBK154138|NBK1265|NBK1341|NBK1463|NBK6816|NBK1874|NBK1967|NBK1271|NBK7014|NBK447258|NBK1407|NBK3821|NBK1178|NBK148820|NBK1114|NBK1514|NBK4144|NBK1183|NBK1249|NBK1512|NBK1531|NBK378974|NBK1315|NBK55062|NBK1112|NBK1406|NBK1343|NBK1213|NBK1410|NBK1489|NBK3822|NBK1453|NBK1402|NBK1449|NBK1397|NBK349624|NBK1416|NBK1339|NBK20221	
evaluation of relatives at risk	677	NBK1396|NBK1435|NBK1419|NBK1372|NBK1418|NBK1516|NBK1152|NBK1493|NBK1264|NBK299311|NBK1483|NBK355754|NBK84111|NBK263441|NBK1169|NBK355518|NBK43797|NBK1475|NBK1431|NBK1381|NBK1193|NBK1273|NBK1172|NBK24599|NBK1454|NBK26471|NBK1519|NBK1207|NBK1108|NBK268647|NBK1450|NBK1267|NBK1236|NBK1365|NBK333437|NBK1429|NBK1144|NBK1360|NBK114459|NBK1317|NBK1456|NBK1154|NBK5300|NBK208534|NBK100238|NBK1159|NBK51784|NBK1255|NBK253404|NBK2591|NBK1131|NBK26468|NBK1241|NBK1426|NBK390611|NBK327153|NBK247162|NBK1363|NBK1151|NBK1503|NBK32534|NBK1421|NBK169615|NBK1522|NBK91457|NBK1322|NBK1398|NBK55063|NBK1380|NBK424403|NBK1441|NBK1247|NBK1517|NBK1212|NBK373577|NBK1167|NBK1394|NBK284774|NBK1258|NBK1500|NBK99168|NBK1171|NBK1760|NBK1234|NBK246980|NBK32533|NBK1286|NBK169825|NBK22925|NBK1385|NBK1328|NBK326661|NBK1386|NBK1513|NBK25565|NBK1293|NBK1391|NBK62112|NBK5313|NBK1110|NBK1332|NBK1359|NBK1104|NBK1544|NBK84551|NBK154653|NBK47457|NBK1156|NBK1727|NBK154652|NBK1250|NBK1186|NBK1348|NBK1259|NBK99496|NBK1387|NBK1106|NBK1117|NBK304142|NBK333201|NBK5188|NBK1137|NBK84550|NBK1337|NBK5189|NBK52917|NBK1181|NBK1127|NBK396257|NBK1346|NBK1291|NBK1168|NBK1539|NBK45014|NBK1205|NBK1285|NBK1511|NBK201366|NBK1242|NBK1187|NBK1468|NBK1340|NBK153601|NBK169431|NBK1374|NBK1876|NBK1342|NBK131811|NBK1482|NBK7046|NBK410087|NBK1507|NBK1527|NBK1253|NBK1461|NBK1455|NBK3794|NBK2690|NBK1245|NBK1458|NBK1400|NBK1409|NBK5200|NBK1289|NBK1533|NBK1474|NBK1119|NBK1674|NBK1309|NBK1185|NBK1216|NBK1434|NBK11167|NBK1191|NBK1158|NBK99494|NBK385626|NBK100664|NBK269029|NBK1209|NBK1536|NBK1272|NBK1251|NBK57098|NBK7040|NBK7047|NBK1350|NBK22301|NBK220444|NBK1447|NBK1534|NBK84112|NBK1878|NBK1508|NBK1491|NBK1373|NBK1190|NBK258640|NBK367946|NBK344340|NBK327268|NBK3823|NBK333438|NBK1492|NBK25442|NBK1501|NBK1157|NBK1304|NBK1125|NBK1369|NBK1200|NBK1123|NBK1306|NBK1436|NBK1244|NBK1279|NBK1494|NBK1462|NBK453432|NBK54467|NBK1263|NBK190102|NBK1142|NBK100826|NBK121284|NBK1163|NBK236968|NBK1235|NBK1401|NBK1292|NBK1368|NBK56080|NBK1345|NBK5201|NBK425540|NBK1206|NBK1180|NBK7050|NBK1147|NBK1676|NBK1388|NBK114458|NBK2534|NBK1227|NBK1543|NBK1673|NBK368474|NBK1384|NBK1281|NBK1459|NBK1443|NBK1199|NBK1371|NBK1505|NBK1506|NBK285321|NBK253403|NBK1518|NBK51671|NBK1136|NBK1364|NBK1269|NBK1446|NBK1318|NBK11168|NBK1135|NBK1430|NBK164500|NBK1547|NBK1523|NBK1198|NBK1481|NBK385627|NBK1312|NBK1261|NBK26372|NBK115333|NBK1344|NBK5941|NBK55061|NBK349073|NBK114807|NBK1529|NBK100239|NBK1404|NBK1495|NBK1440|NBK169003|NBK1423|NBK333439|NBK390610|NBK1139|NBK1121|NBK97260|NBK1351|NBK1375|NBK25507|NBK1444|NBK1252|NBK100241|NBK185330|NBK1395|NBK1211|NBK1392|NBK1524|NBK1150|NBK1111|NBK1530|NBK1338|NBK1287|NBK3789|NBK49247|NBK1769|NBK1390|NBK1509|NBK1274|NBK1305|NBK1367|NBK1768|NBK53700|NBK1496|NBK174884|NBK1260|NBK2587|NBK1477|NBK1472|NBK1243|NBK1262|NBK1476|NBK258641|NBK190103|NBK1675|NBK97965|NBK1118|NBK453433|NBK1470|NBK1170|NBK1405|NBK1325|NBK1478|NBK1469|NBK62111|NBK114806|NBK425128|NBK201978|NBK1333|NBK349072|NBK47079|NBK1334|NBK390670|NBK1238|NBK1203|NBK1484|NBK338165|NBK1389|NBK305870|NBK43417|NBK1298|NBK1457|NBK47312|NBK1521|NBK1383|NBK184570|NBK1408|NBK1313|NBK1174|NBK1420|NBK1311|NBK338540|NBK368476|NBK1149|NBK1133|NBK1480|NBK1361|NBK1308|NBK1208|NBK343782|NBK1215|NBK5199|NBK1974|NBK107219|NBK1335|NBK390803|NBK1424|NBK274564|NBK153723|NBK1356|NBK1354|NBK97333|NBK50780|NBK84258|NBK274565|NBK401562|NBK24676|NBK52787|NBK385289|NBK61984|NBK9674|NBK1284|NBK195853|NBK1233|NBK1538|NBK1257|NBK1413|NBK1520|NBK214367|NBK1499|NBK1473|NBK1146|NBK174452|NBK9587|NBK7041|NBK1239|NBK279760|NBK1303|NBK1502|NBK1828|NBK1875|NBK24701|NBK1214|NBK1535|NBK1130|NBK1231|NBK1290|NBK1179|NBK373578|NBK45015|NBK1728|NBK1433|NBK1425|NBK396098|NBK1162|NBK148668|NBK92947|NBK1192|NBK1498|NBK1319|NBK1128|NBK1422|NBK185329|NBK1432|NBK1415|NBK1412|NBK2689|NBK425723|NBK1414|NBK5299|NBK1355|NBK1165|NBK1466|NBK1132|NBK1173|NBK321516|NBK1428|NBK1177|NBK1288|NBK368475|NBK1141|NBK1109|NBK1201|NBK1176|NBK1357|NBK185066|NBK1124|NBK1331|NBK1370|NBK1296|NBK51754|NBK1166|NBK1232|NBK1510|NBK1188|NBK1295|NBK1427|NBK1248|NBK1393|NBK1327|NBK1126|NBK154378|NBK447152|NBK190101|NBK1451|NBK1548|NBK1223|NBK1448|NBK9673|NBK1280|NBK1122|NBK6852|NBK1486|NBK1537|NBK1467|NBK242617|NBK47027|NBK1464|NBK1230|NBK395975|NBK1297|NBK1283|NBK2692|NBK316514|NBK65707|NBK1465|NBK1488|NBK153722|NBK26472|NBK100240|NBK1266|NBK1490|NBK1246|NBK1326|NBK1460|NBK1504|NBK1197|NBK1182|NBK1221|NBK247161|NBK99167|NBK174451|NBK143129|NBK121283|NBK447920|NBK196157|NBK1485|NBK327267|NBK1229|NBK299584|NBK1347|NBK92946|NBK99495|NBK1973|NBK84399|NBK1487|NBK1148|NBK426063|NBK1330|NBK1113|NBK1115|NBK52764|NBK1153|NBK1270|NBK1353|NBK1452|NBK1222|NBK1497|NBK299312|NBK83985|NBK268648|NBK1240|NBK114805|NBK195854|NBK1324|NBK1526|NBK1237|NBK1129|NBK83297|NBK435692|NBK3795|NBK1184|NBK1175|NBK1757|NBK1202|NBK1225|NBK1399|NBK1362|NBK1438|NBK1275|NBK54582|NBK1196|NBK231880|NBK1140|NBK1256|NBK1268|NBK63582|NBK1105|NBK379665|NBK1189|NBK1756|NBK1145|NBK1164|NBK1219|NBK1277|NBK201365|NBK1377|NBK1321|NBK1376|NBK431123|NBK442323|NBK1143|NBK2594|NBK1352|NBK1310|NBK144284|NBK1228|NBK1479|NBK1300|NBK1210|NBK1307|NBK1382|NBK45978|NBK1160|NBK1107|NBK1827|NBK8828|NBK304122|NBK1195|NBK1302|NBK131810|NBK396561|NBK6803|NBK425223|NBK1379|NBK1525|NBK23758|NBK5942|NBK1218|NBK274566|NBK1445|NBK1532|NBK1366|NBK5192|NBK1276|NBK1194|NBK1349|NBK26373|NBK1437|NBK1403|NBK114628|NBK425926|NBK1103|NBK447257|NBK1282|NBK395611|NBK1220|NBK350554|NBK1515|NBK1323|NBK453434|NBK154138|NBK1265|NBK1341|NBK1463|NBK6816|NBK1874|NBK1967|NBK1271|NBK7014|NBK447258|NBK1407|NBK3821|NBK1178|NBK148820|NBK1114|NBK1514|NBK4144|NBK1183|NBK1249|NBK1512|NBK1531|NBK378974|NBK1315|NBK55062|NBK1112|NBK1406|NBK1343|NBK1213|NBK1410|NBK1489|NBK3822|NBK1453|NBK1402|NBK1449|NBK1397|NBK349624|NBK1416|NBK1339|NBK20221	
search clinicaltrials	664	NBK1396|NBK1435|NBK1419|NBK1372|NBK1418|NBK1516|NBK1152|NBK1493|NBK1264|NBK299311|NBK1483|NBK355754|NBK84111|NBK263441|NBK1169|NBK355518|NBK43797|NBK1475|NBK1431|NBK1381|NBK1193|NBK1273|NBK1172|NBK24599|NBK1454|NBK26471|NBK1519|NBK1207|NBK1108|NBK268647|NBK1450|NBK1267|NBK1161|NBK1365|NBK1429|NBK1144|NBK1360|NBK114459|NBK1317|NBK1456|NBK1154|NBK5300|NBK1159|NBK51784|NBK1255|NBK253404|NBK2591|NBK1131|NBK26468|NBK1241|NBK1426|NBK390611|NBK327153|NBK247162|NBK1363|NBK1151|NBK1503|NBK1421|NBK169615|NBK1204|NBK1522|NBK91457|NBK1322|NBK1398|NBK55063|NBK1380|NBK424403|NBK1441|NBK1247|NBK1517|NBK1212|NBK373577|NBK1167|NBK1394|NBK284774|NBK1258|NBK1500|NBK99168|NBK1171|NBK1760|NBK1234|NBK246980|NBK32533|NBK1286|NBK169825|NBK22925|NBK1385|NBK1328|NBK326661|NBK1386|NBK1513|NBK25565|NBK1293|NBK1391|NBK5313|NBK1110|NBK1332|NBK1359|NBK1104|NBK1544|NBK84551|NBK154653|NBK1156|NBK1727|NBK154652|NBK1250|NBK1186|NBK1348|NBK1259|NBK99496|NBK1387|NBK1106|NBK1117|NBK304142|NBK333201|NBK5188|NBK1137|NBK84550|NBK1337|NBK5189|NBK52917|NBK1181|NBK1127|NBK396257|NBK1346|NBK1291|NBK1168|NBK1539|NBK45014|NBK1358|NBK1205|NBK1285|NBK1511|NBK201366|NBK1242|NBK1187|NBK1468|NBK1340|NBK153601|NBK169431|NBK1374|NBK1876|NBK1342|NBK131811|NBK1482|NBK7046|NBK410087|NBK1507|NBK1527|NBK1253|NBK1461|NBK1455|NBK3794|NBK2690|NBK1245|NBK1458|NBK1400|NBK1409|NBK5200|NBK1289|NBK1533|NBK1474|NBK1119|NBK1674|NBK1309|NBK1185|NBK1216|NBK11167|NBK1191|NBK1158|NBK385626|NBK100664|NBK269029|NBK1209|NBK1536|NBK1272|NBK1251|NBK57098|NBK7040|NBK7047|NBK1350|NBK22301|NBK220444|NBK1447|NBK1534|NBK1878|NBK1508|NBK1491|NBK1373|NBK1190|NBK258640|NBK367946|NBK344340|NBK327268|NBK3823|NBK333438|NBK1492|NBK25442|NBK1501|NBK1157|NBK1304|NBK1125|NBK1369|NBK1200|NBK1123|NBK1306|NBK1436|NBK1244|NBK1279|NBK1494|NBK1462|NBK453432|NBK54467|NBK1263|NBK190102|NBK1142|NBK100826|NBK121284|NBK1163|NBK236968|NBK1235|NBK1401|NBK1292|NBK1368|NBK56080|NBK1345|NBK5201|NBK425540|NBK1206|NBK1180|NBK7050|NBK1147|NBK1676|NBK1388|NBK2534|NBK1227|NBK1543|NBK1673|NBK368474|NBK1384|NBK1281|NBK1459|NBK1443|NBK1199|NBK1371|NBK1505|NBK1506|NBK285321|NBK253403|NBK1518|NBK51671|NBK1136|NBK1364|NBK1269|NBK1446|NBK1318|NBK11168|NBK1135|NBK1430|NBK164500|NBK1547|NBK1523|NBK1198|NBK1481|NBK385627|NBK1312|NBK1261|NBK26372|NBK115333|NBK1344|NBK5941|NBK55061|NBK349073|NBK114807|NBK1529|NBK100239|NBK1404|NBK1495|NBK1440|NBK169003|NBK2701|NBK1423|NBK333439|NBK390610|NBK1139|NBK97260|NBK1351|NBK1375|NBK25507|NBK1444|NBK1252|NBK100241|NBK185330|NBK1395|NBK1211|NBK1392|NBK1524|NBK1150|NBK1111|NBK1530|NBK1338|NBK1287|NBK3789|NBK49247|NBK1769|NBK1390|NBK1509|NBK1274|NBK1305|NBK1367|NBK1768|NBK53700|NBK1496|NBK174884|NBK1260|NBK2587|NBK1477|NBK1472|NBK1243|NBK1262|NBK1476|NBK190103|NBK1675|NBK97965|NBK1118|NBK453433|NBK1470|NBK1170|NBK1405|NBK1325|NBK1478|NBK1469|NBK62111|NBK114806|NBK425128|NBK201978|NBK1333|NBK349072|NBK47079|NBK1334|NBK390670|NBK1238|NBK1203|NBK1484|NBK338165|NBK1389|NBK305870|NBK1298|NBK1457|NBK47312|NBK1521|NBK1383|NBK184570|NBK1313|NBK1174|NBK1420|NBK1311|NBK338540|NBK368476|NBK1149|NBK1133|NBK1480|NBK1361|NBK1308|NBK1208|NBK343782|NBK1215|NBK5199|NBK1974|NBK107219|NBK1335|NBK390803|NBK1424|NBK274564|NBK153723|NBK1356|NBK1354|NBK97333|NBK50780|NBK84258|NBK274565|NBK401562|NBK24676|NBK52787|NBK385289|NBK61984|NBK9674|NBK1284|NBK195853|NBK1233|NBK1538|NBK1257|NBK1413|NBK1520|NBK1499|NBK1473|NBK1146|NBK174452|NBK9587|NBK7041|NBK1239|NBK279760|NBK1303|NBK1502|NBK1828|NBK1875|NBK24701|NBK1214|NBK1535|NBK1130|NBK1231|NBK1290|NBK1179|NBK373578|NBK45015|NBK1728|NBK1433|NBK1425|NBK396098|NBK1162|NBK148668|NBK92947|NBK1192|NBK1498|NBK1319|NBK1128|NBK1422|NBK185329|NBK1432|NBK1415|NBK1412|NBK2689|NBK425723|NBK1414|NBK5299|NBK1355|NBK1165|NBK1466|NBK1132|NBK1173|NBK121988|NBK321516|NBK1428|NBK1177|NBK1288|NBK368475|NBK1141|NBK1201|NBK1176|NBK1357|NBK185066|NBK1124|NBK1331|NBK1370|NBK1296|NBK51754|NBK1166|NBK1232|NBK1510|NBK1188|NBK1295|NBK1427|NBK1248|NBK1393|NBK1327|NBK1126|NBK154378|NBK447152|NBK1451|NBK1548|NBK1223|NBK1448|NBK9673|NBK1280|NBK1122|NBK6852|NBK1486|NBK1537|NBK1467|NBK242617|NBK47027|NBK1464|NBK1230|NBK395975|NBK1297|NBK1283|NBK2692|NBK316514|NBK65707|NBK1465|NBK1488|NBK153722|NBK26472|NBK100240|NBK1266|NBK1246|NBK1326|NBK1460|NBK1504|NBK1197|NBK1182|NBK1221|NBK247161|NBK99167|NBK1329|NBK174451|NBK143129|NBK121283|NBK447920|NBK196157|NBK1485|NBK327267|NBK1229|NBK299584|NBK1347|NBK92946|NBK99495|NBK1973|NBK84399|NBK1487|NBK1148|NBK426063|NBK1330|NBK1113|NBK1115|NBK52764|NBK1153|NBK1270|NBK1353|NBK1452|NBK1222|NBK1497|NBK299312|NBK83985|NBK268648|NBK1240|NBK114805|NBK1417|NBK195854|NBK1324|NBK1526|NBK1237|NBK1129|NBK83297|NBK435692|NBK3795|NBK1184|NBK1175|NBK1757|NBK1202|NBK1225|NBK1399|NBK1362|NBK1438|NBK1275|NBK1471|NBK54582|NBK1196|NBK231880|NBK1140|NBK1256|NBK1268|NBK63582|NBK1105|NBK379665|NBK1189|NBK1756|NBK1145|NBK1164|NBK1219|NBK1277|NBK201365|NBK1377|NBK1321|NBK1376|NBK431123|NBK442323|NBK1143|NBK2594|NBK1352|NBK1310|NBK1228|NBK1479|NBK1300|NBK1210|NBK1307|NBK1382|NBK45978|NBK1160|NBK1107|NBK1827|NBK8828|NBK304122|NBK1195|NBK1302|NBK131810|NBK396561|NBK6803|NBK425223|NBK1379|NBK1525|NBK23758|NBK5942|NBK1218|NBK274566|NBK1445|NBK1532|NBK1366|NBK5192|NBK1276|NBK1194|NBK1349|NBK26373|NBK1437|NBK1403|NBK114628|NBK425926|NBK1103|NBK447257|NBK1282|NBK395611|NBK1220|NBK1515|NBK1323|NBK453434|NBK154138|NBK1265|NBK1341|NBK1463|NBK6816|NBK1874|NBK1967|NBK1271|NBK7014|NBK447258|NBK1407|NBK3821|NBK1178|NBK148820|NBK1114|NBK1514|NBK4144|NBK1183|NBK1249|NBK1512|NBK1531|NBK378974|NBK1315|NBK55062|NBK1112|NBK1406|NBK1343|NBK1213|NBK1410|NBK1489|NBK3822|NBK1453|NBK1402|NBK1449|NBK1397|NBK349624|NBK1416|NBK1339|NBK20221	
evaluations following initial diagnosis	660	NBK1396|NBK1435|NBK1419|NBK1372|NBK1418|NBK1516|NBK1152|NBK1493|NBK1264|NBK299311|NBK1483|NBK355754|NBK84111|NBK263441|NBK1169|NBK355518|NBK43797|NBK1475|NBK1431|NBK1381|NBK1193|NBK1273|NBK1172|NBK24599|NBK1454|NBK26471|NBK1519|NBK1207|NBK1108|NBK268647|NBK1450|NBK1267|NBK1236|NBK333437|NBK1429|NBK1144|NBK114459|NBK1317|NBK1456|NBK1154|NBK5300|NBK208534|NBK100238|NBK1159|NBK51784|NBK1255|NBK253404|NBK2591|NBK1131|NBK26468|NBK1241|NBK1426|NBK390611|NBK327153|NBK247162|NBK1363|NBK1151|NBK1503|NBK32534|NBK1421|NBK169615|NBK1204|NBK1522|NBK91457|NBK1322|NBK1398|NBK55063|NBK1380|NBK424403|NBK1441|NBK1247|NBK1517|NBK1212|NBK373577|NBK1167|NBK1394|NBK284774|NBK1258|NBK1500|NBK99168|NBK1171|NBK1760|NBK1234|NBK246980|NBK32533|NBK1286|NBK169825|NBK22925|NBK1385|NBK1328|NBK326661|NBK1386|NBK1513|NBK25565|NBK1293|NBK1391|NBK62112|NBK5313|NBK1110|NBK1104|NBK1544|NBK84551|NBK154653|NBK1156|NBK1727|NBK154652|NBK1250|NBK1186|NBK1348|NBK1259|NBK99496|NBK1387|NBK1106|NBK1117|NBK304142|NBK333201|NBK5188|NBK1137|NBK84550|NBK1337|NBK5189|NBK52917|NBK1181|NBK1127|NBK396257|NBK1346|NBK1291|NBK1168|NBK1539|NBK45014|NBK1205|NBK1285|NBK1511|NBK201366|NBK1242|NBK1187|NBK1468|NBK1340|NBK153601|NBK169431|NBK1374|NBK1876|NBK1342|NBK131811|NBK1482|NBK7046|NBK410087|NBK1507|NBK1527|NBK1253|NBK1461|NBK1455|NBK3794|NBK2690|NBK1245|NBK1458|NBK1400|NBK1409|NBK5200|NBK1289|NBK1533|NBK1474|NBK1119|NBK1674|NBK1185|NBK1216|NBK11167|NBK1191|NBK1158|NBK99494|NBK385626|NBK100664|NBK269029|NBK1209|NBK1536|NBK1272|NBK1251|NBK57098|NBK7040|NBK7047|NBK1350|NBK22301|NBK220444|NBK1447|NBK1534|NBK84112|NBK1878|NBK1508|NBK1491|NBK1373|NBK1190|NBK258640|NBK367946|NBK344340|NBK327268|NBK3823|NBK333438|NBK1492|NBK25442|NBK1501|NBK1157|NBK1304|NBK1125|NBK1369|NBK1200|NBK1123|NBK1306|NBK1436|NBK1244|NBK1279|NBK1494|NBK1462|NBK453432|NBK54467|NBK1263|NBK190102|NBK1142|NBK100826|NBK121284|NBK1163|NBK236968|NBK1235|NBK1401|NBK1292|NBK1368|NBK56080|NBK1345|NBK5201|NBK425540|NBK1206|NBK1180|NBK7050|NBK1147|NBK1676|NBK1388|NBK114458|NBK2534|NBK1227|NBK1543|NBK1673|NBK368474|NBK1384|NBK1281|NBK1459|NBK1443|NBK1199|NBK1371|NBK1505|NBK1506|NBK285321|NBK253403|NBK51671|NBK1136|NBK1364|NBK1269|NBK1446|NBK1318|NBK11168|NBK1135|NBK1430|NBK164500|NBK1523|NBK1198|NBK1481|NBK385627|NBK1312|NBK1261|NBK26372|NBK115333|NBK1344|NBK5941|NBK55061|NBK349073|NBK114807|NBK1529|NBK100239|NBK1404|NBK1495|NBK1440|NBK169003|NBK2701|NBK1423|NBK333439|NBK390610|NBK1139|NBK1121|NBK97260|NBK1351|NBK25507|NBK1444|NBK1252|NBK100241|NBK185330|NBK1395|NBK1211|NBK1392|NBK1524|NBK1150|NBK1111|NBK1530|NBK1338|NBK1287|NBK3789|NBK49247|NBK1769|NBK1390|NBK1274|NBK1305|NBK1367|NBK1768|NBK53700|NBK1496|NBK174884|NBK1260|NBK2587|NBK1477|NBK1472|NBK1243|NBK1262|NBK1476|NBK258641|NBK190103|NBK1675|NBK97965|NBK1118|NBK453433|NBK1470|NBK1170|NBK1405|NBK1325|NBK1478|NBK1469|NBK62111|NBK114806|NBK425128|NBK201978|NBK1333|NBK47079|NBK1334|NBK390670|NBK1238|NBK1203|NBK1484|NBK338165|NBK1389|NBK305870|NBK43417|NBK1298|NBK1457|NBK47312|NBK1521|NBK1383|NBK1313|NBK1174|NBK1420|NBK1311|NBK338540|NBK368476|NBK1149|NBK1133|NBK1480|NBK1361|NBK1308|NBK1208|NBK343782|NBK1215|NBK5199|NBK1974|NBK107219|NBK1335|NBK390803|NBK1424|NBK274564|NBK153723|NBK1356|NBK1354|NBK97333|NBK50780|NBK84258|NBK274565|NBK401562|NBK24676|NBK52787|NBK385289|NBK61984|NBK9674|NBK1284|NBK195853|NBK1233|NBK1538|NBK1257|NBK1413|NBK1520|NBK214367|NBK1499|NBK1473|NBK1146|NBK174452|NBK9587|NBK7041|NBK1239|NBK279760|NBK1303|NBK1502|NBK1828|NBK1875|NBK24701|NBK1214|NBK1535|NBK1130|NBK1231|NBK1290|NBK373578|NBK45015|NBK1728|NBK1433|NBK1425|NBK396098|NBK1162|NBK148668|NBK92947|NBK1192|NBK1319|NBK1128|NBK1422|NBK185329|NBK1432|NBK1415|NBK1412|NBK2689|NBK425723|NBK1414|NBK5299|NBK1355|NBK1165|NBK1466|NBK1132|NBK121988|NBK321516|NBK1428|NBK1177|NBK1288|NBK368475|NBK1141|NBK1109|NBK1201|NBK1176|NBK1357|NBK185066|NBK1124|NBK1331|NBK1370|NBK1296|NBK51754|NBK1166|NBK1510|NBK1188|NBK1295|NBK1427|NBK1248|NBK1393|NBK1327|NBK1126|NBK154378|NBK447152|NBK190101|NBK1451|NBK1548|NBK1448|NBK9673|NBK1280|NBK1122|NBK6852|NBK1486|NBK1537|NBK1467|NBK242617|NBK47027|NBK1464|NBK1230|NBK395975|NBK1283|NBK2692|NBK316514|NBK65707|NBK1465|NBK1488|NBK153722|NBK26472|NBK100240|NBK1266|NBK1490|NBK1246|NBK1326|NBK1460|NBK1504|NBK1197|NBK1182|NBK1221|NBK247161|NBK99167|NBK1329|NBK174451|NBK143129|NBK121283|NBK196157|NBK1485|NBK327267|NBK1229|NBK299584|NBK1347|NBK92946|NBK99495|NBK1973|NBK84399|NBK1487|NBK1148|NBK426063|NBK1330|NBK1113|NBK1115|NBK52764|NBK1153|NBK1270|NBK1353|NBK1452|NBK1222|NBK1497|NBK299312|NBK83985|NBK268648|NBK1240|NBK114805|NBK195854|NBK1324|NBK1526|NBK1237|NBK1129|NBK83297|NBK435692|NBK3795|NBK1184|NBK1175|NBK1757|NBK1202|NBK1225|NBK1399|NBK1362|NBK1438|NBK1275|NBK1471|NBK54582|NBK1196|NBK231880|NBK1140|NBK1256|NBK1268|NBK63582|NBK1105|NBK379665|NBK1189|NBK1756|NBK1145|NBK1164|NBK1219|NBK1277|NBK201365|NBK1377|NBK1321|NBK1376|NBK431123|NBK442323|NBK1143|NBK2594|NBK1352|NBK1310|NBK144284|NBK1228|NBK1479|NBK1300|NBK1210|NBK1307|NBK1382|NBK45978|NBK1160|NBK1107|NBK1827|NBK8828|NBK304122|NBK1195|NBK1302|NBK131810|NBK396561|NBK6803|NBK425223|NBK1379|NBK1525|NBK23758|NBK5942|NBK1218|NBK274566|NBK1445|NBK1532|NBK1366|NBK5192|NBK1276|NBK1194|NBK1349|NBK26373|NBK1437|NBK1403|NBK114628|NBK425926|NBK1103|NBK1282|NBK395611|NBK1220|NBK350554|NBK1515|NBK1323|NBK453434|NBK154138|NBK1265|NBK1341|NBK1463|NBK6816|NBK1874|NBK1967|NBK1271|NBK7014|NBK447258|NBK1407|NBK3821|NBK1178|NBK148820|NBK1114|NBK1514|NBK4144|NBK1183|NBK1249|NBK1512|NBK1531|NBK378974|NBK1315|NBK55062|NBK1112|NBK1406|NBK1343|NBK1213|NBK1410|NBK1489|NBK3822|NBK1453|NBK1402|NBK1449|NBK1397|NBK349624|NBK1416|NBK1339|NBK20221	
surveillance	642	NBK1396|NBK1435|NBK1419|NBK1372|NBK1418|NBK1152|NBK1493|NBK1264|NBK299311|NBK1483|NBK355754|NBK84111|NBK263441|NBK1169|NBK43797|NBK1475|NBK1431|NBK1381|NBK1193|NBK1273|NBK1172|NBK24599|NBK1454|NBK26471|NBK1519|NBK1207|NBK1108|NBK268647|NBK1450|NBK1267|NBK1236|NBK333437|NBK1429|NBK1144|NBK1360|NBK114459|NBK1456|NBK1154|NBK5300|NBK208534|NBK100238|NBK1159|NBK51784|NBK1255|NBK253404|NBK2591|NBK1131|NBK26468|NBK1241|NBK1426|NBK390611|NBK327153|NBK247162|NBK1363|NBK1151|NBK1503|NBK32534|NBK1421|NBK169615|NBK1204|NBK1522|NBK91457|NBK1322|NBK1398|NBK55063|NBK1380|NBK424403|NBK1441|NBK1247|NBK1517|NBK1212|NBK373577|NBK1167|NBK1394|NBK284774|NBK1258|NBK1500|NBK99168|NBK1171|NBK1760|NBK1234|NBK246980|NBK32533|NBK1286|NBK22925|NBK1385|NBK1328|NBK326661|NBK1386|NBK1513|NBK25565|NBK1293|NBK1391|NBK62112|NBK5313|NBK1110|NBK1332|NBK1359|NBK1104|NBK84551|NBK154653|NBK47457|NBK1156|NBK1727|NBK154652|NBK1186|NBK1348|NBK1259|NBK99496|NBK1387|NBK1106|NBK1117|NBK304142|NBK5188|NBK1137|NBK84550|NBK1337|NBK5189|NBK52917|NBK1181|NBK1127|NBK396257|NBK1346|NBK1291|NBK1168|NBK1539|NBK45014|NBK1205|NBK1285|NBK1511|NBK201366|NBK1242|NBK1187|NBK1468|NBK1340|NBK153601|NBK169431|NBK1374|NBK1876|NBK1342|NBK131811|NBK1482|NBK7046|NBK410087|NBK1507|NBK1527|NBK1253|NBK1461|NBK1455|NBK3794|NBK2690|NBK1245|NBK1458|NBK1400|NBK1409|NBK5200|NBK1289|NBK1533|NBK1474|NBK1119|NBK1674|NBK1309|NBK1185|NBK1216|NBK1434|NBK11167|NBK1191|NBK1158|NBK99494|NBK385626|NBK100664|NBK269029|NBK1209|NBK1536|NBK1272|NBK1251|NBK57098|NBK7040|NBK7047|NBK1350|NBK22301|NBK220444|NBK1447|NBK1534|NBK84112|NBK1878|NBK1508|NBK1491|NBK1373|NBK1190|NBK258640|NBK367946|NBK344340|NBK327268|NBK3823|NBK333438|NBK1492|NBK25442|NBK1501|NBK1157|NBK1304|NBK1125|NBK1369|NBK1123|NBK1306|NBK1436|NBK1244|NBK1279|NBK1494|NBK1462|NBK453432|NBK54467|NBK1263|NBK190102|NBK1142|NBK100826|NBK121284|NBK1163|NBK236968|NBK1235|NBK1401|NBK1292|NBK1368|NBK56080|NBK1345|NBK5201|NBK425540|NBK1206|NBK1180|NBK7050|NBK1147|NBK1676|NBK114458|NBK2534|NBK1227|NBK1543|NBK1673|NBK368474|NBK1281|NBK1459|NBK1443|NBK1199|NBK1506|NBK285321|NBK253403|NBK1518|NBK51671|NBK1136|NBK1364|NBK1269|NBK1318|NBK11168|NBK1135|NBK1430|NBK164500|NBK1547|NBK1523|NBK1198|NBK1481|NBK385627|NBK1312|NBK1261|NBK26372|NBK115333|NBK1344|NBK5941|NBK55061|NBK114807|NBK1529|NBK100239|NBK1404|NBK1495|NBK1440|NBK169003|NBK2701|NBK1423|NBK333439|NBK390610|NBK1139|NBK1121|NBK97260|NBK1351|NBK1375|NBK25507|NBK1444|NBK1252|NBK100241|NBK185330|NBK1395|NBK1211|NBK1524|NBK1150|NBK1111|NBK1530|NBK1338|NBK1287|NBK3789|NBK49247|NBK1769|NBK1390|NBK1509|NBK1274|NBK1305|NBK1367|NBK1768|NBK53700|NBK1496|NBK174884|NBK2587|NBK1477|NBK1472|NBK1243|NBK1262|NBK1476|NBK258641|NBK190103|NBK1675|NBK97965|NBK1118|NBK453433|NBK1470|NBK1170|NBK1405|NBK1325|NBK1478|NBK1469|NBK62111|NBK114806|NBK425128|NBK201978|NBK1333|NBK349072|NBK47079|NBK1334|NBK390670|NBK1203|NBK1484|NBK1389|NBK305870|NBK43417|NBK1298|NBK47312|NBK320989|NBK1521|NBK1383|NBK184570|NBK1408|NBK1313|NBK1174|NBK1420|NBK1311|NBK338540|NBK368476|NBK1149|NBK1133|NBK1480|NBK1361|NBK1308|NBK1208|NBK343782|NBK1215|NBK5199|NBK1974|NBK107219|NBK1335|NBK390803|NBK1424|NBK274564|NBK153723|NBK1356|NBK1354|NBK97333|NBK50780|NBK84258|NBK274565|NBK401562|NBK24676|NBK52787|NBK385289|NBK61984|NBK9674|NBK1284|NBK195853|NBK1233|NBK1538|NBK1257|NBK1413|NBK1520|NBK214367|NBK1499|NBK1473|NBK174452|NBK9587|NBK7041|NBK1239|NBK1303|NBK1502|NBK1828|NBK1875|NBK24701|NBK1214|NBK1130|NBK1231|NBK1290|NBK1179|NBK373578|NBK45015|NBK1433|NBK1425|NBK396098|NBK1162|NBK148668|NBK92947|NBK1192|NBK1319|NBK1422|NBK185329|NBK1432|NBK1415|NBK1412|NBK2689|NBK425723|NBK1165|NBK1466|NBK1132|NBK1173|NBK121988|NBK321516|NBK1428|NBK1177|NBK1288|NBK368475|NBK1109|NBK1201|NBK1176|NBK1357|NBK185066|NBK1124|NBK1331|NBK1370|NBK1296|NBK51754|NBK1166|NBK1232|NBK1510|NBK1188|NBK1295|NBK1427|NBK1248|NBK1393|NBK1327|NBK1126|NBK154378|NBK447152|NBK190101|NBK1451|NBK1548|NBK1448|NBK9673|NBK1280|NBK1122|NBK6852|NBK1486|NBK1467|NBK242617|NBK47027|NBK1464|NBK1230|NBK395975|NBK1297|NBK1283|NBK2692|NBK316514|NBK65707|NBK1465|NBK1488|NBK153722|NBK26472|NBK100240|NBK1266|NBK1490|NBK1246|NBK1326|NBK1460|NBK1504|NBK1197|NBK1182|NBK1221|NBK247161|NBK99167|NBK174451|NBK143129|NBK121283|NBK447920|NBK196157|NBK1485|NBK327267|NBK1229|NBK299584|NBK1347|NBK92946|NBK99495|NBK1973|NBK84399|NBK1487|NBK1148|NBK426063|NBK1330|NBK1113|NBK1115|NBK52764|NBK1153|NBK1270|NBK1353|NBK1452|NBK1222|NBK1497|NBK299312|NBK83985|NBK268648|NBK1240|NBK1417|NBK195854|NBK1324|NBK1526|NBK1237|NBK1129|NBK83297|NBK435692|NBK3795|NBK1184|NBK1175|NBK1757|NBK1202|NBK1225|NBK1399|NBK1362|NBK1438|NBK1275|NBK1471|NBK54582|NBK1196|NBK231880|NBK1140|NBK1256|NBK1268|NBK63582|NBK1105|NBK379665|NBK1189|NBK1756|NBK1145|NBK1164|NBK1219|NBK1277|NBK201365|NBK1377|NBK1321|NBK1376|NBK431123|NBK442323|NBK1143|NBK2594|NBK1352|NBK1310|NBK144284|NBK1228|NBK1479|NBK1300|NBK1210|NBK1307|NBK1382|NBK45978|NBK1160|NBK1107|NBK1827|NBK8828|NBK304122|NBK1195|NBK1302|NBK131810|NBK396561|NBK6803|NBK425223|NBK1379|NBK1525|NBK23758|NBK5942|NBK274566|NBK1445|NBK1366|NBK1194|NBK1349|NBK26373|NBK1437|NBK1403|NBK114628|NBK425926|NBK447257|NBK1282|NBK395611|NBK1220|NBK1515|NBK1323|NBK453434|NBK154138|NBK1265|NBK1341|NBK1463|NBK1874|NBK1967|NBK1271|NBK7014|NBK447258|NBK1407|NBK3821|NBK1178|NBK148820|NBK1114|NBK1514|NBK4144|NBK1183|NBK1249|NBK1512|NBK1531|NBK378974|NBK1315|NBK55062|NBK1112|NBK1406|NBK1343|NBK1213|NBK1410|NBK1489|NBK3822|NBK1453|NBK1402|NBK1449|NBK1397|NBK349624|NBK1416|NBK20221	
agents/circumstances to avoid	448	NBK1435|NBK1418|NBK1152|NBK1493|NBK1264|NBK299311|NBK1483|NBK84111|NBK263441|NBK43797|NBK1431|NBK1193|NBK1273|NBK24599|NBK1454|NBK26471|NBK1519|NBK1108|NBK1450|NBK1267|NBK1236|NBK333437|NBK1144|NBK1360|NBK114459|NBK208534|NBK100238|NBK1159|NBK51784|NBK253404|NBK1131|NBK1241|NBK1426|NBK390611|NBK247162|NBK1363|NBK1151|NBK32534|NBK1421|NBK169615|NBK1204|NBK1522|NBK1322|NBK1398|NBK1380|NBK1247|NBK1517|NBK1212|NBK1167|NBK284774|NBK1258|NBK1500|NBK1171|NBK32533|NBK22925|NBK1328|NBK1513|NBK25565|NBK1293|NBK1391|NBK62112|NBK5313|NBK1110|NBK1332|NBK1104|NBK84551|NBK47457|NBK1156|NBK1727|NBK154652|NBK1186|NBK1259|NBK99496|NBK1387|NBK304142|NBK333201|NBK5188|NBK84550|NBK1337|NBK52917|NBK1181|NBK1127|NBK396257|NBK1346|NBK1168|NBK1539|NBK45014|NBK1358|NBK1205|NBK1285|NBK1511|NBK201366|NBK1242|NBK1187|NBK1468|NBK1340|NBK153601|NBK169431|NBK1374|NBK1876|NBK1342|NBK1482|NBK7046|NBK1527|NBK1253|NBK1245|NBK1458|NBK1400|NBK1409|NBK1289|NBK1474|NBK1119|NBK1674|NBK1216|NBK1434|NBK11167|NBK99494|NBK100664|NBK269029|NBK1209|NBK1536|NBK1272|NBK1251|NBK7047|NBK1350|NBK22301|NBK220444|NBK1447|NBK1534|NBK84112|NBK1508|NBK1491|NBK1373|NBK258640|NBK367946|NBK1492|NBK25442|NBK1501|NBK1157|NBK1304|NBK1125|NBK1369|NBK1123|NBK1306|NBK1436|NBK1244|NBK1279|NBK1494|NBK1462|NBK54467|NBK190102|NBK1142|NBK100826|NBK121284|NBK1163|NBK1401|NBK1292|NBK1368|NBK1345|NBK5201|NBK1180|NBK1388|NBK1227|NBK1543|NBK1673|NBK1384|NBK1281|NBK1371|NBK1505|NBK1506|NBK253403|NBK1518|NBK51671|NBK1364|NBK1269|NBK1318|NBK1135|NBK1430|NBK164500|NBK1523|NBK1198|NBK385627|NBK1312|NBK1261|NBK26372|NBK1344|NBK5941|NBK55061|NBK114807|NBK1529|NBK100239|NBK1404|NBK1495|NBK1440|NBK169003|NBK2701|NBK333439|NBK390610|NBK1121|NBK97260|NBK1351|NBK1375|NBK1444|NBK100241|NBK1395|NBK1211|NBK1392|NBK1524|NBK1150|NBK1111|NBK1338|NBK1287|NBK3789|NBK49247|NBK1769|NBK1390|NBK1509|NBK1305|NBK1367|NBK1768|NBK53700|NBK1496|NBK174884|NBK1262|NBK1476|NBK258641|NBK1118|NBK1170|NBK1405|NBK1325|NBK1478|NBK1333|NBK349072|NBK1203|NBK338165|NBK1389|NBK305870|NBK320989|NBK1521|NBK1383|NBK184570|NBK1408|NBK1313|NBK1174|NBK1420|NBK1311|NBK1149|NBK1133|NBK1480|NBK1361|NBK1308|NBK1208|NBK343782|NBK1215|NBK5199|NBK1974|NBK1335|NBK1424|NBK274564|NBK153723|NBK1356|NBK1354|NBK97333|NBK50780|NBK401562|NBK61984|NBK9674|NBK195853|NBK1233|NBK1257|NBK1520|NBK1473|NBK1146|NBK174452|NBK1239|NBK279760|NBK1303|NBK1502|NBK24701|NBK1214|NBK1535|NBK1130|NBK1231|NBK1290|NBK1179|NBK373578|NBK148668|NBK92947|NBK1128|NBK1422|NBK2689|NBK425723|NBK5299|NBK1355|NBK1165|NBK1466|NBK1132|NBK1173|NBK1428|NBK1177|NBK1288|NBK368475|NBK1141|NBK1109|NBK1201|NBK1176|NBK1357|NBK185066|NBK1124|NBK1331|NBK1370|NBK1296|NBK1166|NBK1232|NBK1510|NBK1295|NBK1427|NBK1248|NBK154378|NBK447152|NBK1451|NBK1548|NBK1448|NBK9673|NBK1280|NBK1122|NBK6852|NBK1486|NBK1467|NBK242617|NBK47027|NBK1464|NBK1230|NBK395975|NBK1297|NBK1283|NBK2692|NBK316514|NBK65707|NBK1465|NBK1488|NBK26472|NBK1266|NBK1490|NBK1246|NBK1504|NBK1182|NBK1221|NBK247161|NBK99167|NBK143129|NBK121283|NBK1485|NBK327267|NBK1229|NBK299584|NBK92946|NBK1973|NBK84399|NBK1487|NBK1148|NBK1113|NBK1115|NBK52764|NBK1353|NBK1452|NBK1222|NBK1497|NBK299312|NBK83985|NBK114805|NBK1417|NBK195854|NBK1237|NBK1129|NBK83297|NBK435692|NBK3795|NBK1184|NBK1175|NBK1225|NBK1399|NBK1362|NBK1438|NBK1275|NBK1471|NBK54582|NBK231880|NBK1140|NBK1268|NBK63582|NBK1105|NBK379665|NBK1756|NBK1145|NBK1277|NBK201365|NBK1377|NBK1376|NBK431123|NBK442323|NBK1143|NBK1310|NBK1382|NBK45978|NBK304122|NBK1195|NBK1302|NBK131810|NBK1379|NBK1525|NBK23758|NBK5942|NBK274566|NBK1445|NBK1194|NBK1349|NBK26373|NBK1437|NBK1403|NBK1103|NBK1220|NBK1515|NBK1323|NBK154138|NBK1265|NBK1341|NBK1463|NBK6816|NBK1967|NBK1271|NBK7014|NBK447258|NBK1178|NBK1114|NBK1514|NBK1183|NBK1249|NBK1512|NBK378974|NBK1112|NBK1406|NBK1343|NBK1410|NBK1453|NBK1397|NBK1416|NBK20221	
prevention of secondary complications	408	NBK1396|NBK1435|NBK1419|NBK1372|NBK1152|NBK1264|NBK299311|NBK1483|NBK263441|NBK1169|NBK43797|NBK1381|NBK1193|NBK1273|NBK1172|NBK26471|NBK1519|NBK1207|NBK1108|NBK1267|NBK333437|NBK1144|NBK1360|NBK1456|NBK1154|NBK5300|NBK208534|NBK1159|NBK51784|NBK2591|NBK26468|NBK1426|NBK247162|NBK1363|NBK1503|NBK32534|NBK1380|NBK1247|NBK1517|NBK1394|NBK1258|NBK1171|NBK1760|NBK1234|NBK32533|NBK1286|NBK22925|NBK1385|NBK1328|NBK1513|NBK25565|NBK1391|NBK5313|NBK1110|NBK1332|NBK1104|NBK84551|NBK47457|NBK1156|NBK1727|NBK154652|NBK1186|NBK1348|NBK1259|NBK1387|NBK1117|NBK5188|NBK1137|NBK84550|NBK1337|NBK1181|NBK1127|NBK1346|NBK1291|NBK1168|NBK45014|NBK1358|NBK1205|NBK1285|NBK1242|NBK1187|NBK1468|NBK1340|NBK169431|NBK1374|NBK1876|NBK1342|NBK131811|NBK7046|NBK1507|NBK1527|NBK1253|NBK1461|NBK1455|NBK2690|NBK1245|NBK1458|NBK1400|NBK1409|NBK5200|NBK1289|NBK1533|NBK1474|NBK1119|NBK1674|NBK1185|NBK1216|NBK1434|NBK1158|NBK99494|NBK100664|NBK7040|NBK7047|NBK22301|NBK220444|NBK1447|NBK1534|NBK84112|NBK1508|NBK1373|NBK1190|NBK367946|NBK1492|NBK25442|NBK1157|NBK1304|NBK1125|NBK1369|NBK1306|NBK1436|NBK1244|NBK1279|NBK1462|NBK453432|NBK1263|NBK190102|NBK100826|NBK121284|NBK1163|NBK1401|NBK1292|NBK1368|NBK56080|NBK5201|NBK425540|NBK1180|NBK7050|NBK1147|NBK1676|NBK2534|NBK1227|NBK1543|NBK1673|NBK1459|NBK285321|NBK253403|NBK1518|NBK1136|NBK1364|NBK1269|NBK1446|NBK1318|NBK1135|NBK1430|NBK164500|NBK1523|NBK385627|NBK1312|NBK1261|NBK26372|NBK115333|NBK1344|NBK5941|NBK55061|NBK1529|NBK100239|NBK1404|NBK1495|NBK1440|NBK2701|NBK1423|NBK333439|NBK1121|NBK1351|NBK1375|NBK25507|NBK1444|NBK100241|NBK1392|NBK1150|NBK1111|NBK1530|NBK1338|NBK1287|NBK3789|NBK1769|NBK1390|NBK1509|NBK1274|NBK1305|NBK1367|NBK1768|NBK53700|NBK1496|NBK2587|NBK1477|NBK1472|NBK190103|NBK1675|NBK97965|NBK1118|NBK1170|NBK1405|NBK1325|NBK1478|NBK1469|NBK62111|NBK201978|NBK1333|NBK349072|NBK1334|NBK1203|NBK1484|NBK338165|NBK1389|NBK305870|NBK43417|NBK1298|NBK1457|NBK47312|NBK320989|NBK1521|NBK1383|NBK1420|NBK1311|NBK1149|NBK1133|NBK1361|NBK1308|NBK1208|NBK343782|NBK1974|NBK1335|NBK1424|NBK1354|NBK9674|NBK1284|NBK1233|NBK1538|NBK1257|NBK1413|NBK1499|NBK1239|NBK1303|NBK1502|NBK1828|NBK1875|NBK24701|NBK1214|NBK1535|NBK1130|NBK1231|NBK1290|NBK1179|NBK45015|NBK1162|NBK148668|NBK92947|NBK1192|NBK1319|NBK1432|NBK1415|NBK425723|NBK1414|NBK5299|NBK1165|NBK1466|NBK121988|NBK1177|NBK1288|NBK368475|NBK1141|NBK1201|NBK1357|NBK185066|NBK1370|NBK1296|NBK1510|NBK1295|NBK1427|NBK1393|NBK1327|NBK1126|NBK154378|NBK1451|NBK1548|NBK1448|NBK9673|NBK1280|NBK1122|NBK6852|NBK1486|NBK242617|NBK47027|NBK1230|NBK1297|NBK1283|NBK65707|NBK1465|NBK26472|NBK1490|NBK1326|NBK1197|NBK1182|NBK247161|NBK1329|NBK121283|NBK1485|NBK1229|NBK299584|NBK92946|NBK1973|NBK1487|NBK1330|NBK1113|NBK1115|NBK1270|NBK1353|NBK1452|NBK1222|NBK1497|NBK83985|NBK1240|NBK1526|NBK1237|NBK1129|NBK83297|NBK1184|NBK1175|NBK1757|NBK1202|NBK1225|NBK1399|NBK1362|NBK1438|NBK1275|NBK1471|NBK54582|NBK1196|NBK1256|NBK1268|NBK1189|NBK1756|NBK1145|NBK1164|NBK1219|NBK1277|NBK1377|NBK1376|NBK442323|NBK1143|NBK2594|NBK1352|NBK1479|NBK1300|NBK1210|NBK1307|NBK1382|NBK45978|NBK1160|NBK1827|NBK8828|NBK304122|NBK1302|NBK1525|NBK23758|NBK5942|NBK1218|NBK1194|NBK26373|NBK1437|NBK1403|NBK1103|NBK1282|NBK395611|NBK1220|NBK1515|NBK6816|NBK1967|NBK1271|NBK7014|NBK1407|NBK1114|NBK1514|NBK4144|NBK1183|NBK1249|NBK1512|NBK1112|NBK1343|NBK1213|NBK1410|NBK1489|NBK1453|NBK1402|NBK1449|NBK1397|NBK20221	
pregnancy management	293	NBK1435|NBK1419|NBK1152|NBK1264|NBK299311|NBK263441|NBK1193|NBK1519|NBK1108|NBK1267|NBK333437|NBK208534|NBK100238|NBK1159|NBK253404|NBK1131|NBK1241|NBK1426|NBK247162|NBK1363|NBK1151|NBK1503|NBK32534|NBK169615|NBK1322|NBK424403|NBK1517|NBK1212|NBK284774|NBK1500|NBK99168|NBK1171|NBK246980|NBK32533|NBK1328|NBK326661|NBK1513|NBK25565|NBK1293|NBK1391|NBK5313|NBK84551|NBK154652|NBK1250|NBK1186|NBK1259|NBK99496|NBK5188|NBK84550|NBK52917|NBK1168|NBK45014|NBK1205|NBK1285|NBK201366|NBK1468|NBK1340|NBK1342|NBK131811|NBK7046|NBK1527|NBK1253|NBK1458|NBK1400|NBK1409|NBK1289|NBK1533|NBK1474|NBK1674|NBK1309|NBK7047|NBK1350|NBK22301|NBK1447|NBK1534|NBK1508|NBK1491|NBK258640|NBK1492|NBK25442|NBK1501|NBK1157|NBK1304|NBK1125|NBK1369|NBK1306|NBK1436|NBK1244|NBK1279|NBK1494|NBK1462|NBK54467|NBK190102|NBK100826|NBK121284|NBK1163|NBK1401|NBK1345|NBK1180|NBK7050|NBK114458|NBK2534|NBK1227|NBK1543|NBK1673|NBK1281|NBK1459|NBK1443|NBK253403|NBK1518|NBK1269|NBK1318|NBK1523|NBK1481|NBK1312|NBK1261|NBK26372|NBK1344|NBK5941|NBK55061|NBK114807|NBK1529|NBK1404|NBK1495|NBK1440|NBK1423|NBK333439|NBK1139|NBK97260|NBK1351|NBK1375|NBK25507|NBK1444|NBK100241|NBK185330|NBK1395|NBK1211|NBK1524|NBK1111|NBK1338|NBK1287|NBK3789|NBK1509|NBK1367|NBK1768|NBK53700|NBK1496|NBK174884|NBK1477|NBK1472|NBK190103|NBK1675|NBK97965|NBK1170|NBK1405|NBK1478|NBK1469|NBK201978|NBK349072|NBK1484|NBK43417|NBK1457|NBK1383|NBK1313|NBK1420|NBK1311|NBK1133|NBK1308|NBK343782|NBK1335|NBK1424|NBK274564|NBK1356|NBK1354|NBK84258|NBK61984|NBK1233|NBK1257|NBK1520|NBK214367|NBK1499|NBK1146|NBK1239|NBK1828|NBK1231|NBK1290|NBK373578|NBK1162|NBK1319|NBK1128|NBK1422|NBK2689|NBK1355|NBK1165|NBK1132|NBK1177|NBK1288|NBK368475|NBK1109|NBK1201|NBK1357|NBK185066|NBK1331|NBK1370|NBK1166|NBK1232|NBK1188|NBK1295|NBK1427|NBK154378|NBK447152|NBK1451|NBK1548|NBK9673|NBK1280|NBK1122|NBK6852|NBK1486|NBK395975|NBK1283|NBK316514|NBK65707|NBK1465|NBK26472|NBK1246|NBK1460|NBK1504|NBK1221|NBK247161|NBK143129|NBK121283|NBK196157|NBK1485|NBK327267|NBK1229|NBK92946|NBK1487|NBK1148|NBK1113|NBK1115|NBK1353|NBK299312|NBK83985|NBK268648|NBK114805|NBK1417|NBK1129|NBK83297|NBK435692|NBK1175|NBK1225|NBK1438|NBK1140|NBK1256|NBK63582|NBK1756|NBK201365|NBK1377|NBK1143|NBK1310|NBK1479|NBK45978|NBK8828|NBK304122|NBK131810|NBK1379|NBK23758|NBK274566|NBK1366|NBK1349|NBK26373|NBK1103|NBK1282|NBK1515|NBK154138|NBK1341|NBK1463|NBK6816|NBK1967|NBK1271|NBK7014|NBK447258|NBK1178|NBK148820|NBK1514|NBK4144|NBK1249|NBK1512|NBK1531|NBK1112|NBK1213|NBK1397|NBK20221	
other	225	NBK1396|NBK1419|NBK1493|NBK355754|NBK43797|NBK43797|NBK1475|NBK1193|NBK1454|NBK26471|NBK1519|NBK1519|NBK1450|NBK1450|NBK1267|NBK1267|NBK1161|NBK1365|NBK1429|NBK1144|NBK1159|NBK253404|NBK26468|NBK1241|NBK1426|NBK247162|NBK1421|NBK169615|NBK1204|NBK1380|NBK424403|NBK1247|NBK1212|NBK1258|NBK1500|NBK1513|NBK1110|NBK1332|NBK1359|NBK84551|NBK1250|NBK1387|NBK1117|NBK1137|NBK1337|NBK1127|NBK1127|NBK1346|NBK1358|NBK201366|NBK1468|NBK1340|NBK1340|NBK169431|NBK1374|NBK1342|NBK1482|NBK410087|NBK1507|NBK1253|NBK1461|NBK1458|NBK1400|NBK1400|NBK1409|NBK1119|NBK1185|NBK1191|NBK1508|NBK25442|NBK1157|NBK1304|NBK1125|NBK1369|NBK1369|NBK1279|NBK1462|NBK1263|NBK1142|NBK100826|NBK121284|NBK1163|NBK1292|NBK56080|NBK1180|NBK1543|NBK1543|NBK1443|NBK1506|NBK285321|NBK253403|NBK1364|NBK1269|NBK1318|NBK1261|NBK1261|NBK1261|NBK1344|NBK349073|NBK114807|NBK1404|NBK1495|NBK1139|NBK25507|NBK1444|NBK100241|NBK1392|NBK1530|NBK1338|NBK1287|NBK1305|NBK1367|NBK1367|NBK1496|NBK1675|NBK1118|NBK1405|NBK1325|NBK1469|NBK1333|NBK1238|NBK43417|NBK1457|NBK1311|NBK1149|NBK1133|NBK1480|NBK1480|NBK1361|NBK1308|NBK343782|NBK1974|NBK1335|NBK274564|NBK97333|NBK401562|NBK401562|NBK1413|NBK1499|NBK1473|NBK174452|NBK1239|NBK1535|NBK1130|NBK1231|NBK1179|NBK1425|NBK1162|NBK425723|NBK425723|NBK1165|NBK1173|NBK1428|NBK1288|NBK1109|NBK1357|NBK1296|NBK1448|NBK1122|NBK1464|NBK2692|NBK100240|NBK1266|NBK1490|NBK1504|NBK1197|NBK1182|NBK143129|NBK1229|NBK92946|NBK92946|NBK1487|NBK1330|NBK1113|NBK1115|NBK1270|NBK1497|NBK1417|NBK1417|NBK1237|NBK1129|NBK3795|NBK1184|NBK1175|NBK1202|NBK1399|NBK1362|NBK1275|NBK1471|NBK1140|NBK1268|NBK379665|NBK1756|NBK1376|NBK1143|NBK1352|NBK1310|NBK1228|NBK1300|NBK1160|NBK1195|NBK1525|NBK1218|NBK1445|NBK1194|NBK425926|NBK1103|NBK447257|NBK1515|NBK1265|NBK1341|NBK1341|NBK1271|NBK447258|NBK1514|NBK4144|NBK378974|NBK1112|NBK1343|NBK1213|NBK1489|NBK1402|NBK1449|NBK1397|NBK1339	
prevention of primary manifestations	219	NBK1396|NBK1435|NBK1372|NBK1493|NBK1264|NBK1483|NBK1193|NBK1454|NBK1108|NBK1365|NBK1429|NBK100238|NBK1159|NBK51784|NBK1131|NBK1138|NBK1241|NBK1426|NBK390611|NBK1151|NBK169615|NBK1522|NBK1322|NBK1380|NBK1247|NBK1517|NBK1212|NBK284774|NBK1500|NBK1171|NBK1286|NBK1328|NBK1332|NBK84551|NBK1156|NBK1727|NBK154652|NBK99496|NBK52917|NBK1181|NBK1127|NBK1168|NBK1205|NBK1374|NBK7046|NBK410087|NBK1527|NBK1253|NBK3794|NBK1458|NBK1400|NBK1409|NBK1289|NBK1533|NBK1474|NBK1434|NBK1251|NBK1350|NBK220444|NBK1508|NBK25442|NBK1501|NBK1157|NBK1304|NBK1369|NBK1244|NBK1279|NBK190102|NBK100826|NBK1163|NBK1401|NBK1292|NBK1368|NBK56080|NBK1345|NBK1147|NBK1227|NBK1673|NBK1459|NBK1506|NBK1518|NBK51671|NBK1364|NBK1269|NBK1430|NBK1312|NBK1261|NBK26372|NBK1344|NBK5941|NBK55061|NBK114807|NBK1529|NBK1404|NBK1495|NBK1440|NBK169003|NBK333439|NBK1139|NBK97260|NBK1351|NBK1444|NBK100241|NBK1211|NBK1392|NBK1524|NBK1150|NBK1338|NBK3789|NBK1274|NBK1367|NBK1768|NBK53700|NBK1496|NBK174884|NBK1260|NBK1262|NBK258641|NBK1118|NBK1170|NBK1405|NBK1469|NBK1333|NBK1238|NBK1457|NBK320989|NBK184570|NBK1174|NBK1311|NBK1149|NBK1361|NBK1308|NBK1335|NBK1424|NBK1356|NBK61984|NBK1233|NBK1538|NBK1257|NBK1413|NBK1520|NBK1146|NBK1130|NBK1231|NBK1425|NBK1162|NBK148668|NBK1319|NBK1422|NBK2689|NBK5299|NBK1355|NBK1177|NBK1357|NBK185066|NBK1370|NBK1166|NBK1232|NBK1327|NBK154378|NBK447152|NBK190101|NBK1451|NBK1448|NBK1280|NBK6852|NBK1486|NBK395975|NBK1297|NBK1283|NBK2692|NBK316514|NBK65707|NBK1488|NBK26472|NBK1266|NBK1504|NBK1197|NBK174451|NBK143129|NBK121283|NBK92946|NBK1973|NBK84399|NBK1148|NBK1330|NBK1113|NBK1270|NBK1353|NBK83985|NBK1129|NBK1184|NBK1175|NBK1268|NBK63582|NBK1377|NBK431123|NBK1307|NBK23758|NBK1194|NBK1349|NBK1437|NBK1403|NBK1103|NBK1282|NBK1515|NBK6816|NBK1271|NBK7014|NBK1178|NBK1512|NBK1315|NBK1406|NBK1410|NBK1489|NBK1453|NBK1402|NBK1397|NBK20221	
consultation with a clinical geneticist and/or genetic counselor	200	NBK1418|NBK1493|NBK1483|NBK355754|NBK355518|NBK1475|NBK1454|NBK1207|NBK1108|NBK333437|NBK26468|NBK1241|NBK390611|NBK327153|NBK1421|NBK1398|NBK1380|NBK424403|NBK1517|NBK1212|NBK373577|NBK1394|NBK22925|NBK326661|NBK25565|NBK1293|NBK5313|NBK84551|NBK47457|NBK154652|NBK1186|NBK1348|NBK99496|NBK84550|NBK52917|NBK1127|NBK396257|NBK1168|NBK1539|NBK1285|NBK1468|NBK1340|NBK131811|NBK7046|NBK410087|NBK1527|NBK1253|NBK3794|NBK1400|NBK1400|NBK1409|NBK1289|NBK1674|NBK385626|NBK269029|NBK1209|NBK1536|NBK1272|NBK1251|NBK7040|NBK22301|NBK1491|NBK367946|NBK344340|NBK333438|NBK1492|NBK1501|NBK1157|NBK1369|NBK1436|NBK54467|NBK190102|NBK100826|NBK1292|NBK1227|NBK1543|NBK368474|NBK1281|NBK1364|NBK385627|NBK1312|NBK169003|NBK390610|NBK1351|NBK1252|NBK100241|NBK1150|NBK1111|NBK1390|NBK1367|NBK53700|NBK174884|NBK190103|NBK1675|NBK453433|NBK1469|NBK201978|NBK1333|NBK349072|NBK1334|NBK390670|NBK1313|NBK1174|NBK1420|NBK338540|NBK368476|NBK107219|NBK390803|NBK153723|NBK1356|NBK50780|NBK401562|NBK385289|NBK1257|NBK1413|NBK1413|NBK1413|NBK1214|NBK1179|NBK373578|NBK396098|NBK1162|NBK148668|NBK1415|NBK425723|NBK1355|NBK1173|NBK368475|NBK1176|NBK185066|NBK185066|NBK1124|NBK1510|NBK1188|NBK1248|NBK154378|NBK447152|NBK1486|NBK1537|NBK47027|NBK1464|NBK395975|NBK316514|NBK65707|NBK1465|NBK1488|NBK1266|NBK1490|NBK1326|NBK99167|NBK143129|NBK447920|NBK299584|NBK92946|NBK1973|NBK1330|NBK52764|NBK1353|NBK83985|NBK1237|NBK435692|NBK1184|NBK1275|NBK379665|NBK1377|NBK1376|NBK431123|NBK442323|NBK1479|NBK1195|NBK1302|NBK396561|NBK6803|NBK425223|NBK23758|NBK1437|NBK425926|NBK1282|NBK395611|NBK1220|NBK350554|NBK1341|NBK1463|NBK1271|NBK1407|NBK1178|NBK1514|NBK1249|NBK1512|NBK1531|NBK378974|NBK1112|NBK1406|NBK1343|NBK1213|NBK1410|NBK1453|NBK1397|NBK349624|NBK20221	
clinical genetics consultation	166	NBK1396|NBK1264|NBK263441|NBK1169|NBK1381|NBK1172|NBK26471|NBK1450|NBK1144|NBK1360|NBK1317|NBK1456|NBK1154|NBK5300|NBK1255|NBK253404|NBK247162|NBK1151|NBK169615|NBK1522|NBK1258|NBK1500|NBK99168|NBK246980|NBK1286|NBK169825|NBK1386|NBK1391|NBK154653|NBK1259|NBK1117|NBK304142|NBK1337|NBK5189|NBK1205|NBK1482|NBK1461|NBK2690|NBK1245|NBK5200|NBK1119|NBK1216|NBK1216|NBK1191|NBK99494|NBK1350|NBK220444|NBK220444|NBK1534|NBK1878|NBK1508|NBK1373|NBK3823|NBK1125|NBK1306|NBK1142|NBK121284|NBK1235|NBK1206|NBK1180|NBK7050|NBK114458|NBK285321|NBK11168|NBK1430|NBK1481|NBK114807|NBK100239|NBK2701|NBK1139|NBK1121|NBK1444|NBK1395|NBK1392|NBK1338|NBK1287|NBK49247|NBK1769|NBK1305|NBK1260|NBK258641|NBK114806|NBK47079|NBK1389|NBK305870|NBK43417|NBK1298|NBK47312|NBK1521|NBK1408|NBK1149|NBK1335|NBK274565|NBK195853|NBK1538|NBK214367|NBK1146|NBK174452|NBK1502|NBK1828|NBK1875|NBK1130|NBK1290|NBK1728|NBK92947|NBK1422|NBK1412|NBK1414|NBK5299|NBK121988|NBK1428|NBK1177|NBK1288|NBK1109|NBK1201|NBK1357|NBK1331|NBK1296|NBK1232|NBK1295|NBK1427|NBK1548|NBK1280|NBK1122|NBK6852|NBK242617|NBK1283|NBK26472|NBK100240|NBK1197|NBK1182|NBK247161|NBK174451|NBK1229|NBK1153|NBK1497|NBK195854|NBK1526|NBK83297|NBK3795|NBK1175|NBK1399|NBK1438|NBK1196|NBK1256|NBK63582|NBK1277|NBK1143|NBK2594|NBK1310|NBK144284|NBK1300|NBK45978|NBK1827|NBK8828|NBK1525|NBK5942|NBK1445|NBK1403|NBK114628|NBK6816|NBK1874|NBK4144|NBK1315|NBK1449|NBK1416	
the following are appropriate:	135	NBK1372|NBK1483|NBK1475|NBK1381|NBK1381|NBK1273|NBK1172|NBK1144|NBK253404|NBK1421|NBK1212|NBK1394|NBK1394|NBK1258|NBK1386|NBK1391|NBK1104|NBK1104|NBK154653|NBK154652|NBK1348|NBK1259|NBK1387|NBK1346|NBK1291|NBK169431|NBK1342|NBK131811|NBK3794|NBK2690|NBK5200|NBK1185|NBK1216|NBK269029|NBK1536|NBK1272|NBK1878|NBK1491|NBK1190|NBK367946|NBK333438|NBK1157|NBK1436|NBK1436|NBK1462|NBK54467|NBK1263|NBK100826|NBK121284|NBK1292|NBK5201|NBK1180|NBK1676|NBK368474|NBK285321|NBK51671|NBK11168|NBK1430|NBK1198|NBK1423|NBK1121|NBK185330|NBK1477|NBK1243|NBK114806|NBK1203|NBK338165|NBK1457|NBK1457|NBK47312|NBK1521|NBK1408|NBK1313|NBK338540|NBK343782|NBK1974|NBK24676|NBK61984|NBK1499|NBK9587|NBK7041|NBK1502|NBK1130|NBK373578|NBK1192|NBK1415|NBK1165|NBK321516|NBK1177|NBK1288|NBK185066|NBK1166|NBK1232|NBK1188|NBK1295|NBK154378|NBK1467|NBK1464|NBK395975|NBK100240|NBK1329|NBK1113|NBK1153|NBK1353|NBK1497|NBK299312|NBK268648|NBK1240|NBK1324|NBK1526|NBK1237|NBK435692|NBK1757|NBK1438|NBK1471|NBK1164|NBK1219|NBK1277|NBK201365|NBK1376|NBK442323|NBK1310|NBK1228|NBK1382|NBK1827|NBK1366|NBK1194|NBK447257|NBK395611|NBK1874|NBK1271|NBK1178|NBK1514|NBK1531|NBK20221	
medical genetics consultation	73	NBK1372|NBK1273|NBK24599|NBK1267|NBK114459|NBK208534|NBK1159|NBK91457|NBK284774|NBK1760|NBK32533|NBK1385|NBK1513|NBK1156|NBK1106|NBK5188|NBK1346|NBK1511|NBK1187|NBK169431|NBK1876|NBK1158|NBK100664|NBK84112|NBK1462|NBK1163|NBK5201|NBK2534|NBK1371|NBK1506|NBK253403|NBK1136|NBK1423|NBK1274|NBK2587|NBK1477|NBK1262|NBK1484|NBK1457|NBK1974|NBK1354|NBK9674|NBK1284|NBK1233|NBK1499|NBK1473|NBK1239|NBK1303|NBK1433|NBK1128|NBK185329|NBK1132|NBK1393|NBK1126|NBK1451|NBK1467|NBK1230|NBK1487|NBK1270|NBK268648|NBK1129|NBK1362|NBK1140|NBK1268|NBK1756|NBK201365|NBK1321|NBK1210|NBK26373|NBK154138|NBK1967|NBK7014|NBK1489	
evaluations can include:	50	NBK1435|NBK1419|NBK1493|NBK1483|NBK355754|NBK1454|NBK1151|NBK1380|NBK1394|NBK22925|NBK1293|NBK1332|NBK1250|NBK84550|NBK1168|NBK1340|NBK1527|NBK3794|NBK1458|NBK1400|NBK269029|NBK22301|NBK1436|NBK1494|NBK1292|NBK1364|NBK1261|NBK1111|NBK1334|NBK1308|NBK1257|NBK1179|NBK148668|NBK368475|NBK185066|NBK154378|NBK447152|NBK65707|NBK1326|NBK1504|NBK1452|NBK1103|NBK1220|NBK1515|NBK1265|NBK3821|NBK1514|NBK1531|NBK1112|NBK1453	
neurologic examination	39	NBK1255|NBK1258|NBK326661|NBK326661|NBK1291|NBK45014|NBK1511|NBK1876|NBK1253|NBK1461|NBK1492|NBK25442|NBK1384|NBK51671|NBK1318|NBK1392|NBK1274|NBK1260|NBK2587|NBK1262|NBK1238|NBK43417|NBK1149|NBK1413|NBK1535|NBK1428|NBK1370|NBK299312|NBK83297|NBK1184|NBK1225|NBK1399|NBK1275|NBK1256|NBK1321|NBK1827|NBK4144|NBK1315|NBK1489	
avoid the following:	35	NBK208534|NBK51784|NBK253404|NBK390611|NBK247162|NBK1258|NBK1250|NBK1387|NBK1458|NBK1400|NBK220444|NBK54467|NBK26372|NBK5941|NBK114807|NBK1404|NBK1440|NBK390610|NBK97260|NBK1769|NBK1170|NBK343782|NBK97333|NBK9674|NBK154378|NBK6852|NBK1283|NBK247161|NBK99167|NBK143129|NBK1353|NBK195854|NBK231880|NBK1349|NBK6816	
developmental assessment	33	NBK1372|NBK1475|NBK1267|NBK1159|NBK1234|NBK1544|NBK333201|NBK1342|NBK1482|NBK7047|NBK3823|NBK51671|NBK1274|NBK1274|NBK2587|NBK425128|NBK390670|NBK97333|NBK1413|NBK214367|NBK396098|NBK1162|NBK1173|NBK1486|NBK1465|NBK299584|NBK426063|NBK1270|NBK1277|NBK1143|NBK26373|NBK1874|NBK148820	
ophthalmologic examination	33	NBK1475|NBK1456|NBK1154|NBK1322|NBK424403|NBK1258|NBK1328|NBK326661|NBK1186|NBK1348|NBK1137|NBK1461|NBK1245|NBK1190|NBK114458|NBK390610|NBK2587|NBK84258|NBK401562|NBK7041|NBK92947|NBK1192|NBK2689|NBK1428|NBK368475|NBK1370|NBK1270|NBK1526|NBK1275|NBK6803|NBK425223|NBK1874|NBK349624	
ophthalmologic evaluation	33	NBK1207|NBK169825|NBK1544|NBK154653|NBK154652|NBK1185|NBK344340|NBK1292|NBK425540|NBK425540|NBK1206|NBK114458|NBK453433|NBK1383|NBK61984|NBK1233|NBK1520|NBK1179|NBK1728|NBK2689|NBK1173|NBK1201|NBK1124|NBK99167|NBK1153|NBK1376|NBK1310|NBK1194|NBK1282|NBK1282|NBK350554|NBK1249|NBK349624	
the following should be avoided:	31	NBK1426|NBK1522|NBK1539|NBK7046|NBK1123|NBK1244|NBK1518|NBK1430|NBK100239|NBK1495|NBK1444|NBK3789|NBK174884|NBK1405|NBK1133|NBK1335|NBK1473|NBK1239|NBK1231|NBK447152|NBK2692|NBK316514|NBK1246|NBK1326|NBK1973|NBK1145|NBK1277|NBK431123|NBK1403|NBK1103|NBK1410	
neurologic	26	NBK355754|NBK355754|NBK355754|NBK1450|NBK333437|NBK26468|NBK1186|NBK22301|NBK453432|NBK453432|NBK425540|NBK425540|NBK349073|NBK390803|NBK97333|NBK174452|NBK92947|NBK1412|NBK100240|NBK426063|NBK426063|NBK453434|NBK378974|NBK378974|NBK1397|NBK1397	
brain mri	24	NBK1493|NBK26471|NBK1255|NBK327153|NBK1258|NBK1234|NBK52917|NBK1342|NBK1409|NBK5200|NBK453432|NBK100241|NBK9674|NBK1214|NBK1535|NBK1179|NBK368475|NBK153722|NBK426063|NBK3795|NBK1399|NBK1277|NBK1382|NBK1315	
seizures	24	NBK26471|NBK424403|NBK1293|NBK5189|NBK3794|NBK11167|NBK1191|NBK453432|NBK425540|NBK114458|NBK164500|NBK1150|NBK320989|NBK184570|NBK1173|NBK1428|NBK426063|NBK1115|NBK1195|NBK274566|NBK447257|NBK1220|NBK453434|NBK1183	
cardiovascular	23	NBK355754|NBK355754|NBK355754|NBK253404|NBK1279|NBK1462|NBK1462|NBK425540|NBK425540|NBK1133|NBK343782|NBK1335|NBK1335|NBK1162|NBK1412|NBK425723|NBK425723|NBK425723|NBK447920|NBK447920|NBK426063|NBK1277|NBK1249	
consultation with a medical geneticist and/or genetic counselor	21	NBK45014|NBK11167|NBK25442|NBK1123|NBK1388|NBK1440|NBK1243|NBK1383|NBK343782|NBK52787|NBK2689|NBK1165|NBK1165|NBK321516|NBK1370|NBK1370|NBK51754|NBK51754|NBK304122|NBK3821|NBK1183	
eyes	21	NBK1409|NBK1373|NBK333438|NBK425540|NBK425540|NBK1180|NBK1287|NBK1287|NBK425128|NBK349072|NBK390670|NBK1480|NBK5199|NBK447920|NBK447920|NBK426063|NBK426063|NBK1445|NBK453434|NBK1397|NBK1397	
gastrointestinal	20	NBK299311|NBK26471|NBK1267|NBK1250|NBK1186|NBK1157|NBK1279|NBK453432|NBK453432|NBK425540|NBK425540|NBK343782|NBK1412|NBK425723|NBK425723|NBK100240|NBK426063|NBK426063|NBK453434|NBK1249	
respiratory	20	NBK26471|NBK1391|NBK1250|NBK1250|NBK1250|NBK1250|NBK1507|NBK164500|NBK1325|NBK425128|NBK5199|NBK97333|NBK148668|NBK148668|NBK425723|NBK425723|NBK425723|NBK1326|NBK426063|NBK2594	
echocardiogram	20	NBK1131|NBK247162|NBK1328|NBK1386|NBK62112|NBK344340|NBK1401|NBK5201|NBK1459|NBK115333|NBK1274|NBK5199|NBK61984|NBK1473|NBK1327|NBK1277|NBK425223|NBK5192|NBK1403|NBK349624	
hearing loss	20	NBK1513|NBK1117|NBK84112|NBK1263|NBK425540|NBK114458|NBK2534|NBK1443|NBK1443|NBK1121|NBK390670|NBK368476|NBK274565|NBK214367|NBK1162|NBK1415|NBK2689|NBK425723|NBK1295|NBK1445	
growth	19	NBK1152|NBK1398|NBK1544|NBK5189|NBK1507|NBK453432|NBK164500|NBK164500|NBK390610|NBK425128|NBK390670|NBK148668|NBK148668|NBK447920|NBK447920|NBK1324|NBK1756|NBK447257|NBK20221	
musculoskeletal	19	NBK1186|NBK22301|NBK1462|NBK1462|NBK453432|NBK164500|NBK164500|NBK425128|NBK425128|NBK368476|NBK148668|NBK148668|NBK1412|NBK447920|NBK447920|NBK426063|NBK426063|NBK447257|NBK453434	
skin	17	NBK1519|NBK1267|NBK1157|NBK1304|NBK1125|NBK1543|NBK1543|NBK1252|NBK1287|NBK1287|NBK1287|NBK1769|NBK349072|NBK1220|NBK1397|NBK1397|NBK1397	
skeletal	17	NBK253404|NBK1513|NBK1507|NBK1543|NBK1543|NBK349073|NBK1325|NBK390670|NBK1133|NBK5199|NBK1335|NBK1335|NBK1875|NBK1162|NBK425723|NBK1277|NBK425926	
cardiac	16	NBK1454|NBK1186|NBK1186|NBK1507|NBK1507|NBK1507|NBK1119|NBK164500|NBK164500|NBK1111|NBK5199|NBK24701|NBK148668|NBK148668|NBK1427|NBK1220	
search clinical trials	16	NBK1236|NBK333437|NBK208534|NBK100238|NBK32534|NBK62112|NBK47457|NBK99494|NBK114458|NBK258641|NBK43417|NBK1408|NBK214367|NBK190101|NBK144284|NBK350554	
hearing	16	NBK1360|NBK1544|NBK1373|NBK164500|NBK5199|NBK148668|NBK148668|NBK425723|NBK1201|NBK1448|NBK1448|NBK1445|NBK1265|NBK1341|NBK1397|NBK1397	
dental	16	NBK1513|NBK1127|NBK1507|NBK22301|NBK333438|NBK1279|NBK1543|NBK1543|NBK164500|NBK1769|NBK1828|NBK148668|NBK148668|NBK1412|NBK425926|NBK1220	
see treatment of manifestations	16	NBK1727|NBK52917|NBK3794|NBK258640|NBK1312|NBK1440|NBK1351|NBK1308|NBK242617|NBK316514|NBK65707|NBK1504|NBK1352|NBK1103|NBK1282|NBK1489	
gene therapy	16	NBK1250|NBK99496|NBK1119|NBK1269|NBK1430|NBK1344|NBK1174|NBK1130|NBK1231|NBK1283|NBK1417|NBK1377|NBK1377|NBK1352|NBK1410|NBK20221	
hearing evaluation	14	NBK1207|NBK1363|NBK1190|NBK425540|NBK1543|NBK5199|NBK7041|NBK1124|NBK92946|NBK83985|NBK83985|NBK1219|NBK425223|NBK1249	
endocrine	14	NBK1267|NBK1186|NBK1373|NBK333438|NBK1118|NBK425128|NBK425128|NBK390670|NBK274564|NBK447920|NBK426063|NBK1249|NBK378974|NBK378974	
renal ultrasound examination	13	NBK1117|NBK344340|NBK1383|NBK5199|NBK401562|NBK52787|NBK214367|NBK1124|NBK1270|NBK1240|NBK1526|NBK274566|NBK5192	
evaluation	12	NBK453432|NBK425540|NBK425540|NBK425128|NBK425128|NBK447920|NBK447920|NBK426063|NBK426063|NBK447257|NBK1515|NBK453434	
table 4	12	NBK453432|NBK425540|NBK97260|NBK174884|NBK425128|NBK1257|NBK1319|NBK1427|NBK1266|NBK447920|NBK426063|NBK453434	
eye	11	NBK253404|NBK1543|NBK164500|NBK164500|NBK1769|NBK1133|NBK1335|NBK1335|NBK148668|NBK148668|NBK1464	
and	11	NBK1517|NBK1351|NBK3789|NBK1274|NBK1354|NBK1124|NBK1166|NBK1427|NBK1283|NBK1377|NBK1382	
the following are indicated:	11	NBK1536|NBK1272|NBK7047|NBK47079|NBK1354|NBK84258|NBK52787|NBK185329|NBK1353|NBK1445|NBK1249	
gov)	11	NBK22301|NBK1304|NBK1174|NBK1425|NBK1425|NBK185329|NBK1173|NBK154378|NBK1490|NBK1195|NBK1220	
surveillance includes the following:	10	NBK1475|NBK1291|NBK131811|NBK114458|NBK1203|NBK1412|NBK321516|NBK1188|NBK1526|NBK1403	
pulmonary	10	NBK26468|NBK84550|NBK1119|NBK22301|NBK1261|NBK425128|NBK343782|NBK100240|NBK1352|NBK1220	
hearing assessment	10	NBK327153|NBK1544|NBK201366|NBK425540|NBK11168|NBK368476|NBK1162|NBK1415|NBK268648|NBK201365	
org	10	NBK1517|NBK1447|NBK333439|NBK1305|NBK1305|NBK97333|NBK1201|NBK1201|NBK447152|NBK65707	
treatment includes the following:	10	NBK154653|NBK333438|NBK1206|NBK114458|NBK1136|NBK1198|NBK1472|NBK24676|NBK1422|NBK1412	
ophthalmologic	10	NBK1186|NBK1216|NBK1462|NBK1462|NBK1325|NBK1162|NBK1412|NBK100240|NBK1302|NBK1220	
5 g/m2	10	NBK1458|NBK1458|NBK1458|NBK1458|NBK97260|NBK97260|NBK1217|NBK1217|NBK1217|NBK1217	
audiology evaluation	10	NBK100664|NBK1523|NBK148668|NBK425723|NBK447920|NBK92946|NBK6803|NBK425223|NBK1531|NBK349624	
table 3	10	NBK453432|NBK333439|NBK97260|NBK174884|NBK425128|NBK447920|NBK426063|NBK447257|NBK1515|NBK1249	
complete blood count	9	NBK1493|NBK1212|NBK425540|NBK1673|NBK305870|NBK1176|NBK299584|NBK431123|NBK1271	
nutrition	9	NBK299311|NBK247162|NBK97260|NBK305870|NBK320989|NBK1231|NBK1176|NBK1370|NBK1352	
renal disease	9	NBK1267|NBK1267|NBK1267|NBK410087|NBK1292|NBK114458|NBK53700|NBK1325|NBK401562	
echocardiography	9	NBK253404|NBK1409|NBK54467|NBK1261|NBK1133|NBK343782|NBK1335|NBK24701|NBK1113	
developmental evaluation	9	NBK32534|NBK154653|NBK201978|NBK1484|NBK92947|NBK92947|NBK92946|NBK1195|NBK114628	
evaluations include:	9	NBK154652|NBK7047|NBK1312|NBK100241|NBK1973|NBK1353|NBK1437|NBK1341|NBK1271	
enzyme replacement therapy (ert)	8	NBK1396|NBK1292|NBK1269|NBK1261|NBK1150|NBK1274|NBK1162|NBK148668	
genetics consultation	8	NBK1516|NBK1544|NBK1507|NBK1443|NBK1529|NBK7041|NBK1307|NBK1194	
treatment is symptomatic	8	NBK355518|NBK1358|NBK1285|NBK201366|NBK1340|NBK236968|NBK447152|NBK9673	
nutritional assessment	8	NBK26471|NBK1234|NBK1507|NBK115333|NBK1121|NBK92947|NBK195854|NBK1489	
renal	8	NBK1207|NBK1157|NBK1252|NBK1118|NBK5199|NBK1326|NBK1445|NBK1220	
sensorineural hearing loss	8	NBK2591|NBK304142|NBK201366|NBK1876|NBK57098|NBK1331|NBK201365|NBK378974	
ecg	8	NBK1131|NBK247162|NBK1400|NBK26372|NBK1174|NBK195853|NBK24701|NBK1377	
motor dysfunction	8	NBK424403|NBK453432|NBK425540|NBK201978|NBK447920|NBK426063|NBK447257|NBK453434	
gross motor dysfunction	8	NBK424403|NBK453432|NBK425540|NBK201978|NBK447920|NBK426063|NBK447257|NBK453434	
consider use of durable medical equipment as needed (e	8	NBK424403|NBK453432|NBK425540|NBK201978|NBK447920|NBK426063|NBK447257|NBK453434	
fine motor dysfunction	8	NBK424403|NBK453432|NBK425540|NBK201978|NBK447920|NBK426063|NBK447257|NBK453434	
oral motor dysfunction	8	NBK424403|NBK453432|NBK425540|NBK201978|NBK447920|NBK426063|NBK447257|NBK453434	
audiologic evaluation	8	NBK169825|NBK1513|NBK1878|NBK1233|NBK1520|NBK1179|NBK1407|NBK349624	
liver function tests	8	NBK1110|NBK1332|NBK1312|NBK1325|NBK305870|NBK1424|NBK299584|NBK425223	
medications	8	NBK1181|NBK1163|NBK1135|NBK114807|NBK1121|NBK1367|NBK92946|NBK299312	
dental evaluation	8	NBK1346|NBK1342|NBK1461|NBK100664|NBK114458|NBK148668|NBK447920|NBK1407	
developmental pediatricians can provide assistance with transition to adulthood	8	NBK453432|NBK425540|NBK201978|NBK425723|NBK447920|NBK426063|NBK447257|NBK453434	
some issues to consider:	8	NBK453432|NBK425540|NBK201978|NBK425723|NBK447920|NBK426063|NBK447257|NBK453434	
system	8	NBK453432|NBK425540|NBK425540|NBK425128|NBK425128|NBK447920|NBK447920|NBK447257	
liver transplantation	8	NBK26372|NBK114807|NBK114807|NBK100241|NBK1231|NBK92947|NBK154378|NBK1515	
appropriate surveillance includes:	8	NBK1344|NBK1769|NBK390803|NBK84258|NBK1432|NBK1248|NBK100240|NBK55062	
eeg	8	NBK1238|NBK9674|NBK1357|NBK1175|NBK1225|NBK1195|NBK396561|NBK453434	
obesity	7	NBK1152|NBK1267|NBK1267|NBK1267|NBK2701|NBK174884|NBK247161	
diabetes mellitus	7	NBK1493|NBK1398|NBK2701|NBK174884|NBK1170|NBK4144|NBK378974	
cardiac evaluation	7	NBK1207|NBK390803|NBK84258|NBK1233|NBK1520|NBK1173|NBK1282	
hypothyroidism	7	NBK1267|NBK1110|NBK1332|NBK185066|NBK247161|NBK174451|NBK378974	
appropriate surveillance includes the following:	7	NBK327153|NBK1149|NBK1356|NBK52787|NBK174452|NBK26373|NBK1514	
renal anomalies	7	NBK1380|NBK1380|NBK1380|NBK1523|NBK114806|NBK390670|NBK274566	
neurologic evaluation	7	NBK1500|NBK1186|NBK453432|NBK426063|NBK396561|NBK1282|NBK1874	
audiologic assessment	7	NBK326661|NBK1461|NBK1216|NBK338165|NBK299312|NBK1228|NBK395611	
eeg if seizures are suspected	7	NBK5200|NBK425128|NBK47079|NBK390803|NBK92947|NBK6803|NBK425223	
medical history	7	NBK1474|NBK1129|NBK1757|NBK1202|NBK1225|NBK1399|NBK1256	
table 2	7	NBK327268|NBK453432|NBK1768|NBK154378|NBK447920|NBK426063|NBK447257	
comment	7	NBK453432|NBK425540|NBK425128|NBK447920|NBK426063|NBK447257|NBK453434	
manifestation	7	NBK453432|NBK425540|NBK425128|NBK447920|NBK426063|NBK447257|NBK453434	
treatment	7	NBK453432|NBK425540|NBK425128|NBK447920|NBK426063|NBK447257|NBK453434	
communication issues	7	NBK453432|NBK425540|NBK201978|NBK447920|NBK426063|NBK447257|NBK453434	
neurologic assessment	7	NBK1292|NBK1281|NBK115333|NBK1121|NBK1305|NBK92947|NBK368475	
iopd	7	NBK1261|NBK1261|NBK1261|NBK1261|NBK1261|NBK1261|NBK1261	
development	6	NBK1152|NBK1544|NBK5189|NBK174452|NBK1448|NBK1464	
urinalysis	6	NBK1207|NBK1367|NBK1118|NBK1132|NBK1183|NBK1249	
pulmonary disease	6	NBK1267|NBK1267|NBK1267|NBK1370|NBK1122|NBK1122	
cardiomyopathy	6	NBK1267|NBK1267|NBK1261|NBK320989|NBK97333|NBK1173	
bleeding	6	NBK208534|NBK1287|NBK1287|NBK1287|NBK1370|NBK1178	
the following are recommended:	6	NBK284774|NBK349072|NBK1109|NBK1331|NBK154378|NBK1230	
craniofacial	6	NBK1513|NBK1455|NBK1133|NBK425723|NBK1277|NBK1302	
failure to thrive	6	NBK1110|NBK1332|NBK1259|NBK390670|NBK1280|NBK1525	
dehydration	6	NBK1250|NBK3789|NBK395975|NBK2692|NBK1973|NBK1377	
anesthesia	6	NBK1186|NBK1117|NBK1340|NBK164500|NBK24701|NBK148668	
malignancy	6	NBK1186|NBK84550|NBK84550|NBK1507|NBK1176|NBK1246	
evaluations can include the following:	6	NBK99496|NBK100826|NBK1673|NBK395975|NBK1294|NBK1512	
orthopedic	6	NBK84550|NBK1119|NBK1769|NBK184570|NBK97333|NBK2594	
treatment is supportive	6	NBK396257|NBK195853|NBK1473|NBK373578|NBK1319|NBK327267	
forearm crutches or canes for gait stability	6	NBK1539|NBK1285|NBK1511|NBK1468|NBK153601|NBK169431	
special shoes, including those with good ankle support	6	NBK1205|NBK1285|NBK1511|NBK201366|NBK1468|NBK169431	
pulmonary fibrosis	6	NBK22301|NBK22301|NBK1287|NBK1287|NBK1287|NBK1287	
considerations/other	6	NBK453432|NBK425540|NBK425128|NBK447920|NBK426063|NBK447257	
standard recommendations may vary from country to country	6	NBK453432|NBK201978|NBK425723|NBK447920|NBK426063|NBK447257	
ages 0-3 years	6	NBK453432|NBK425540|NBK201978|NBK425723|NBK447920|NBK453434	
ages 3-5 years	6	NBK453432|NBK425540|NBK201978|NBK425723|NBK447920|NBK453434	
ages 5-21 years	6	NBK453432|NBK425540|NBK201978|NBK425723|NBK447920|NBK453434	
all ages	6	NBK453432|NBK425540|NBK201978|NBK425723|NBK447920|NBK453434	
recommended evaluations following initial diagnosis	6	NBK425540|NBK425540|NBK426063|NBK426063|NBK453434|NBK453434	
lopd	6	NBK1261|NBK1261|NBK1261|NBK1261|NBK1261|NBK1261	
250 mg/kg	6	NBK154378|NBK154378|NBK1217|NBK1217|NBK1217|NBK1217	
gerd = gastroesophageal reflux disease	6	NBK426063|NBK426063|NBK447257|NBK447257|NBK447257|NBK447257	
canes and walkers help prevent falls	6	NBK1184|NBK1225|NBK1399|NBK1275|NBK1471|NBK1256	
short stature	5	NBK1152|NBK1171|NBK84550|NBK1215|NBK425926	
anemia	5	NBK1493|NBK84550|NBK84550|NBK1364|NBK1351	
no specific therapy is available	5	NBK355518|NBK169825|NBK236968|NBK9673|NBK9673	
hypertension	5	NBK1193|NBK1180|NBK174884|NBK1246|NBK1376	
prevention of secondary manifestations	5	NBK1454|NBK1429|NBK1281|NBK1313|NBK1463	
electrocardiogram	5	NBK26471|NBK1517|NBK1403|NBK6816|NBK1249	
nutritional status	5	NBK1450|NBK1328|NBK7040|NBK7040|NBK453433	
hyperlipidemia	5	NBK1267|NBK1267|NBK208534|NBK305870|NBK1370	
hepatic disease	5	NBK1267|NBK1267|NBK1267|NBK100826|NBK121284	
neurologic manifestations	5	NBK1267|NBK333437|NBK115333|NBK435692|NBK1376	
evaluation following initial diagnosis	5	NBK1365|NBK1360|NBK349072|NBK1173|NBK1232	
intellectual disability	5	NBK2591|NBK1191|NBK1484|NBK214367|NBK1183	
ataxia	5	NBK2591|NBK338165|NBK184570|NBK247161|NBK3795	
cancer	5	NBK26468|NBK1398|NBK22301|NBK22301|NBK1237	
physical therapy	5	NBK247162|NBK327268|NBK1279|NBK453432|NBK1121	
bone marrow transplantation (bmt)	5	NBK1398|NBK1364|NBK1269|NBK1149|NBK1410	
mothertobaby	5	NBK1517|NBK447152|NBK65707|NBK1515|NBK1512	
special education	5	NBK326661|NBK2587|NBK43417|NBK1535|NBK1277	
developmental delay	5	NBK1110|NBK1332|NBK425128|NBK1415|NBK274566	
eye examination	5	NBK1110|NBK1332|NBK1274|NBK373578|NBK1219	
see www	5	NBK1104|NBK114807|NBK1405|NBK1515|NBK1512	
consultation with a clinical geneticist	5	NBK1104|NBK1458|NBK1676|NBK51671|NBK1405	
dermatologic evaluation	5	NBK154652|NBK1186|NBK390610|NBK51754|NBK1237	
1-0	5	NBK99496|NBK1474|NBK1180|NBK1283|NBK2692	
hematopoietic stem cell transplantation (hsct)	5	NBK99496|NBK1127|NBK1533|NBK1162|NBK1370	
hematologic	5	NBK84550|NBK22301|NBK1279|NBK1118|NBK1237	
alcohol	5	NBK1181|NBK2701|NBK1338|NBK247161|NBK1115	
treatment is symptomatic and may include the following:	5	NBK1205|NBK1511|NBK1468|NBK153601|NBK169431	
complete physical and neurologic examination	5	NBK1507|NBK327268|NBK1383|NBK1124|NBK1249	
family history	5	NBK1245|NBK1190|NBK1392|NBK1243|NBK1222	
physical therapy assessment	5	NBK1119|NBK390610|NBK1233|NBK1520|NBK195854	
dystonia	5	NBK1216|NBK453432|NBK320989|NBK1173|NBK378974	
physical and neurologic examination	5	NBK1191|NBK1199|NBK47079|NBK390803|NBK1310	
no clinical guidelines for surveillance are available	5	NBK7040|NBK115333|NBK92947|NBK6803|NBK425223	
genitourinary	5	NBK22301|NBK343782|NBK1412|NBK447920|NBK426063	
fasting	5	NBK220444|NBK1496|NBK1231|NBK154378|NBK6852	
children	5	NBK1508|NBK174884|NBK97965|NBK305870|NBK83985	
ophthalmology	5	NBK333438|NBK425723|NBK1353|NBK1265|NBK1341	
in the united states:	5	NBK453432|NBK201978|NBK447920|NBK447257|NBK453434	
consider evaluation for alternative means of communication (e	5	NBK453432|NBK425540|NBK201978|NBK447257|NBK453434	
table 5	5	NBK425540|NBK425128|NBK1319|NBK1217|NBK453434	
surgery	5	NBK26372|NBK148668|NBK1414|NBK196157|NBK3822	
liver phk deficiency	5	NBK55061|NBK55061|NBK55061|NBK55061|NBK55061	
muscle phk deficiency	5	NBK55061|NBK55061|NBK55061|NBK55061|NBK55061	
agents	5	NBK2689|NBK2689|NBK2689|NBK2689|NBK1230	
yes	5	NBK1283|NBK1283|NBK1283|NBK1283|NBK1283	
tremor-controlling drugs do not work well for cerebellar tremors	5	NBK1184|NBK1399|NBK1275|NBK1471|NBK1268	
no dietary factor has been shown to curtail symptoms	5	NBK1225|NBK1399|NBK1275|NBK1256|NBK1268	
hbh disease	4	NBK1435|NBK1435|NBK1435|NBK1435	
complete skeletal survey	4	NBK1516|NBK1317|NBK1350|NBK373578	
respiratory status	4	NBK1516|NBK1317|NBK5189|NBK350554	
ocular	4	NBK355754|NBK355754|NBK355754|NBK1207	
see agents/circumstances to avoid	4	NBK1193|NBK1193|NBK169003|NBK143129	
plasma amino acids	4	NBK26471|NBK247162|NBK220444|NBK1231	
liver	4	NBK1519|NBK390610|NBK1448|NBK1326	
appropriate measures include the following:	4	NBK1429|NBK169615|NBK1253|NBK26373	
annual	4	NBK1426|NBK1110|NBK1332|NBK327268	
smoking	4	NBK390611|NBK174884|NBK1246|NBK1220	
inquire about frequency and severity of chest infections	4	NBK1503|NBK1503|NBK1503|NBK1503	
deafness	4	NBK22925|NBK2689|NBK3795|NBK274566	
dietary management	4	NBK1328|NBK1231|NBK1319|NBK92946	
use of antiepileptic medication during pregnancy reduces this risk	4	NBK1293|NBK1491|NBK201978|NBK1465	
5-1	4	NBK1156|NBK1319|NBK1319|NBK1319	
annual:	4	NBK1156|NBK201366|NBK114458|NBK299584	
measurement of blood pressure	4	NBK1156|NBK153723|NBK1132|NBK1326	
exocrine pancreatic insufficiency	4	NBK1250|NBK1250|NBK1250|NBK1250	
audiologic	4	NBK1186|NBK1216|NBK1875|NBK1302	
dermatologic	4	NBK1186|NBK22301|NBK390610|NBK1237	
scoliosis	4	NBK1259|NBK1215|NBK426063|NBK148820	
mri	4	NBK99496|NBK148668|NBK1414|NBK1175	
nutritional evaluation	4	NBK304142|NBK425540|NBK92947|NBK5942	
treatment follows routine practices	4	NBK304142|NBK4144|NBK4144|NBK4144	
immunologic	4	NBK84550|NBK425540|NBK425540|NBK1118	
gov	4	NBK1337|NBK1527|NBK1496|NBK97965	
aro	4	NBK1127|NBK1127|NBK1127|NBK1127	
adoii	4	NBK1127|NBK1127|NBK1127|NBK1127	
measurement of height, weight, and head circumference	4	NBK1346|NBK1676|NBK51671|NBK51754	
speech therapy	4	NBK1168|NBK201366|NBK43417|NBK1214	
some individuals require forearm crutches or canes for gait stability	4	NBK1358|NBK1187|NBK1340|NBK1374	
detailed family history	4	NBK1205|NBK1468|NBK1374|NBK49247	
multidisciplinary developmental evaluation	4	NBK1507|NBK327268|NBK1383|NBK1124	
cognitive	4	NBK1507|NBK1828|NBK426063|NBK426063	
caregivers	4	NBK385626|NBK367946|NBK385627|NBK379665	
developmental and neurologic assessment	4	NBK7040|NBK1164|NBK425223|NBK1403	
heart defects	4	NBK1373|NBK114806|NBK274566|NBK1445	
psychotropic medication may also be indicated	4	NBK327268|NBK327268|NBK327268|NBK327268	
constipation	4	NBK327268|NBK1132|NBK426063|NBK453434	
antiepileptic drugs	4	NBK25442|NBK453432|NBK1214|NBK453434	
spasticity	4	NBK453432|NBK338165|NBK184570|NBK247161	
global developmental disability / intellectual disability educational issues	4	NBK453432|NBK425540|NBK201978|NBK453434	
private supportive therapies based on the affected individual’s needs	4	NBK453432|NBK447920|NBK426063|NBK447257	
routine	4	NBK453432|NBK426063|NBK426063|NBK426063	
0-3	4	NBK1368|NBK1319|NBK1319|NBK1148	
ophthalmologic assessment	4	NBK56080|NBK368476|NBK121988|NBK1490	
deep brain stimulation (dbs)	4	NBK56080|NBK1414|NBK121988|NBK1489	
immunizations	4	NBK164500|NBK1121|NBK148668|NBK1377	
pulmonary function testing	4	NBK390610|NBK1274|NBK195854|NBK1377	
sodium benzoate	4	NBK97260|NBK1357|NBK154378|NBK1217	
author, personal observation]	4	NBK97965|NBK1357|NBK447152|NBK1397	
developmental	4	NBK114806|NBK390670|NBK1412|NBK100240	
feeding	4	NBK425128|NBK184570|NBK5199|NBK1448	
psychomotor development	4	NBK368476|NBK401562|NBK1177|NBK20221	
8-2	4	NBK1133|NBK1319|NBK1319|NBK1319	
growth parameters	4	NBK1215|NBK24701|NBK1270|NBK26373	
val804met+p	4	NBK1257|NBK1257|NBK1257|NBK1257	
baseline ophthalmologic examination	4	NBK1828|NBK1875|NBK1165|NBK1302	
antioxidants	4	NBK1231|NBK190101|NBK84399|NBK1512	
organ transplantation	4	NBK1231|NBK1283|NBK2692|NBK92946	
hypogonadism	4	NBK247161|NBK1330|NBK4144|NBK378974	
asd = autism spectrum disorder	4	NBK447920|NBK447920|NBK447257|NBK447257	
see published guidelines/consensus statements	4	NBK1148|NBK1148|NBK1377|NBK1377	
audiology	4	NBK1353|NBK1265|NBK1341|NBK1341	
or x	4	NBK1515|NBK1515|NBK1515|NBK1515	
0 ml/kg	4	NBK1217|NBK1217|NBK1217|NBK1217	
low-frequency sensorineural hearing loss (lfsnhl)	4	NBK4144|NBK4144|NBK4144|NBK4144	
audiometry	3	NBK1396|NBK1396|NBK1300	
skeletal assessment	3	NBK1396|NBK1396|NBK1269	
hydrocephalus	3	NBK1419|NBK1152|NBK1484	
org)	3	NBK1418|NBK1146|NBK196157	
urologic	3	NBK299311|NBK1267|NBK1267	
measurement of intraocular pressure	3	NBK84111|NBK1360|NBK2690	
adrenal insufficiency	3	NBK1431|NBK190103|NBK174451	
other treatments	3	NBK1193|NBK1490|NBK1143	
see therapies under investigation	3	NBK1454|NBK1370|NBK1184	
hepatic	3	NBK26471|NBK1118|NBK92947	
cbc	3	NBK26471|NBK1156|NBK1515	
urine organic acids	3	NBK26471|NBK220444|NBK63582	
liver disease	3	NBK1519|NBK1250|NBK1250	
evaluation of renal function	3	NBK1207|NBK1361|NBK1194	
molecular genetic testing	3	NBK1207|NBK395975|NBK1307	
see mothertobaby for further information on medication use during pregnancy	3	NBK1108|NBK1308|NBK1465	
pulmonary function tests	3	NBK1450|NBK1400|NBK1261	
progressive sensorineural hearing loss	3	NBK1267|NBK1267|NBK1267	
renal function	3	NBK333437|NBK1360|NBK1367	
renal manifestations	3	NBK333437|NBK3789|NBK1376	
wilms tumor	3	NBK1360|NBK1360|NBK1219	
dialysis	3	NBK100238|NBK1283|NBK2692	
valproic acid	3	NBK51784|NBK1430|NBK174452	
emg	3	NBK1255|NBK1499|NBK1382	
surveillance should include annual neurologic examination	3	NBK1255|NBK25442|NBK1501	
surgical stabilization of the spine may be required	3	NBK253404|NBK1133|NBK1335	
pectus excavatum can be severe	3	NBK253404|NBK1133|NBK1335	
contact sports, competitive sports, and isometric exercise	3	NBK253404|NBK1133|NBK1335	
optic atrophy	3	NBK2591|NBK1876|NBK4144	
chelation therapy	3	NBK1426|NBK1281|NBK431123	
uveal melanoma	3	NBK390611|NBK390611|NBK390611	
malignant mesothelioma	3	NBK390611|NBK390611|NBK390611	
bethlem myopathy	3	NBK1503|NBK1503|NBK1503	
appropriate treatment includes the following:	3	NBK169615|NBK269029|NBK7050	
for ages 0-3 years	3	NBK424403|NBK426063|NBK447257	
for ages 3-5 years	3	NBK424403|NBK426063|NBK447257	
for ages 5-21 years	3	NBK424403|NBK426063|NBK447257	
for all ages	3	NBK424403|NBK426063|NBK447257	
social/behavioral difficulties	3	NBK424403|NBK447920|NBK447257	
infertility	3	NBK1441|NBK22925|NBK1518	
05-0	3	NBK1171|NBK1361|NBK1319	
precocious puberty	3	NBK1171|NBK274564|NBK274564	
blood pressure	3	NBK1171|NBK1171|NBK153723	
neonatal/infantile canavan disease	3	NBK1234|NBK1234|NBK1234	
orthopedic evaluation	3	NBK169825|NBK453432|NBK1352	
educational intervention is insufficient to completely remediate these deficiencies	3	NBK22925|NBK1434|NBK100664	
weight control to avoid obesity	3	NBK1385|NBK1476|NBK1408	
audiologic examination	3	NBK326661|NBK1186|NBK4144	
feeding difficulties	3	NBK1391|NBK1191|NBK1183	
osteopenia	3	NBK1110|NBK425926|NBK1416	
regular follow up of ophthalmologic and/or audiologic abnormalities	3	NBK1104|NBK131811|NBK321516	
cardiac ultrasound examination	3	NBK1544|NBK368475|NBK1270	
management is supportive	3	NBK1544|NBK185330|NBK1140	
0-2	3	NBK1156|NBK1518|NBK1319	
hearing screen	3	NBK1156|NBK1828|NBK1875	
immunization for hepatitis a and b is recommended	3	NBK154652|NBK100826|NBK121284	
avoidance of sunlight and uv light	3	NBK154652|NBK100826|NBK121284	
, estrogens)	3	NBK154652|NBK100826|NBK121284	
pulmonary function studies	3	NBK1259|NBK1476|NBK1230	
colitis	3	NBK99496|NBK1287|NBK1287	
electroretinogram	3	NBK1337|NBK1222|NBK3821	
feeding and nutrition	3	NBK5189|NBK385289|NBK1448	
orthopedic surgery	3	NBK45014|NBK1393|NBK1407	
exercise within the individual's capability	3	NBK1205|NBK1285|NBK1511	
complete family history	3	NBK1285|NBK1187|NBK1307	
fewer than 5% need wheelchairs	3	NBK1285|NBK1187|NBK1374	
symptomatic treatment	3	NBK201366|NBK5201|NBK431123	
respiratory dysfunction	3	NBK201366|NBK1443|NBK1443	
see prevention of primary manifestations	3	NBK7046|NBK1279|NBK6816	
pharmacologic treatment	3	NBK410087|NBK174884|NBK1295	
ophthalmology evaluation	3	NBK1507|NBK425723|NBK447920	
central nervous system	3	NBK1507|NBK1480|NBK1220	
endocrinopathies	3	NBK1507|NBK274564|NBK274564	
hypoglycemia	3	NBK1507|NBK55061|NBK55061	
spine	3	NBK1455|NBK1180|NBK148668	
5-0	3	NBK3794|NBK1361|NBK1283	
0 g/m2	3	NBK1458|NBK1458|NBK97260	
fitting with appropriate hearing aids	3	NBK1536|NBK1272|NBK1383	
enrollment in an appropriate educational program for the hearing impaired	3	NBK1536|NBK1272|NBK1383	
comprehensive neurologic examination and developmental/cognitive assessment	3	NBK7040|NBK6803|NBK425223	
adults	3	NBK1508|NBK97965|NBK83985	
see hereditary hearing loss and deafness overview	3	NBK1373|NBK214367|NBK1302	
baseline audiologic evaluation	3	NBK327268|NBK1331|NBK1249	
growth hormone deficiency	3	NBK327268|NBK247161|NBK1324	
genetic counseling	3	NBK327268|NBK1199|NBK1222	
tolerance to different primary layers varies	3	NBK1157|NBK1304|NBK1125	
nonstick products (e	3	NBK1157|NBK1125|NBK1369	
silicone-based products without adhesive (e	3	NBK1157|NBK1304|NBK1125	
rolls of gauze (e	3	NBK1157|NBK1304|NBK1125	
the most common secondary complication is infection	3	NBK1157|NBK1304|NBK1125	
both antibiotics and antiseptics need to be employed	3	NBK1157|NBK1304|NBK1125	
psychiatric	3	NBK1279|NBK447920|NBK453434	
affected system	3	NBK453432|NBK426063|NBK426063	
if seizures are suspected	3	NBK453432|NBK426063|NBK426063	
cleft palate	3	NBK1263|NBK368476|NBK1407	
the following should be performed on a regular basis:	3	NBK56080|NBK121988|NBK1490	
iron chelation	3	NBK56080|NBK121988|NBK1490	
miscellaneous / other	3	NBK425540|NBK447920|NBK453434	
consultation w/a clinical geneticist and/or genetic counselor	3	NBK425540|NBK425128|NBK426063	
neutropenia	3	NBK425540|NBK285321|NBK1364	
physical therapy is recommended to maximize mobility	3	NBK425540|NBK447257|NBK453434	
surveillance includes:	3	NBK1206|NBK190103|NBK1467	
the following measures are appropriate:	3	NBK1676|NBK1420|NBK385289	
papillomatosis	3	NBK1543|NBK1543|NBK1543	
genetic	3	NBK1543|NBK1111|NBK1397	
no specific treatment is available	3	NBK1384|NBK1384|NBK1384	
abdominal ultrasound examination	3	NBK1459|NBK115333|NBK1377	
pain	3	NBK1443|NBK1443|NBK1525	
age	3	NBK1269|NBK1768|NBK174884	
ketogenic diet	3	NBK1318|NBK1430|NBK379665	
height	3	NBK11168|NBK11168|NBK1382	
neuropsychological assessment	3	NBK1430|NBK385627|NBK396561	
7-2	3	NBK1312|NBK1312|NBK1319	
nutrition/feeding	3	NBK1261|NBK1261|NBK2594	
annual hearing evaluation	3	NBK1261|NBK62111|NBK1248	
cardiac manifestations	3	NBK115333|NBK1170|NBK373578	
pediatric issues	3	NBK1404|NBK1495|NBK7014	
none	3	NBK333439|NBK333439|NBK333439	
cataract	3	NBK390610|NBK2689|NBK1237	
complete blood count with differential	3	NBK390610|NBK1231|NBK435692	
liver function	3	NBK100241|NBK1170|NBK1448	
urinary tract	3	NBK1211|NBK343782|NBK154138	
enzyme replacement therapy	3	NBK1150|NBK1370|NBK1370	
hearing test	3	NBK1274|NBK1282|NBK1282	
the transplanted kidney does not develop the disease	3	NBK53700|NBK1356|NBK1356	
supportive therapy includes the following:	3	NBK2587|NBK43417|NBK1535	
use of respiratory aids when indicated	3	NBK1476|NBK1408|NBK1303	
neurology consultation	3	NBK258641|NBK9587|NBK274566	
genitourinary abnormalities	3	NBK190103|NBK368476|NBK1324	
developmental progress	3	NBK114806|NBK390670|NBK1284	
clinical evaluation	3	NBK1389|NBK9674|NBK1362	
0 cm	3	NBK1133|NBK1335|NBK1120	
epilepsy	3	NBK274565|NBK1284|NBK3795	
see hereditary hearing loss and deafness	3	NBK274565|NBK201365|NBK378974	
8 yrs	3	NBK1257|NBK1257|NBK1257	
men 2a	3	NBK1257|NBK1257|NBK1257	
fmtc	3	NBK1257|NBK1257|NBK1257	
men 2b	3	NBK1257|NBK1257|NBK1257	
complete ophthalmologic examination	3	NBK1473|NBK1331|NBK1114	
supportive and symptomatic management is indicated	3	NBK1828|NBK1875|NBK24701	
antibiotic prophylaxis	3	NBK24701|NBK1178|NBK1402	
click here for full text	3	NBK1130|NBK1407|NBK1407	
9-2	3	NBK1319|NBK1319|NBK1319	
2(1	3	NBK1319|NBK1319|NBK1319	
0(1	3	NBK1319|NBK1319|NBK1319	
5-2	3	NBK1319|NBK1319|NBK1319	
7-4	3	NBK1319|NBK1319|NBK1319	
neuroimaging	3	NBK1319|NBK3795|NBK1275	
infection	3	NBK1319|NBK1178|NBK1178	
dysphagia	3	NBK1126|NBK1115|NBK378974	
vision	3	NBK1448|NBK1265|NBK1341	
pulmonary hypertension	3	NBK1230|NBK1377|NBK1377	
severe atp8b1 deficiency	3	NBK1297|NBK1297|NBK1297	
mild atp8b1 deficiency	3	NBK1297|NBK1297|NBK1297	
1 year	3	NBK1266|NBK1266|NBK1266	
care by a pediatric endocrinologist is recommended	3	NBK174451|NBK174451|NBK174451	
pituitary blastoma	3	NBK196157|NBK196157|NBK196157	
pineoblastoma	3	NBK196157|NBK196157|NBK196157	
standard management	3	NBK426063|NBK426063|NBK453434	
dental examination	3	NBK83985|NBK83985|NBK201365	
assessment of iron status	3	NBK1377|NBK1377|NBK431123	
for trps ii only	3	NBK425926|NBK425926|NBK425926	
x(until normal)	3	NBK1515|NBK1515|NBK1515	
blood tests	2	NBK1396|NBK1396	
consider consultation with a clinical geneticist and/or genetic counselor	2	NBK1435|NBK447258	
craniosynostosis	2	NBK1419|NBK1415	
obstructive sleep apnea	2	NBK1152|NBK425128	
kyphosis	2	NBK1152|NBK1152	
spinal stenosis	2	NBK1152|NBK1152	
neurologic findings	2	NBK1493|NBK1333	
retinal degeneration	2	NBK1493|NBK1256	
complete blood count (cbc)	2	NBK1483|NBK99496	
cutaneous/cranial	2	NBK355754|NBK355754	
limb	2	NBK355754|NBK1111	
slit lamp examination	2	NBK84111|NBK2690	
measurement of axial length	2	NBK84111|NBK1135	
there are no published guidelines for surveillance	2	NBK263441|NBK1163	
psychiatric evaluation if behavioral problems are present	2	NBK355518|NBK51754	
cleft lip/palate	2	NBK43797|NBK268648	
chronic treatment	2	NBK1431|NBK1353	
hypogonadotropic hypogonadism	2	NBK1431|NBK174451	
european porphyria network	2	NBK1193|NBK1193	
complete neurologic assessment	2	NBK1172|NBK100239	
urology	2	NBK1454|NBK1407	
formal assessment of vision and hearing	2	NBK26471|NBK195854	
movement disorder	2	NBK26471|NBK3794	
ophthalmologist	2	NBK26471|NBK5199	
annually	2	NBK26471|NBK2692	
lung disease	2	NBK1519|NBK1180	
vaccination against hepatitis a and b	2	NBK1519|NBK169003	
antioxidant therapy	2	NBK1519|NBK1281	
males	2	NBK1207|NBK1292	
females	2	NBK1207|NBK1292	
speech evaluation	2	NBK1450|NBK425723	
dilated cardiomyopathy	2	NBK1267|NBK1119	
orthopedic abnormalities	2	NBK1267|NBK51754	
rod-cone dystrophy	2	NBK1267|NBK1267	
exercise	2	NBK1267|NBK1119	
these include:	2	NBK333437|NBK1377	
aniridic fibrosis syndrome	2	NBK1360|NBK1360	
see wilms tumor overview	2	NBK1360|NBK1360	
glaucoma	2	NBK1360|NBK1132	
no definitive treatments for the limb-girdle muscular dystrophies exist	2	NBK114459|NBK1408	
examination of cranial nerve function	2	NBK1456|NBK1154	
routine visits to the neurologist are appropriate	2	NBK1456|NBK1874	
gait	2	NBK5300|NBK1208	
see author notes	2	NBK5300|NBK1425	
platelet count	2	NBK208534|NBK1367	
splenomegaly	2	NBK208534|NBK5188	
abdominal pain	2	NBK208534|NBK1370	
thrombocytopenia	2	NBK208534|NBK1364	
kidney transplantation	2	NBK100238|NBK1231	
plasma ammonia concentration	2	NBK1159|NBK154378	
complete neurologic evaluation	2	NBK1159|NBK1484	
reducing the risk of neurologic damage	2	NBK1159|NBK154378	
9-13	2	NBK1159|NBK154378	
8-15	2	NBK51784|NBK1458	
excess protein intake	2	NBK51784|NBK1458	
obvious exposure to communicable diseases	2	NBK51784|NBK1458	
, scoliosis)	2	NBK253404|NBK447920	
see deafness and hereditary hearing loss overview, management	2	NBK2591|NBK1876	
holter monitoring	2	NBK1131|NBK1289	
cbc with differential	2	NBK26468|NBK1424	
immunodeficiency	2	NBK26468|NBK1287	
additional studies are in progress	2	NBK26468|NBK1119	
cardiac examination	2	NBK1241|NBK7041	
some symptoms (e	2	NBK1241|NBK1178	
bone marrow transplantation	2	NBK1426|NBK1271	
osteoporosis	2	NBK1426|NBK1513	
3 years	2	NBK247162|NBK1266	
coenzyme q10	2	NBK247162|NBK220444	
rapid enlargement should prompt evaluation for possible hydrocephalus	2	NBK1151|NBK61984	
no evidence for the efficacy of regular neuroimaging exists	2	NBK1151|NBK61984	
skin should be examined at least annually	2	NBK1151|NBK61984	
evaluation of degree of muscle weakness and mobility	2	NBK1503|NBK1503	
assessment of respiratory status	2	NBK1503|NBK1503	
ullrich cmd	2	NBK1503|NBK1503	
assessments of respiratory function to detect asymptomatic decline	2	NBK1503|NBK1503	
in-depth neurologic examination	2	NBK32534|NBK201978	
kcnq2-bfne	2	NBK32534|NBK32534	
kcnq2-nee	2	NBK32534|NBK32534	
the eeg at 24 months should be normal	2	NBK32534|NBK201978	
symptoms typically resolve within days	2	NBK169615|NBK320989	
there is no consensus on clinical surveillance	2	NBK1522|NBK1252	
radiation exposure	2	NBK1522|NBK3789	
evaluation for psychomotor deficits	2	NBK1322|NBK1322	
evaluation for sensorineural hearing loss	2	NBK1322|NBK1322	
consultation with a metabolic specialist or clinical geneticist	2	NBK1322|NBK1322	
second branchial arch anomalies	2	NBK1380|NBK1380	
otologic anomalies	2	NBK1380|NBK1380	
education of parents regarding common seizure presentations is appropriate	2	NBK424403|NBK350554	
, contractures, scoliosis, hip dislocation)	2	NBK424403|NBK201978	
parkinsonism	2	NBK424403|NBK47027	
other features	2	NBK424403|NBK114806	
ovarian insufficiency	2	NBK1441|NBK242617	
hormone replacement therapy (hrt)	2	NBK1441|NBK1247	
breast cancer	2	NBK1247|NBK1139	
chemoprevention	2	NBK1247|NBK1345	
oral glucose tolerance test	2	NBK1212|NBK1248	
cardiology and/or echocardiographic assessment for structural heart defects	2	NBK373577|NBK214367	
cardiac defects are managed in a routine manner	2	NBK373577|NBK214367	
medical genetics consultation may also be considered	2	NBK1167|NBK1208	
assessment of neonates for hypoglycemia	2	NBK1394|NBK1219	
blood gases	2	NBK284774|NBK1458	
lipid profile	2	NBK1171|NBK1514	
bone mineral density	2	NBK1171|NBK1170	
mild/juvenile canavan disease	2	NBK1234|NBK1234	
evaluation for scoliosis	2	NBK246980|NBK25507	
may be repeated as needed)	2	NBK1286|NBK1286	
(see malignant hyperthermia susceptibility	2	NBK1385|NBK1165	
complete blood count to monitor for cytopenias	2	NBK1328|NBK92946	
eeg and brain mri in symptomatic individuals	2	NBK1328|NBK92946	
levocarnitine	2	NBK1328|NBK92946	
developmental and neurocognitive progress, as age-appropriate	2	NBK1328|NBK92946	
physical therapy and rehabilitation to improve motor function	2	NBK326661|NBK43417	
orthopedic complications	2	NBK1513|NBK114458	
headaches	2	NBK1293|NBK1370	
neurologic deficits	2	NBK1293|NBK304142	
see malignant hyperthermia susceptibility for more details	2	NBK1391|NBK1391	
orthopedic referral	2	NBK62112|NBK1350	
they can tolerate carbohydrates, fats, and protein	2	NBK1110|NBK1332	
oral motor dysfunction with persistent vomiting	2	NBK1110|NBK1332	
consultation with a gastroenterologist and nutritionist is often necessary	2	NBK1110|NBK1332	
"infantile catastrophic phase	2	NBK1110|NBK1332	
strabismus	2	NBK1110|NBK1332	
stroke-like episodes	2	NBK1110|NBK1332	
coagulopathy	2	NBK1110|NBK1332	
deep venous thrombosis (dvt)	2	NBK1110|NBK1332	
independent living issues	2	NBK1110|NBK1332	
periodic assessment of bleeding and clotting parameters by a hematologist	2	NBK1110|NBK1332	
follow up with an orthopedist when scoliosis becomes evident	2	NBK1110|NBK1332	
to prevent secondary complications:	2	NBK1104|NBK1514	
echocardiogram and electrocardiogram	2	NBK84551|NBK84551	
affected individuals	2	NBK47457|NBK1176	
complete neurologic examination	2	NBK1156|NBK1473	
dental assessment	2	NBK154652|NBK1228	
ocular manifestations	2	NBK154652|NBK1331	
aeruginosa in airway cultures	2	NBK1250|NBK1250	
bronchodilator	2	NBK1250|NBK1250	
hypertonic saline	2	NBK1250|NBK1250	
dornase alfa	2	NBK1250|NBK1250	
airway clearance	2	NBK1250|NBK1250	
fertility	2	NBK1250|NBK1547	
endocrine evaluation	2	NBK1186|NBK1117	
electroencephalogram if seizures are suspected	2	NBK1186|NBK9587	
cognitive development	2	NBK1186|NBK385289	
refractive errors may be managed with spectacles or contact lenses	2	NBK1348|NBK1190	
to improve alignment in primary gaze position	2	NBK1348|NBK1190	
contractures	2	NBK1259|NBK453432	
sleep studies	2	NBK1259|NBK1290	
swallowing assessment	2	NBK1387|NBK99167	
a structured general medical history and family history	2	NBK304142|NBK1505	
physical examination and neurologic examination	2	NBK304142|NBK1505	
pulmonary function testing to detect and stage respiratory involvement	2	NBK304142|NBK5942	
adequate nutrition and weight maintenance are essential	2	NBK304142|NBK5942	
appropriate bracing and stretching can minimize contractures	2	NBK304142|NBK5942	
antidepressants are often required to treat concurrent depression	2	NBK304142|NBK5942	
further studies are needed to clarify this issue	2	NBK304142|NBK1505	
neurologic examination including:	2	NBK333201|NBK379665	
ocular abnormalities	2	NBK5188|NBK1415	
imaging	2	NBK84550|NBK1538	
skeletal dysplasia	2	NBK84550|NBK84550	
immunodeficiency and infection	2	NBK84550|NBK84550	
funduscopic examination	2	NBK1337|NBK1222	
services provided vary based on age and needs	2	NBK1337|NBK1222	
clinicaltrials	2	NBK1337|NBK1295	
niccd	2	NBK1181|NBK1181	
investigate feeding pattern	2	NBK1181|NBK1181	
fttdcd	2	NBK1181|NBK1181	
ctln2	2	NBK1181|NBK1181	
radiologic examinations if spinal deformity is observed	2	NBK1291|NBK1168	
medical treatment	2	NBK1168|NBK1120	
physical and occupational therapy	2	NBK1168|NBK1203	
ventilatory support	2	NBK1168|NBK1427	
daily heel cord stretching exercises to prevent achilles tendon shortening	2	NBK1539|NBK1511	
click here for an up-to-date list	2	NBK45014|NBK1340	
fewer than 5% of individuals need wheelchairs	2	NBK1358|NBK1205	
nerve biopsy has shown lymphocytic infiltration	2	NBK1358|NBK1205	
ile99thr) [donaghy et al 2000]	2	NBK1358|NBK1205	
placebo in 110 subjects with cmt1a	2	NBK1358|NBK1205	
nerve conduction velocity (ncv)	2	NBK1285|NBK49247	
emg with ncv	2	NBK1511|NBK1307	
visual evoked potentials	2	NBK1511|NBK1473	
odontoid hypoplasia	2	NBK201366|NBK148668	
trpv4-associated neuromuscular disorders	2	NBK201366|NBK201366	
trpv4-associated skeletal dysplasias	2	NBK201366|NBK201366	
exercise within the individual's capability to remain physically active	2	NBK1468|NBK169431	
hearing aids as needed	2	NBK131811|NBK321516	
management includes the following:	2	NBK1482|NBK453433	
0 mm in diameter	2	NBK7046|NBK1246	
bone density	2	NBK1507|NBK1279	
general anesthesia	2	NBK1253|NBK1496	
otolaryngologic evaluation	2	NBK1461|NBK1407	
assessment for exposure keratopathy	2	NBK1455|NBK1415	
sodium benzoate: 250 mg/kg or 5	2	NBK1458|NBK1458	
sodium phenylacetate: 250 mg/kg or 5	2	NBK1458|NBK1458	
10% arginine hcl: 600 mg/kg or 12	2	NBK1458|NBK1458	
reversal of catabolism	2	NBK1458|NBK154378	
age-appropriate immunizations including the influenza vaccine should be provided	2	NBK1458|NBK220444	
gene therapy has been suggested	2	NBK1458|NBK1424	
thyroid function studies	2	NBK1400|NBK1376	
resting ecg	2	NBK1289|NBK1289	
recommended drugs are nadolol (1-2	2	NBK1289|NBK1289	
prednisone	2	NBK1119|NBK1425	
bmd	2	NBK1119|NBK1119	
blood	2	NBK1119|NBK1373	
measurement of height and weight	2	NBK11167|NBK274565	
physical examination for skeletal anomalies (e	2	NBK1191|NBK1183	
gastroesophageal reflux should be addressed in a standard manner	2	NBK1191|NBK1183	
ophthalmologic abnormalities are treated in the standard manner	2	NBK1191|NBK1183	
skeletal abnormalities (e	2	NBK1191|NBK1183	
hearing loss is treated with a trial of hearing aids	2	NBK1191|NBK1183	
infants benefit from enrollment in an early-intervention program	2	NBK1158|NBK390803	
73 m2 (ckd stage 3b)	2	NBK99494|NBK99494	
repeat audiometry to confirm stability of hearing loss	2	NBK1536|NBK1272	
hepatic function	2	NBK7040|NBK7040	
afp and hepatic sonography to monitor for hepatocellular carcinoma	2	NBK7040|NBK7040	
preterm delivery	2	NBK7047|NBK447152	
physical therapy consultation	2	NBK1350|NBK114628	
cancer surveillance	2	NBK22301|NBK1401	
blood transfusions	2	NBK22301|NBK1401	
thiamine	2	NBK220444|NBK1282	
riboflavin	2	NBK220444|NBK299312	
initial treatment	2	NBK1447|NBK1375	
long-term medical management	2	NBK1447|NBK1375	
levodopa	2	NBK1508|NBK1489	
treatment of psychiatric problems with appropriate psychotropic medications	2	NBK1491|NBK1438	
adaptation of environment and care to the level of dementia	2	NBK1491|NBK1438	
heart	2	NBK1373|NBK1445	
kidneys	2	NBK1373|NBK1445	
individuals with severe heart block may require pacemaker implantation	2	NBK1373|NBK1111	
growth retardation	2	NBK1373|NBK1370	
general physical examination	2	NBK1190|NBK1492	
0 mg/dl	2	NBK258640|NBK1973	
complete review of systems	2	NBK367946|NBK47079	
physical examination	2	NBK367946|NBK1305	
general clinical examination	2	NBK344340|NBK50780	
cardiology evaluation	2	NBK327268|NBK1249	
feeding therapy	2	NBK327268|NBK447257	
surveillance for individuals with the 7q11	2	NBK327268|NBK327268	
23 duplication syndrome	2	NBK327268|NBK327268	
test/measurement	2	NBK327268|NBK1249	
clinical examination	2	NBK3823|NBK24701	
oral medications are usually tried first:	2	NBK1492|NBK378974	
baclofen (lioresal®)	2	NBK1492|NBK378974	
benzodiazepines	2	NBK1492|NBK1318	
renal ultrasound	2	NBK1157|NBK153722	
primary layers include the following:	2	NBK1157|NBK1125	
, telfa®, n-terface®)	2	NBK1157|NBK1125	
, mepitel®, mepilex®)	2	NBK1157|NBK1125	
calcium and vitamin d replacement for osteopenia and osteoporosis	2	NBK1157|NBK1125	
in general, activities that traumatize the skin (e	2	NBK1157|NBK1304	
clinical genetics consultation may also be considered	2	NBK1304|NBK1200	
, kerlix®) are commonly used	2	NBK1125|NBK1369	
hypotrichosis	2	NBK1200|NBK1112	
monitoring of respiratory function	2	NBK1436|NBK1408	
eeg and video eeg	2	NBK453432|NBK426063	
consultation w/clinical geneticist and/or genetic counselor	2	NBK453432|NBK453434	
treatment of manifestations in individuals with ethylmalonic encephalopathy	2	NBK453432|NBK453432	
gorman et al [2016]	2	NBK453432|NBK453432	
enrollment in developmental disabilities administration (dda) is recommended	2	NBK453432|NBK447257	
, contractures)	2	NBK453432|NBK1107	
surveillance should be individualized based on symptoms and organs affected	2	NBK453432|NBK1179	
recommended surveillance for individuals with ethylmalonic encephalopathy	2	NBK453432|NBK453432	
frequency	2	NBK453432|NBK447920	
chest roentgenogram	2	NBK54467|NBK5201	
hernia	2	NBK54467|NBK1277	
arterial abnormalities	2	NBK54467|NBK5201	
acute photosensitivity	2	NBK100826|NBK121284	
grey or smoke-colored filters provide only partial protection	2	NBK100826|NBK121284	
topical sunscreens are typically not useful	2	NBK100826|NBK121284	
close monitoring is warranted	2	NBK100826|NBK121284	
hepatic function should be monitored every six to 12 months	2	NBK100826|NBK121284	
respiratory function	2	NBK236968|NBK2594	
examination by an ophthalmologist	2	NBK1401|NBK54582	
referral to an endocrinologist	2	NBK1401|NBK1257	
cardiac evaluation, including echocardiography	2	NBK1292|NBK1282	
testing should include:	2	NBK1368|NBK1148	
multiple phospholipid-dependent coagulation assays for a lupus inhibitor	2	NBK1368|NBK1148	
protein c activity	2	NBK1368|NBK1148	
antithrombin activity	2	NBK1368|NBK1148	
protein s activity or free protein s antigen	2	NBK1368|NBK1148	
treatment of thrombosis in children	2	NBK1368|NBK1148	
pregnancy	2	NBK1368|NBK1367	
prophylactic anticoagulation during pregnancy:	2	NBK1368|NBK1148	
prevention of pregnancy loss	2	NBK1368|NBK1148	
other pregnancy complications	2	NBK1368|NBK1148	
intrathecal baclofen pump	2	NBK56080|NBK45978	
adrenal tumors	2	NBK1345|NBK1345	
see clinicaltrials	2	NBK1345|NBK1345	
pulmonary vessel angiogram	2	NBK5201|NBK343782	
inguinal hernias	2	NBK5201|NBK1413	
antoun et al [2016]	2	NBK425540|NBK425540	
huemer et al [2015]	2	NBK425540|NBK425540	
recommended surveillance for individuals with fbxl4-related mtdna depletion syndrome	2	NBK425540|NBK425540	
ent/mouth	2	NBK425540|NBK425128	
monitoring for orthopedic complications such as foot deformity and scoliosis	2	NBK1206|NBK1408	
referral of the family to support groups and other resources	2	NBK114458|NBK1526	
cryptorchidism	2	NBK114458|NBK268648	
dental problems	2	NBK114458|NBK1132	
audiologic screening	2	NBK114458|NBK401562	
cervical spine instability	2	NBK2534|NBK164500	
fragile x syndrome	2	NBK1384|NBK1384	
fxtas	2	NBK1384|NBK1384	
poi	2	NBK1384|NBK1384	
curefa	2	NBK1281|NBK1281	
org]	2	NBK1281|NBK1281	
epi-743	2	NBK1281|NBK1174	
other therapies	2	NBK1281|NBK1295	
ophthalmologic disease	2	NBK1443|NBK1443	
repair of polydactyly should be undertaken on an elective basis	2	NBK1446|NBK1465	
seizures are treated symptomatically	2	NBK1446|NBK1465	
thus, good sleep hygiene should be encouraged	2	NBK1318|NBK379665	
corticosteroids	2	NBK1318|NBK379665	
immunoglobulins	2	NBK1318|NBK379665	
joint range of motion by an orthopedist/physiotherapist	2	NBK11168|NBK11168	
gm1 gangliosidosis	2	NBK164500|NBK164500	
mps ivb	2	NBK164500|NBK164500	
assessment for the following:	2	NBK164500|NBK164500	
evaluation by an otolaryngologist for adenotonsillectomy	2	NBK164500|NBK148668	
hormone therapy	2	NBK1547|NBK1174	
educational programming directed to the specific disabilities identified	2	NBK1198|NBK24676	
ongoing pediatric care with regular immunizations	2	NBK1198|NBK1310	
3 mmol/l	2	NBK26372|NBK5941	
and after activity	2	NBK55061|NBK55061	
6 to 2	2	NBK55061|NBK55061	
(see malignant hyperthermia susceptibility)	2	NBK55061|NBK55061	
consult with a clinical geneticist and/or genetic counselor	2	NBK349073|NBK1496	
prevention of acute attacks	2	NBK114807|NBK114807	
com	2	NBK114807|NBK1395	
referral to a hemophilia treatment center	2	NBK1404|NBK1495	
for locations:	2	NBK1404|NBK1495	
worldwide, see world federation of hæmophilia	2	NBK1404|NBK1495	
us only, see national hemophilia foundation	2	NBK1404|NBK1495	
intramuscular injections should be avoided unless under factor coverage	2	NBK1404|NBK1495	
intramuscular injections	2	NBK1404|NBK1495	
identification of at-risk relatives	2	NBK1404|NBK1495	
early determination of the genetic status of males at risk	2	NBK1404|NBK1495	
determination of genetic status of females at risk	2	NBK1404|NBK1495	
obstetric issues	2	NBK1404|NBK1495	
newborn males	2	NBK1404|NBK1495	
non-expressing p	2	NBK1440|NBK1440	
cys282tyr homozygotes	2	NBK1440|NBK1440	
cys282tyr	2	NBK1440|NBK1440	
evaluation for excess hepatic iron	2	NBK169003|NBK143129	
dietary guidelines for hereditary fructose intolerance (hfi)	2	NBK333439|NBK333439	
adapted from www	2	NBK333439|NBK333439	
edu/aldolase/hfi/treatment/sugar_table	2	NBK333439|NBK333439	
htm	2	NBK333439|NBK333439	
baseline complete blood count with differential	2	NBK390610|NBK1237	
lung	2	NBK390610|NBK185066	
pancreas	2	NBK390610|NBK1266	
colon cancer	2	NBK1139|NBK1211	
adolescents and adults	2	NBK97260|NBK3795	
250 mg/kg/day	2	NBK97260|NBK97260	
sodium phenylacetate	2	NBK97260|NBK154378	
mechanisms of drug action in treatment of hyperammonemia	2	NBK97260|NBK97260	
raises insulin levels	2	NBK97260|NBK97260	
induces anabolic state	2	NBK97260|NBK97260	
causes protein sparing effect from skeletal muscle amino acids	2	NBK97260|NBK97260	
stimulates secretion of insulin	2	NBK97260|NBK97260	
eliminates one amino group in the urine	2	NBK97260|NBK97260	
eliminates two amino groups in the urine	2	NBK97260|NBK97260	
a non-essential amino acid in humans	2	NBK97260|NBK97260	
surgical management	2	NBK1375|NBK196157	
evaluation and monitoring of pt, ptt, and fibrinogen	2	NBK1444|NBK1406	
evaluation of swallowing and nutritional status	2	NBK100241|NBK431123	
renal and liver function	2	NBK100241|NBK100241	
full blood count	2	NBK100241|NBK100241	
electrolytes	2	NBK100241|NBK1424	
treatment may need to be discontinued if:	2	NBK100241|NBK431123	
saffron	2	NBK100241|NBK431123	
nuts	2	NBK100241|NBK431123	
mussels	2	NBK100241|NBK431123	
dark chocolate	2	NBK100241|NBK431123	
psychological support	2	NBK1150|NBK1416	
table 7	2	NBK1338|NBK1283	
principles of treatment for individuals with hokpp	2	NBK1338|NBK1338	
avoid:	2	NBK1338|NBK395975	
add 0	2	NBK1338|NBK1338	
3 meq/kg/h	2	NBK1338|NBK1338	
(2) in the work setting	2	NBK1338|NBK1338	
prolonged immobility	2	NBK1338|NBK1338	
myopathy	2	NBK1338|NBK1476	
behavior	2	NBK1769|NBK390803	
drugs to reduce muscle spasticity (e	2	NBK1509|NBK247161	
, oxybutynin)	2	NBK1509|NBK247161	
depression	2	NBK1305|NBK47027	
cd46	2	NBK1367|NBK1367	
cfh	2	NBK1367|NBK1367	
dgke	2	NBK1367|NBK1367	
thbd	2	NBK1367|NBK1367	
beta blockers	2	NBK1768|NBK1129	
adapted from gersh et al [2011]	2	NBK1768|NBK1768	
symptoms	2	NBK1768|NBK1230	
hyperuricemia/gout	2	NBK53700|NBK1356	
lifelong therapy with allopurinol may be required	2	NBK53700|NBK1356	
high meat and seafood intake could exacerbate gout	2	NBK53700|NBK1356	
particularly important are:	2	NBK53700|NBK1356	
current recommended drug therapies for adults with fh	2	NBK174884|NBK174884	
15% 1, 3	2	NBK174884|NBK174884	
50% 5	2	NBK174884|NBK174884	
often ineffective in hofh	2	NBK174884|NBK174884	
kastelein et al [2008]	2	NBK174884|NBK174884	
rader et al [2003]	2	NBK174884|NBK174884	
approved only for adults with hofh	2	NBK174884|NBK174884	
cuchel et al [2014]	2	NBK174884|NBK174884	
raal & santos [2012]	2	NBK174884|NBK174884	
240 (170)	2	NBK174884|NBK174884	
a parent, sib, or child	2	NBK174884|NBK174884	
first-degree relatives share about half of their genes	2	NBK174884|NBK174884	
a first cousin, great-grandparent, or great-grandchild	2	NBK174884|NBK174884	
during pregnancy	2	NBK174884|NBK1504	
ezetimibe	2	NBK174884|NBK114805	
physical therapy to improve motor function	2	NBK2587|NBK1535	
pharmacologic treatment of spasticity and seizures	2	NBK1675|NBK121988	
serum concentration of bun and creatinine	2	NBK1118|NBK1249	
nutrition assessment	2	NBK1118|NBK1370	
formal developmental assessment	2	NBK453433|NBK1497	
maintenance therapy	2	NBK1170|NBK1349	
neuroleptic treatment may exacerbate parkinsonism	2	NBK1478|NBK26472	
clinical genetics consultation is appropriate	2	NBK62111|NBK1160	
thyroid function tests	2	NBK114806|NBK1249	
evaluation of males for cryptorchidism	2	NBK114806|NBK390670	
echocardiogram for congenital heart defects	2	NBK114806|NBK390670	
evaluation for laryngomalacia if respiratory issues are present	2	NBK114806|NBK390670	
genital anomalies	2	NBK114806|NBK390670	
surgery as required	2	NBK114806|NBK1324	
routine management	2	NBK114806|NBK426063	
thyroid hormone replacement as needed	2	NBK114806|NBK390670	
contractures and/or scoliosis	2	NBK114806|NBK390670	
recommended evaluations following initial diagnosis of kcnk9 imprinting syndrome	2	NBK425128|NBK425128	
treatment of manifestations in individuals with kcnk9 imprinting syndrome	2	NBK425128|NBK425128	
standard treatment for scoliosis	2	NBK425128|NBK1457	
recommended surveillance for individuals with kcnk9 imprinting syndrome	2	NBK425128|NBK425128	
frequency/comment	2	NBK425128|NBK426063	
every 6 months until age 2 years, then annually	2	NBK425128|NBK425128	
at least annually	2	NBK425128|NBK425128	
developmental disabilities administration (dda) enrollment is recommended	2	NBK201978|NBK453434	
social/behavioral issues	2	NBK201978|NBK425723	
speech	2	NBK1333|NBK5199	
gynecomastia	2	NBK1333|NBK1416	
gastrointestinal tract	2	NBK349072|NBK343782	
sleep history	2	NBK47079|NBK390803	
therapeutic management of the sleep disorder	2	NBK47079|NBK1310	
specialized neurologic care for individuals with epilepsy	2	NBK47079|NBK24676	
management of seizures in accordance with standard practice	2	NBK47079|NBK1310	
auditory amplification if hearing loss is identified	2	NBK47079|NBK1310	
gonadotropin therapy	2	NBK1334|NBK1334	
spastic paraplegia	2	NBK1484|NBK1284	
general guidelines can be followed	2	NBK1484|NBK1284	
consultation with clinical geneticist and/or genetic counselor	2	NBK338165|NBK447257	
physical therapy/occupational therapy assessment	2	NBK43417|NBK1535	
antiepileptic drugs (aed) if epileptic seizures are present	2	NBK43417|NBK1535	
acidosis	2	NBK320989|NBK1173	
psychological support for the affected individual and family is essential	2	NBK320989|NBK1173	
cardiac evaluation with echocardiography and electrocardiography	2	NBK1383|NBK1124	
clinical and radiographic assessment of spine and rib cage	2	NBK1383|NBK1124	
brain and cervical spine mri if neurologic symptoms are present	2	NBK1383|NBK1124	
gerd	2	NBK368476|NBK426063	
neurobehavioral symptoms	2	NBK1149|NBK1195	
the choice should be left to personal preference	2	NBK1133|NBK1335	
dural ectasia is usually asymptomatic	2	NBK1133|NBK1335	
no effective therapies for symptomatic dural ectasia currently exist	2	NBK1133|NBK1335	
hernias tend to recur after surgical intervention	2	NBK1133|NBK1335	
activities that cause joint injury or pain	2	NBK1133|NBK1335	
, scuba diving)	2	NBK1133|NBK1335	
long-term treatment	2	NBK1361|NBK154378	
additional therapies	2	NBK1361|NBK1490	
behavioral assessment	2	NBK390803|NBK447920	
fibrous dysplasia	2	NBK274564|NBK274564	
fgf23-mediated phosphate wasting	2	NBK274564|NBK274564	
hypercortisolism	2	NBK274564|NBK274564	
thyroid	2	NBK274564|NBK185066	
see thyroid evaluation	2	NBK274564|NBK274564	
kidney transplantation cures adtkd-umod	2	NBK1356|NBK1356	
joint contractures	2	NBK97333|NBK1525	
developmental delay/cognitive impairment	2	NBK97333|NBK4144	
3 microdeletion, the following evaluations are recommended:	2	NBK50780|NBK61984	
comprehensive developmental assessment	2	NBK84258|NBK61984	
specialized learning programs to meet individual needs	2	NBK84258|NBK52787	
no specific antiepileptic or antipsychotic medications are indicated	2	NBK84258|NBK52787	
routine pediatric care	2	NBK84258|NBK52787	
cardiac malformations	2	NBK274565|NBK349624	
treatment should follow standard practice	2	NBK401562|NBK401562	
mody5	2	NBK401562|NBK401562	
measurement of height and weight to assess growth	2	NBK1233|NBK1520	
assessment of cognitive abilities	2	NBK1233|NBK1520	
pituitary tumors	2	NBK1538|NBK1538	
biochemical investigations	2	NBK1538|NBK1538	
yearly, beginning at the specified age:	2	NBK1538|NBK1538	
risk for aggressive mtc based on genotype and recommended interventions	2	NBK1257|NBK1257	
20 yrs	2	NBK1257|NBK1257	
ata = american thyroid association	2	NBK1257|NBK1257	
ser649leu and p	2	NBK1257|NBK1257	
hpt = hyperparathyroidism	2	NBK1257|NBK1257	
pathogenic variants in cis configuration on one allele	2	NBK1257|NBK1257	
criteria: normal annual basal and or stimulated serum calcitonin	2	NBK1257|NBK1257	
normal annual neck ultrasound examination	2	NBK1257|NBK1257	
family history of less aggressive mtc	2	NBK1257|NBK1257	
pheochromocytoma	2	NBK1257|NBK1463	
menkes disease	2	NBK1413|NBK1413	
baseline audiology evaluation	2	NBK174452|NBK1412	
congenital heart defects	2	NBK1502|NBK1403	
stretching exercises are ineffective and painful	2	NBK1828|NBK1875	
sillence, personal communication]	2	NBK1875|NBK24701	
fiberoptic intubation must be available	2	NBK1875|NBK24701	
the following treatment is appropriate:	2	NBK1214|NBK26373	
evaluations at initial diagnosis	2	NBK1179|NBK1297	
joints	2	NBK373578|NBK1302	
pathophysiology	2	NBK1162|NBK1162	
all individuals	2	NBK148668|NBK1973	
reasons for 28 hospitalizations in 15 infants with msud	2	NBK1319|NBK1319	
strauss et al [2010]	2	NBK1319|NBK1319	
4(2	2	NBK1319|NBK1319	
3(1	2	NBK1319|NBK1319	
1(1	2	NBK1319|NBK1319	
5-6	2	NBK1319|NBK1103	
3-9	2	NBK1319|NBK1319	
3-1	2	NBK1319|NBK1515	
0(3	2	NBK1319|NBK1319	
7(3	2	NBK1319|NBK1319	
7-7	2	NBK1319|NBK1319	
2(5	2	NBK1319|NBK1319	
50(0	2	NBK1319|NBK1319	
43-0	2	NBK1319|NBK1319	
58)	2	NBK1319|NBK1319	
from strauss et al [2010]	2	NBK1319|NBK1319	
with permission from elsevier	2	NBK1319|NBK1319	
acute pancreatitis	2	NBK1319|NBK190101	
developmental assessment in children	2	NBK1415|NBK1109	
see hirschsprung disease overview	2	NBK1412|NBK1427	
audiometric evaluation	2	NBK2689|NBK2689	
bleeding tendency	2	NBK2689|NBK2689	
cataracts	2	NBK2689|NBK1417	
circumstances	2	NBK2689|NBK2689	
, contact sports)	2	NBK2689|NBK1302	
neuropsychiatric	2	NBK425723|NBK425723	
baseline neurologic examination	2	NBK1165|NBK1165	
pulmonary function test	2	NBK1165|NBK1165	
assessment of cognitive ability	2	NBK1165|NBK1165	
cataracts can be removed if they impair vision	2	NBK1165|NBK1466	
dietary assessment	2	NBK121988|NBK1141	
head mri	2	NBK1201|NBK1757	
other tumors	2	NBK1201|NBK196157	
assessment of growth	2	NBK1176|NBK20221	
npd-b	2	NBK1370|NBK1370	
child syndrome	2	NBK51754|NBK51754	
ck syndrome	2	NBK51754|NBK51754	
photodysphoria (discomfort in bright light	2	NBK1166|NBK1232	
orthopedic treatment	2	NBK1295|NBK83985	
dental treatment	2	NBK1295|NBK83985	
clinical evaluations to characterize cchs phenotype based on phox2b variant	2	NBK1427|NBK1427	
x 2	2	NBK1427|NBK1427	
adapted from weese-mayer et al [2010]	2	NBK1427|NBK1427	
, 20/24	2	NBK1427|NBK1427	
nparm = non-polyalanine repeat expansion mutation (i	2	NBK1427|NBK1427	
exogenous and endogenous gas challenges	2	NBK1427|NBK1427	
comprehensive age-appropriate clinical autonomic testing	2	NBK1427|NBK1427	
exon or whole-gene deletion or duplication	2	NBK1427|NBK1427	
treatment of decreased visual acuity is symptomatic (e	2	NBK1248|NBK4144	
, low-vision aids)	2	NBK1248|NBK4144	
patient weight	2	NBK154378|NBK1217	
components of infusion solution	2	NBK154378|NBK1217	
200 mg/kg	2	NBK154378|NBK1217	
5,500 mg/m2	2	NBK154378|NBK154378	
batshaw et al [2001]	2	NBK154378|NBK154378	
loading dose given over 90 to 120 minutes	2	NBK154378|NBK154378	
maintenance dose given over 24 hours	2	NBK154378|NBK154378	
the typical dilution is 1:10	2	NBK154378|NBK154378	
arginine infusion not to exceed 150mg/kg/h	2	NBK154378|NBK154378	
bleeding disorder	2	NBK447152|NBK447152	
cardiac fibrosis	2	NBK447152|NBK447152	
evaluation of pancreatic endocrine function (i	2	NBK190101|NBK84399	
, assessment of glucose tolerance)	2	NBK190101|NBK84399	
consideration of pancreatic cancer surveillance in persons with chronic pancreatitis	2	NBK190101|NBK84399	
surgery has been reported to be helpful by many patients	2	NBK190101|NBK84399	
fecal elastase-1 analysis (schebo® biotech ag	2	NBK190101|NBK84399	
, cck-8) or receptor agonists (e	2	NBK190101|NBK84399	
their nature (e	2	NBK190101|NBK84399	
blocking of pancreatic lipase (e	2	NBK190101|NBK84399	
diseases of the intestinal mucosa	2	NBK190101|NBK84399	
diffusion-weighted mri	2	NBK190101|NBK84399	
monitoring for glucose intolerance	2	NBK190101|NBK84399	
low-fat diet	2	NBK190101|NBK84399	
no formal guidelines for amount of dietary fat exist	2	NBK190101|NBK84399	
multiple small meals	2	NBK190101|NBK84399	
no evidence-based guidelines exist	2	NBK190101|NBK84399	
good hydration	2	NBK190101|NBK84399	
dehydration worsens episodes of acute pancreatitis	2	NBK190101|NBK84399	
dilated eye examination	2	NBK1451|NBK92946	
monitoring includes the following:	2	NBK1548|NBK431123	
hypoventilation	2	NBK47027|NBK426063	
respiratory infections	2	NBK1230|NBK1403	
forced vital capacity (fvc)	2	NBK1230|NBK1352	
grade 1	2	NBK395975|NBK395975	
grade 2	2	NBK395975|NBK395975	
grade 3	2	NBK395975|NBK395975	
consider aspirin treatment	2	NBK395975|NBK395975	
thyroid function testing	2	NBK1283|NBK1283	
electrocardiogram to evaluate for an associated atrioventricular block	2	NBK1283|NBK1283	
reduction of calcium oxalate supersaturation	2	NBK1283|NBK2692	
only if affected person is known to be b6 responsive	2	NBK1283|NBK1283	
from cochat et al [2012]	2	NBK1283|NBK1283	
recommendations assume the availability of facilities	2	NBK1283|NBK1283	
pox= plasma oxalate	2	NBK1283|NBK1283	
mcap syndrome	2	NBK153722|NBK153722	
see note	2	NBK1266|NBK1266	
screening and surveillance guidelines for peutz-jeghers syndrome	2	NBK1266|NBK1266	
8, 18 1	2	NBK1266|NBK1266	
3 years 1	2	NBK1266|NBK1266	
monthly	2	NBK1266|NBK1515	
adapted from syngal et al [2015]	2	NBK1266|NBK1266	
mre = magnetic resonance enterography	2	NBK1266|NBK1266	
mrcp = magnetic resonance cholangiopancreatography	2	NBK1266|NBK1266	
ct enterography may be used as an alternative	2	NBK1266|NBK1266	
digital mammography if mri not available	2	NBK1266|NBK1266	
discuss prophylactic mastectomy	2	NBK1266|NBK1266	
discuss prophylactic hysterectomy and oophorectomy	2	NBK1266|NBK1266	
aortic dissection	2	NBK1246|NBK1246	
renal cell carcinoma	2	NBK1246|NBK1463	
visual impairment	2	NBK247161|NBK1300	
assessment of special educational needs	2	NBK1329|NBK350554	
cys282tyr / p	2	NBK143129|NBK143129	
evaluations and referrals following initial diagnosis	2	NBK447920|NBK447257	
treatment of medical manifestations in individuals with ptls	2	NBK447920|NBK447920	
standard treatment as recommended by dentist/orthodontist	2	NBK447920|NBK447257	
poor weight gain / failure to thrive	2	NBK447920|NBK447257	
global developmental delay / intellectual disability educational issues	2	NBK447920|NBK447257	
, orthotics, adaptive strollers)	2	NBK447920|NBK447257	
recommended surveillance for individuals with ptls	2	NBK447920|NBK447920	
ent / mouth	2	NBK447920|NBK447257	
a child psychologist can assess cognitive & behavioral issues	2	NBK447920|NBK447920	
ovarian sex cord-stromal tumors	2	NBK196157|NBK196157	
chemotherapy	2	NBK196157|NBK196157	
5 years	2	NBK196157|NBK1112	
joint pain	2	NBK327267|NBK425926	
medical genetics consultation is appropriate	2	NBK1347|NBK1145	
as needed	2	NBK426063|NBK426063	
assessment for constipation	2	NBK426063|NBK1526	
treatment of manifestations in individuals with pura-related neurodevelopmental disorders	2	NBK426063|NBK426063	
recommended surveillance for individuals with pura-related neurodevelopmental disorders	2	NBK426063|NBK426063	
brain imaging to exclude stroke	2	NBK1115|NBK1115	
eeg to evaluate possibility of seizures	2	NBK1115|NBK1115	
rdp	2	NBK1115|NBK1115	
ahc	2	NBK1115|NBK1115	
sleep	2	NBK1115|NBK2594	
capos syndrome	2	NBK1115|NBK1115	
psychiatric symptoms	2	NBK1115|NBK3795	
psychological stress	2	NBK1115|NBK1115	
the frequency has not been well established	2	NBK83985|NBK83985	
biannual:	2	NBK195854|NBK195854	
occupational therapy and physical therapy assessments	2	NBK195854|NBK195854	
skeletal abnormalities	2	NBK1324|NBK1756	
speech assessment	2	NBK1471|NBK54582	
every four months until age four years	2	NBK1219|NBK1219	
annually after age seven years	2	NBK1219|NBK1219	
refer to clinicaltrials	2	NBK1377|NBK1377	
results of these trials are not yet available	2	NBK1352|NBK1352	
blood pressure measurement	2	NBK1479|NBK154138	
early regular physiotherapy can prevent contractures to a certain extent	2	NBK1307|NBK1160	
treatments include the following:	2	NBK6803|NBK425223	
standard treatment with antiepileptic drugs for seizures	2	NBK6803|NBK425223	
physical, occupational, and speech therapies, if necessary	2	NBK26373|NBK55062	
see also therapies under investigation	2	NBK26373|NBK1410	
ongoing developmental assessments	2	NBK26373|NBK55062	
standard treatment is indicated	2	NBK1403|NBK1403	
for trps i and trps ii	2	NBK425926|NBK425926	
recommended evaluations following initial diagnosis of trio-related intellectual disability	2	NBK447257|NBK447257	
treatment of manifestations in individuals with trio-related intellectual disability	2	NBK447257|NBK447257	
afp = alpha-fetoprotein	2	NBK1515|NBK1515	
alt/ast = alanine transaminase/aspartate transaminase	2	NBK1515|NBK1515	
bun = blood urea nitrogen	2	NBK1515|NBK1515	
cbc = complete blood count	2	NBK1515|NBK1515	
ggt = gamma-glutamyl transferase	2	NBK1515|NBK1515	
pt/ptt = prothrombin time/partial thromboplastin time	2	NBK1515|NBK1515	
iv ammonia scavenger therapy protocol	2	NBK1217|NBK1217	
cps & otc	2	NBK1217|NBK1217	
5 ml/kg	2	NBK1217|NBK1217	
ass1 & asl	2	NBK1217|NBK1217	
55 ml/m2	2	NBK1217|NBK1217	
before dilution	2	NBK1217|NBK1217	
>90-120 minutes	2	NBK1217|NBK1217	
>24 hours	2	NBK1217|NBK1217	
arginine infusion not to exceed 150 mg/kg/h	2	NBK1217|NBK1217	
treatment of manifestations in individuals with unc80 deficiency	2	NBK453434|NBK453434	
vestibular function	2	NBK1265|NBK1341	
see retinitis pigmentosa overview, management	2	NBK1265|NBK1341	
vitamin a supplements	2	NBK1265|NBK1341	
lutein supplements	2	NBK1265|NBK1341	
endolymphatic sac tumors (elst)	2	NBK1463|NBK1463	
educational support	2	NBK1874|NBK148820	
consultation with other specialists as applicable	2	NBK1407|NBK1407	
hearing impairment	2	NBK4144|NBK349624	
wolfram syndrome	2	NBK4144|NBK4144	
surveillance for williams syndrome	2	NBK1249|NBK1249	
renal and bladder ultrasound	2	NBK1249|NBK1249	
except as noted	2	NBK1249|NBK1249	
if normal, ogtt should be repeated every five years	2	NBK1249|NBK1249	
ectodermal	2	NBK378974|NBK378974	
gov/books/n/gene/a-mannosidosis	1	NBK1396	
neuropsychological testing to establish functional level and learning capacity	1	NBK1396	
clinical examination and immunologic tests (e	1	NBK1396	
bone densitometry to detect osteopenia or osteoporosis	1	NBK1396	
medical measures	1	NBK1396	
early use of antibiotics for bacterial infections	1	NBK1396	
insertion	1	NBK1396	
physiotherapy including hydrotherapy to avoid strain on the joints	1	NBK1396	
use of a wheelchair if necessary	1	NBK1396	
orthopedic intervention if necessary	1	NBK1396	
special shoes may help with ankle and foot support	1	NBK1396	
therefore, ventriculocaval shunts are preferred	1	NBK1396	
educational opportunities/social considerations	1	NBK1396	
use of sign language in individuals with significant hearing loss	1	NBK1396	
early educational intervention for development of social skills	1	NBK1396	
speech therapy to improve speech	1	NBK1396	
special education to maximize learning	1	NBK1396	
planning housing for possible future wheelchair use	1	NBK1396	
most affected individuals are clinically normal at birth	1	NBK1396	
neuropsychological testing to establish functional level and learning capacities	1	NBK1396	
immunologic status, focusing on sle, is recommended	1	NBK1396	
bone densitometry every two to five years to assess osteopenia	1	NBK1396	
peripheral blood stem cell transplantation (pbsct)	1	NBK1396	
enzyme activity was slightly below normal	1	NBK1396	
fibroblasts	1	NBK1396	
mouse	1	NBK1396	
human	1	NBK1396	
gov/books/n/gene/a-thal	1	NBK1435	
hemoglobin bart hydrops fetalis (hb bart) syndrome	1	NBK1435	
see prenatal testing and preimplantation genetic diagnosis	1	NBK1435	
hemoglobin h (hbh) disease	1	NBK1435	
consider referral to a hematologist	1	NBK1435	
hb bart syndrome	1	NBK1435	
inappropriate iron therapy	1	NBK1435	
oxidant drugs including sulphonamides	1	NBK1435	
some antimalarials because of the risk of hemolytic crisis	1	NBK1435	
monitoring for these possible complications is recommended	1	NBK1435	
gov/books/n/gene/abs	1	NBK1419	
assessment for airway problems in individuals with skeletal malformations	1	NBK1419	
additional studies that may be indicated:	1	NBK1419	
echocardiogram if a heart defect is suspected	1	NBK1419	
cortisol deficiency	1	NBK1419	
genital abnormalities	1	NBK1419	
hypospadias and cryptorchidism may be corrected with surgery	1	NBK1419	
vaginal reconstruction may be performed in females with vaginal hypoplasia	1	NBK1419	
ovarian cysts	1	NBK1419	
nasal stints or tracheotomy may be required	1	NBK1419	
joint contractures and elbow synostosis	1	NBK1419	
adrenal crisis	1	NBK1419	
lack of or poor pubertal development in males and females	1	NBK1419	
sleepiness and fatigue	1	NBK1419	
screening evaluations are likely to underestimate cognitive abilities	1	NBK1419	
the characteristic urinary steroid profile:	1	NBK1419	
significantly elevated metabolites associated with:	1	NBK1419	
fertility may be a concern	1	NBK1419	
no reports describe reproduction in individuals with pord	1	NBK1419	
hepatic drug metabolism	1	NBK1419	
the common pathogenic variant p	1	NBK1419	
gov/books/n/gene/accpn	1	NBK1372	
physical therapy assessment to determine strength and self-help skills	1	NBK1372	
early developmental/educational intervention is appropriate for cognitive delays	1	NBK1372	
low-dose neuroleptics may be useful for psychiatric manifestations	1	NBK1372	
referral for psychiatric evaluation is appropriate	1	NBK1372	
no specific treatment is available for the sensorimotor neuropathy	1	NBK1372	
gov/books/n/gene/achm	1	NBK1418	
standard clinical ophthalmologic evaluation and testing	1	NBK1418	
electrophysiologic examination	1	NBK1418	
color vision evaluation	1	NBK1418	
dark adaptometry	1	NBK1418	
low vision aids include high-powered magnifiers for reading	1	NBK1418	
achromat	1	NBK1418	
ophthalmologic examination is indicated:	1	NBK1418	
every two to three years in adults	1	NBK1418	
gov/books/n/gene/achon1b	1	NBK1516	
provide palliative care for viable newborns	1	NBK1516	
gov/books/n/gene/achondroplasia	1	NBK1152	
clinical manifestations in achondroplasia vary modestly	1	NBK1152	
baseline computerized tomography of the brain	1	NBK1152	
only modest effects on adult stature seem to accrue	1	NBK1152	
measures to avoid obesity should start in early childhood	1	NBK1152	
craniocervical junction constriction	1	NBK1152	
the best predictors of need for suboccipital decompression include:	1	NBK1152	
lower-limb hyperreflexia or clonus	1	NBK1152	
central hypopnea demonstrated by polysomnography	1	NBK1152	
treatment may include the following:	1	NBK1152	
adenotonsillectomy	1	NBK1152	
weight reduction	1	NBK1152	
continuous positive airway pressure	1	NBK1152	
tracheostomy for extreme cases	1	NBK1152	
middle ear dysfunction	1	NBK1152	
varus deformity	1	NBK1152	
various interventions may be elected (e	1	NBK1152	
socialization	1	NBK1152	
head growth and risk for hydrocephalus	1	NBK1152	
craniocervical junction	1	NBK1152	
sleep apnea	1	NBK1152	
ears and hearing	1	NBK1152	
legs	1	NBK1152	
adaptation to difference	1	NBK1152	
gov/books/n/gene/acp	1	NBK1493	
iron deposition	1	NBK1493	
glucose tolerance test	1	NBK1493	
blood concentrations of insulin and hba1c	1	NBK1493	
examination of the optic fundi and fluorescein angiography	1	NBK1493	
desferrioxamine	1	NBK1493	
treatment with iron chelating agents (i	1	NBK1493	
deferasirox	1	NBK1493	
deferiprone	1	NBK1493	
fresh-frozen human plasma	1	NBK1493	
iron supplements	1	NBK1493	
gov/books/n/gene/acpp	1	NBK1264	
serum potassium concentrations at baseline and during attacks of weakness	1	NBK1264	
12-lead ecg and 24-hour holter monitor	1	NBK1264	
verification that serum tsh concentration is within normal limits	1	NBK1264	
if the serum potassium concentration is low (<3	1	NBK1264	
lifestyle and dietary modification to avoid known triggers	1	NBK1264	
affected individuals should avoid medications known to prolong qt intervals	1	NBK1264	
see crediblemeds® for a complete and updated list	1	NBK1264	
gov/books/n/gene/actg2-dis	1	NBK299311	
clinical genetics consultation with complete family history	1	NBK299311	
treatment for actg2-related disorders remains supportive	1	NBK299311	
urologic manifestations	1	NBK299311	
management of bladder dysfunction by an urologist is recommended	1	NBK299311	
gastrointestinal manifestations	1	NBK299311	
however, bladder catheterization was still required	1	NBK299311	
, cipo)	1	NBK299311	
surveillance should be individualized using a multidisciplinary approach	1	NBK299311	
gov/books/n/gene/ada	1	NBK1483	
measurement of erythrocyte daxp concentration to evaluate metabolic severity	1	NBK1483	
liver function testing to assess for metabolic hepatitis	1	NBK1483	
auditory testing	1	NBK1483	
prophylaxis for pneumocystis jiroveci	1	NBK1483	
intravenous immunoglobulin (ivig)	1	NBK1483	
bmt/sct from a “non-ideal” donor	1	NBK1483	
ert is not curative	1	NBK1483	
more than 300 affected individuals have received peg-ada	1	NBK1483	
in individuals who lack an hla-identical donor)	1	NBK1483	
chan et al 2005	1	NBK1483	
kaufman et al 2005	1	NBK1483	
husain et al 2007	1	NBK1483	
author, unpublished data]	1	NBK1483	
a third affected individual died of hepatoblastoma after 2	1	NBK1483	
5 years of ert	1	NBK1483	
these are of no clinical significance	1	NBK1483	
individuals on ert also require periodic monitoring as follows:	1	NBK1483	
plasma levels of peg-ada activity	1	NBK1483	
erythrocyte daxp concentration	1	NBK1483	
monitoring for the appearance or recurrence of dermatofibrosarcoma protuberans	1	NBK1483	
gov/books/n/gene/adams-oliver	1	NBK355754	
consideration of skull x-ray	1	NBK355754	
ultrasonography and ct can also help assess skull involvement	1	NBK355754	
consultation with a pediatric cardiologist	1	NBK355754	
any evidence for pulmonary hypertension should be sought	1	NBK355754	
systemic blood pressure should be checked	1	NBK355754	
mr angiography and venography to show the vascular anatomy	1	NBK355754	
abdominal ultrasound to look for liver or renal anomalies	1	NBK355754	
wounds without calvarial involvement	1	NBK355754	
plastic wrap (e	1	NBK355754	
, duoderm®)	1	NBK355754	
other less preferred, less costly dressings are:	1	NBK355754	
wounds with calvarial defects: acute care	1	NBK355754	
wounds with calvarial defects: late calvarial reconstruction	1	NBK355754	
early physiotherapy can maximize motor function and range of motion	1	NBK355754	
management of seizures is per routine	1	NBK355754	
gov/books/n/gene/adamtsl4-eyes	1	NBK84111	
determination of visual acuity and refractive error	1	NBK84111	
ophthalmoscopy	1	NBK84111	
the following may also provide important information:	1	NBK84111	
orthoptic examination, particularly in children	1	NBK84111	
corneal topography including measurement of central corneal thickness	1	NBK84111	
gonioscopy	1	NBK84111	
if typical signs (e	1	NBK84111	
gov/books/n/gene/adcy5-dysk	1	NBK263441	
medication has been variably effective in suppressing debilitating symptoms	1	NBK263441	
j friedman, personal observation]	1	NBK263441	
fm hisama, personal observation]	1	NBK263441	
stress management	1	NBK263441	
gov/books/n/gene/adnfle	1	NBK1169	
intrafamilial variation in pharmaco-responsiveness occurs	1	NBK1169	
therefore, all appropriate aeds should be tried	1	NBK1169	
serial evaluation of eegs to monitor disease progression is appropriate	1	NBK1169	
gov/books/n/gene/adnp-dis	1	NBK355518	
anamnestic interview focusing on sleep problems and feeding difficulties	1	NBK355518	
evaluation for autism spectrum disorder and intellectual disability	1	NBK355518	
ultrasound of the heart to evaluate for cardiac anomalies	1	NBK355518	
speech, occupational, and physical therapy	1	NBK355518	
specialized learning programs depending on individual needs	1	NBK355518	
nutritional support if necessary	1	NBK355518	
routine treatment of cardiac and ophthalmologic findings	1	NBK355518	
gov/books/n/gene/aec	1	NBK43797	
gastroenterology for growth and nutrition issues	1	NBK43797	
dietary if there are concerns about failure to thrive	1	NBK43797	
audiology to evaluate for hearing loss	1	NBK43797	
dental to evaluate and address issues of hypodontia	1	NBK43797	
prosthodontics to address potential need for dental implants	1	NBK43797	
ankyloblepharon filiforme adnatum	1	NBK43797	
larger ones may require surgical separation by an ophthalmologist	1	NBK43797	
ectodermal defects	1	NBK43797	
skin erosions	1	NBK43797	
empiric treatment (i	1	NBK43797	
clefting should be addressed as soon as developmentally possible	1	NBK43797	
in particular:	1	NBK43797	
dental findings over time may warrant use of dental prosthetics	1	NBK43797	
nfed	1	NBK43797	
gov/books/n/gene/ags	1	NBK1475	
assessment of feeding and nutritional status	1	NBK1475	
eeg to evaluate for seizures, if suspected	1	NBK1475	
chest physiotherapy and vigorous treatment of respiratory complications	1	NBK1475	
management of seizures using standard protocols	1	NBK1475	
monitoring for signs of diabetes insipidus in the neonatal period	1	NBK1475	
monitoring of the spine for the development of scoliosis	1	NBK1475	
the clinical benefit of such treatment is unproven	1	NBK1475	
gov/books/n/gene/ahc	1	NBK1431	
serum and urine concentrations of electrolytes	1	NBK1431	
serum concentration of glucose, cortisol and acth	1	NBK1431	
assessment of arterial blood gases in those who are unwell	1	NBK1431	
measurement of aldosterone and plasma renin activity	1	NBK1431	
some samples may need careful handling (e	1	NBK1431	
acute episodes	1	NBK1431	
correction of hyperkalemia may be needed	1	NBK1431	
, solu-cortef®)	1	NBK1431	
adequate sodium must be provided	1	NBK1431	
treatment during stress	1	NBK1431	
, intercurrent illness, surgery, trauma)	1	NBK1431	
glucose and sodium may be needed	1	NBK1431	
parents should have access to rapid medical advice	1	NBK1431	
guidelines for hospital admission should be clear	1	NBK1431	
acth levels should normalize when replacement therapy is adequate	1	NBK1431	
this should not be delayed unnecessarily	1	NBK1431	
if puberty does start spontaneously it is likely to arrest	1	NBK1431	
thus, careful monitoring of testosterone levels is needed	1	NBK1431	
if physiologic stress is unavoidable (e	1	NBK1431	
gov/books/n/gene/aic	1	NBK1381	
costovertebral defects can lead to scoliosis	1	NBK1381	
routine dermatologic evaluation to monitor for vascular and other malignancies	1	NBK1381	
gov/books/n/gene/aip	1	NBK1193	
referral to clinical genetics for counseling	1	NBK1193	
acute neurovisceral attack	1	NBK1193	
clinical assessment should include a full neurologic evaluation	1	NBK1193	
investigations should include:	1	NBK1193	
full blood count (fbc)	1	NBK1193	
serum and urine osmolality	1	NBK1193	
urine sodium concentration if hyponatremic	1	NBK1193	
, crp, blood cultures, ck, magnesium	1	NBK1193	
mri should be considered if cns symptoms are present	1	NBK1193	
general measures	1	NBK1193	
restore energy balance using an enteral route if possible	1	NBK1193	
treat intercurrent infections and other diseases promptly	1	NBK1193	
supportive treatment	1	NBK1193	
pain relief	1	NBK1193	
nausea and vomiting	1	NBK1193	
prochloperazine, promazine or ondansetron are considered safe	1	NBK1193	
beta blockers are considered safe	1	NBK1193	
fluid balance and electrolytes	1	NBK1193	
dextrose saline is preferred	1	NBK1193	
specific treatment	1	NBK1193	
it is infused over at least 30 minutes	1	NBK1193	
recurrent acute attacks	1	NBK1193	
gynecological review and bone density monitoring are recommended	1	NBK1193	
prophylactic hemin infusion	1	NBK1193	
however, evidence for clinical efficacy remains elusive	1	NBK1193	
, medicalert® or similar)	1	NBK1193	
see resources	1	NBK1193	
seek timely treatment of systemic illness or infection	1	NBK1193	
avoid excessive alcohol consumption and smoking	1	NBK1193	
a few other countries have also initiated screening	1	NBK1193	
note: serum α-fetoprotein measurement is not helpful	1	NBK1193	
excessive alcohol consumption and smoking should be avoided	1	NBK1193	
the drug database for acute porphyria	1	NBK1193	
the american porphyria foundation	1	NBK1193	
porphyria south africa	1	NBK1193	
welsh medicines information centre - porphyria information service	1	NBK1193	
british national formulary (subscription required)	1	NBK1193	
stress should be minimized by providing good analgesia	1	NBK1193	
es/aipgene for details)	1	NBK1193	
gov/books/n/gene/alagille	1	NBK1273	
a full cardiac evaluation, including echocardiogram	1	NBK1273	
an ophthalmologic examination to identify anterior chamber involvement	1	NBK1273	
liver transplantation for end-stage liver disease has an 80	1	NBK1273	
cardiac involvement is treated in a standard manner	1	NBK1273	
renal anomalies are treated in a standard manner	1	NBK1273	
vascular accidents should be treated in a standard manner	1	NBK1273	
head injuries and neurologic symptoms should be evaluated aggressively	1	NBK1273	
ophthalmologic abnormalities rarely need intervention	1	NBK1273	
vertebral anomalies are rarely symptomatic	1	NBK1273	
optimization of nutrition to maximize growth and development	1	NBK1273	
individuals with liver disease should avoid alcohol consumption	1	NBK1273	
gov/books/n/gene/alexander	1	NBK1172	
formal, age-appropriate developmental assessment	1	NBK1172	
examination for possible scoliosis	1	NBK1172	
no specific therapy is currently available for alexander disease	1	NBK1172	
swallow studies and nutritional intervention (i	1	NBK1172	
early recognition of abnormal tone and spinal problems (i	1	NBK1172	
gov/books/n/gene/alk-nbs	1	NBK24599	
neuroblastoma and ganglioneuroblastoma	1	NBK24599	
asymptomatic children at risk	1	NBK24599	
less frequent intervals may also be appropriate	1	NBK24599	
every 1-2 months in infants age ≤12 months	1	NBK24599	
every 3-4 months in children age ≤10 years	1	NBK24599	
gov/books/n/gene/alkap	1	NBK1454	
electrocardiogram and echocardiogram in individuals older than age 40 years	1	NBK1454	
aortic stenosis may necessitate valve replacement	1	NBK1454	
ochronotic prostate stones appear on radiography	1	NBK1454	
all had elevated plasma tyrosine concentrations	1	NBK1454	
plasma tyrosine averaged 800μm without dietary restriction	1	NBK1454	
side effects were minimal	1	NBK1454	
additional trials are currently underway to establish clinical benefit	1	NBK1454	
gov/books/n/gene/alpers	1	NBK26471	
electroencephalogram (eeg) and video eeg monitoring	1	NBK26471	
swallowing study, if bulbar signs are present	1	NBK26471	
baseline pulmonary function testing	1	NBK26471	
treatment is limited to symptom management and supportive care	1	NBK26471	
alpers-huttenlocher syndrome	1	NBK26471	
family education is critical	1	NBK26471	
supportive therapies	1	NBK26471	
treatment with cpap or bipap as indicated is appropriate	1	NBK26471	
seizure control is a goal of treatment	1	NBK26471	
other phenotypes	1	NBK26471	
gastrostomy may be required to provide adequate nutrition	1	NBK26471	
surgery for ptosis may provide symptomatic relief for some	1	NBK26471	
primary care provider	1	NBK26471	
neurologist	1	NBK26471	
clinical geneticist	1	NBK26471	
hepatologist or gastroenterologist	1	NBK26471	
physiatrist	1	NBK26471	
psychiatrist	1	NBK26471	
pulmonologist	1	NBK26471	
laboratory tests	1	NBK26471	
every three months	1	NBK26471	
urine analysis	1	NBK26471	
serum concentration of lactic acid	1	NBK26471	
biannually	1	NBK26471	
imaging and diagnostic procedures	1	NBK26471	
liver ultrasound examination annually	1	NBK26471	
eeg and video eeg monitoring (e	1	NBK26471	
, for suspicion of subclinical status epilepticus	1	NBK26471	
presence of epilepsia partialis continua	1	NBK26471	
audiogram and brain stem auditory evoked responses as clinically indicated	1	NBK26471	
barium swallow study as clinically indicated	1	NBK26471	
gov/books/n/gene/alpha1-a	1	NBK1519	
lungs	1	NBK1519	
, influenza and pneumococcal)	1	NBK1519	
controls	1	NBK1519	
recommend intravenous aat augmentation therapy for individuals with established emphysema	1	NBK1519	
, fev1 35%-60% predicted)	1	NBK1519	
2 months post-liver transplant and not achieving statistical significance	1	NBK1519	
panniculitis	1	NBK1519	
complete cessation of smoking	1	NBK1519	
avoidance of dusty occupational exposures	1	NBK1519	
yearly vaccination against influenza and pneumococcus	1	NBK1519	
no such drug has yet been approved	1	NBK1519	
drugs to enhance autophagy (e	1	NBK1519	
human trials are under way	1	NBK1519	
results from more recent studies are not currently available	1	NBK1519	
gov/books/n/gene/alport	1	NBK1207	
overt proteinuria (urine protein-creatinine ratio >0	1	NBK1207	
hypertensive individuals should receive appropriate management	1	NBK1207	
male relative without hematuria	1	NBK1207	
male relative with hematuria	1	NBK1207	
female relative without hematuria	1	NBK1207	
female relative with hematuria (i	1	NBK1207	
, heterozygous female)	1	NBK1207	
cochlear	1	NBK1207	
hearing aids should be prescribed when appropriate	1	NBK1207	
some individuals develop cataracts that interfere with vision	1	NBK1207	
these should be extracted when necessary	1	NBK1207	
diffuse leiomyomatosis	1	NBK1207	
symptomatic leiomyomas may require surgical intervention	1	NBK1207	
exposure to loud noise should be minimized	1	NBK1207	
a single urinalysis is sufficient in a male	1	NBK1207	
gov/books/n/gene/alps	1	NBK1108	
measurement of autoantibodies to assess for autoimmunity	1	NBK1108	
monitoring for and treatment of lymphoproliferation and hypersplenism	1	NBK1108	
however, sirolimus is not without side effects	1	NBK1108	
treatment of lymphoma is according to conventional protocols	1	NBK1108	
treatment of cytopenias and other autoimmune diseases	1	NBK1108	
relatives who have the family-specific pathogenic variant should:	1	NBK1108	
undergo alps-specific evaluations at initial diagnosis (e	1	NBK1108	
, lymphoma) become apparent (see surveillance)	1	NBK1108	
gov/books/n/gene/als-ftd	1	NBK268647	
electromyography in case of als and/or lower motor signs	1	NBK268647	
discussion of advanced care planning	1	NBK268647	
caregiver and patient support groups are valuable	1	NBK268647	
options include:	1	NBK268647	
ssris	1	NBK268647	
venlafaxine	1	NBK268647	
clinical, neurologic, and neuropsychological follow up is necessary	1	NBK268647	
gov/books/n/gene/als-overview	1	NBK1450	
electrophysiologic investigations	1	NBK1450	
emg/ncv (3 extremities)	1	NBK1450	
laboratory workup	1	NBK1450	
radiologic	1	NBK1450	
neuropsychologic testing (if applicable) to assess cognitive impairment	1	NBK1450	
however, weakness and lethargy are common side effects	1	NBK1450	
low-tech (e	1	NBK1450	
, alphabet board) and high-tech (i	1	NBK1450	
specialized multidisciplinary als clinic evaluations are suggested every three months	1	NBK1450	
pt/ot evaluation	1	NBK1450	
further investigations are needed	1	NBK1450	
gov/books/n/gene/alstrom	1	NBK1267	
cone-rod dystrophy	1	NBK1267	
ophthalmologic evaluation, including electroretinogram and visual field testing	1	NBK1267	
measurement of weight and height	1	NBK1267	
calculation of body mass index (bmi)	1	NBK1267	
assessment of otitis media and conductive hearing loss	1	NBK1267	
insulin resistance/type 2 diabetes mellitus	1	NBK1267	
fasting plasma glucose, even in infancy	1	NBK1267	
a fasting lipid profile, including triglycerides	1	NBK1267	
endocrine abnormalities	1	NBK1267	
measurement of pituitary hormones	1	NBK1267	
history to document urinary difficulties	1	NBK1267	
baseline blood pressure	1	NBK1267	
24-hour blood pressure monitoring	1	NBK1267	
measurement of plasma bun, creatinine, urea and electrolytes	1	NBK1267	
if renal function testing is abnormal, ultrasound examination	1	NBK1267	
if abnormalities, refer to a nephrologist	1	NBK1267	
measurement of plasma alt, ast, and ggt concentration	1	NBK1267	
liver ultrasonography to evaluate for possible hepatomegaly and portal hypertension	1	NBK1267	
if clinically indicated, screening esophagogastroduodenoscopy for varices	1	NBK1267	
educational evaluation for intervention and iep	1	NBK1267	
neurologic evaluation with eeg to examine for seizures	1	NBK1267	
no therapy exists to prevent the progressive organ involvement	1	NBK1267	
hearing can be maximized with bilateral digital hearing aids	1	NBK1267	
and metformin	1	NBK1267	
hypertriglyceridemia	1	NBK1267	
pancreatitis should be treated as in the general population	1	NBK1267	
prevention of primary complications	1	NBK1267	
care must be taken during sedation or operative procedures	1	NBK1267	
audiometry should be performed yearly	1	NBK1267	
insulin resistance/type 2 diabetes	1	NBK1267	
patients should be monitored annually for thyroid abnormalities	1	NBK1267	
severe dyslipidemia	1	NBK1267	
and hyperglycemia	1	NBK1267	
intensive multidisciplinary surveillance of any pregnancy would be mandatory	1	NBK1267	
gov/books/n/gene/alzheimer-early	1	NBK1236	
history (especially first symptoms, duration, progression)	1	NBK1236	
examination (especially mental status)	1	NBK1236	
mri, pet	1	NBK1236	
depression and seizures should be treated with appropriate medications	1	NBK1236	
monthly surveillance to identify and manage secondary complications is indicated	1	NBK1236	
sudden changes in environment and over-sedation should be avoided	1	NBK1236	
gov/books/n/gene/alzheimer	1	NBK1161	
the first such drug was tacrine	1	NBK1161	
however, this agent is also hepatotoxic	1	NBK1161	
antidepressant medication may improve associated depression	1	NBK1161	
other approaches to this model are under investigation	1	NBK1161	
gov/books/n/gene/amish-mcph	1	NBK1365	
refer to general references on microcephaly for guidance	1	NBK1365	
no recommendations are specific to mcpha	1	NBK1365	
seizures have occurred in some affected infants	1	NBK1365	
gov/books/n/gene/amrf	1	NBK333437	
offering psychosocial support may be helpful	1	NBK333437	
lifelong clinical follow up should include the following:	1	NBK333437	
renal function monitoring by measurement of: blood pressure	1	NBK333437	
body weight	1	NBK333437	
serum concentrations of creatinine, albumin, and cholesterol	1	NBK333437	
24-hour urinary protein	1	NBK333437	
and creatinine clearance	1	NBK333437	
standard measures for prevention of fetopathy should be followed	1	NBK333437	
possible changes of medication prior to pregnancy	1	NBK333437	
gov/books/n/gene/androgen	1	NBK1429	
assignment of sex of rearing	1	NBK1429	
even in cais this may not always be easy	1	NBK1429	
cais	1	NBK1429	
however, the issue of gonadectomy is controversial	1	NBK1429	
pais with predominantly female genitalia (incomplete ais)	1	NBK1429	
pais with ambiguous genitalia or predominantly male genitalia	1	NBK1429	
gynecomastia that develops in puberty eventually requires reduction mammoplasty	1	NBK1429	
mais	1	NBK1429	
regular weight-bearing exercises are encouraged to maintain bone health	1	NBK1429	
gov/books/n/gene/angelman	1	NBK1144	
baseline brain mri and eeg	1	NBK1144	
musculoskeletal examination for scoliosis and gait impairment (e	1	NBK1144	
, extent of foot pronation or ankle subluxation	1	NBK1144	
orthopedic referral as needed	1	NBK1144	
evaluation for gastroesophageal reflux in infants and young children	1	NBK1144	
dietary evaluation to assure optimal nutritional status	1	NBK1144	
the customary medical treatment (i	1	NBK1144	
sometimes fundoplication as required	1	NBK1144	
no one drug has proven superior	1	NBK1144	
medications used for minor motor seizures (e	1	NBK1144	
hypermotoric behaviors are typically resistant to behavioral therapies	1	NBK1144	
unstable or nonambulatory children may benefit from physical therapy	1	NBK1144	
individualization and flexibility in the school are important educational strategies	1	NBK1144	
administration of 0	1	NBK1144	
strabismus may require surgical correction	1	NBK1144	
these limitations place them at risk for social disruptions	1	NBK1144	
older adults tend to become less mobile and less active	1	NBK1144	
annual clinical examination for scoliosis	1	NBK1144	
excessive tongue protrusion causes drooling	1	NBK1144	
available surgical or medication treatments (e	1	NBK1144	
gov/books/n/gene/aniridia	1	NBK1360	
aniridia	1	NBK1360	
simple measures are often the most important:	1	NBK1360	
regular eye examinations and correction of refractive errors	1	NBK1360	
occlusion therapy for anisometropic amblyopia or strabismic amblyopia in childhood	1	NBK1360	
advice and help with schooling	1	NBK1360	
social support	1	NBK1360	
lens	1	NBK1360	
children rarely require surgery (lens aspiration or lensectomy)	1	NBK1360	
in adults, phacoemulsification can be successful	1	NBK1360	
intraocular pressure	1	NBK1360	
glaucoma is usually initially treated with topical anti-glaucoma medication	1	NBK1360	
trabeculectomy with or without antimetabolites (e	1	NBK1360	
medical treatment is generally ineffective and surgery is required	1	NBK1360	
cornea	1	NBK1360	
amblyopia and refractive error	1	NBK1360	
detection of later-onset eye pathology	1	NBK1360	
optic disc examination	1	NBK1360	
visual field assessment, when possible	1	NBK1360	
gov/books/n/gene/ano5-md	1	NBK114459	
the need for orthoses or other assistive devices varies individually	1	NBK114459	
most patients remain ambulatory without assistance for decades	1	NBK114459	
for asymptomatic persons, evaluate less frequently	1	NBK114459	
gov/books/n/gene/anophthalmia-ov	1	NBK1378	
treatment of mac spectrum	1	NBK1378	
prosthetic intervention is appropriate in severe microphthalmia and anophthalmia	1	NBK1378	
gov/books/n/gene/ao2	1	NBK1317	
provide palliative care for the viable newborn	1	NBK1317	
gov/books/n/gene/aoa	1	NBK1456	
examination of cognitive function	1	NBK1456	
low-cholesterol diet is advised	1	NBK1456	
gov/books/n/gene/aoa2	1	NBK1154	
assessment of cognitive function	1	NBK1154	
physical therapy and occupational therapy assessment of strength and balance	1	NBK1154	
educational support (e	1	NBK1154	
a low-cholesterol diet is advised	1	NBK1154	
routine visits to the attending neurologist are indicated	1	NBK1154	
gov/books/n/gene/apbd	1	NBK5300	
, behavioralists) who can provide the following:	1	NBK5300	
gait safety devices including canes and wheel chairs	1	NBK5300	
behavioral modification and cognitive aids as needed	1	NBK5300	
periodic assessment of the following:	1	NBK5300	
bladder function	1	NBK5300	
sensation in the distal lower extremities	1	NBK5300	
cognition (e	1	NBK5300	
, executive function)	1	NBK5300	
a randomized controlled trial of trihepatnoin for apbd is ongoing	1	NBK5300	
gov/books/n/gene/apoe-leu167del	1	NBK208534	
physical examination to screen for splenomegaly	1	NBK208534	
there are no formal management guidelines for apoe p	1	NBK208534	
leu167del-related lipid disorders	1	NBK208534	
in patients with fasting triglyceride levels:	1	NBK208534	
splenectomy should be avoided as it may worsen hyperlipidemia	1	NBK208534	
liver function abnormalities	1	NBK208534	
persistent nausea	1	NBK208534	
vomiting	1	NBK208534	
yellow discoloration of the skin	1	NBK208534	
bruising	1	NBK208534	
any new petechial rash	1	NBK208534	
there are no formal guidelines regarding surveillance	1	NBK208534	
the authors suggest obtaining the following:	1	NBK208534	
counsel patients regarding the signs of liver dysfunction	1	NBK208534	
splenectomy as it worsens the hypertriglyceridemia	1	NBK208534	
leu167del variant	1	NBK208534	
if the apoe p	1	NBK208534	
a woman with the apoe p	1	NBK208534	
gov/books/n/gene/aprt-def	1	NBK100238	
assessment of kidney involvement:	1	NBK100238	
measure serum creatinine concentration	1	NBK100238	
screen for albuminuria or proteinuria	1	NBK100238	
assess kidney stone burden with ultrasound or ct examination	1	NBK100238	
ophthalmology consultation if eye symptoms are present	1	NBK100238	
allopurinol	1	NBK100238	
febuxostat	1	NBK100238	
treatment of esrd	1	NBK100238	
no surveillance guidelines have been developed	1	NBK100238	
monitor kidney function	1	NBK100238	
facilitate medication compliance	1	NBK100238	
azathioprine should be avoided by individuals taking xdh inhibitors	1	NBK100238	
they are usually identified during family screening	1	NBK100238	
gov/books/n/gene/arg1	1	NBK1159	
plasma arginine concentration	1	NBK1159	
arginine supplementation is obviously contraindicated	1	NBK1159	
rapidly reducing plasma ammonia concentration	1	NBK1159	
pharmacologic management to allow alternative pathway excretion of excess nitrogen	1	NBK1159	
in early treatment, feeding 1	1	NBK1159	
0 to 1	1	NBK1159	
older children require and tolerate lower protein intake	1	NBK1159	
seizures are easily treated by phenobarbital or carbamazepine	1	NBK1159	
restriction of dietary protein through use of specialized formulas	1	NBK1159	
administration of oral nitrogen scavenging drugs	1	NBK1159	
0 g/m2/day in larger patients	1	NBK1159	
particularly, elevated prothrombin time	1	NBK1159	
arginine is the substrate for nitric oxide synthase	1	NBK1159	
plasma quantitative amino acid analysis	1	NBK1159	
analysis of enzymatic activity in red blood cells	1	NBK1159	
immunizations can be provided on the usual schedule	1	NBK1159	
multivitamin and fluoride supplementation are indicated for all affected individuals	1	NBK1159	
appropriate use of antipyretics is indicated	1	NBK1159	
ibuprofen is preferred over acetaminophen	1	NBK1159	
gov/books/n/gene/args-aciduria	1	NBK51784	
complete neurocognitive evaluation	1	NBK51784	
discontinuing oral protein intake	1	NBK51784	
intravenous nitrogen scavenging therapy	1	NBK51784	
ammonia levels usually normalize with therapy	1	NBK51784	
nitrogen scavenging therapy needs to be continued during hemodialysis	1	NBK51784	
diet	1	NBK51784	
arginine base supplementation	1	NBK51784	
oral nitrogen scavenging therapy	1	NBK51784	
orthotopic liver transplantation (olt)	1	NBK51784	
electrolyte (potassium) supplementation is appropriate when indicated	1	NBK51784	
periodic evaluation of liver function tests may be necessary	1	NBK51784	
the appropriate frequency is unknown	1	NBK51784	
periodic evaluation of serum electrolytes is appropriate	1	NBK51784	
the frequency unknown	1	NBK51784	
large boluses of protein or amino acids	1	NBK51784	
less than recommended intake of protein	1	NBK51784	
prolonged fasting or starvation	1	NBK51784	
intravenous steroids	1	NBK51784	
hepatotoxic drugs in those with hepatic involvement	1	NBK51784	
gov/books/n/gene/arsacs	1	NBK1255	
retinal examination	1	NBK1255	
curative therapy is not available	1	NBK1255	
gov/books/n/gene/arterial-t	1	NBK253404	
skeletal radiographs depending on the clinical findings (e	1	NBK253404	
clinical history studies are limited	1	NBK253404	
aneurysms and focal stenoses are amenable to surgical intervention	1	NBK253404	
hernias may recur after surgical repair	1	NBK253404	
emphysema is treated symptomatically	1	NBK253404	
, swimming) performed in moderation	1	NBK253404	
pulmonary follow up	1	NBK253404	
increased vigilance for emphysema is appropriate	1	NBK253404	
, serial radiographs to evaluate for progression of scoliosis	1	NBK253404	
all pregnancies had a good outcome	1	NBK253404	
peripartum intensive monitoring is advised	1	NBK253404	
medication-associated risks to the fetus	1	NBK253404	
, a beta-blocker) prior to conception	1	NBK253404	
gov/books/n/gene/arts	1	NBK2591	
audiometry for evidence of hearing loss	1	NBK2591	
eye examination for evidence of optic atrophy	1	NBK2591	
assessment of intellectual abilities	1	NBK2591	
no treatment is available	1	NBK2591	
see hereditary ataxias, management	1	NBK2591	
an annual influenza immunization	1	NBK2591	
routine immunizations against other common childhood infections (e	1	NBK2591	
measles, mumps)	1	NBK2591	
visual impairment appears to be progressive	1	NBK2591	
thus, regular evaluation by an ophthalmologist is recommended	1	NBK2591	
gov/books/n/gene/arvd	1	NBK1131	
noninvasive monitoring	1	NBK1131	
, an implantable cardioverter defibrillator)	1	NBK1131	
beta blockers are considered first line therapy	1	NBK1131	
management relies on personalized recommendations based on clinical assessment	1	NBK1131	
implantable cardioverter-defibrillators (icds)	1	NBK1131	
syncope was found to predict appropriate icd discharge	1	NBK1131	
class ii indications (i	1	NBK1131	
screening recommendations:	1	NBK1131	
ecg, annually or more frequently depending on symptoms	1	NBK1131	
echocardiogram, annually or more frequently depending on symptoms	1	NBK1131	
holter monitoring, event monitoring, implantable loop recorder	1	NBK1131	
exercise stress testing	1	NBK1131	
cardiac mri, with frequency depending on symptoms and findings	1	NBK1131	
ecg, with consideration of signal-averaged electrocardiogram	1	NBK1131	
cardiac mri	1	NBK1131	
gov/books/n/gene/ataxia-telangiectas	1	NBK26468	
nutrition and feeding assessment	1	NBK26468	
chest x-ray and pulmonary function for baseline	1	NBK26468	
however, individual responses to specific medications (e	1	NBK26468	
(see also therapies under investigation	1	NBK26468	
pulmonary and nutritional complications of dysphagia are common	1	NBK26468	
periodic cbcs are warranted	1	NBK26468	
research suggests the following:	1	NBK26468	
antioxidants (e	1	NBK26468	
a clinical trial is presently underway	1	NBK26468	
gov/books/n/gene/ataxias	1	NBK1138	
speech therapy may benefit persons with dysarthria	1	NBK1138	
gov/books/n/gene/aved	1	NBK1241	
electroretinogram (erg)	1	NBK1241	
echocardiography and ecg to assess for cardiomyopathy	1	NBK1241	
neurophysiologic examination	1	NBK1241	
one of the following vitamin e preparations is used:	1	NBK1241	
the naturally occurring form, rrr-α-tocopherol	1	NBK1241	
, every 6 months), especially in children	1	NBK1241	
individuals with aved should avoid:	1	NBK1241	
occupations requiring quick responses or good balance	1	NBK1241	
gov/books/n/gene/b-thal	1	NBK1426	
see establishing the diagnosis	1	NBK1426	
confirmed diagnosis of thalassemia	1	NBK1426	
facial changes	1	NBK1426	
poor growth	1	NBK1426	
bony fractures	1	NBK1426	
clinically significant extramedullary hematopoiesis	1	NBK1426	
thalassemia major	1	NBK1426	
transfusions are usually given every two to three weeks	1	NBK1426	
thalassemia intermedia	1	NBK1426	
cord blood transplantation	1	NBK1426	
transfusional iron overload	1	NBK1426	
assessment of iron overload	1	NBK1426	
serum ferritin concentration	1	NBK1426	
liver biopsy	1	NBK1426	
desferrioxamine b (dfo)	1	NBK1426	
, hepatic iron concentration <7	1	NBK1426	
dfo administration also increases susceptibility to yersinia infections	1	NBK1426	
cardiac disease	1	NBK1426	
ophthalmologic and audiologic examinations	1	NBK1426	
bone densitometry to assess for osteoporosis in the adult	1	NBK1426	
iron-containing preparations	1	NBK1426	
new chelation strategies are under investigation	1	NBK1426	
gov/books/n/gene/bap1-tpds	1	NBK390611	
uveal melanoma (um)	1	NBK390611	
dilated eye examination and imaging by an ocular oncologist	1	NBK390611	
malignant mesothelioma (mme)	1	NBK390611	
no screening modalities exist	1	NBK390611	
clear cell renal cell carcinoma (ccrcc)	1	NBK390611	
thus, a cure is unlikely	1	NBK390611	
cutaneous melanoma	1	NBK390611	
consensus management recommendations have not been established	1	NBK390611	
no reliable early disease symptoms or screening modalities	1	NBK390611	
cutaneous melanoma, basal cell carcinoma and atypical spitz tumors	1	NBK390611	
clear cell renal cell carcinoma	1	NBK390611	
arc welding	1	NBK390611	
asbestos	1	NBK390611	
unnecessary and prolonged sun exposure	1	NBK390611	
gov/books/n/gene/baraitser-winter	1	NBK327153	
ophthalmologic examination including fundoscopy	1	NBK327153	
eeg (if brain mri is abnormal)	1	NBK327153	
neurocognitive evaluation	1	NBK327153	
echocardiogram for evidence of congenital heart defects	1	NBK327153	
there is no specific treatment of bwcff syndrome	1	NBK327153	
symptomatic management involves the following	1	NBK327153	
ptosis may require surgical treatment	1	NBK327153	
hearing loss may require routine care including hearing aids	1	NBK327153	
epilepsy is treated using standard protocols	1	NBK327153	
early detection allows specific treatment of intraocular hypertension	1	NBK327153	
routine follow up of deafness for any evidence of progression	1	NBK327153	
screening for malignancies	1	NBK327153	
gov/books/n/gene/barth	1	NBK247162	
complete blood count and differential	1	NBK247162	
management of heart failure	1	NBK247162	
management of neutropenia	1	NBK247162	
78 ± 0	1	NBK247162	
45-12	1	NBK247162	
8 years, with an average exposure of 7	1	NBK247162	
educational support in school	1	NBK247162	
antibiotic prophylaxis has been used to prevent recurrent infections	1	NBK247162	
potassium issues:	1	NBK247162	
increased risk for hypokalemia	1	NBK247162	
increased risk for hyperkalemia	1	NBK247162	
the use of rectal thermometers in those with neutropenia	1	NBK247162	
pantothenic acid	1	NBK247162	
carnitine	1	NBK247162	
arginine	1	NBK247162	
gov/books/n/gene/bbs	1	NBK1363	
fundoscopic photographs should be filed for later comparison	1	NBK1363	
examination of the genitalia in both sexes	1	NBK1363	
pelvic ultrasound examination is preferred	1	NBK1363	
baseline blood pressure assessment	1	NBK1363	
cardiac evaluation including auscultation, ecg, and echocardiography	1	NBK1363	
consider referral to a clinical geneticist	1	NBK1363	
, renal or hepatic dysfunction)	1	NBK1363	
indicators are functional interference and poorly fitting footwear	1	NBK1363	
dental extractions are appropriate as required for dental crowding	1	NBK1363	
insertion of grommets is commonplace	1	NBK1363	
suggested surveillance is summarized here:	1	NBK1363	
routine (at least annual) measurement of blood pressure	1	NBK1363	
annual endocrinology review	1	NBK1363	
gov/books/n/gene/bcns	1	NBK1151	
physical examination for birth defects of clinical significance (e	1	NBK1151	
, orofacial clefts, polydactyly)	1	NBK1151	
evaluation by a dentist or orthodontist familiar with nbccs	1	NBK1151	
skin examination by a dermatologist familiar with nbccs	1	NBK1151	
manifestations should be treated by specialists (e	1	NBK1151	
keratocysts usually require surgical excision	1	NBK1151	
systemic treatment with retinoids (e	1	NBK1151	
complete sunblock should be used	1	NBK1151	
diagnostic x-rays should be used sparingly	1	NBK1151	
excessive sun exposure increases the likelihood of developing bccs	1	NBK1151	
gov/books/n/gene/bethlem	1	NBK1503	
joint examination for contractures	1	NBK1503	
ullrich congenital muscular dystrophy (cmd)	1	NBK1503	
examination of back for scoliosis	1	NBK1503	
joint examination for contractures and hyperlaxity	1	NBK1503	
assessment of growth and feeding	1	NBK1503	
contractures tend to be aggressive and may require surgery	1	NBK1503	
once scoliosis is evident, regular orthopedic follow up	1	NBK1503	
clinical assessment of nutritional status	1	NBK1503	
however, prenatal physiotherapy may be indicated	1	NBK1503	
gov/books/n/gene/bfns	1	NBK32534	
individuals with benign familial neonatal epilepsy (bfne)	1	NBK32534	
individuals with neonatal epileptic encephalopathy (nee)	1	NBK32534	
cognitive and behavioral neuropsychological testing	1	NBK32534	
assessment of digestive and other non-neurologic comorbidities	1	NBK32534	
all individuals with a kcnq2-related disorder	1	NBK32534	
refractory seizures are uncommon in kcnq2-related bfne	1	NBK32534	
augmentative communication techniques can be valuable for many patients	1	NBK32534	
some children may require lifelong antiepileptic treatment	1	NBK32534	
gov/books/n/gene/bgc	1	NBK1421	
thorough neurologic and neuropsychiatric assessment	1	NBK1421	
antiepileptic treatment for seizures	1	NBK1421	
symptomatic treatment for headaches	1	NBK1421	
thorough neurologic and neuropsychiatric assessment is indicated annually	1	NBK1421	
gov/books/n/gene/bgd-biotin	1	NBK169615	
neurologic evaluation by a pediatric neurologist	1	NBK169615	
psychology evaluation for assessment of iq	1	NBK169615	
biotin and thiamine therapy	1	NBK169615	
biotin and thiamine need to be given lifelong	1	NBK169615	
in the acute stage empiric treatment with antimicrobial/antiviral agents	1	NBK169615	
fever control	1	NBK169615	
antiepileptic drugs for effective control of seizures	1	NBK169615	
symptomatic treatment of dystonia, including administration of l-dopa	1	NBK169615	
rehabilitation, physiotherapy, occupational therapy, and speech therapy	1	NBK169615	
educational programs adapted to individual needs	1	NBK169615	
avoidance of triggers/stressors including trauma and surgery	1	NBK169615	
affected women should continue biotin and thiamine therapy during pregnancy	1	NBK169615	
gov/books/n/gene/bgs	1	NBK1204	
testing of relatives at risk	1	NBK1204	
gov/books/n/gene/bhd	1	NBK1522	
detailed dermatologic examination and punch biopsy of suspected cutaneous lesion	1	NBK1522	
therefore, renal tumors greater than 3	1	NBK1522	
no preventive or curative treatment is available for bhds	1	NBK1522	
renal tumor screening	1	NBK1522	
if any suspicious lesion (<1	1	NBK1522	
renal tumors less than 3	1	NBK1522	
0 cm in diameter are monitor by periodic imaging	1	NBK1522	
melanoma	1	NBK1522	
cigarette smoking	1	NBK1522	
high ambient pressures, which may precipitate spontaneous pneumothorax	1	NBK1522	
gov/books/n/gene/bietti-cd	1	NBK91457	
fundoscopic examination	1	NBK91457	
full-field electroretinogram (fferg) to establish a baseline	1	NBK91457	
no treatment for bcd currently exists	1	NBK91457	
gov/books/n/gene/biotin	1	NBK1322	
physical examination for neurologic findings (e	1	NBK1322	
ophthalmologic examination (for finding such as optic atrophy)	1	NBK1322	
biotin therapy is lifelong	1	NBK1322	
a protein-restricted diet is not necessary	1	NBK1322	
for all children with biotinidase deficiency:	1	NBK1322	
regularly scheduled appointments with primary care physicians or as needed	1	NBK1322	
an optimal prenatal dose has not been determined	1	NBK1322	
gov/books/n/gene/bloom	1	NBK1398	
determination of plasma immunoglobulin concentrations	1	NBK1398	
observation of urination for evidence of urethral obstruction	1	NBK1398	
psychosocial	1	NBK1398	
gov/books/n/gene/bofs	1	NBK55063	
echocardiogram if there is a murmur or cardiac symptoms	1	NBK55063	
renal ultrasonography	1	NBK55063	
the following consultations are recommended:	1	NBK55063	
referral to a nephrologist if renal abnormalities are identified	1	NBK55063	
referral to an audiologist	1	NBK55063	
monitoring for depression, attention dysregulation	1	NBK55063	
milunsky et al [2011] provided management guidelines	1	NBK55063	
see table iii)	1	NBK55063	
they should not be cauterized	1	NBK55063	
most larger skin defects require surgical excision	1	NBK55063	
monitor for changes related to the major findings over time	1	NBK55063	
gov/books/n/gene/bor	1	NBK1380	
cervical examination for fistulae	1	NBK1380	
otologic findings	1	NBK1380	
tests of renal function: bun and creatinine	1	NBK1380	
urinanalysis	1	NBK1380	
recommended treatment:	1	NBK1380	
excise branchial cleft cysts/fistulae	1	NBK1380	
fit with appropriate aural habilitation as indicated	1	NBK1380	
enroll in an appropriate educational program for the hearing impaired	1	NBK1380	
consider canaloplasty to correct an atretic canal	1	NBK1380	
treat urologic and renal abnormalities in the standard manner	1	NBK1380	
if renal anomalies (e	1	NBK1380	
if esrd develops, consider renal transplantation	1	NBK1380	
branchial arch anomalies can be surgically corrected	1	NBK1380	
regular assessment of renal function to prevent progression to esrd	1	NBK1380	
gov/books/n/gene/bpan	1	NBK424403	
assessment of nutrition by a nutritionist or dietician	1	NBK424403	
global developmental disability/intellectual disability	1	NBK424403	
disordered sleep	1	NBK424403	
ophthalmologic findings	1	NBK424403	
eye findings are treated in a routine manner	1	NBK424403	
regular pulmonary hygiene to manage risk for pulmonary complications	1	NBK424403	
tracheostomy as indicated when secretions are difficult to manage	1	NBK424403	
follow-up ophthalmologic examination every one to two years	1	NBK424403	
gov/books/n/gene/bpes	1	NBK1441	
in uninformative families or simplex cases (i	1	NBK1441	
eyelid surgery	1	NBK1441	
timing of eyelid surgery is controversial	1	NBK1441	
however, it remains controversial	1	NBK1441	
gov/books/n/gene/brca1	1	NBK1247	
consider prophylactic bilateral mastectomy	1	NBK1247	
the sample size, however, was extremely small	1	NBK1247	
ovarian cancer/fallopian tube cancer	1	NBK1247	
salpingectomy	1	NBK1247	
tubal ligation	1	NBK1247	
women	1	NBK1247	
monthly breast self-examination	1	NBK1247	
annual mammogram beginning at age 30	1	NBK1247	
men	1	NBK1247	
annual clinical breast examination beginning at age 35	1	NBK1247	
annual prostate cancer screening beginning at age 45	1	NBK1247	
women and men	1	NBK1247	
, pancreatic cancer)	1	NBK1247	
the postoperative follow up was 3	1	NBK1247	
6 years	1	NBK1247	
4 years	1	NBK1247	
gov/books/n/gene/brugada	1	NBK1517	
electrophysiologic study to assess risk of sudden cardiac death	1	NBK1517	
it is important to:	1	NBK1517	
controversy exists regarding the treatment of asymptomatic individuals	1	NBK1517	
febrile state	1	NBK1517	
vagotonic agents	1	NBK1517	
α-adrenergic agonists [miyazaki et al 1996]	1	NBK1517	
β-adrenergic antagonists	1	NBK1517	
tricyclic antidepressants	1	NBK1517	
first-generation antihistamines (dimenhydrinate)	1	NBK1517	
cocaine toxicity	1	NBK1517	
class 1c antiarrhythmic drugs including flecainide and propafenone	1	NBK1517	
class 1a agents including procainamide and disopyramide	1	NBK1517	
gov/books/n/gene/bscl	1	NBK1212	
when appropriate, clamp glucose homeostasis study	1	NBK1212	
echocardiogram to evaluate for cardiac hypertrophy	1	NBK1212	
renal ultrasound examination to evaluate for kidney size	1	NBK1212	
bone age and assessment of sexual maturity rating/pubertal status	1	NBK1212	
assessment of cognitive ability with age-appropriate scales	1	NBK1212	
periodic screening for glycosuria as a manifestation of diabetes mellitus	1	NBK1212	
yearly cardiac ultrasound and ekg	1	NBK1212	
yearly or biennial liver ultrasound examination to detect fatty infiltration	1	NBK1212	
excessive dietary fat intake should be avoided	1	NBK1212	
pregnancy may increase the risk of diabetic decompensation	1	NBK1212	
gov/books/n/gene/burn-mckeown	1	NBK373577	
ophthalmology assessment for lower-eyelid coloboma for possible corneal involvement	1	NBK373577	
examination for midline cleft palate or unilateral cleft lip/palate	1	NBK373577	
referral to multidisciplinary cleft palate team as required	1	NBK373577	
treatment of craniofacial manifestations (e	1	NBK373577	
gov/books/n/gene/bvd	1	NBK1167	
there are no reports on the use of aflibercept	1	NBK1167	
the cnv regressed and the subretinal hemorrhage resolved	1	NBK1167	
genetic counseling and occupational counseling should be offered	1	NBK1167	
gov/books/n/gene/bws	1	NBK1394	
assessment for airway sufficiency in the presence of macroglossia	1	NBK1394	
abdominal wall repair for omphalocele soon after birth	1	NBK1394	
generally, this surgery is well tolerated	1	NBK1394	
management of difficulties arising from macroglossia:	1	NBK1394	
some children benefit from tongue reduction surgery	1	NBK1394	
orthodontic intervention as needed in later childhood/adolescence	1	NBK1394	
assessment of speech difficulties	1	NBK1394	
management of cleft palate following standard protocols	1	NBK1394	
referral to a craniofacial surgeon if facial hemihyperplasia is significant	1	NBK1394	
treatment of neoplasias following standard pediatric oncology protocols	1	NBK1394	
, nephrocalcinosis)	1	NBK1394	
management of cardiac problems following standard protocols	1	NBK1394	
monitoring for hypoglycemia, especially in the neonatal period	1	NBK1394	
otherwise, clinical examination alone was recommended	1	NBK1394	
developmental screening as part of routine childcare	1	NBK1394	
gov/books/n/gene/ca5a-def	1	NBK284774	
when stable for monitoring, preferably fasting)	1	NBK284774	
consideration of:	1	NBK284774	
neurodevelopmental testing	1	NBK284774	
during acute episodes	1	NBK284774	
restrict protein intake if plasma ammonia is elevated	1	NBK284774	
without carglumic acid, hyperammonemia persisted longer (i	1	NBK284774	
, an additional 1-2 days)	1	NBK284774	
serum lactate and glucose	1	NBK284774	
liver parameters	1	NBK284774	
and urine organic acids	1	NBK284774	
for an affected mother	1	NBK284774	
no pregnancy manaagement issues are known	1	NBK284774	
for an affected child	1	NBK284774	
no special management is required during pregnancy	1	NBK284774	
gov/books/n/gene/cach	1	NBK1258	
physical therapy/occupational therapy assessment as needed	1	NBK1258	
stressful emotional and physical situations (e	1	NBK1258	
, extreme temperatures)	1	NBK1258	
gov/books/n/gene/cadasil	1	NBK1500	
psychometrics with particular attention to executive function	1	NBK1500	
standard brain mri (flair sequence)	1	NBK1500	
psychiatric consultation should be considered	1	NBK1500	
there is no treatment of proven efficacy for cadasil	1	NBK1500	
there are no preventive measures for stroke or vascular dementia	1	NBK1500	
there are no standard international surveillance guidelines for cadasil	1	NBK1500	
consultation of other medical specialists (e	1	NBK1500	
gov/books/n/gene/caffey	1	NBK99168	
currently, no standard surveillance protocols exist	1	NBK99168	
gov/books/n/gene/cah	1	NBK1171	
to assess for salt wasting	1	NBK1171	
plasma renin activity (pra)	1	NBK1171	
serum electrolytes	1	NBK1171	
to assess the degree of prenatal virilization in females	1	NBK1171	
careful physical examination of the external genitalia and its orifices	1	NBK1171	
vaginogram to assess the anatomy of urethra and vagina	1	NBK1171	
bone maturation assessment by bone age	1	NBK1171	
classic 21-ohd cah	1	NBK1171	
glucocorticoid replacement therapy	1	NBK1171	
the use of oral hydrocortisone suspension is discouraged	1	NBK1171	
during periods of stress (e	1	NBK1171	
affected individuals should carry medical information regarding emergency steroid dosing	1	NBK1171	
mineralocorticoid replacement therapy	1	NBK1171	
sodium chloride supplementation may not be necessary after infancy	1	NBK1171	
feminizing genitoplasty	1	NBK1171	
the systematic evidence for this belief is lacking	1	NBK1171	
testicular adrenal rest tumors	1	NBK1171	
transition from adolescence to adulthood	1	NBK1171	
women with classic cah had increased diastolic blood pressure	1	NBK1171	
subjective health status was significantly impaired and fertility compromised	1	NBK1171	
adrenalectomy	1	NBK1171	
non-classic 21-ohd cah	1	NBK1171	
salt-wasting crisis	1	NBK1171	
evaluation may be less often thereafter	1	NBK1171	
monitoring for testicular abnormalities in males	1	NBK1171	
monitoring fertility and metabolic risks in adults	1	NBK1171	
fecundity and fertility	1	NBK1171	
weight	1	NBK1171	
imaging studies	1	NBK1171	
increased doses of glucocorticoids are recommended in these situations	1	NBK1171	
pregnant females with classic 21-ohd cah	1	NBK1171	
affected female fetus with genital ambiguity	1	NBK1171	
treatment of short stature	1	NBK1171	
gov/books/n/gene/campo-dysp	1	NBK1760	
3-q25	1	NBK1760	
hearing screening	1	NBK1760	
most survivors with cd require orthopedic care	1	NBK1760	
club feet require surgical correction	1	NBK1760	
the hips should be checked for luxation	1	NBK1760	
bracing is usually not helpful	1	NBK1760	
gov/books/n/gene/canavan	1	NBK1234	
seizures may be treated with antiepileptic drugs (aeds)	1	NBK1234	
diamox® seems to reduce intracranial pressure	1	NBK1234	
botox® injections may be used to relieve spasticity	1	NBK1234	
annual routine follow up is indicated	1	NBK1234	
humans	1	NBK1234	
three developed aav2 neutralizing antibodies	1	NBK1234	
no children improved	1	NBK1234	
animal models	1	NBK1234	
these experiments were short term	1	NBK1234	
gov/books/n/gene/cantu	1	NBK246980	
cardiology evaluation with echocardiogram and electrocardiogram	1	NBK246980	
skeletal survey to assess for the associated bone abnormalities	1	NBK246980	
scoliosis may require bracing or surgical correction	1	NBK246980	
polyhydramnios	1	NBK246980	
the cause of polyhydramnios is unknown	1	NBK246980	
macrosomia	1	NBK246980	
gov/books/n/gene/carasil	1	NBK32533	
t2* gradient echo imaging to check cerebral microbleeds	1	NBK32533	
personality change may require antipsychotic medication	1	NBK32533	
a wig or hairpiece may be helpful for alopecia	1	NBK32533	
anti-platelet therapy and anti-hypertension therapy may be recommended	1	NBK32533	
however, there is no evidence for their effectiveness	1	NBK32533	
gov/books/n/gene/carney	1	NBK1286	
in males, testicular ultrasonography at the initial evaluation	1	NBK1286	
in females, transabdominal ultrasonography during the first evaluation	1	NBK1286	
the following interventions are routine:	1	NBK1286	
cardiac myxoma	1	NBK1286	
open-heart surgery	1	NBK1286	
cutaneous and mammary myxoma	1	NBK1286	
surgical excision	1	NBK1286	
cushing syndrome	1	NBK1286	
bilateral adrenalectomy	1	NBK1286	
pituitary adenoma	1	NBK1286	
transsphenoidal surgery	1	NBK1286	
thyroid adenomas	1	NBK1286	
surgery if cancerous	1	NBK1286	
lccsct	1	NBK1286	
pms	1	NBK1286	
surgery to remove primary and/or metastatic lesions	1	NBK1286	
pre-pubertal pediatric individuals	1	NBK1286	
echocardiogram (annually	1	NBK1286	
testicular ultrasound for boys	1	NBK1286	
post-pubertal pediatric and adult individuals	1	NBK1286	
testicular ultrasound (annually)	1	NBK1286	
thyroid ultrasound (baseline examination	1	NBK1286	
transabdominal ultrasound of the ovaries (baseline examination	1	NBK1286	
urinary free cortisol levels (annually)	1	NBK1286	
serum igf-1 levels (annually)	1	NBK1286	
adrenal computed tomography	1	NBK1286	
pituitary mri	1	NBK1286	
three-hour oral glucose tolerance test (ogtt)	1	NBK1286	
90-minute thyroid releasing hormone (trh) testing	1	NBK1286	
gov/books/n/gene/cask-dis	1	NBK169825	
neurologic evaluation including eeg	1	NBK169825	
assessment of feeding	1	NBK169825	
gov/books/n/gene/catsper-mi	1	NBK22925	
molecular genetic testing for the causative contiguous gene deletion	1	NBK22925	
otologic examination and audiologic assessment	1	NBK22925	
gov/books/n/gene/cav	1	NBK1385	
orthopedic examination to assess the presence of scoliosis	1	NBK1385	
cardiac examination: 24-hour electrocardiogram and echocardiogram	1	NBK1385	
no specific treatment is currently available for caveolinopathies	1	NBK1385	
management should include the following:	1	NBK1385	
periodic monitoring of the following is recommended:	1	NBK1385	
respiratory function: spirometry	1	NBK1385	
cardiac function: 24-hour electrocardiography and echocardiography	1	NBK1385	
mobility and muscle function: physiatrist and physical therapist consultation	1	NBK1385	
gov/books/n/gene/cbl	1	NBK1328	
in an unstable patient:	1	NBK1328	
once the patient becomes stable:	1	NBK1328	
infants are started with daily 1	1	NBK1328	
0 mg intramuscular or subcutaneous injections	1	NBK1328	
acute metabolic decompensation	1	NBK1328	
long-term management	1	NBK1328	
these are accomplished by:	1	NBK1328	
parenteral ohcbl	1	NBK1328	
0 mg (~0	1	NBK1328	
betaine	1	NBK1328	
optimal dosing and monitoring have not been adequately established	1	NBK1328	
folate and folinic acid	1	NBK1328	
the adult dose of folate is 1	1	NBK1328	
5 mg for maintenance	1	NBK1328	
other therapeutic considerations that have not been fully validated:	1	NBK1328	
methionine supplementation	1	NBK1328	
pyridoxine	1	NBK1328	
indicated for low plasma carnitine levels	1	NBK1328	
flu prevention (i	1	NBK1328	
clinical evaluation should include assessment of:	1	NBK1328	
growth including weight, linear growth, and head circumference	1	NBK1328	
feeding ability	1	NBK1328	
laboratory evaluation should include:	1	NBK1328	
complete blood count (cbc) to monitor for cytopenias	1	NBK1328	
routine evaluations should include:	1	NBK1328	
brain mri and/or eeg as clinically indicated	1	NBK1328	
potentially exacerbating circumstances:	1	NBK1328	
methionine restriction	1	NBK1328	
0 mg im, folic acid 5	1	NBK1328	
gov/books/n/gene/cc2-leuk	1	NBK326661	
ophthalmologic examination with attention to visual acuity and visual fields	1	NBK326661	
for adult males: evaluation of testicular function	1	NBK326661	
supportive therapy includes the following as needed:	1	NBK326661	
treatment of headache	1	NBK326661	
guidance for visual impairment	1	NBK326661	
annual evaluations including:	1	NBK326661	
gov/books/n/gene/cca	1	NBK1386	
musculoskeletal examination for the presence of contractures and kyphosis/scoliosis	1	NBK1386	
classic cca	1	NBK1386	
this type of therapy is best instituted in childhood	1	NBK1386	
surgical release of contractures may be necessary	1	NBK1386	
consultation with an orthopedist is encouraged	1	NBK1386	
severe/lethal cca	1	NBK1386	
no general recommendations exist	1	NBK1386	
at least annual physical examination for evidence of kyphosis/scoliosis	1	NBK1386	
gov/books/n/gene/ccd	1	NBK1513	
speech therapy may be required during periods of dental treatment	1	NBK1513	
sinus and middle ear infections require aggressive and timely treatment	1	NBK1513	
helmets may be advised for high-risk activities	1	NBK1513	
children with ccd should be monitored for the following:	1	NBK1513	
dental abnormalities	1	NBK1513	
upper-airway obstruction	1	NBK1513	
sinus and ear infections	1	NBK1513	
gov/books/n/gene/ccfdn	1	NBK25565	
visual impairment (ophthalmologic examination)	1	NBK25565	
the treatment of cataracts is surgical	1	NBK25565	
regular rehabilitation can prevent or postpone osteoporosis	1	NBK25565	
gov/books/n/gene/ccm	1	NBK1293	
in those with epilepsy:	1	NBK1293	
electoencephalogram (eeg) and/or video-eeg	1	NBK1293	
recurrent hemorrhage or mass effect	1	NBK1293	
neuropsychological testing may be considered prior to any neurosurgical procedure	1	NBK1293	
microsurgical techniques rely on intraoperative examination for precise localization	1	NBK1293	
other medications that increase risk of hemorrhage (e	1	NBK1293	
of the 16 women, hemorrhage occured in ten	1	NBK1293	
6% compared with 1	1	NBK1293	
fasudil is approved in japan for treatment of vasodilation	1	NBK1293	
gov identifier: nct01764451)	1	NBK1293	
gov identifier: nct02603328)	1	NBK1293	
gov/books/n/gene/cco	1	NBK1391	
physical and occupational therapy assessments	1	NBK1391	
hypotonia and weakness	1	NBK1391	
patients may benefit from physical therapy	1	NBK1391	
scoliosis and joint contractures	1	NBK1391	
patients with more severe symptoms may require respiratory support	1	NBK1391	
secondary complications can include respiratory compromise from scoliosis	1	NBK1391	
immunization against influenza is encouraged	1	NBK1391	
prompt treatment of respiratory infection is important	1	NBK1391	
sleep studies especially when patients show signs of nocturnal hypoxia	1	NBK1391	
gov/books/n/gene/cd-chst3	1	NBK62112	
referral to a specialized skeletal dysplasia clinic if available	1	NBK62112	
thus far, heart valve dysplasia has not required correction	1	NBK62112	
activities with a high impact on joints (e	1	NBK62112	
, jogging) should be avoided	1	NBK62112	
gov/books/n/gene/cda1	1	NBK5313	
hemoglobin concentration and serum bilirubin concentration	1	NBK5313	
abdominal ultrasound examination to evaluate for biliary stones	1	NBK5313	
peginterferon-α2b has also been given once a week	1	NBK5313	
the mechanism behind this response is unknown	1	NBK5313	
splenectomy is of unproved value	1	NBK5313	
recommended monitoring for iron overload:	1	NBK5313	
avoid any preparation containing iron	1	NBK5313	
gov/books/n/gene/cdg-1a	1	NBK1110	
measurement of serum albumin concentration	1	NBK1110	
urinalysis to evaluate for proteinuria	1	NBK1110	
echocardiogram to evaluate for pericardial effusions	1	NBK1110	
renal ultrasound examination to evaluate for microcysts	1	NBK1110	
orthopedic issues—thorax shortening, scoliosis/kyphosis	1	NBK1110	
occasionally, surgical treatment of spinal curvature is warranted	1	NBK1110	
gov/books/n/gene/cdg	1	NBK1332	
others may have a more refractory course	1	NBK1332	
renal issues	1	NBK1332	
immunologic status	1	NBK1332	
most individuals affected with cdgs have functional immune systems	1	NBK1332	
additional management issues of adults with cdg	1	NBK1332	
orthopedic issues — thorax shortening, scoliosis/kyphosis	1	NBK1332	
thyroid panel	1	NBK1332	
gov/books/n/gene/cdh-ov	1	NBK1359	
recently, therapy may start in the prenatal period	1	NBK1359	
postnatal treatment	1	NBK1359	
emphasis must be on preventing secondary lung injury	1	NBK1359	
it is unclear whether ecmo improves survival in cdh	1	NBK1359	
prenatal treatment	1	NBK1359	
animal models of cdh	1	NBK1359	
gov/books/n/gene/cdls	1	NBK1104	
plotting growth parameters on cdls-specific growth charts	1	NBK1104	
cdlsusa	1	NBK1104	
org (girls	1	NBK1104	
boys)	1	NBK1104	
radiographs of the upper extremities to evaluate for radioulnar synostosis	1	NBK1104	
echocardiogram to screen for cardiac defects	1	NBK1104	
neurologic evaluation and eeg in all affected individuals	1	NBK1104	
renal ultrasonography to evaluate for structural kidney anomalies	1	NBK1104	
urologic evaluation in males with hypospadias and/or cryptorchidism	1	NBK1104	
pelvic ultrasound to evaluate for bicornuate uterus in females	1	NBK1104	
complete blood count, immune profile (consisting of immunoglobulins	1	NBK1104	
antibodies to tetanus, dipetheria, and pneumococcus	1	NBK1104	
b-cell panel	1	NBK1104	
surgical correction of intestinal malrotation if present	1	NBK1104	
alternative communicative methods (e	1	NBK1104	
standard treatment for hearing loss	1	NBK1104	
standard interventions for cardiac defects	1	NBK1104	
appropriate treatment for seizures	1	NBK1104	
antibiotic prophylaxis and follow up for vesicoureteral reflux	1	NBK1104	
orchiopexy if cryptorchidism is present	1	NBK1104	
standard intervention for bicornuate uterus, if present	1	NBK1104	
preoperative evaluation for thrombocytopenia and cardiac disease	1	NBK1104	
annual gastrointestinal evaluation including monitoring of growth	1	NBK1104	
routine monitoring of existing cardiac or renal anomalies	1	NBK1104	
no known agents exacerbate the severity of cdls	1	NBK1104	
gov/books/n/gene/cdp1-xlr	1	NBK1544	
full skeletal survey	1	NBK1544	
growth measures	1	NBK1544	
assessment of upper and lower airways if stridor is present	1	NBK1544	
polysomnography	1	NBK1544	
brain imaging studies	1	NBK1544	
cervical spine stenosis may require decompression	1	NBK1544	
thoracic and lumbar spine (for scoliosis)	1	NBK1544	
gov/books/n/gene/cdsp	1	NBK84551	
serum creatine kinase (ck) concentration	1	NBK84551	
liver transaminases	1	NBK84551	
pre-prandial blood glucose concentration	1	NBK84551	
l-carnitine supplementation	1	NBK84551	
l-carnitine supplementation has relatively few side effects:	1	NBK84551	
hypoglycemic episodes are treated with intravenous dextrose infusion	1	NBK84551	
cardiomyopathy requires management by specialists in cardiology	1	NBK84551	
perform annually during childhood and less frequently in adulthood	1	NBK84551	
plasma carnitine concentration	1	NBK84551	
serum ck concentration and liver transaminases	1	NBK84551	
consider measuring during acute illnesses	1	NBK84551	
gov/books/n/gene/ce-dysp	1	NBK154653	
a biopsy is often taken after detection of abnormalities	1	NBK154653	
liver ultrasound examination and measurement of liver enzymes	1	NBK154653	
evaluation by a pulmonologist	1	NBK154653	
cardiac evaluation for detection of possible structural heart defects	1	NBK154653	
correction of polydactyly (optional)	1	NBK154653	
orthopedic care as required (e	1	NBK154653	
, for hip dysplasia)	1	NBK154653	
dental care	1	NBK154653	
standard treatment for renal and liver abnormalities	1	NBK154653	
pneumonia should be treated with antibiotics	1	NBK154653	
asthma can be treated with steroids	1	NBK154653	
standard treatment for cardiac abnormalities	1	NBK154653	
annual ophthalmologic examinations starting at age four years	1	NBK154653	
gov/books/n/gene/cebpa-aml	1	NBK47457	
evaluations following initial diagnosis of	1	NBK47457	
the timing of lp in aml is controversial	1	NBK47457	
asymptomatic carriers	1	NBK47457	
, abnormalities in cbc)	1	NBK47457	
gov/books/n/gene/ced	1	NBK1156	
baseline blood pressure if considering treatment with losartan	1	NBK1156	
no consensus management guidelines have been developed to date	1	NBK1156	
improving gait, exercise tolerance, and flexion contractures	1	NBK1156	
unsuccessful steroid therapy was reported in one adult	1	NBK1156	
less symptomatic individuals can be started on 0	1	NBK1156	
0 mg/kg every other day	1	NBK1156	
higher-dose steroids may help with acute pain crises	1	NBK1156	
calcitonin	1	NBK1156	
losartan	1	NBK1156	
pain in the tibia resolved completely following the surgery	1	NBK1156	
corticosteroids may delay skull hyperostosis and cranial nerve impingement	1	NBK1156	
three underwent internal auditory canal decompression with mixed results	1	NBK1156	
whether this is related to ced is unknown	1	NBK1156	
the authors are unaware of any other similar cases	1	NBK1156	
bisphosphonates	1	NBK1156	
excess phosphate	1	NBK1156	
gov/books/n/gene/celiac	1	NBK1727	
celiac disease	1	NBK1727	
a dietitian experienced in treating celiac disease should be involved	1	NBK1727	
, 100 mg) can damage the small intestine	1	NBK1727	
note that a slice of bread contains approximately 2	1	NBK1727	
5 grams of gluten	1	NBK1727	
some hidden sources of gluten:	1	NBK1727	
non-starchy foods such as soy sauce and beer	1	NBK1727	
, lipstick)	1	NBK1727	
refractory sprue or celiac disease	1	NBK1727	
a later age of onset of symptoms	1	NBK1727	
treatment with a gluten-free diet can:	1	NBK1727	
reduce the excess risk of mortality in symptomatic individuals	1	NBK1727	
gov/books/n/gene/cep	1	NBK154652	
serum calcium and vitamin d concentrations	1	NBK154652	
bone densitometry	1	NBK154652	
hepatic function tests	1	NBK154652	
cutaneous photosensitivity	1	NBK154652	
reflectant sunscreens containing zinc oxide or titanium dioxide	1	NBK154652	
skin trauma should be avoided	1	NBK154652	
wound care is essential to prevent infection of opened blisters	1	NBK154652	
laser hair removal can be used to treat facial hypertrichosis	1	NBK154652	
topical antibiotics for corneal ulcers, scleritis, and blepharitis	1	NBK154652	
bone manifestations	1	NBK154652	
hemolytic anemia	1	NBK154652	
consider blood transfusions when hemolysis is significant	1	NBK154652	
strict avoidance of sunlight and protection from light are indicated	1	NBK154652	
monitor the following:	1	NBK154652	
note: individuals receiving transfusion therapy need closer monitoring	1	NBK154652	
hepatic function every six to twelve months	1	NBK154652	
gov/books/n/gene/cf	1	NBK1250	
fecal elastase	1	NBK1250	
fecal fat content based on 72-hour stool collection	1	NBK1250	
vitamin a, d, and e serum concentrations	1	NBK1250	
prothrombin time and international normalized ratio (inr)	1	NBK1250	
random glucose	1	NBK1250	
overall clinical status / extent of disease	1	NBK1250	
cbc with differential and cell count	1	NBK1250	
serum electrolytes, bun, creatinine	1	NBK1250	
liver function tests (alt, ast)	1	NBK1250	
consultation with a genetic counselor	1	NBK1250	
cystic fibrosis (cf)	1	NBK1250	
inhaled dornase alfa in all individuals age ≥6 years	1	NBK1250	
inhaled hypertonic saline in all individuals age ≥6 years	1	NBK1250	
recommended sequence for inhaled medications:	1	NBK1250	
an aerosolized antibiotic	1	NBK1250	
gly551asp and other specific pathogenic variants	1	NBK1250	
phe508del	1	NBK1250	
lung or heart/lung transplantation	1	NBK1250	
an option for some individuals with severe disease	1	NBK1250	
oral pancreatic enzyme replacement with meals	1	NBK1250	
congenital absence of the vas deferens (cavd)	1	NBK1250	
prevention of primary manifestations – cystic fibrosis	1	NBK1250	
aerosolized antibiotic	1	NBK1250	
all routine immunizations should be given at the recommended times	1	NBK1250	
pancreatic enzyme replacement and supplementation of fat-soluble vitamins	1	NBK1250	
high-calorie, high-fat nutritional supplements	1	NBK1250	
consultation with a nutritionist specializing in cf	1	NBK1250	
surveillance – cystic fibrosis	1	NBK1250	
culture respiratory tract secretions at least four times yearly	1	NBK1250	
75 g/kg, or 75 g maximum	1	NBK1250	
evaluate bone mineral density in adolescence	1	NBK1250	
agents/circumstances to avoid – cystic fibrosis	1	NBK1250	
respiratory irritants (e	1	NBK1250	
, smoke, dust)	1	NBK1250	
individuals with respiratory infections	1	NBK1250	
deterioration during pregnancy may precipitate preterm delivery	1	NBK1250	
mode of delivery is based on usual obstetric indications	1	NBK1250	
cftr pathogenic variant-specific candidate drugs:	1	NBK1250	
phe508del)	1	NBK1250	
gene therapy is in early clinical trials	1	NBK1250	
aeruginosa has not yet been developed	1	NBK1250	
gov/books/n/gene/cfc	1	NBK1186	
complete physical examination including measurement of growth parameters	1	NBK1186	
nutrition and feeding evaluation	1	NBK1186	
consideration of swallow study	1	NBK1186	
psychomotor developmental evaluation	1	NBK1186	
mri of the brain to detect any structural changes	1	NBK1186	
cardiac evaluation including echocardiogram and electrocardiogram	1	NBK1186	
obtain history for possible bleeding diathesis	1	NBK1186	
increasing caloric intake may be of benefit	1	NBK1186	
constipation affects the majority of individuals	1	NBK1186	
seizures are treated as in the general population	1	NBK1186	
recurrent otitis media may require placement of pe tubes	1	NBK1186	
hyperkeratoses are treated as in the general population	1	NBK1186	
monitor for signs of precocious puberty	1	NBK1186	
annual evaluation of hearing is recommended	1	NBK1186	
periodic evaluation for scoliosis during young childhood is recommended	1	NBK1186	
over-exposure to heat	1	NBK1186	
individuals with cfc syndrome report heat intolerance	1	NBK1186	
gov/books/n/gene/cfeom	1	NBK1348	
palpebral fissure size measurement	1	NBK1348	
anterior segment evaluation to detect corneal exposure	1	NBK1348	
levator function testing	1	NBK1348	
optional forced duction testing	1	NBK1348	
refraction, including cycloplegic refraction in children	1	NBK1348	
photographic documentation for future comparison	1	NBK1348	
strongly recommended if eye muscle surgery is planned:	1	NBK1348	
nonsurgical treatment of ophthalmologic findings:	1	NBK1348	
correction of ptosis	1	NBK1348	
eye muscle surgery	1	NBK1348	
to correct or improve a compensatory head posture	1	NBK1348	
to improve ambulation and gross motor development in young children	1	NBK1348	
principles of surgical approach:	1	NBK1348	
profound weakening procedures (e	1	NBK1348	
cfeom is congenital and is believed to be non-progressive	1	NBK1348	
gov/books/n/gene/cftd	1	NBK1259	
weakness	1	NBK1259	
hypotonia	1	NBK1259	
respiratory rate	1	NBK1259	
signs of respiratory distress	1	NBK1259	
history of recurrent chest infections	1	NBK1259	
ability to maintain oxygen saturation	1	NBK1259	
evaluation should include echocardiogram and electrocardiogram	1	NBK1259	
physical therapy and occupational therapy assessment	1	NBK1259	
orthodontic evaluation and appropriate intervention may be necessary	1	NBK1259	
contractures may be avoided by consistent joint movement or therapy	1	NBK1259	
and lung function tests, including fev1 and fvc	1	NBK1259	
gov/books/n/gene/cgd	1	NBK99496	
poor iron absorption is common in cgd-related colitis	1	NBK99496	
albumin	1	NBK99496	
affected organs / manifestations of cgd on imaging	1	NBK99496	
lungs / pneumonia [godoy et al 2008]	1	NBK99496	
chest x-ray	1	NBK99496	
consolidation, reticular nodular opacities, scarring	1	NBK99496	
empyema or abscess	1	NBK99496	
calcifications if granuloma present	1	NBK99496	
single to multiple small or large abscesses, sharply defined	1	NBK99496	
calcifications	1	NBK99496	
musculoskeletal / osteomyelitis [galluzzo et al 2008]	1	NBK99496	
genitourinary / cystitis [walther et al 1992]	1	NBK99496	
inflammatory pseudotumors of the bladder	1	NBK99496	
on us appear as focal wall thickening	1	NBK99496	
obstruction	1	NBK99496	
esophagus: strictures, diverticula, dysmotility	1	NBK99496	
thickening of bowel wall, fistulae	1	NBK99496	
gastric wall thickening on us, ct, or mri	1	NBK99496	
fungal sinusitis hyperdense	1	NBK99496	
abscesses with typical appearance on mri with ring-enhancing lesions	1	NBK99496	
treatment of colitis in cgd can be difficult	1	NBK99496	
corticosteroid treatment of heightened inflammatory response	1	NBK99496	
granulocyte infusions	1	NBK99496	
granulocyte infusions are generally well tolerated	1	NBK99496	
males with x-linked cgd	1	NBK99496	
, they are kell negative)	1	NBK99496	
kell-negative blood products are rarely available	1	NBK99496	
antibacterial prophylaxis	1	NBK99496	
antifungal prophylaxis	1	NBK99496	
immunomodulatory therapy	1	NBK99496	
9 months	1	NBK99496	
13 to 0	1	NBK99496	
4 per patient year	1	NBK99496	
the data for this are anecdotal and unimpressive	1	NBK99496	
for bsa >0	1	NBK99496	
for bsa ≤0	1	NBK99496	
5/m2 the dose is 1	1	NBK99496	
5 μg/kg subcutaneously 3x/week	1	NBK99496	
allogeneic hsct is the only known cure for cgd	1	NBK99496	
, aspergillosis)	1	NBK99496	
exposures	1	NBK99496	
therefore, the following should be avoided:	1	NBK99496	
exposure to mulch	1	NBK99496	
potting of plants or gardening	1	NBK99496	
raking leaves or mowing lawns	1	NBK99496	
swimming in stagnant water, brackish water, or ponds	1	NBK99496	
transfusion considerations	1	NBK99496	
data regarding teratogenicity of itraconazole are limited	1	NBK99496	
one had resolution of infection with 1	1	NBK99496	
1% of neutrophils regaining gp91phox expression	1	NBK99496	
gov/books/n/gene/chac	1	NBK1387	
neuropsychological assessment to identify and address possible psychosocial complications	1	NBK1387	
clinical genetics consultation may be considered	1	NBK1387	
splints can be tried for foot drop	1	NBK1387	
the following are advised:	1	NBK1387	
prevention of falls	1	NBK1387	
eeg approximately every third year	1	NBK1387	
seizure-provoking circumstances (e	1	NBK1387	
, sleep deprivation, alcohol intake)	1	NBK1387	
anticonvulsants that may worsen involuntary movements (e	1	NBK1387	
, carbamazepine, lamotrigine)	1	NBK1387	
gov/books/n/gene/char	1	NBK1106	
gov/books/n/gene/charge	1	NBK1117	
when possible, clinical testing of visual fields	1	NBK1117	
cardiac evaluation for cardiovascular anomalies	1	NBK1117	
ent and audiologic evaluation:	1	NBK1117	
evaluation for cleft palate, including submucous cleft palate	1	NBK1117	
choanal atresia	1	NBK1117	
feeding/swallowing dysfunction	1	NBK1117	
renal evaluation	1	NBK1117	
renal ultrasound examination is recommended in all children	1	NBK1117	
coloboma	1	NBK1117	
hearing loss should be assumed until proven otherwise	1	NBK1117	
communication	1	NBK1117	
deaf-blind service referral	1	NBK1117	
referral to deafblind education services (e	1	NBK1117	
frequent rest breaks may be needed	1	NBK1117	
myofacial release can improve posture and flexibility	1	NBK1117	
occasionally, sleep studies show obstructive apnea	1	NBK1117	
gi consultation is often indicated	1	NBK1117	
obsessive-compulsive disorder	1	NBK1117	
pervasive developmental disorder	1	NBK1117	
sensory processing issues are likely implicated	1	NBK1117	
attention-deficit hyperactivity disorder	1	NBK1117	
understanding this is critical to devising appropriate interventional strategies	1	NBK1117	
facial palsy	1	NBK1117	
frequent clinical and radiologic dental evaluations should be performed	1	NBK1117	
prophylaxis for retinal detachment is not appropriate	1	NBK1117	
gov/books/n/gene/chchd10-dis	1	NBK304142	
screening to detect depression and assess need for psychosocial support	1	NBK304142	
general	1	NBK304142	
mitochondrial myopathy	1	NBK304142	
assistance with ambulation and posture	1	NBK304142	
surgical correction of ptosis as needed	1	NBK304142	
amyotrophic lateral sclerosis	1	NBK304142	
(als)	1	NBK304142	
frontotemporal dementia (ftd)	1	NBK304142	
spinal motor neuronopathy	1	NBK304142	
neurologic examination including assessment of memory, personality changes	1	NBK304142	
psychiatric abnormalities	1	NBK304142	
assessment for signs including depression and suicidal ideation	1	NBK304142	
impaired respiratory function	1	NBK304142	
audiologic examination including speech discrimination testing	1	NBK304142	
the following should be noted:	1	NBK304142	
baclofen used to treat spasticity can sometimes worsen muscle weakness	1	NBK304142	
gov/books/n/gene/chd2-dis	1	NBK333201	
clinical genetics and/or child neurology consultation	1	NBK333201	
seizures should be managed by an experienced pediatric neurologist	1	NBK333201	
avoid flickering lights that may provoke seizures	1	NBK333201	
gov/books/n/gene/chediak-higashi	1	NBK5188	
history of unexplained, persistent, or recurrent fever	1	NBK5188	
cytopenia of at least two cell lines	1	NBK5188	
signs of liver dysfunction including hypertriglyceridemia and/or hypofibrinogenemia	1	NBK5188	
elevated serum ferritin concentration	1	NBK5188	
elevated soluble interleukin-2 receptor level	1	NBK5188	
evidence of hemophagocytosis in bone marrow and/or cerebrospinal fluid	1	NBK5188	
comprehensive neurologic examination	1	NBK5188	
screening for a history of frequent or unusual infections	1	NBK5188	
screening for clinical signs of lymphoma	1	NBK5188	
hematologic and immunologic defects	1	NBK5188	
select individuals may also receive intrathecal methotrexate and prednisilone	1	NBK5188	
once remission occurs, prompt hsct is recommended	1	NBK5188	
correction of refractive errors may improve visual acuity	1	NBK5188	
skin hypopigmentation	1	NBK5188	
skin protection varies depending on the degree of hypopigmentation	1	NBK5188	
neurologic abnormalities	1	NBK5188	
immunizations are generally well tolerated and should be administered	1	NBK5188	
intravenous ddavp (0	1	NBK5188	
2-0	1	NBK5188	
no guidelines for surveillance of classic chs exist	1	NBK5188	
abdominal ultrasound examination to monitor for hepatosplenomegaly	1	NBK5188	
cbc to evaluate for cytopenias	1	NBK5188	
measurement of serum ferritin concentration	1	NBK5188	
soluble interleukin-2 receptor measurement	1	NBK5188	
all nonsteroidal anti-inflammatory drugs (nsaids) (e	1	NBK5188	
the infants were normal	1	NBK5188	
gov/books/n/gene/cherubism	1	NBK1137	
radiologic assessment to determine facial bone involvement	1	NBK1137	
orthodontic assessment	1	NBK1137	
assessment of family history	1	NBK1137	
early treatment (i	1	NBK1137	
gov/books/n/gene/chh	1	NBK84550	
testing	1	NBK84550	
complete blood count with differential cell count	1	NBK84550	
cd3, 4, 8, 19, 16/56	1	NBK84550	
post-vaccine titers	1	NBK84550	
other immunologic parameters:	1	NBK84550	
allogeneic lymphocyte cytotoxicity (alc)	1	NBK84550	
t-cell receptor excision circles (trec) analysis	1	NBK84550	
t-cell repertoire	1	NBK84550	
proliferation response to pha	1	NBK84550	
proliferation response to anti-cd3	1	NBK84550	
consultations	1	NBK84550	
evaluation for evidence of respiratory disease	1	NBK84550	
gastroenterologic	1	NBK84550	
evaluation for congenital megacolon if clinical observation is suggestive	1	NBK84550	
orthopedic surgery may be complicated by low bone density	1	NBK84550	
early diagnosis of relatives (i	1	NBK84550	
completely asymptomatic individuals need not be tested	1	NBK84550	
no issues are known	1	NBK84550	
however, experience is limited	1	NBK84550	
gov/books/n/gene/choroid	1	NBK1337	
optical coherence tomography (oct)	1	NBK1337	
nutrition and ocular health have become increasingly topical:	1	NBK1337	
gov/books/n/gene/chrom17-lis	1	NBK5189	
evaluation of:	1	NBK5189	
gov/books/n/gene/ciss	1	NBK52917	
swallowing tests and esophageal manometry	1	NBK52917	
eeg when seizures are observed or suspected	1	NBK52917	
preparedness for appropriate countermeasures (e	1	NBK52917	
an apnea monitor is recommended	1	NBK52917	
anticonvulsants may be required	1	NBK52917	
surgical instrumentation or prolonged	1	NBK52917	
bracing may be required to correct a progressive thoracolumbar scoliosis	1	NBK52917	
paradoxical sweating	1	NBK52917	
treatment should be reserved for adults and older children	1	NBK52917	
clonidine	1	NBK52917	
oral clonidine, at starting doses of 0	1	NBK52917	
05 mg to 0	1	NBK52917	
1 mg four times daily may be required	1	NBK52917	
abrupt cessation of clonidine can lead to prominent hypertension	1	NBK52917	
moxonidine was well tolerated in the short term	1	NBK52917	
however, long-term observations are not yet available	1	NBK52917	
surveillance includes monitoring for evidence of scoliosis and its progression	1	NBK52917	
females with ciss may conceive normally	1	NBK52917	
no complications during pregnancy have been reported to date	1	NBK52917	
the prescription of clonidine should not be discontinued abruptly	1	NBK52917	
gov/books/n/gene/citrin	1	NBK1181	
assess the size of the liver and spleen	1	NBK1181	
all phenotypes	1	NBK1181	
the treatment with therapeutic formulas is not lifelong	1	NBK1181	
other treatments include the following:	1	NBK1181	
saheki et al 2010	1	NBK1181	
yazaki et al 2010	1	NBK1181	
ohura et al, personal communication	1	NBK1181	
okano et al, personal communication]	1	NBK1181	
high-carbohydrate meals and alcohol should be avoided	1	NBK1181	
arginine administration may be effective in preventing hyperammonemic crises	1	NBK1181	
, height, weight, and head circumference	1	NBK1181	
plasma citrulline concentration	1	NBK1181	
serum psti concentration	1	NBK1181	
low-protein/high-caloric (high-carbohydrate) diet	1	NBK1181	
infusion of sugars including glycerol, fructose, and glucose	1	NBK1181	
gov/books/n/gene/clcn7	1	NBK1127	
ultrasonography of abdomen to evaluate for hepatosplenomegaly	1	NBK1127	
ophthalmologic examination including veps to evaluate for optic nerve atrophy	1	NBK1127	
otorhinolaryngologic examination to evaluate for choanal stenosis	1	NBK1127	
eeg to detect pathologic changes associated with neurodegeneration	1	NBK1127	
neurologic examination to evaluate development	1	NBK1127	
orthopedic treatment is often required for fractures and arthritis	1	NBK1127	
a schulz and u kornak, unpublished results]	1	NBK1127	
schulz and moshous, personal communication]	1	NBK1127	
the possible manifestations and complications of osteopetrosis require repeat investigations	1	NBK1127	
activities with high fracture risk should be avoided	1	NBK1127	
gov/books/n/gene/clpb-def	1	NBK396257	
complete physical examination	1	NBK396257	
for those with significant neurologic problems:	1	NBK396257	
no specific dietary or other metabolic treatment is available	1	NBK396257	
gov/books/n/gene/cls	1	NBK1346	
developmental assessment and formulation of an intervention plan	1	NBK1346	
radiographic assessment if clinically indicated	1	NBK1346	
developmental, age-appropriate hearing assessment	1	NBK1346	
ophthalmologic evaluation, including refraction and fundoscopy	1	NBK1346	
evaluation of appropriate family members for signs of the condition	1	NBK1346	
a trial of antiepileptic drugs (aeds) (e	1	NBK1346	
treatment of behavioral problems is standard and requires periodic reassessment	1	NBK1346	
periodic tests of hearing and vision	1	NBK1346	
monitoring of the spine for the development of progressive kyphoscoliosis	1	NBK1346	
gov/books/n/gene/cmd-overview	1	NBK1291	
no definitive treatments exist for the congenital muscular dystrophies	1	NBK1291	
speech therapy may be indicated	1	NBK1291	
close attention to oral hygiene is indicated	1	NBK1291	
stretching exercises to prevent contractures	1	NBK1291	
gov/books/n/gene/cms	1	NBK1168	
neurologic/neuropediatric examination	1	NBK1168	
assessment of strength and motor function	1	NBK1168	
respiratory care	1	NBK1168	
polysomnography to identify individuals with nocturnal hypoventilation	1	NBK1168	
assessment of contractures and joint deformities by physiatrists and orthopedists	1	NBK1168	
acetylcholineesterase (ache) inhibitors (pyridostigmine)	1	NBK1168	
3,4-diaminopyridine (3,4-dap)	1	NBK1168	
quinidine, fluoxetine	1	NBK1168	
however, it may induce suicidal ideation	1	NBK1168	
non-medical treatment	1	NBK1168	
orthotics or a wheelchair	1	NBK1168	
a percutaneous gastric tube	1	NBK1168	
these individuals should receive prophylactic anticholinesterase therapy	1	NBK1168	
routine surveillance of muscle strength and respiratory function is recommended	1	NBK1168	
symptoms of nighttime hypoventilation should be considered	1	NBK1168	
data on pregnancies in cms are limited	1	NBK1168	
gov/books/n/gene/cmt-4a	1	NBK1539	
exercise within the affected individual's capability	1	NBK1539	
note: (1) fatigue may improve with exercise	1	NBK1539	
wheelchair for mobility because of gait instability	1	NBK1539	
lower urinary tract involvement [krhut et al 2014]	1	NBK1539	
vocal cord paresis	1	NBK1539	
regular evaluations to determine:	1	NBK1539	
need for change in diet to control weight	1	NBK1539	
need to involve specialists to evaluate and treat potential complications	1	NBK1539	
obesity because of its negative effect on gait and balance	1	NBK1539	
gov/books/n/gene/cmt-dib	1	NBK45014	
ophthalmologic examination for cataract	1	NBK45014	
treatment may include:	1	NBK45014	
ankle/foot orthoses	1	NBK45014	
forearm crutches or canes	1	NBK45014	
rarely, wheelchairs	1	NBK45014	
career and employment counseling	1	NBK45014	
gov/books/n/gene/cmt	1	NBK1358	
anticipatory counseling is appropriate	1	NBK1358	
gov/books/n/gene/cmt1	1	NBK1205	
forearm crutches or canes for gait stability for some individuals	1	NBK1205	
many remain physically active	1	NBK1205	
no treatment reverses or slows the natural progression of cmt	1	NBK1205	
gov/books/n/gene/cmt2	1	NBK1285	
the following may be indicated:	1	NBK1285	
gov/books/n/gene/cmt2a	1	NBK1511	
wheelchairs for mobility because of gait instability	1	NBK1511	
no similar report on cmt2a exists	1	NBK1511	
gov/books/n/gene/cmt2c	1	NBK201366	
pulmonary function testing and dynamic breathing chest x-ray	1	NBK201366	
skeletal x-rays to document any associated skeletal dysplasia	1	NBK201366	
clinical genetics/genetic counseling consultation	1	NBK201366	
for treatment of findings common to all	1	NBK201366	
trpv4-associated disorders	1	NBK201366	
pain and depression	1	NBK201366	
neuropathy	1	NBK201366	
vocal cord involvement	1	NBK201366	
respiratory therapy/support (e	1	NBK201366	
, bipap)	1	NBK201366	
physical therapy/exercise to maintain as much function as possible	1	NBK201366	
orthopedic evaluation with consideration of surgical intervention (i	1	NBK201366	
patients undergoing surgical fusion typically do well	1	NBK201366	
ent consultation with laryngoscopy	1	NBK201366	
dynamic breathing chest x-ray	1	NBK201366	
annual assessment for the development of joint pain and scoliosis	1	NBK201366	
a child reaches school age	1	NBK201366	
surgical procedures involving general anesthesia	1	NBK201366	
for neuromuscular disorders	1	NBK201366	
for skeletal dysplasias	1	NBK201366	
gov/books/n/gene/cmt2d	1	NBK1242	
appropriate treatment includes:	1	NBK1242	
prosthetic and adaptive devices for weak hands	1	NBK1242	
gov/books/n/gene/cmt2e	1	NBK1187	
gov/books/n/gene/cmt4	1	NBK1468	
ankle/foot orthoses to correct foot drop and aid walking	1	NBK1468	
fewer than 5% of affected individuals need wheelchairs	1	NBK1468	
no specific pregnancy management recommendations have been published	1	NBK1468	
gov/books/n/gene/cmt4c	1	NBK1340	
treatment of spinal deformities	1	NBK1340	
physiotherapy helps to preserve flexibility	1	NBK1340	
treatment of foot deformities	1	NBK1340	
physiotherapy to preserve flexibility	1	NBK1340	
treatment of pain and cramps	1	NBK1340	
, pregabalin, gabapentin)	1	NBK1340	
cramps can be controlled with quinine	1	NBK1340	
some need wheelchairs	1	NBK1340	
physical activity (e	1	NBK1340	
scoliosis needs to be closely followed	1	NBK1340	
monitoring four times a year is recommended	1	NBK1340	
the symptoms of cmt can worsen during pregnancy	1	NBK1340	
in particular: cramps, subjective sensitivity (e	1	NBK1340	
, paresthesias), difficulty walking, and fatigue	1	NBK1340	
see grandis & shy [2005]	1	NBK1340	
blockers of the neuromuscular junction should be used with caution	1	NBK1340	
gov/books/n/gene/cmt4h	1	NBK153601	
clinical genetics consultation and/or pediatric neurology consultation	1	NBK153601	
surgery to correct spine deformities	1	NBK153601	
wheelchairs as needed because of gait instability	1	NBK153601	
gov/books/n/gene/cmt4j	1	NBK169431	
pulmonary function tests to determine whether respiratory functions are compromised	1	NBK169431	
no specific treatment reverses the manifestations of cmt4j	1	NBK169431	
severely affected individuals need wheelchairs	1	NBK169431	
bipap for those with respiratory muscle weakness	1	NBK169431	
no obvious effect has been observed	1	NBK169431	
gov/books/n/gene/cmtx	1	NBK1374	
ncv to determine axonal, demyelinating, or mixed features	1	NBK1374	
gov/books/n/gene/cmtx5	1	NBK1876	
pure tone audiograms, auditory brain stem response test	1	NBK1876	
evaluation of visual acuity, fundoscopic examination	1	NBK1876	
peripheral neuropathy	1	NBK1876	
see charcot-marie-tooth hereditary neuropathy overview, management	1	NBK1876	
gov/books/n/gene/cockayne	1	NBK1342	
measurement of growth	1	NBK1342	
dermatologic evaluations	1	NBK1342	
ophthalmologic evaluations (possibly including electroretinogram)	1	NBK1342	
audiologic evaluation (including audiogram)	1	NBK1342	
laboratory studies to assess renal and hepatic function	1	NBK1342	
testing for diabetes mellitus and disorders of calcium metabolism	1	NBK1342	
skeletal x-rays to document the presence of skeletal dysplasia	1	NBK1342	
individualized educational program for developmental delay	1	NBK1342	
feeding gastrostomy tube placement for failure to thrive	1	NBK1342	
management of hearing loss	1	NBK1342	
management of cataracts and other ophthalmologic complications	1	NBK1342	
use of sunscreens for cutaneous photosensitivity	1	NBK1342	
use of sunglasses for lens and retina protection	1	NBK1342	
recommended measures:	1	NBK1342	
physical therapy to prevent joint contractures	1	NBK1342	
aggressive dental care to minimize dental caries	1	NBK1342	
home safety assessments to prevent falls	1	NBK1342	
yearly reassessment for known potential complications (e	1	NBK1342	
, hypertension	1	NBK1342	
renal or hepatic dysfunction	1	NBK1342	
declining vision and hearing) is appropriate	1	NBK1342	
excessive sun exposure should be avoided	1	NBK1342	
gov/books/n/gene/coffin-siris	1	NBK131811	
gastrointestinal evaluation for feeding difficulties or poor growth	1	NBK131811	
dietary evaluation by a nutritionist as needed	1	NBK131811	
echocardiogram to evaluate for structural cardiac defects	1	NBK131811	
gov/books/n/gene/cohen	1	NBK1482	
spectacle correction of refractive errors	1	NBK1482	
psychosocial support for affected individuals and their families	1	NBK1482	
recurrent infections should be treated per standard therapy	1	NBK1482	
growth and weight gain should be monitored	1	NBK1482	
gov/books/n/gene/col4a1-dis	1	NBK7046	
brain angiographic ct scan	1	NBK7046	
ophthalmologic examination including fundoscopic examination and slit-lamp examination	1	NBK7046	
kidney and liver ultrasound examination or ct	1	NBK7046	
measurement of serum ck concentration	1	NBK7046	
evaluation for the presence of hematuria	1	NBK7046	
electrocardiogram (ecg)	1	NBK7046	
no specific support exists for individuals with col4a1-related disorders	1	NBK7046	
seizures are managed using standard protocols	1	NBK7046	
glaucoma is initially treated with topical anti-glaucoma medication	1	NBK7046	
annual clinical evaluation is reasonable	1	NBK7046	
smoking because it increases the global risk of stroke	1	NBK7046	
hypertension because it increases the risk of stroke	1	NBK7046	
anticoagulant use [gould et al 2006]	1	NBK7046	
gov/books/n/gene/coq10-def	1	NBK410087	
neurologic evaluation including brain mri	1	NBK410087	
renal evaluation with particular attention to the presence of proteinuria	1	NBK410087	
audiometry with particular attention to possible sensorineural hearing loss	1	NBK410087	
coenzyme q10 supplementation	1	NBK410087	
coq4-related coenzyme q10 deficiency	1	NBK410087	
coq6-related coenzyme q10 deficiency	1	NBK410087	
homozygotes for the pathogenic variants p	1	NBK410087	
gly255arg or p	1	NBK410087	
ala353asp responded [heeringa et al 2011]	1	NBK410087	
coq8b-related coenzyme q10 deficiency	1	NBK410087	
pdss2-related coenzyme q10 deficiency	1	NBK410087	
coq8a-related coenzyme q10 deficiency	1	NBK410087	
coq9-related coenzyme q10 deficiency	1	NBK410087	
gov/books/n/gene/costello	1	NBK1507	
plotting of growth parameters, including head circumference	1	NBK1507	
most infants require nasogastric or gastrostomy feeding	1	NBK1507	
pyloric stenosis is treated surgically	1	NBK1507	
anecdotally, affected children have very high caloric needs	1	NBK1507	
kyphoscoliosis may require surgical correction	1	NBK1507	
dental abnormalities should be addressed by a pediatric dentist	1	NBK1507	
papillomata	1	NBK1507	
thus, cortisol deficiency may also be considered	1	NBK1507	
malignant tumors	1	NBK1507	
treatment of malignant tumors follows standard protocols	1	NBK1507	
care should be individualized	1	NBK1507	
sedation	1	NBK1507	
however, studies are ongoing	1	NBK1507	
growth hormone (gh) treatment	1	NBK1507	
unproven benefit	1	NBK1507	
true growth hormone deficiency requires gh replacement	1	NBK1507	
cardiac hypertrophy	1	NBK1507	
, kerr et al [2003])	1	NBK1507	
gov/books/n/gene/cpt1a	1	NBK1527	
info and ghr	1	NBK1527	
prevention of hypoglycemia reduces the risk of related neurologic damage	1	NBK1527	
gov/books/n/gene/cpt2	1	NBK1253	
strength testing	1	NBK1253	
review of dietary association of symptoms	1	NBK1253	
current treatment for long-chain fatty-acid oxidation disorders:	1	NBK1253	
avoid known triggers	1	NBK1253	
infusions of glucose during intercurrent infections to prevent catabolism	1	NBK1253	
note: oral glucose cannot achieve this effect	1	NBK1253	
frequent meals and avoidance of extended fasting	1	NBK1253	
avoidance of prolonged exercise and other known triggers	1	NBK1253	
extended fasting and prolonged exercise are to be avoided	1	NBK1253	
valproic acid [kottlors et al 2001]	1	NBK1253	
ibuprofen	1	NBK1253	
diazepam in high doses [bonnefont et al 1999]	1	NBK1253	
acute fatty liver of pregnancy	1	NBK1253	
maternal liver disease	1	NBK1253	
gov/books/n/gene/cranio-md	1	NBK1461	
radiologic assessment	1	NBK1461	
endocrinologic tests to assess bone metabolism	1	NBK1461	
treatment consists primarily of surgical intervention	1	NBK1461	
gov/books/n/gene/craniosynostosis	1	NBK1455	
spinal x-rays to evaluate for vertebral anomalies	1	NBK1455	
cytokine administration may shorten the consolidation period	1	NBK1455	
timing of subsequent craniofacial surgeries influences their success	1	NBK1455	
limbs	1	NBK1455	
, hydrocephalus, cognitive impairment)	1	NBK1455	
six of 29 persons with the fgfr3 pathogenic variant p	1	NBK1455	
gov/books/n/gene/creatine	1	NBK3794	
neuropsychological assessment of cognition and speech	1	NBK3794	
video documentation of movement disorder	1	NBK3794	
eeg, if any clinical seizures	1	NBK3794	
ecg and echocardiogram for cardiac involvement	1	NBK3794	
behavior therapy for behavior problems by developmental pediatrician	1	NBK3794	
seizure management with antiepileptic drugs by epilepsy specialist	1	NBK3794	
treatment of movement disorder by movement disorder specialist	1	NBK3794	
gamt deficiency	1	NBK3794	
treatment is as follows:	1	NBK3794	
4-0	1	NBK3794	
8g/kg/day)	1	NBK3794	
available databases (e	1	NBK3794	
treatment outcome of symptomatic individuals with gamt deficiency	1	NBK3794	
in 18% of individuals seizures were eliminated	1	NBK3794	
in 49% seizure frequency decreased	1	NBK3794	
improvement was seen in 60% of individuals	1	NBK3794	
treatment outcome of asymptomatic individuals with gamt deficiency	1	NBK3794	
agat deficiency	1	NBK3794	
treatment outcome of symptomatic individuals with agat deficiency	1	NBK3794	
treatment outcome of asymptomatic individuals with agat deficiency	1	NBK3794	
crtr deficiency	1	NBK3794	
the goal of treatment is to replenish cerebral creatine levels	1	NBK3794	
treatment has included:	1	NBK3794	
glycine 150 mg/kg bw/day in 3 doses	1	NBK3794	
treatment outcome of individuals with crtr deficiency	1	NBK3794	
for patients undergoing treatment:	1	NBK3794	
perform neuropsychological assessment of cognitive functions and speech	1	NBK3794	
gov/books/n/gene/csc-dys	1	NBK2690	
assessment of visual acuity	1	NBK2690	
assessment of refractive error	1	NBK2690	
measurement of corneal thickness using pachymetry	1	NBK2690	
spectacles or contact lenses for correction of refractive errors	1	NBK2690	
management of strabismus	1	NBK2690	
penetrating keratoplasty	1	NBK2690	
most grafts remain clear after penetrating keratoplasty	1	NBK2690	
patching to prevent amblyopia in children with strabismus is appropriate	1	NBK2690	
gov/books/n/gene/csnb	1	NBK1245	
electroretinography	1	NBK1245	
dark adaptation (optional)	1	NBK1245	
gov/books/n/gene/ctlm	1	NBK1458	
urinary organic acids	1	NBK1458	
and urinary orotic acid	1	NBK1458	
assessment of intracranial pressure and overall neurologic status	1	NBK1458	
see acmg-act sheet, acmg algorithm	1	NBK1458	
acute management of hyperammonemia	1	NBK1458	
rapidly decreasing plasma ammonia concentration	1	NBK1458	
scavenger therapy should be continued while dialysis is being performed	1	NBK1458	
note: exchange transfusions have no place in hyperammonemic treatment	1	NBK1458	
0-1	1	NBK1458	
control of intracranial pressure	1	NBK1458	
cerebral edema and ischemia may be documented by mri	1	NBK1458	
chronic management	1	NBK1458	
protein restriction	1	NBK1458	
nitrogen scavenger therapy	1	NBK1458	
as children grow, doses change to 9	1	NBK1458	
9-13 g/m2/day of sodium phenylbutyrate and 8	1	NBK1458	
4 g/m2/day of arginine	1	NBK1458	
the initial dosage for phenylbutyrate-naïve patients is 4	1	NBK1458	
5-11	1	NBK1458	
2 ml/m2/day (5-12	1	NBK1458	
4 g/m2/day)	1	NBK1458	
living related-donor liver transplantation	1	NBK1458	
monitoring should include:	1	NBK1458	
success has not been achieved to date	1	NBK1458	
gov/books/n/gene/ctns	1	NBK1400	
in individuals who are initially diagnosed at any age:	1	NBK1400	
height and weight, plotted on age-appropriate growth charts	1	NBK1400	
glomerular filtration rate (gfr) or creatinine clearance test	1	NBK1400	
lipid panel	1	NBK1400	
renal ultrasound examination for evaluation of nephrocalcinosis	1	NBK1400	
baseline ophthalmology evaluation, including a fundoscopic examination	1	NBK1400	
renal fanconi syndrome	1	NBK1400	
phosphate replacement to prevent and treat rickets	1	NBK1400	
renal glomerular disease	1	NBK1400	
renal transplantation	1	NBK1400	
73 m2 and azotemia and hypertension rapidly progress	1	NBK1400	
symptoms often determine the exact time of transplantation	1	NBK1400	
retinal involvement is irreversible	1	NBK1400	
nutrition must be adequate for growth	1	NBK1400	
oral l-thyroxine replacement for hypothyroidism	1	NBK1400	
insulin for diabetes mellitus	1	NBK1400	
speech therapy and physical therapy	1	NBK1400	
standard treatment for benign intracranial hypertension	1	NBK1400	
other central nervous system complications are irreversible	1	NBK1400	
3 to 1	1	NBK1400	
95 g/m2/day)	1	NBK1400	
procysbi® is taken every 12 hours	1	NBK1400	
cysteamine increases gastrin synthesis and gastric acid production	1	NBK1400	
55% solution with benzalkonium chloride 0	1	NBK1400	
carnitine supplementation may improve muscle strength in pre-transplant individuals	1	NBK1400	
in advanced disease (i	1	NBK1400	
chest ct for detection of coronary and other vascular calcification	1	NBK1400	
dehydration, which compromises remaining renal function	1	NBK1400	
sun exposure, which can exacerbate photophobia	1	NBK1400	
it is appropriate to evaluate relatives at risk (e	1	NBK1400	
gov/books/n/gene/ctx	1	NBK1409	
cardiologic evaluation including ekg and echocardiogram	1	NBK1409	
evaluation for osteoporosis	1	NBK1409	
chenodeoxycholic acid (cdca)	1	NBK1409	
normalization of nerve conduction velocities and subsequent stabilization	1	NBK1409	
cdca treatment may be more useful when started early	1	NBK1409	
luyckx et al 2014]	1	NBK1409	
coenzyme q10 (coq10) treatment may improve muscle weakness	1	NBK1409	
calcium and vitamin d supplementation improve osteoporosis	1	NBK1409	
recommended annual surveillance includes the following:	1	NBK1409	
neurologic and neuropsychologic evaluation	1	NBK1409	
cholestanol plasma concentration	1	NBK1409	
measurement of total body density (tbd)	1	NBK1409	
treatment with chenodeoxycholic acid should not be interrupted during pregnancy	1	NBK1409	
gov/books/n/gene/cutis-laxa	1	NBK5200	
ortolani sign for detection of hip dislocation	1	NBK5200	
hip ultrasound examination as needed based on clinical findings	1	NBK5200	
assessment for inguinal hernias	1	NBK5200	
baseline neurodevelopmental evaluation	1	NBK5200	
evaluation for a bleeding disorder linked to coagulation factor deficiencies	1	NBK5200	
repair of inguinal hernia(s)	1	NBK5200	
routine management of hip dislocation	1	NBK5200	
routine management of refractive errors	1	NBK5200	
antiepileptic drugs (aeds): valproate	1	NBK5200	
or a combination of aeds can be used	1	NBK5200	
psychological help as needed for self-image issues	1	NBK5200	
gov/books/n/gene/cvt	1	NBK1289	
holter monitoring, as arrhythmias develop when heart rate increases	1	NBK1289	
exercise stress test both for diagnosis and monitoring of therapy	1	NBK1289	
echocardiogram and/or mri to evaluate for structural defects	1	NBK1289	
flecainide	1	NBK1289	
secondary complications are mainly related to therapy	1	NBK1289	
beta-blockers could worsen allergic asthma	1	NBK1289	
the reasons for this are under investigation	1	NBK1289	
these visits should include the following:	1	NBK1289	
echo and mri at least every two years	1	NBK1289	
competitive sports and other strenuous exercise are always contraindicated	1	NBK1289	
gov/books/n/gene/cyclic-n	1	NBK1533	
dental examination for gingival and periodontal disease	1	NBK1533	
granulocyte colony-stimulating factor (g-csf)	1	NBK1533	
dale, unpublished observations]	1	NBK1533	
, 5-10 µg/kg/day)	1	NBK1533	
observation should include the following:	1	NBK1533	
blood counts several times a year	1	NBK1533	
otherwise serial ancs can be evaluated	1	NBK1533	
other findings included:	1	NBK1533	
unrelated cord blood transplantation for neutropenia is being investigated	1	NBK1533	
gov/books/n/gene/dbh	1	NBK1474	
consultation with a clinical geneticist or genetic counselor	1	NBK1474	
however, urinary ne excretion exceeds normal levels	1	NBK1474	
fludrocortisone, at dosages of 0	1	NBK1474	
ptosis can be corrected by surgery	1	NBK1474	
sinus problems should be treated as needed	1	NBK1474	
the effect of droxidopa on renal function is unknown	1	NBK1474	
plasma magnesium and potassium should also be assessed	1	NBK1474	
adjustment of dosage may be required	1	NBK1474	
dose adjustment may also be required post partum	1	NBK1474	
gov/books/n/gene/dbmd	1	NBK1119	
mean lvef increased from 36% to 53%	1	NBK1119	
measurement of reduced sphericity indicated improved ventricular geometry	1	NBK1119	
scoliosis treatment as needed is appropriate	1	NBK1119	
corticosteroid therapy	1	NBK1119	
75 mg/kg/day or 1	1	NBK1119	
5 and 0	1	NBK1119	
6 mg/kg/day [fenichel et al 1991]	1	NBK1119	
follow-up studies showed that a dose of 0	1	NBK1119	
3 mg/kg/day [fenichel et al 1991]	1	NBK1119	
35 mg/kg/day) in both dmd and bmd	1	NBK1119	
4 mg/kg/day	1	NBK1119	
at lower doses of 0	1	NBK1119	
alternate-day dosing and intermittent dosing (e	1	NBK1119	
side effects did not negatively affect quality of life	1	NBK1119	
initiation and length of treatment	1	NBK1119	
75 mg/kg/day, prednisone 0	1	NBK1119	
published guidelines	1	NBK1119	
the optimal maintenance dose of prednisone (0	1	NBK1119	
3 mg/kg/day	1	NBK1119	
5 mg/kg/day	1	NBK1119	
3 mg/kg/day after three to four months	1	NBK1119	
deflazacort (0	1	NBK1119	
cardiorespiratory	1	NBK1119	
nutritional	1	NBK1119	
assessment if:	1	NBK1119	
dysphagia is present	1	NBK1119	
patient is chronically constipated	1	NBK1119	
major surgery has been planned	1	NBK1119	
patient is malnourished	1	NBK1119	
muscular	1	NBK1119	
physical therapy to promote mobility and prevent contractures	1	NBK1119	
bone health	1	NBK1119	
magnesium and parathyroid hormone levels may be considered	1	NBK1119	
urine (calcium, sodium, creatinine)	1	NBK1119	
dual energy x-ray absorptiometry (dexa) scanning	1	NBK1119	
spine radiograph	1	NBK1119	
if back pain is present	1	NBK1119	
to exclude vertebral compression fracture	1	NBK1119	
to assess degree of kyphoscoliosis if present on physical examination	1	NBK1119	
interventions:	1	NBK1119	
intravenous bisphosphonates	1	NBK1119	
use of oral biphosphonates for prophylaxis or treatment remains controversial	1	NBK1119	
dmd	1	NBK1119	
evaluations should continue at least every two years	1	NBK1119	
confinement to a wheelchair	1	NBK1119	
reduction in vital capacity below 80% predicted	1	NBK1119	
age 12 years	1	NBK1119	
manual and mechanically assisted cough techniques	1	NBK1119	
evaluation for surgical interventions as needed	1	NBK1119	
individuals with dmd/bmd should avoid botulinum toxin injections	1	NBK1119	
pregnancy management for heterozygous females	1	NBK1119	
aminoglycosides	1	NBK1119	
in a preliminary study in which gentamicin (7	1	NBK1119	
boys who did not lose ambulation experienced a 67	1	NBK1119	
a phase iii multicenter study is currently in progress	1	NBK1119	
immunosuppression with azathioprine is not beneficial	1	NBK1119	
myoblast transfer has been inefficient	1	NBK1119	
however, no functional improvement was noted	1	NBK1119	
the study was not powered to look for efficacy	1	NBK1119	
gov/books/n/gene/dcm-lmna	1	NBK1674	
comprehensive cardiovascular evaluation	1	NBK1674	
evaluation for conduction system disease and arrhythmia:	1	NBK1674	
, 24-hour monitoring or event monitors)	1	NBK1674	
evaluation for left ventricular dysfunction and dcm:	1	NBK1674	
measurement of serum ck concentration to evaluate for skeletal myopathy	1	NBK1674	
elements of the guidelines include the following:	1	NBK1674	
consider therapy based on cardiac phenotype (i	1	NBK1674	
, dcm or arrhythmia)	1	NBK1674	
cardiac conduction system disease and arrhythmias	1	NBK1674	
, atrial or atrioventricular node ablations)	1	NBK1674	
lmna-related dcm	1	NBK1674	
whether conventional medical therapy (e	1	NBK1674	
drugs (e	1	NBK1674	
, coronary artery disease)	1	NBK1674	
, left ventricular enlargement but normal function	1	NBK1674	
gov/books/n/gene/dcm-ov	1	NBK1309	
symptomatic dcm represents late disease	1	NBK1309	
individuals with idiopathic or familial dilated cardiomyopathy should:	1	NBK1309	
an asymptomatic person with a known pathogenic variant	1	NBK1309	
in most cases, pregnancy is contraindicated in dcm	1	NBK1309	
gov/books/n/gene/dcx	1	NBK1185	
neurologic/neuropediatric evaluation, including eeg and cerebral mri	1	NBK1185	
epileptic seizures require antiepileptic drugs (aeds)	1	NBK1185	
special adaptive chairs or positioners may be required	1	NBK1185	
monitoring of seizure activity by regular neurologic examination and eeg	1	NBK1185	
monitoring of orthopedic complications including foot deformity and scoliosis	1	NBK1185	
gov/books/n/gene/ddon	1	NBK1216	
affected males	1	NBK1216	
neurologic evaluation for dystonia and ataxia	1	NBK1216	
formal audiologic assessment	1	NBK1216	
speech and language evaluation for assessment of speech therapy requirements	1	NBK1216	
ophthalmologic evaluation, including erg	1	NBK1216	
in adults, evaluation for dementia and/or psychiatric disturbance	1	NBK1216	
carrier females	1	NBK1216	
neurologic evaluation for focal dystonia	1	NBK1216	
educational	1	NBK1216	
spectacle correction is appropriate where indicated	1	NBK1216	
agammaglobulinemia (see x-linked agammaglobulinemia)	1	NBK1216	
annual audiologic assessment	1	NBK1216	
live viral vaccines should be avoided if agammaglobulinemia is present	1	NBK1216	
gov/books/n/gene/deafness-overview	1	NBK1434	
sequential audiologic examinations are essential to:	1	NBK1434	
document the stability or progression of the hearing loss	1	NBK1434	
gov/books/n/gene/del16p11_2	1	NBK11167	
2 recurrent microdeletion, the following are recommended:	1	NBK11167	
audiologic testing	1	NBK11167	
manifestations of the 16p11	1	NBK11167	
early diagnosis and provision of therapies facilitate the best outcome	1	NBK11167	
referral to other appropriate medical specialists (sue	1	NBK11167	
neurodevelopmental disabilities including asd	1	NBK11167	
obesity and overweight	1	NBK11167	
maintain an active lifestyle	1	NBK11167	
chiari i malformation or syringomyelia	1	NBK11167	
surveillance should include the following:	1	NBK11167	
monitoring of height, weight, and bmi	1	NBK11167	
clinical screening for scoliosis until the age of skeletal maturity	1	NBK11167	
some medications used to treat behavioral problems (e	1	NBK11167	
gov/books/n/gene/del1p36	1	NBK1191	
, scoliosis, lower-limb asymmetry)	1	NBK1191	
periodic thyroid function screening	1	NBK1191	
the spasms are responsive to acth	1	NBK1191	
special feeding techniques or devices, e	1	NBK1191	
structural anomalies (e	1	NBK1191	
hypothyroidism is treated in a standard manner	1	NBK1191	
gov/books/n/gene/del2q37_2	1	NBK1158	
complete physical and dysmorphology examination	1	NBK1158	
specialty evaluation of obesity or failure to thrive	1	NBK1158	
echocardiogram to evaluate for congenital cardiac anomaly	1	NBK1158	
ophthalmology evaluation for strabismus and/or refractive errors	1	NBK1158	
audiologic assessment for possible hearing loss	1	NBK1158	
eeg for evaluation of seizures and treatment monitoring	1	NBK1158	
1, although screening intervals are not delineated	1	NBK1158	
the following are also appropriate:	1	NBK1158	
ongoing routine pediatric care	1	NBK1158	
gov/books/n/gene/dent	1	NBK99494	
assessment of renal function (measured or estimated gfr	1	NBK99494	
urine protein excretion)	1	NBK99494	
assessment for nephrocalcinosis and kidney stones by imaging studies	1	NBK99494	
in children, evaluation of stature using standard growth charts	1	NBK99494	
no guidelines have been established for treatment of dent disease	1	NBK99494	
thiazide diuretics in doses greater than 0	1	NBK99494	
however, their effectiveness has not been clear	1	NBK99494	
gov/books/n/gene/depdc5-epilepsy	1	NBK385626	
detailed clinical history to establish seizure type and frequency	1	NBK385626	
routine eeg	1	NBK385626	
the response to antiepileptic drugs (aeds) is variable	1	NBK385626	
gov/books/n/gene/df-lamm	1	NBK100664	
ophthalmology evaluation for strabismus and hypermetropia	1	NBK100664	
routine ophthalmologic management of strabismus, if present	1	NBK100664	
gov/books/n/gene/dfn-myop	1	NBK269029	
ophthalmology evaluation for myopia and other ocular comorbidities	1	NBK269029	
routine correction of refractive error	1	NBK269029	
ent and audiology evaluations at least yearly	1	NBK269029	
regular speech and language evaluation to monitor language development	1	NBK269029	
individuals with hearing loss should avoid the following:	1	NBK269029	
known environmental factors for hearing loss (e	1	NBK269029	
, loud noises)	1	NBK269029	
ototoxic medications	1	NBK269029	
gov/books/n/gene/dfna2	1	NBK1209	
audiometry, including bone conduction testing	1	NBK1209	
evaluations may include:	1	NBK1209	
gov/books/n/gene/dfna3	1	NBK1536	
gov/books/n/gene/dfnb1	1	NBK1272	
ophthalmologic evaluation for refractive errors	1	NBK1272	
annual examination by a physician familiar with hereditary hearing impairment	1	NBK1272	
gov/books/n/gene/dfnb9	1	NBK1251	
see hereditary deafness and hearing loss overview for details	1	NBK1251	
hearing habilitation	1	NBK1251	
for those with nonsyndromic bilateral congenital hearing loss	1	NBK1251	
hearing aids should be fitted as soon as possible	1	NBK1251	
educational programs designed for individuals with hearing impairment are appropriate	1	NBK1251	
for individuals with ts-nsan:	1	NBK1251	
prevent febrile episodes	1	NBK1251	
for individuals with nonsyndromic bilateral congenital hearing loss:	1	NBK1251	
individuals with ts-nsan	1	NBK1251	
avoid excessive body temperatures when possible	1	NBK1251	
gov/books/n/gene/dfnx1	1	NBK57098	
pure tone audiograms, auditory brain stem response testing	1	NBK57098	
assessment of the vestibular function	1	NBK57098	
see deafness and hereditary hearing loss overview	1	NBK57098	
gov/books/n/gene/dguok-mtddepl	1	NBK7040	
for both neonatal multisystem diseases and isolated hepatic disease	1	NBK7040	
hepatic sonography and afp to screen for hepatocellular carcinoma	1	NBK7040	
additional evaluation for neonatal multisystem diseases	1	NBK7040	
measurement of plasma lactate and fasting blood sugar	1	NBK7040	
neuroimaging may be considered	1	NBK7040	
additional evaluation for isolated hepatic disease	1	NBK7040	
management of neurologic manifestations in neonatal multisystem disease	1	NBK7040	
hypotonia may be significant	1	NBK7040	
the one-year survival rate was 64%	1	NBK7040	
five of the 14 survived longer than five years	1	NBK7040	
neonatal multisystem disease:	1	NBK7040	
isolated hepatic disease	1	NBK7040	
evidence of renal disease (proteinuria and aminoaciduria)	1	NBK7040	
gov/books/n/gene/diamond-b	1	NBK7047	
evaluation by a hematologist	1	NBK7047	
ultrasound examination of the kidney and urinary tract	1	NBK7047	
evaluation by a nephrologist and a urologist, as appropriate	1	NBK7047	
evaluation by a cardiologist including echocardiography	1	NBK7047	
corticosteroid administration	1	NBK7047	
corticosteroids may be slowly tapered to the minimal effective dose	1	NBK7047	
the recommended maximum maintenance dose is ≤0	1	NBK7047	
red blood cell transfusion	1	NBK7047	
7% ±10	1	NBK7047	
1% ±11	1	NBK7047	
survival was the best (92	1	NBK7047	
cancer treatment	1	NBK7047	
treatment of malignancies should be coordinated by an oncologist	1	NBK7047	
mri for assessing iron loading in the liver and heart	1	NBK7047	
deferasirox is recommended in individuals age two years or older	1	NBK7047	
the recommended initial dose is 40 mg/kg/day	1	NBK7047	
the maximum dose is 50-60 mg/kg/day	1	NBK7047	
complete blood counts several times a year	1	NBK7047	
monitoring of blood pressure in individuals who are steroid dependent	1	NBK7047	
evaluation by an endocrinologist	1	NBK7047	
cancer surveillance includes the following:	1	NBK7047	
consideration of other testing (e	1	NBK7047	
during pregnancy the maternal hemoglobin level must be monitored	1	NBK7047	
intrauterine growth retardation	1	NBK7047	
preeclampsia	1	NBK7047	
retroplacental hematoma	1	NBK7047	
in utero fetal death	1	NBK7047	
gov/books/n/gene/diastrophic-d	1	NBK1350	
, for clubfeet)	1	NBK1350	
physical therapy may prevent early joint contractures	1	NBK1350	
gov/books/n/gene/dkc	1	NBK22301	
suggested studies to consider include:	1	NBK22301	
thorough skin and nail examination	1	NBK22301	
growth and development evaluation	1	NBK22301	
ophthalmic	1	NBK22301	
otolaryngology	1	NBK22301	
gastrointestinal and hepatic	1	NBK22301	
history of potential swallowing difficulties and/or enteropathy	1	NBK22301	
baseline liver function tests	1	NBK22301	
for males, assessment for urethral stenosis	1	NBK22301	
consideration of baseline bone mineral density scan	1	NBK22301	
history of any joint problems	1	NBK22301	
if early-onset neurologic findings (e	1	NBK22301	
consideration of bubble echocardiography to evaluate for pulmonary arteriovenous malformations	1	NBK22301	
increased risk of cancer	1	NBK22301	
comprehensive coordinated care among specialties is required	1	NBK22301	
bone marrow failure (bmf)	1	NBK22301	
, aggression, mood swings)	1	NBK22301	
the suggested starting dose of oxymetholone is 0	1	NBK22301	
hematopoietic growth factors may be useful in bmf	1	NBK22301	
this risk has not been quantitated	1	NBK22301	
studies are ongoing	1	NBK22301	
individuals with dc should not smoke cigarettes or drink alcohol	1	NBK22301	
bone marrow failure	1	NBK22301	
individuals on androgen therapy for bone marrow failure	1	NBK22301	
perform liver ultrasound examination semiannually for adenomas	1	NBK22301	
annual cancer screening by an otolaryngologist	1	NBK22301	
annual gynecologic examination	1	NBK22301	
annual skin cancer screening by a dermatologist	1	NBK22301	
oral and dental surveillance	1	NBK22301	
schedule routine screening and dental hygiene visits every six months	1	NBK22301	
maintain good oral hygiene	1	NBK22301	
all blood products should be leukodepleted and irradiated	1	NBK22301	
radiation	1	NBK22301	
androgens and growth factors	1	NBK22301	
cancer prevention	1	NBK22301	
telomere length testing	1	NBK22301	
they should be followed closely by a perinatologist	1	NBK22301	
danazol may have fewer side effects than oxymetholone	1	NBK22301	
gov/books/n/gene/dld-def	1	NBK220444	
in the acute setting, measurement/evaluation of:	1	NBK220444	
blood acid-base status	1	NBK220444	
plasma/serum concentration of lactate, glucose, and ammonia	1	NBK220444	
plasma total and free carnitine	1	NBK220444	
liver function and transaminases (alt/ast)	1	NBK220444	
liver size via physical examination and/or ultrasonography	1	NBK220444	
cardiac size via echocardiography	1	NBK220444	
after metabolic stability has been achieved:	1	NBK220444	
clinical assessment of physical growth and development status	1	NBK220444	
formal ophthalmologic evaluation if concern for vision loss	1	NBK220444	
dld pathogenic variants cause variable deficiency in three enzymatic pathways	1	NBK220444	
branched chain alpha-ketoacid dehydrogenase (bckdh) complex	1	NBK220444	
α-ketoglutarate dehydrogenase (αkgdh) complex	1	NBK220444	
pyruvate dehydrogenase (pdh) complex	1	NBK220444	
early-onset neurologic presentation	1	NBK220444	
review of treatment strategies	1	NBK220444	
protein/bcaa-restriction	1	NBK220444	
ketogenic/high-fat diet	1	NBK220444	
five had no clinical or biochemical benefit	1	NBK220444	
two improved clinically	1	NBK220444	
carbohydrate tolerance	1	NBK220444	
dichloroacetate (dca)	1	NBK220444	
additional therapies used with limited success include:	1	NBK220444	
lipoic acid	1	NBK220444	
biotin	1	NBK220444	
empiric recommendations	1	NBK220444	
for acute management (based on the above review)	1	NBK220444	
this is typically achieved by the following:	1	NBK220444	
promotion of an anabolic state:	1	NBK220444	
maintain serum glucose concentration in the normal range	1	NBK220444	
protein should then be reintroduced gradually	1	NBK220444	
hepatic presentation	1	NBK220444	
correction of metabolic acidosis with sodium bicarbonate	1	NBK220444	
correction of any coagulopathy with fresh frozen plasma	1	NBK220444	
avoidance of liver-toxic medications	1	NBK220444	
episodes of catabolic stress (e	1	NBK220444	
as such, empiric recommendations include the following:	1	NBK220444	
supplement with levocarnitine if deficient	1	NBK220444	
avoid liver-toxic medications	1	NBK220444	
catabolic stressors	1	NBK220444	
liver-toxic medications	1	NBK220444	
gov/books/n/gene/dmn	1	NBK1447	
caution:	1	NBK1447	
high doses are usually required (0	1	NBK1447	
4-1	1	NBK1447	
0 mg/kg/day of glibenclamide)	1	NBK1447	
transfer protocols are available at www	1	NBK1447	
diabetesgenes	1	NBK1447	
high caloric intake should be maintained to achieve weight gain	1	NBK1447	
glycemic targets for children younger than age six years:	1	NBK1447	
90-130 mg/dl before meals	1	NBK1447	
90-150 mg/dl at bedtime/overnight	1	NBK1447	
hemoglobin a1c value < 7	1	NBK1447	
urinalysis for microalbuminuria	1	NBK1447	
ophthalmologic examination to screen for retinopathy	1	NBK1447	
gov/books/n/gene/dmtn	1	NBK1534	
neurologic examination and developmental assessment	1	NBK1534	
brain mri scan if evidence of developmental delay or hypotonia	1	NBK1534	
serum glucose concentration	1	NBK1534	
c peptide measurement	1	NBK1534	
pancreatic beta cell autoantibody measurements	1	NBK1534	
liver function and thyroid function tests	1	NBK1534	
a pediatric endocrinology consultation for follow up of diabetes	1	NBK1534	
insulin can be discontinued when blood glucose concentrations stabilize	1	NBK1534	
, some residual endogenous insulin remains)	1	NBK1534	
note: macroglossia could potentially cause airway obstruction	1	NBK1534	
, at least every six months)	1	NBK1534	
developmental assessment to identify any special educational needs is appropriate	1	NBK1534	
general factors that predispose to late-onset diabetes (e	1	NBK1534	
recommendations vary by underlying genetic mechanism:	1	NBK1534	
gov/books/n/gene/dnmt1-ddsn	1	NBK84112	
past medical history to determine extent of autonomic involvement	1	NBK84112	
currently no effective treatment exists for any type of hsan	1	NBK84112	
sensory impairment	1	NBK84112	
dementia	1	NBK84112	
perform annual routine clinical testing for dementia:	1	NBK84112	
observation of behavior	1	NBK84112	
perform annual audiogram	1	NBK84112	
gov/books/n/gene/donnai	1	NBK1878	
neuroimaging (preferably mri scan)	1	NBK1878	
detailed ophthalmologic examination including glaucoma screening	1	NBK1878	
quantitative urine protein determination	1	NBK1878	
eeg if symptoms suggest a seizure disorder	1	NBK1878	
provision of corrective lenses for myopia	1	NBK1878	
treatment of retinal detachments or glaucoma	1	NBK1878	
antiepileptic drugs for seizures	1	NBK1878	
frequent and serial monitoring is needed	1	NBK1878	
the schedule should be determined by the findings present	1	NBK1878	
treatments (e	1	NBK1878	
gov/books/n/gene/drd	1	NBK1508	
neurologic examination to assess the severity of motor disturbances	1	NBK1508	
gradual increase to higher doses is recommended	1	NBK1508	
discontinuation of levodopa treatment usually results in return of symptoms	1	NBK1508	
two women reported mild deterioration of dystonia	1	NBK1508	
an increase in dose was required in one	1	NBK1508	
gov/books/n/gene/drpla	1	NBK1491	
eeg in the presence of seizures	1	NBK1491	
head mri to monitor progression of the disease	1	NBK1491	
neuropsychological testing for evidence of dementia and psychiatric disturbance	1	NBK1491	
consultation with a rehabilitation therapist	1	NBK1491	
for affected children, adaptation of educational programming to abilities	1	NBK1491	
surveillance is individualized based on disease progression	1	NBK1491	
see mothertobaby	1	NBK1491	
org for further information on medication use during pregnancy	1	NBK1491	
gov/books/n/gene/drrs	1	NBK1373	
baseline cbc to evaluate for thrombocytopenia and/or leukocytosis	1	NBK1373	
duane anomaly	1	NBK1373	
severe strabismus may require eye surgery	1	NBK1373	
radial ray malformations	1	NBK1373	
hearing deficits	1	NBK1373	
hearing aids may be required	1	NBK1373	
in those with cardiac malformations or conduction defects:	1	NBK1373	
in those with renal anomalies:	1	NBK1373	
the frequency depends on the clinical situation	1	NBK1373	
certain medications may be contraindicated in individuals with arrhythmias	1	NBK1373	
gov/books/n/gene/duane	1	NBK1190	
evaluation for aberrant movements	1	NBK1190	
the following may be considered:	1	NBK1190	
nonsurgical treatment of ophthalmologic findings	1	NBK1190	
surgical treatment of ophthalmologic findings (extraocular muscle surgery)	1	NBK1190	
to correct or improve compensatory head posture	1	NBK1190	
to improve upshoot or downshoot	1	NBK1190	
principles of surgical approach as reviewed in	1	NBK1190	
kekunnaya et al [2015]	1	NBK1190	
type 1 and type 3	1	NBK1190	
type 2	1	NBK1190	
gov/books/n/gene/duarte-gal	1	NBK258640	
approach for non-treatment	1	NBK258640	
approach for treatment	1	NBK258640	
the galactose challenge	1	NBK258640	
for example:	1	NBK258640	
, after the introduction of solid foods)	1	NBK258640	
gov/books/n/gene/dup15q	1	NBK367946	
assessment of possible feeding difficulties associated with hypotonia	1	NBK367946	
neurologic examination including assessment for seizure activity and baseline eeg	1	NBK367946	
supportive care may include the following:	1	NBK367946	
occupational and physical therapy	1	NBK367946	
alternative and augmentative communication	1	NBK367946	
behavioral therapy (e	1	NBK367946	
, applied behavioral analysis therapy)	1	NBK367946	
psychotropic medications for behavioral manifestations	1	NBK367946	
many of these are preventable	1	NBK367946	
ongoing pediatric care with regular immunizations is indicated	1	NBK367946	
periodic neurodevelopmental and/or developmental/behavioral assessments	1	NBK367946	
seizure triggers (e	1	NBK367946	
2-q13	1	NBK367946	
currently, no clinical trials for dup15q exist	1	NBK367946	
gov/books/n/gene/dup17q12	1	NBK344340	
seizures should be managed by a neurologist using standard practice	1	NBK344340	
gov/books/n/gene/dup7q11_23	1	NBK327268	
plotting of growth parameters	1	NBK327268	
evaluation by a cardiologist	1	NBK327268	
genitourinary system evaluation	1	NBK327268	
ultrasound examination of the kidneys	1	NBK327268	
physical examination of males for cryptorchidism	1	NBK327268	
baseline ophthalmologic evaluation	1	NBK327268	
occupational therapy (including assessment for sensory integration difficulties)	1	NBK327268	
social skills	1	NBK327268	
intellectual abilities	1	NBK327268	
adaptive behavior	1	NBK327268	
vocational skills	1	NBK327268	
attention problems	1	NBK327268	
oppositional behavior/aggression	1	NBK327268	
autism spectrum disorder screening	1	NBK327268	
childhood apraxia of speech	1	NBK327268	
anxiety/selective mutism	1	NBK327268	
autism spectrum disorder (asd)	1	NBK327268	
attention deficit hyperactivity disorder (adhd)	1	NBK327268	
aggression	1	NBK327268	
applied behavior analysis intervention is recommended	1	NBK327268	
oppositionality	1	NBK327268	
specific medical problems are treated in the following ways:	1	NBK327268	
hydrocephalus as needed with ventriculo-peritoneal shunting	1	NBK327268	
aortic dilation with beta blocker therapy in some affected individuals	1	NBK327268	
strabismus in the usual manner	1	NBK327268	
recurrent otitis media in the usual manner	1	NBK327268	
poor feeding in infants	1	NBK327268	
human growth hormone replacement therapy	1	NBK327268	
club feet	1	NBK327268	
casting	1	NBK327268	
interval/age	1	NBK327268	
infancy	1	NBK327268	
every 3 years	1	NBK327268	
assessment of intellectual abilities & academic achievement	1	NBK327268	
adolescents/adults	1	NBK327268	
gov/books/n/gene/dupl22q11	1	NBK3823	
2 duplication, the following are recommended:	1	NBK3823	
educational program should be tailored to individual needs	1	NBK3823	
gov/books/n/gene/dyrk1a-id	1	NBK333438	
sleep history and sleep evaluation if necessary	1	NBK333438	
musculoskeletal examination for signs of hypertonia and spine curvature anomalies	1	NBK333438	
orthopedic referral if needed	1	NBK333438	
physical therapy evaluation regarding interventions needed to achieve optimal ambulation	1	NBK333438	
the following baseline evaluations:	1	NBK333438	
educational programs to address the specific needs identified	1	NBK333438	
speech therapy directed at improving communication skills	1	NBK333438	
therapeutic management of sleep disturbances if necessary	1	NBK333438	
early intervention with occupational therapy for feeding problems	1	NBK333438	
consideration of tube feeding for severe persisting feeding problems	1	NBK333438	
monitoring and guidance as needed for educational and behavior problems	1	NBK333438	
regular lifelong dietary evaluation to assure optimal nutritional status	1	NBK333438	
regular lifelong evaluations of the following:	1	NBK333438	
heart: based on the type of congenital anomaly	1	NBK333438	
gov/books/n/gene/dystonia	1	NBK1492	
thorough history, including family history	1	NBK1492	
consideration of occupational and/or physical therapy evaluation	1	NBK1492	
anticholinergics (e	1	NBK1492	
, trihexyphenidyl)	1	NBK1492	
if medications fail	1	NBK1492	
, prior to sufficient medication trials)	1	NBK1492	
gov/books/n/gene/ea1	1	NBK25442	
detailed medical history of the individual	1	NBK25442	
acetazolamide	1	NBK25442	
sulthiame 50-200 mg daily may reduce the attack rate	1	NBK25442	
known triggers of attacks should be avoided	1	NBK25442	
gov/books/n/gene/ea2	1	NBK1501	
neurologic examination for signs of interictal ataxia and nystagmus	1	NBK1501	
this medication is generally well tolerated	1	NBK1501	
acetazolamide could stabilize channels that fail to properly inactivate	1	NBK1501	
phenytoin has been reported to exacerbate symptoms	1	NBK1501	
gov/books/n/gene/eb-pa	1	NBK1157	
surgical intervention is required to correct pyloric atresia	1	NBK1157	
many children need medical treatment for gastroesophageal reflux disease	1	NBK1157	
use of soft and properly fitted clothing and footwear	1	NBK1157	
selenium and carnitine replacement for possible prevention of dilated cardiomyopathy	1	NBK1157	
see junctional epidermolysis bullosa: management, therapies under investigation	1	NBK1157	
gov/books/n/gene/ebd	1	NBK1304	
primary layers may include any the following:	1	NBK1304	
ordinary band-aids®	1	NBK1304	
non-stick products (e	1	NBK1304	
, telfa® or n-terface®)	1	NBK1304	
, mepitel® or mepilex®)	1	NBK1304	
other nutritional deficiencies must also be addressed:	1	NBK1304	
calcium and vitamin d supplementation for osteopenia and osteoporosis	1	NBK1304	
selenium and carnitine replacement to help prevent dilated cardiomyopathy	1	NBK1304	
zinc replacement to enhance wound healing	1	NBK1304	
occupational therapy may be helpful in preventing progressive hand contractures	1	NBK1304	
psychosocial support including social services and psychological counseling is essential	1	NBK1304	
aureus (mrsa) and pseudomonas	1	NBK1304	
aeruginosa	1	NBK1304	
allogenic transplantation of fibroblasts [fritsch et al 2008]	1	NBK1304	
a lane, stanford university, personal communication]	1	NBK1304	
woodley et al 2013]	1	NBK1304	
bone marrow transplantation:	1	NBK1304	
gov/books/n/gene/ebj	1	NBK1125	
evaluation for existing osteopenia through skeletal radiographs or dexa scan	1	NBK1125	
ordinaryband-aids®	1	NBK1125	
silicone-based products provide a good substitute for tape	1	NBK1125	
gov/books/n/gene/ebs	1	NBK1369	
dressings usually involve three layers:	1	NBK1369	
some individuals with ebs can use ordinary bandages	1	NBK1369	
foam dressings and/or rolls of gauze (e	1	NBK1369	
, one-layer) dressing	1	NBK1369	
infection is the most common secondary complication	1	NBK1369	
surveillance for infection and proper wound healing is indicated	1	NBK1369	
excessive heat may exacerbate blistering and infection in ebs	1	NBK1369	
avoiding activities that traumatize the skin (e	1	NBK1369	
no clinical trials have been carried out	1	NBK1369	
no rigorous clinical trials have been undertaken	1	NBK1369	
gov/books/n/gene/ed2	1	NBK1200	
dystrophic nails	1	NBK1200	
in many cases, wigs are helpful	1	NBK1200	
palmoplantar hyperkeratosis	1	NBK1200	
skin emollients may help relieve palmoplantar hyperkeratosis	1	NBK1200	
gov/books/n/gene/edm-ad	1	NBK1123	
elicitation of pain history	1	NBK1123	
assessment of joint mobility	1	NBK1123	
radiographs to determine the extent and severity of joint involvement	1	NBK1123	
however, pain can be difficult to control	1	NBK1123	
obesity, which increases stress on joints	1	NBK1123	
exercise that causes repetitive strain on affected joints	1	NBK1123	
gov/books/n/gene/edm	1	NBK1306	
height measurement	1	NBK1306	
career counseling is recommended	1	NBK1306	
radiographic surveillance by an orthopedist is appropriate	1	NBK1306	
sports involving joint overload are to be avoided	1	NBK1306	
gov/books/n/gene/edmd	1	NBK1436	
note: electrophysiologic study is often advisable in edmd	1	NBK1436	
more advanced and invasive cardiac assessment may be required	1	NBK1436	
caesarean section delivery may be required	1	NBK1436	
gov/books/n/gene/eds	1	NBK1244	
evaluation of joint mobility with use of the beighton score	1	NBK1244	
evaluation for hypotonia and motor development in infants and children	1	NBK1244	
evaluation of clotting factors if severe easy bruising is present	1	NBK1244	
deep stitches should be applied generously	1	NBK1244	
anti-inflammatory drugs may help with joint pain	1	NBK1244	
cardiovascular problems should be treated in a standard manner	1	NBK1244	
however, there is no limitation	1	NBK1244	
acetylsalicylate (aspirin)	1	NBK1244	
gov/books/n/gene/eds3	1	NBK1279	
modalities must be tailored to the individual	1	NBK1279	
assistive devices	1	NBK1279	
braces are useful to improve joint stability	1	NBK1279	
pain medication	1	NBK1279	
adjustments may be necessary for other populations	1	NBK1279	
nsaids (nonsteroidal anti-inflammatory drugs) (e	1	NBK1279	
cox-2 inhibitors (e	1	NBK1279	
they are also sometimes helpful in treating neuropathic pain	1	NBK1279	
all require gradual titration before reaching therapeutic levels	1	NBK1279	
topiramate and lamotrigine have also been used successfully	1	NBK1279	
nausea is the most common side effect	1	NBK1279	
routine use of benzodiazepines is not recommended	1	NBK1279	
medication precautions	1	NBK1279	
abrupt cessation of anti-seizure medications can precipitate a seizure	1	NBK1279	
when discontinuing, they should be tapered gradually	1	NBK1279	
severity can range from mild to life threatening	1	NBK1279	
surgery and other procedures	1	NBK1279	
anesthetic nerve blocks can provide temporary relief of neuropathic pain	1	NBK1279	
for severe bleeding (e	1	NBK1279	
other treatable causes, such as h	1	NBK1279	
pylori infection, should be investigated	1	NBK1279	
rarely, severe enlargement (>4	1	NBK1279	
5-5	1	NBK1279	
0 cm) requires surgical evaluation	1	NBK1279	
periodontal disease should be identified and treated	1	NBK1279	
temporomandibular joint laxity and dysfunction are difficult to treat	1	NBK1279	
there are no specific interventions of proven benefit	1	NBK1279	
intra-oral devices are sometimes helpful	1	NBK1279	
antidepressants are also of great benefit	1	NBK1279	
consumer support groups are available and can be very beneficial	1	NBK1279	
joint hyperextension may not need to be avoided	1	NBK1279	
resistance exercise can exacerbate joint instability and pain	1	NBK1279	
labor and delivery may progress very rapidly	1	NBK1279	
there is no clear advantage to vaginal vs	1	NBK1279	
cesarean delivery	1	NBK1279	
gov/books/n/gene/eds4	1	NBK1494	
, the uterus in pregnancy)	1	NBK1494	
trauma	1	NBK1494	
arteriography	1	NBK1494	
furthermore, injection pressure may lead to arterial aneurysms	1	NBK1494	
routine colonoscopy	1	NBK1494	
elective surgery	1	NBK1494	
gov/books/n/gene/eds6	1	NBK1462	
evaluation for kyphoscoliosis	1	NBK1462	
bracing may be required to support unstable joints	1	NBK1462	
swimming is recommended	1	NBK1462	
vascular surgery is fraught with danger	1	NBK1462	
routine examination for inguinal hernia and surgical referral as necessary	1	NBK1462	
vigilant observation of blood pressure	1	NBK1462	
delivery should be performed in a medical center	1	NBK1462	
gov/books/n/gene/ee	1	NBK453432	
, dystonia)	1	NBK453432	
feeding evaluation & nutrition assessment	1	NBK453432	
referral to appropriate feeding therapist and/or nutritionist as indicated	1	NBK453432	
assessment for chronic diarrhea	1	NBK453432	
referral to gastroenterologist as needed	1	NBK453432	
referral to orthopedist as needed	1	NBK453432	
miscellaneous /other	1	NBK453432	
antispastic medications	1	NBK453432	
muscle relaxants	1	NBK453432	
severe diarrhea	1	NBK453432	
maintain hydration & caloric intake	1	NBK453432	
tube feeding often necessary	1	NBK453432	
poor energy metabolism & oxidative stress	1	NBK453432	
, feeding, grooming, dressing, writing)	1	NBK453432	
all affected individuals should receive routine immunizations	1	NBK453432	
as well as annual immunizations for influenza	1	NBK453432	
evaluation/action	1	NBK453432	
assess growth and monitor for failure to thrive	1	NBK453432	
at each visit	1	NBK453432	
monitor for epileptic crisis	1	NBK453432	
modify therapy according to clinical presentation and eeg findings	1	NBK453432	
gov/books/n/gene/efemp2-cutis-laxa	1	NBK54467	
3d-ct scan	1	NBK54467	
lung function test	1	NBK54467	
mr angiography (mra) from head to pelvis	1	NBK54467	
routine repair is appropriate	1	NBK54467	
pulmonary emphysema is treated symptomatically	1	NBK54467	
no definitive treatment is available	1	NBK54467	
based on experience in other related disorders (e	1	NBK54467	
aortic aneurysm replacement has been performed successfully	1	NBK54467	
joint hypermobility can be supported by muscle reinforcing physical therapy	1	NBK54467	
annual mra from head to pelvis	1	NBK54467	
cigarette smoking, which can worsen emphysema	1	NBK54467	
sun tanning, which can damage skin	1	NBK54467	
gov/books/n/gene/emanuel	1	NBK1263	
palatal evaluation for cleft palate	1	NBK1263	
cardiac evaluation with an echocardiogram to screen for cardiac defects	1	NBK1263	
renal ultrasound examination to evaluate for structural kidney anomalies	1	NBK1263	
feeding and swallowing assessment	1	NBK1263	
urologic evaluation in males with cryptorchidism and/or micropenis	1	NBK1263	
standard management of gastroesophageal reflux	1	NBK1263	
standard interventions for:	1	NBK1263	
cardiac defects	1	NBK1263	
hip dysplasia and other skeletal complications	1	NBK1263	
cryptorchidism and/or micropenis	1	NBK1263	
refractive errors, strabismus, or other ophthalmologic issues	1	NBK1263	
seizures, if present	1	NBK1263	
gov/books/n/gene/epb42-spherocytosis	1	NBK190102	
hemoglobin concentration and reticulocyte count to evaluate severity of disease	1	NBK190102	
serum bilirubin concentration	1	NBK190102	
transfusion history	1	NBK190102	
serum ferritin concentration to evaluate iron load status	1	NBK190102	
abdominal ultrasound examination to evaluate:	1	NBK190102	
for evidence of cholelithiasis when symptoms are present	1	NBK190102	
then 1 mg 1x daily thereafter)	1	NBK190102	
prevnar-13® and h	1	NBK190102	
the incidence of post-splenectomy sepsis varies among studies	1	NBK190102	
cholecystectomy	1	NBK190102	
note: when indicated, splenectomy is curative	1	NBK190102	
contact sports are not advisable in those with splenomegaly	1	NBK190102	
gov/books/n/gene/epm1	1	NBK1142	
valproic acid is the first drug of choice	1	NBK1142	
it diminishes myoclonus and the frequency of generalized seizures	1	NBK1142	
gov/books/n/gene/epp-ar	1	NBK100826	
the phototoxic pain is not responsive to narcotic analgesics	1	NBK100826	
tanning products	1	NBK100826	
β-carotene	1	NBK100826	
hepatic complications may be accompanied by motor neuropathy	1	NBK100826	
pregnancy is not complicated by epp	1	NBK100826	
gov/books/n/gene/epp-xl	1	NBK121284	
the pain is not responsive to narcotic analgesics	1	NBK121284	
sun creams containing a physical reflecting agent (e	1	NBK121284	
there is no information on pregnancy management in xlp	1	NBK121284	
gov/books/n/gene/etha	1	NBK1163	
reports on treatments in a series involve heterogeneous populations	1	NBK1163	
cooling the extremities reduces pain in a symptomatic person	1	NBK1163	
01) [mork et al 2004]	1	NBK1163	
experts have reported typically mild to moderate pain relief	1	NBK1163	
remissions (i	1	NBK1163	
carbamazepine	1	NBK1163	
oxcarbazepine use in treating em has not been reported	1	NBK1163	
topical application of 1	1	NBK1163	
0% amitriptyline hydrochloride and 0	1	NBK1163	
calcium antagonists	1	NBK1163	
magnesium	1	NBK1163	
cyclosporine was successful in one person with erythromelalgia	1	NBK1163	
sympathetic block, surgical sympathectomy, and epidural infusion	1	NBK1163	
amputation has occasionally been necessary to treat these complications	1	NBK1163	
in some individuals, exercise can trigger symptoms	1	NBK1163	
small molecule inhibitors of the scn9a encoded sodium channel nav1	1	NBK1163	
7 have been developed	1	NBK1163	
gov/books/n/gene/exosc3-pc-hypo-p	1	NBK236968	
orthopedic evaluation to assess joint contractures and scoliosis	1	NBK236968	
electroencephalography in those with suspected liability of seizures	1	NBK236968	
the main problems to manage are:	1	NBK236968	
adaptation of education to the level of cognitive handicap	1	NBK236968	
epilepsy, which is amendable to standard treatments	1	NBK236968	
regular examinations to address:	1	NBK236968	
joint contractures and scoliosis	1	NBK236968	
development or management of epileptic seizures	1	NBK236968	
gov/books/n/gene/ext	1	NBK1235	
detailed history of symptoms from osteochondromas	1	NBK1235	
osteochondromas require no therapy in the absence of clinical problems	1	NBK1235	
leg-length inequalities greater than 2	1	NBK1235	
surgical resection is the treatment for sarcomatous degeneration	1	NBK1235	
encroaching lesions and those causing symptoms may merit excision	1	NBK1235	
gov/books/n/gene/fa	1	NBK1401	
ultrasound examination of the kidneys and urinary tract	1	NBK1401	
formal hearing evaluation	1	NBK1401	
evaluation by a clinical geneticist and genetic counseling	1	NBK1401	
3% (±5	1	NBK1401	
9%) [mehta et al 2017]	1	NBK1401	
mds/aml treatment remains challenging	1	NBK1401	
solid tumors	1	NBK1401	
annual evaluation with a multidisciplinary team including an endocrinologist	1	NBK1401	
individuals receiving androgen therapy	1	NBK1401	
liver function tests every three to six months	1	NBK1401	
annual gynecologic assessment for genital lesions beginning at age 13	1	NBK1401	
suspicious genital tract lesions should be biopsied	1	NBK1401	
unsafe sex practices increase the risk for hpv-associated malignancy	1	NBK1401	
gov/books/n/gene/fabry	1	NBK1292	
examination of the skin for angiokeratomas	1	NBK1292	
formal audiology assessment	1	NBK1292	
acroparesthesia	1	NBK1292	
diphenylhydantoin	1	NBK1292	
a potential side effect of diphenylhydantoin is gingival hypertrophy	1	NBK1292	
carbamazepine has similar effects	1	NBK1292	
chronic hemodialysis and/or renal transplantation have become lifesaving procedures	1	NBK1292	
therefore, successful renal transplantation corrects renal function	1	NBK1292	
2 mg/kg every 2 weeks)	1	NBK1292	
06) [banikazemi et al 2007]	1	NBK1292	
the largest comparative study is the canadian fabry disease initiative	1	NBK1292	
3 g/kg every other week	1	NBK1292	
and compliance should be closely monitored	1	NBK1292	
blood pressure control optimized	1	NBK1292	
at age 12-13 years in asymptomatic boys	1	NBK1292	
annual or more frequent renal function studies	1	NBK1292	
annual cardiology evaluation	1	NBK1292	
annual audiology evaluation	1	NBK1292	
biennial brain mri/mra	1	NBK1292	
therefore, affected individuals should be discouraged from smoking	1	NBK1292	
measure α-gal a enzyme activity	1	NBK1292	
dgj	1	NBK1292	
migalastat amicus therapeutics, nj, usa)	1	NBK1292	
alternative enzyme therapy	1	NBK1292	
substrate reduction therapy for fabry disease has a biochemical rationale	1	NBK1292	
gov/books/n/gene/factor-v-leiden	1	NBK1368	
evaluation in high-risk individuals (i	1	NBK1368	
thrombosis	1	NBK1368	
5 (therapeutic range 2	1	NBK1368	
prophylactic anticoagulation	1	NBK1368	
however, the indications for family testing are unresolved	1	NBK1368	
gov/books/n/gene/fahn	1	NBK56080	
pharmacologic and surgical interventions have focused on palliation of symptoms	1	NBK56080	
weighted gloves can sometimes be used to assist with dysmetria	1	NBK56080	
ablative pallidotomy or thalamotomy	1	NBK56080	
assessment of ambulation, speech, and swallowing	1	NBK56080	
regular review of communication needs and environmental adaptations	1	NBK56080	
no serious treatment-related adverse events occurred	1	NBK56080	
gov/books/n/gene/fap	1	NBK1345	
currently, consensus management guidelines for gapps are unavailable	1	NBK1345	
colonic polyps	1	NBK1345	
types of colectomy include the following:	1	NBK1345	
total colectomy with ileorectal anastomosis (ira)	1	NBK1345	
this is a single-stage procedure	1	NBK1345	
total proctocolectomy with permanent ileostomy	1	NBK1345	
the choice of procedure depends on the clinical circumstances	1	NBK1345	
small-bowel polyps	1	NBK1345	
osteomas may be removed for cosmetic reasons	1	NBK1345	
desmoid tumors	1	NBK1345	
nsaids	1	NBK1345	
in individuals known to have fap	1	NBK1345	
colonoscopy, once polyps are detected	1	NBK1345	
spigelman staging criteria can help determine the frequency	1	NBK1345	
non-fundic gland polyps should be removed endoscopically	1	NBK1345	
thyroid cancer	1	NBK1345	
annual abdominal palpation for desmoids	1	NBK1345	
small-bowel polyps and cancer	1	NBK1345	
screening for hepatoblastoma	1	NBK1345	
efficacy in individuals with fap is unclear	1	NBK1345	
in individuals who have undergone colectomy	1	NBK1345	
in individuals known to have attenuated fap	1	NBK1345	
colectomy	1	NBK1345	
in individuals known to have gapps	1	NBK1345	
surgery and desmoid risk	1	NBK1345	
individuals at high risk for desmoids (women	1	NBK1345	
those with apc pathogenic variants in codons 1395-1493	1	NBK1345	
surgery and fecundity	1	NBK1345	
recommended genetic testing for at-risk family members	1	NBK1345	
pregnancy/fertility/hormone use	1	NBK1345	
trials with similar agents are being planned	1	NBK1345	
curcumin is the main component in the spice turmeric	1	NBK1345	
gov/books/n/gene/fbln5-cutis-laxa	1	NBK5201	
kidney ultrasound examination	1	NBK5201	
if clinically indicated:	1	NBK5201	
barium enema	1	NBK5201	
voiding cystouretrogram (vcug)	1	NBK5201	
appropriate treatment for:	1	NBK5201	
routine repair	1	NBK5201	
cutis laxa	1	NBK5201	
pulmonary emphysema	1	NBK5201	
no treatment available	1	NBK5201	
attention to respiratory function prior to surgery	1	NBK5201	
prophylactic antibiotics (cotrimoxazole) in case of vesicoureteral reflux	1	NBK5201	
smoking is contraindicated	1	NBK5201	
gov/books/n/gene/fbxl4-mtddepl	1	NBK425540	
ent	1	NBK425540	
cardiac evaluation w/electrocardiogram & echocardiography	1	NBK425540	
consider referral to cardiology if results are abnormal	1	NBK425540	
swallowing assessment for feeding difficulties	1	NBK425540	
neurology consultation including comprehensive neurologic examination	1	NBK425540	
brain mri to evaluate extent of the disease	1	NBK425540	
electroencephalogram	1	NBK425540	
if there is a history of seizures	1	NBK425540	
complete blood count to evaluate for neutropenia	1	NBK425540	
no definite treatment is available to date	1	NBK425540	
inadequate nutrition	1	NBK425540	
standard treatment w/antiepileptic drugs	1	NBK425540	
immobility/wheelchair dependence	1	NBK425540	
, wheelchair	1	NBK425540	
cardiomyopathy and arrhythmia	1	NBK425540	
standard treatment per cardiology recommendations	1	NBK425540	
consider granulocyte colony stimulating factor 2	1	NBK425540	
significant acidosis	1	NBK425540	
consider bicarbonate therapy	1	NBK425540	
cataract and/or strabismus	1	NBK425540	
surgical treatment if indicated	1	NBK425540	
hearing aids	1	NBK425540	
regular immunization to prevent life-threatening infections is indicated	1	NBK425540	
no surveillance guidelines have been published	1	NBK425540	
table 6	1	NBK425540	
continued assessment of nutrition and growth	1	NBK425540	
regular neurologic evaluations & developmental assessments	1	NBK425540	
gov/books/n/gene/fcmd	1	NBK1206	
neurologic evaluation, including eeg and brain mri	1	NBK1206	
physical therapy evaluation of joint range of motion	1	NBK1206	
assessment of caloric intake and nutritional status	1	NBK1206	
there is no definite treatment for fcmd	1	NBK1206	
prompt treatment of acute respiratory tract infections	1	NBK1206	
antiepileptic drugs (aeds) when indicated	1	NBK1206	
surgical treatment for gastroesophageal reflux when indicated	1	NBK1206	
gastrostomy when indicated to assure adequate caloric intake	1	NBK1206	
routine therapy of cardiomyopathy	1	NBK1206	
monitoring for foot deformities and scoliosis	1	NBK1206	
gov/books/n/gene/fd	1	NBK1180	
standardized intelligence tests	1	NBK1180	
frequently demonstrate better verbal than motor performance	1	NBK1180	
electroencephalography	1	NBK1180	
magnetic resonance imaging (mri)	1	NBK1180	
feeding problems	1	NBK1180	
maintain adequate nutrition and avoid aspiration	1	NBK1180	
gastroesophageal reflux	1	NBK1180	
orthostatic hypotension	1	NBK1180	
counter-maneuvers (e	1	NBK1180	
squatting had the greatest effect	1	NBK1180	
kidney and bladder	1	NBK1180	
bradyarrhythmia	1	NBK1180	
soft contact lenses can promote corneal healing	1	NBK1180	
corneal transplantation has had limited success	1	NBK1180	
spinal fusion may be necessary	1	NBK1180	
many adults use walkers or wheelchairs when outside the home	1	NBK1180	
sialorrhea is a common	1	NBK1180	
use of general anesthetics requires adequate hydration	1	NBK1180	
exercise can help correct or prevent secondary contractures	1	NBK1180	
routine assessment of growth in children	1	NBK1180	
follow-up frequency depends on findings	1	NBK1180	
screening for sleep-disordered breathing with polysomnography	1	NBK1180	
periodic assessment of psychomotor development and behavior in children	1	NBK1180	
symptoms tend to be worse in hot or humid weather	1	NBK1180	
environmental situations associated with hypobaric hypoxia (e	1	NBK1180	
visceral pain related to contractions during labor is perceived normally	1	NBK1180	
therefor, analgesia should be provided	1	NBK1180	
kinetin	1	NBK1180	
5 mg/kg/d for 28 days	1	NBK1180	
002)	1	NBK1180	
long-term clinical trials are warranted	1	NBK1180	
induced pluripotent stem cells (ipscs)	1	NBK1180	
tocotrienols	1	NBK1180	
pregabalin	1	NBK1180	
phosphatidylserine (ps)	1	NBK1180	
digoxin	1	NBK1180	
gov/books/n/gene/feingold	1	NBK7050	
cardiac investigation (echocardiogram)	1	NBK7050	
renal ultrasound to evaluate for structural abnormalities	1	NBK7050	
audiometry for the possibility of hearing loss	1	NBK7050	
neuropsychological evaluation if there are concerns about psychomotor development	1	NBK7050	
analysis of the family pedigree for other possible affected individuals	1	NBK7050	
surgical treatment of gastrointestinal atresia when present	1	NBK7050	
follow up and treatment of possible cardiac and renal anomalies	1	NBK7050	
treatment for significant hearing loss	1	NBK7050	
developmental or educational intervention for children with learning difficulties	1	NBK7050	
gov/books/n/gene/fevr	1	NBK1147	
ophthalmologic examination, including indirect ophthalmoscopy and scleral depression	1	NBK1147	
retinal avascularity per se often requires no treatment	1	NBK1147	
however, retinal traction continued to progress	1	NBK1147	
gov/books/n/gene/fg	1	NBK1676	
developmental and behavioral assessment	1	NBK1676	
neurologic history and examination for evidence of seizures and hypotonia	1	NBK1676	
evaluation for evidence of spasticity in individuals with fgs1	1	NBK1676	
examination for evidence of anal anomalies in individuals with fgs1	1	NBK1676	
examination for evidence of genitourinary anomalies	1	NBK1676	
cardiology evaluation with echocardiogram	1	NBK1676	
audiology evaluation in individuals with xlos	1	NBK1676	
individualized management of behavior problems	1	NBK1676	
neurologic management of seizures	1	NBK1676	
standard management of chronic constipation for individuals with fgs1	1	NBK1676	
annual audiology evaluation for evidence of hearing loss in xlos	1	NBK1676	
regular dental evaluations for individuals with xlos and ls	1	NBK1676	
gov/books/n/gene/fhm	1	NBK1388	
gov/books/n/gene/fhs	1	NBK114458	
renal ultrasound examination and blood pressure assessment	1	NBK114458	
assessment for cryptorchidism in males	1	NBK114458	
orthopedic assessment of hip dysplasia and clavicular anomalies	1	NBK114458	
communication rehabilitation with sign languages or alternative means of communication	1	NBK114458	
standard treatment for any of the following if identified:	1	NBK114458	
refractive errors and strabismus	1	NBK114458	
investigation for celiac disease if indicated by clinical features	1	NBK114458	
blood pressure measurement and assessment of renal function	1	NBK114458	
standard monitoring for renal anomalies	1	NBK114458	
gov/books/n/gene/flnb-dis	1	NBK2534	
spondylocarpotarsal synostosis (sct) syndrome	1	NBK2534	
ophthalmologic examination for retinal anomalies	1	NBK2534	
audiometry to assess for sensorineural hearing loss	1	NBK2534	
cervical spine films to evaluate for cervical dysplasia	1	NBK2534	
larsen syndrome	1	NBK2534	
audiometry to assess hearing	1	NBK2534	
assessment of the hips for dislocation	1	NBK2534	
large joint dislocations	1	NBK2534	
scoliosis is treated medically	1	NBK2534	
no effective surgical intervention has been described	1	NBK2534	
club feet are managed in a routine manner	1	NBK2534	
vertebral anomalies can lead to progressive scoliosis	1	NBK2534	
orthopedic monitoring is therefore indicated	1	NBK2534	
gov/books/n/gene/fmf	1	NBK1227	
physical examination to assess joint problems	1	NBK1227	
urinalysis for the presence of protein	1	NBK1227	
febrile and inflammatory episodes are usually treated with nsaids	1	NBK1227	
colchicine	1	NBK1227	
homozygotes/compound heterozygotes	1	NBK1227	
individuals who are homozygous for the pathogenic variant p	1	NBK1227	
met694val or compound heterozygous for p	1	NBK1227	
children may need 0	1	NBK1227	
5-1 mg/day according to age and weight	1	NBK1227	
affected individuals should receive colchicine for life	1	NBK1227	
individuals who do not have the p	1	NBK1227	
glu148gln	1	NBK1227	
heterozygotes	1	NBK1227	
treatment of affected individuals who are unresponsive to colchicine	1	NBK1227	
some individuals appear to be unresponsive to colchicine treatment	1	NBK1227	
weekly intravenous colchicine (1	1	NBK1227	
this is not a long-term solution	1	NBK1227	
the possibility of interferon alpha side effects (e	1	NBK1227	
, chills and fatigue) should also be considered	1	NBK1227	
sulphasalazine	1	NBK1227	
she was homozygous for the pathogenic variant p	1	NBK1227	
treatment with colchicine 1	1	NBK1227	
met694val pathogenic variant	1	NBK1227	
cisplatin	1	NBK1227	
met694ile [sasaki et al 2009]	1	NBK1227	
this is especially important when the p	1	NBK1227	
gov/books/n/gene/focal-dh	1	NBK1543	
ectodermal manifestations	1	NBK1543	
limb and skeletal manifestations	1	NBK1543	
eye findings	1	NBK1543	
oral and dental findings	1	NBK1543	
evaluation by a cleft palate team if relevant	1	NBK1543	
gastrointestinal and nutrition	1	NBK1543	
consideration of abdominal ultrasound examination to evaluate for diaphragmatic hernia	1	NBK1543	
renal and urogenital	1	NBK1543	
evaluation by a pediatric gynecologist prior to puberty	1	NBK1543	
cognitive and psychological	1	NBK1543	
camptodactyly often improves with physical and occupational therapy	1	NBK1543	
consultation with:	1	NBK1543	
the papillomas may be friable and prone to bleeding	1	NBK1543	
regular examinations	1	NBK1543	
gov/books/n/gene/folate-mal	1	NBK1673	
assessment by a pediatric neurologist to determine baseline neurologic status	1	NBK1673	
baseline (and follow-up) formal cognitive testing	1	NBK1673	
initial evaluation and follow up by a metabolic genetic specialist	1	NBK1673	
folate formulations	1	NBK1673	
leucovorin is available in oral and parenteral formulations	1	NBK1673	
neither drug is available for parenteral administration	1	NBK1673	
deplin® is available as a 15-mg tablet	1	NBK1673	
folate dosing	1	NBK1673	
with intramuscular injections of approximately 1	1	NBK1673	
serum and csf folate concentrations	1	NBK1673	
serum and csf homocysteine concentrations	1	NBK1673	
poncz & cohen 1996	1	NBK1673	
min et al 2008	1	NBK1673	
goldman, personal communication to author]	1	NBK1673	
gov/books/n/gene/foxp2-sl-dis	1	NBK368474	
family history of speech disorder	1	NBK368474	
assessment of oral motor function including:	1	NBK368474	
examination for evidence of oral motor dyspraxia (e	1	NBK368474	
, ‘kiss and blow’	1	NBK368474	
social skills assessment for the presence of autistic features	1	NBK368474	
additional evaluations:	1	NBK368474	
speech and language deficits	1	NBK368474	
no single recommended treatment exists	1	NBK368474	
dysarthria [pennington et al 2009]	1	NBK368474	
language deficits [law et al 2003]	1	NBK368474	
literacy impairments [snowling & hulme 2012]	1	NBK368474	
cognitive deficits	1	NBK368474	
fine and gross motor deficits	1	NBK368474	
routine care by a general pediatrician	1	NBK368474	
gov/books/n/gene/fragilex	1	NBK1384	
cardiac auscultation for mitral valve prolapse	1	NBK1384	
assessment for hypertension	1	NBK1384	
history for possible seizure activity	1	NBK1384	
ophthalmologic evaluation for possible strabismus	1	NBK1384	
behavioral and psychological assessment	1	NBK1384	
neuroradiologic evaluation	1	NBK1384	
therapy must be individualized and closely monitored	1	NBK1384	
gov/books/n/gene/friedreich	1	NBK1281	
speech and swallowing assessment	1	NBK1281	
assessment for significant scoliosis	1	NBK1281	
assessment by an orthopedic surgeon, as needed	1	NBK1281	
ecg and echocardiogram for evidence of cardiomyopathy	1	NBK1281	
assessment by a cardiologist if abnormal	1	NBK1281	
random blood glucose concentration for evidence of diabetes mellitus	1	NBK1281	
ophthalmologic assessment if ophthalmologic symptoms are present	1	NBK1281	
hearing assessment and referral for amplification apparatus if required	1	NBK1281	
psychological assessment	1	NBK1281	
there is little objective evidence regarding management of frda	1	NBK1281	
speech therapy to maximize communication skills	1	NBK1281	
treatment of sleep apnea by continuous positive airway pressure	1	NBK1281	
measures include the following:	1	NBK1281	
the following are appropriate	1	NBK1281	
annual fasting blood sugar to monitor for diabetes mellitus	1	NBK1281	
alcohol can exacerbate ataxia and should be consumed in moderation	1	NBK1281	
, rough surfaces) should be avoided	1	NBK1281	
a summary of therapies under investigation can be found online	1	NBK1281	
coenzyme q10 and vitamin e	1	NBK1281	
idebenone has shown promise as a treatment for frda:	1	NBK1281	
results from this study have not yet been published	1	NBK1281	
nonspecific iron chelators (e	1	NBK1281	
a clinical trial was terminated for lack of efficacy	1	NBK1281	
neurologic benefit was suggested	1	NBK1281	
increasing frataxin levels	1	NBK1281	
a placebo-controlled study is to commence shortly	1	NBK1281	
gov/books/n/gene/fryns	1	NBK1459	
chest and abdominal radiographs	1	NBK1459	
cranial ultrasound examination	1	NBK1459	
in fryns syndrome, additional anomalies may dictate further consultations	1	NBK1459	
see also congenital diaphragmatic hernia overview	1	NBK1459	
there are no specific surveillance guidelines for fryns syndrome	1	NBK1459	
gov/books/n/gene/fsh	1	NBK1443	
physical examination to assess strength and functional limitations	1	NBK1443	
evaluation for physical therapy and need for assistive devices	1	NBK1443	
assessment of hearing if the individual has symptomatic hearing loss	1	NBK1443	
ophthalmologic evaluation for the presence of retinal telangiectasias	1	NBK1443	
physical therapy and rehabilitation	1	NBK1443	
consultation with a physical therapist is indicated	1	NBK1443	
exercise in fshd	1	NBK1443	
orthopedic intervention	1	NBK1443	
no additional audiometry screening of asymptomatic individuals is necessary	1	NBK1443	
annual dilated ophthalmoscopy in childhood is indicated	1	NBK1443	
the injections were fairly well tolerated	1	NBK1443	
medium dose: 2	1	NBK1443	
2% increase	1	NBK1443	
high dose: 5	1	NBK1443	
3% increase in size)	1	NBK1443	
gov/books/n/gene/ftd-chmp2b	1	NBK1199	
a general medical history and family history	1	NBK1199	
there is no consensus treatment guideline for ftd3	1	NBK1199	
gov/books/n/gene/ftd-grn	1	NBK1371	
detailed general, neurologic, and family history	1	NBK1371	
physical, neurologic, and cognitive examination	1	NBK1371	
gov/books/n/gene/ftdp-17	1	NBK1505	
individuals with seizures are treated with antiepileptic drugs	1	NBK1505	
gov/books/n/gene/fum	1	NBK1506	
evaluation by a pediatric neurologist	1	NBK1506	
this evaluation will likely include a brain mri study	1	NBK1506	
feeding assessment and evaluation of nutritional status	1	NBK1506	
nutritional intervention (e	1	NBK1506	
wheelchairs can be useful for some individuals	1	NBK1506	
gov/books/n/gene/g6pc3-def	1	NBK285321	
, intermittent thrombocytopenia and/or lymphopenia)	1	NBK285321	
consultation with a cardiologist to evaluate for congenital heart disease	1	NBK285321	
renal and pelvic ultrasound examination to look for urogenital malformations	1	NBK285321	
growth parameters in children and pubertal development in adolescents	1	NBK285321	
, growth hormone, gonadotropins, thyroid hormone)	1	NBK285321	
biochemical investigations to look for abnormalities in the lipid profile	1	NBK285321	
5x109/l can vary greatly among patients	1	NBK285321	
fevers and infections require prompt treatment with antibiotics	1	NBK285321	
routine management of hormone deficiencies	1	NBK285321	
chemotherapy and hematopoietic stem cell transplantation for acute myelogeneous leukemia	1	NBK285321	
, absolute neutrophil counts above 0	1	NBK285321	
5x109/l)	1	NBK285321	
monitoring of growth in children and pubertal development in adolescents	1	NBK285321	
biochemical profile including lipid profile	1	NBK285321	
monitoring for development of varicose veins, especially in adults	1	NBK285321	
monitoring for osteopenia/osteoporosis	1	NBK285321	
gov/books/n/gene/gaci	1	NBK253403	
, evidence of autosomal recessive hypophosphatemic rickets)	1	NBK253403	
pediatric cardiology consultation including:	1	NBK253403	
include cervical films to evaluate for cervical spine fusion	1	NBK253403	
audiologic assessment for conductive or sensorineural hearing loss	1	NBK253403	
pediatric nephrology consultation in the setting of refractory hypertension	1	NBK253403	
treatment of arterial calcification	1	NBK253403	
bisphosphonate therapy	1	NBK253403	
026, log-rank test)	1	NBK253403	
the dose of pamidronate has varied from 0	1	NBK253403	
cardiovascular treatment	1	NBK253403	
anti-hypertensive therapy	1	NBK253403	
017-0	1	NBK253403	
068 μg/kg/min [ciana et al 1997]	1	NBK253403	
prevention of coronary thrombosis	1	NBK253403	
treatment of hearing loss	1	NBK253403	
no specific guidelines address the issue of surveillance	1	NBK253403	
gov/books/n/gene/galactosemia	1	NBK1518	
evaluations following initial diagnosis in the newborn period	1	NBK1518	
consultation with a specialist in biochemical genetic disorders	1	NBK1518	
neurologic examination and brain mri as needed	1	NBK1518	
ophthalmologic examination, including slit lamp examination for cataracts	1	NBK1518	
treatment of manifestations and complications	1	NBK1518	
see prevention of primary manifestations for information on dietary intervention	1	NBK1518	
ophthalmologic treatment	1	NBK1518	
speech treatment	1	NBK1518	
this may require years of intensive therapy	1	NBK1518	
premature ovarian insufficiency (poi) treatment	1	NBK1518	
fertility is possible for certain persons with classic galactosemia	1	NBK1518	
dietary intervention	1	NBK1518	
, isomil® or prosobee®)	1	NBK1518	
click here for additional dietary reference intake tables	1	NBK1518	
biochemical testing	1	NBK1518	
, during the introduction of a new food)	1	NBK1518	
values >78 mmol/mol creatinine are abnormal	1	NBK1518	
schedule for individuals with classic or clinical variant galactosemia	1	NBK1518	
biochemical genetics clinic visits	1	NBK1518	
every six months during the second year of life	1	NBK1518	
yearly thereafter	1	NBK1518	
metabolic dietician clinic visits	1	NBK1518	
ophthalmologic evaluations	1	NBK1518	
speech evaluations	1	NBK1518	
developmental evaluations	1	NBK1518	
evaluations for premature ovarian insufficiency (poi)	1	NBK1518	
evaluations for osteopenia	1	NBK1518	
lactose- or galactose-containing drug preparations	1	NBK1518	
gov/books/n/gene/gale-def	1	NBK51671	
nutrition and feeding assessments	1	NBK51671	
ophthalmology consult to evaluate for cataracts	1	NBK51671	
generalized epimerase deficiency galactosemia	1	NBK51671	
, some fruits and vegetables, organ meats)	1	NBK51671	
, hepatic cirrhosis or mature cataracts)	1	NBK51671	
peripheral epimerase deficiency galactosemia	1	NBK51671	
intermediate epimerase deficiency galactosemia	1	NBK51671	
however, insufficient data exist to make firm recommendations	1	NBK51671	
furthermore, such tests may not be available	1	NBK51671	
5 mg/100 ml in red blood cells	1	NBK51671	
follow growth	1	NBK51671	
monitor developmental milestones	1	NBK51671	
propose supportive intervention as needed	1	NBK51671	
diagnostic evaluations can include:	1	NBK51671	
gov/books/n/gene/gan	1	NBK1136	
appropriate ophthalmologic treatment (e	1	NBK1136	
the following should be monitored in persons with gan:	1	NBK1136	
intellectual development/deterioration	1	NBK1136	
the frequency of the monitoring should depend on disease progression	1	NBK1136	
annual or more frequent evaluation is recommended	1	NBK1136	
gov/books/n/gene/gata1	1	NBK1364	
detailed history of age at which hematologic disease was manifest	1	NBK1364	
individuals with gata1-related cytopenia are treated supportively	1	NBK1364	
, ibuprofen)	1	NBK1364	
molecular genetic testing for the familial gata1 pathogenic variant	1	NBK1364	
gov/books/n/gene/gaucher	1	NBK1269	
, enzyme dose and frequency of infusion)	1	NBK1269	
mode of ascertainment (e	1	NBK1269	
, family screening vs disease signs and symptoms)	1	NBK1269	
presence/absence of primary neurologic involvement	1	NBK1269	
transfusion of blood products for severe anemia and bleeding	1	NBK1269	
analgesics for bone pain	1	NBK1269	
, improved joint range of motion)	1	NBK1269	
supplemental treatment	1	NBK1269	
, combined ert and bmt)	1	NBK1269	
it is likely that end-stage histologic changes (e	1	NBK1269	
ert is well tolerated	1	NBK1269	
adverse effects (e	1	NBK1269	
, brain, bones, and lungs)	1	NBK1269	
substrate reduction therapy (srt)	1	NBK1269	
6 to -0	1	NBK1269	
parenchymal abnormalities can be identified as well	1	NBK1269	
screening for pulmonary hypertension	1	NBK1269	
assessment of disease severity	1	NBK1269	
chaperone-mediated enzyme enhancement therapy	1	NBK1269	
gov/books/n/gene/gcps	1	NBK1446	
treatment of manifestations *	1	NBK1446	
surveillance *	1	NBK1446	
author, unpublished observations])	1	NBK1446	
gov/books/n/gene/gefs	1	NBK1318	
cognitive neuropsychological evaluation	1	NBK1318	
behavioral neuropsychological evaluation	1	NBK1318	
clinical genetics evaluation [pal et al 2010]	1	NBK1318	
care is best provided by a physician (e	1	NBK1318	
clobazam (0	1	NBK1318	
topiramate [coppola et al 2002]	1	NBK1318	
ethosuximide	1	NBK1318	
can be effective for absence seizures	1	NBK1318	
levetiracetam (20-80 mg/kg/day)	1	NBK1318	
potassium bromide	1	NBK1318	
phenobarbital	1	NBK1318	
sleep deprivation and illness can exacerbate scn1a-related seizures	1	NBK1318	
routine seizure and personal safety counseling is indicated	1	NBK1318	
seizures are not always responsive to conventional aeds	1	NBK1318	
ethosuximide and high-dose piracetam for myoclonic seizures	1	NBK1318	
placement of an indwelling venous access device	1	NBK1318	
creating a portable microenvironment	1	NBK1318	
having a written emergency department protocol	1	NBK1318	
establishing emergency routines for the family	1	NBK1318	
creating personal time to decrease parent stress	1	NBK1318	
finding respite care	1	NBK1318	
contacting an internet support group	1	NBK1318	
, naproxen)	1	NBK1318	
acetaminophen, which is hepatotoxic in overdose	1	NBK1318	
effect of anticonvulsants on hormonal methods of birth control	1	NBK1318	
effects of anticonvulsants on conception	1	NBK1318	
effect of pregnancy on anticonvulsant metabolism	1	NBK1318	
effect of pregnancy on maternal seizure control	1	NBK1318	
lacosamide has not been studied in scn1a-related seizure disorders	1	NBK1318	
however, it has not been formally studied	1	NBK1318	
gov/books/n/gene/geleophys-dysp	1	NBK11168	
clinical history for evidence of tracheal stenosis and respiratory compromise	1	NBK11168	
liver size by clinical assessment and/or ultrasound examination	1	NBK11168	
eye examination for to evaluate for evidence of glaucoma	1	NBK11168	
joint manifestations: regular physiotherapy to prevent joint limitation	1	NBK11168	
heart: valve replacement	1	NBK11168	
tracheal stenosis: tracheostomy when severe	1	NBK11168	
annual multidisciplinary examination to assess:	1	NBK11168	
trachea for evidence of stenosis and respiratory compromise	1	NBK11168	
liver size for evidence of hepatomegaly	1	NBK11168	
gov/books/n/gene/glc	1	NBK1135	
the examination includes the following:	1	NBK1135	
measurement of corneal diameter	1	NBK1135	
examination of the anterior segment	1	NBK1135	
direct gonioscopy to rule out secondary glaucoma	1	NBK1135	
dilated fundus examination to evaluate for optic nerve damage	1	NBK1135	
surgical treatment	1	NBK1135	
pcg is almost always managed surgically	1	NBK1135	
beta-blockers (e	1	NBK1135	
, timolol), parasympathomimetics (e	1	NBK1135	
, pilocarpine), sympathomimetics (e	1	NBK1135	
treatment of refractive errors	1	NBK1135	
gov/books/n/gene/glut1	1	NBK1430	
eeg (pre-prandial and post-prandial tracings)	1	NBK1430	
brain imaging, including fdg-pet in selected individuals	1	NBK1430	
affected individuals develop a mild compensated metabolic acidosis when ketotic	1	NBK1430	
phenobarbital and valproic acid can inhibit glut1 transport	1	NBK1430	
valproic acid may partially inhibit beta-oxidation of fatty acids	1	NBK1430	
these agents also can cause kidney stones	1	NBK1430	
response has been modest at best	1	NBK1430	
for those who are treated with the ketogenic diet:	1	NBK1430	
l-carnitine supplementation to avoid carnitine deficiency	1	NBK1430	
additionally, valproic acid may inhibit glucose transport	1	NBK1430	
blood measurement of ketone concentration is the preferred method	1	NBK1430	
barbiturates	1	NBK1430	
methylxanthines (e	1	NBK1430	
, anaplerosis)	1	NBK1430	
the primary efficacy objective is reduction in seizure frequency	1	NBK1430	
gov/books/n/gene/gm1-ganglio	1	NBK164500	
physical examination for evidence of hepatosplenomegaly	1	NBK164500	
skeletal survey to determine the extent of skeletal involvement	1	NBK164500	
electroencephalogram to assess for seizure disorder, if indicated	1	NBK164500	
clinical genetics consultation with genetic counseling	1	NBK164500	
maintenance of adequate hydration and adequate calories for growth	1	NBK164500	
aggressive seizure control	1	NBK164500	
medical management of cardiac involvement	1	NBK164500	
tomatsu et al 2011	1	NBK164500	
author, unpublished observations]	1	NBK164500	
assessment of quality of life by a physiotherapist	1	NBK164500	
yearly and before/after major medical events	1	NBK164500	
monitoring of hip joint stability re risk of hip dislocation	1	NBK164500	
yearly evaluation by a neurologist	1	NBK164500	
assessment of quality of life by a physiotherapist:	1	NBK164500	
yearly: track progress and optimize ambulation	1	NBK164500	
neurologic examination every six months	1	NBK164500	
mri neutral position: whole spine every year	1	NBK164500	
these guidelines can be modified as appropriate	1	NBK164500	
polysomnography if any clinical suspicion exists	1	NBK164500	
slit lamp examination of cornea	1	NBK164500	
examination of the posterior segment	1	NBK164500	
evaluation every six months	1	NBK164500	
yearly audiogram	1	NBK164500	
no fda-approved treatments for glb1-related disorders exist	1	NBK164500	
see animal model	1	NBK164500	
gov/books/n/gene/gonad-dys-46xy	1	NBK1547	
the general concepts of care include the following	1	NBK1547	
sex assignment	1	NBK1547	
all individuals should receive a sex of rearing	1	NBK1547	
surgical intervention should focus on functionality	1	NBK1547	
removal of müllerian remnants may be considered	1	NBK1547	
management of gonads	1	NBK1547	
if an individual is given a male sex assignment:	1	NBK1547	
5 standard deviations below the mean for age)	1	NBK1547	
testosterone therapy is typically required to initiate and sustain puberty	1	NBK1547	
if an individual is given a female sex assignment:	1	NBK1547	
estrogen therapy is used to initiate breast development and puberty	1	NBK1547	
psychosocial aspects of care	1	NBK1547	
” [lee et al 2006]	1	NBK1547	
gov/books/n/gene/gr_22q11deletion	1	NBK1523	
tsh level	1	NBK1523	
complete blood cell count with differential	1	NBK1523	
renal ultrasound examination to evaluate for structural renal defects	1	NBK1523	
consideration of ophthalmology evaluation	1	NBK1523	
chest x-ray to evaluate for thoracic vertebral anomalies	1	NBK1523	
assessment for possible feeding problems including significant gastroesophageal reflux	1	NBK1523	
vomiting and constipation	1	NBK1523	
as needed:	1	NBK1523	
later, educational and behavioral therapy are often warranted	1	NBK1523	
, oral polio, mmr)	1	NBK1523	
antibody studies to assess results of immunizations are warranted	1	NBK1523	
consider the following:	1	NBK1523	
possible effects on speech prior to adenoidectomy	1	NBK1523	
pre- and postoperative sleep studies when performing pharyngeal procedures	1	NBK1523	
assessment of platelet volume and function prior to surgical procedures	1	NBK1523	
thyroid studies annually	1	NBK1523	
reevaluation of immunologic status between age nine and 12 months	1	NBK1523	
annual complete blood count and differential	1	NBK1523	
repeat audiology evaluation in infancy and prior to school enrollment	1	NBK1523	
routine surveillance for the development of scoliosis	1	NBK1523	
carbonated drinks and alcohol consumption may exacerbate hypocalcemia	1	NBK1523	
caffeine intake may contribute to or worsen anxiety	1	NBK1523	
skeletal differences such as club foot and craniosynostosis	1	NBK1523	
and umbilical and inguinal hernia	1	NBK1523	
gov/books/n/gene/gr_22q13_3	1	NBK1198	
a complete physical and neurologic examination	1	NBK1198	
comprehensive speech/language evaluation including an audiologic examination	1	NBK1198	
oral-motor therapy to alleviate chewing and swallowing problems	1	NBK1198	
routine protocols to alleviate sleep apnea	1	NBK1198	
tympanostomy tube placement for recurrent ear infections	1	NBK1198	
surgical removal of ingrown toenails to prevent infection	1	NBK1198	
walkers or other assistive walking devices	1	NBK1198	
intravenous fluids to prevent dehydration in individuals with recurrent vomiting	1	NBK1198	
monitoring for symptoms (e	1	NBK1198	
routine monitoring of cardiac abnormalities	1	NBK1198	
in severe cases, monitoring by a vascular surgeon	1	NBK1198	
3 deletion have reduced perspiration and tend to overheat easily	1	NBK1198	
intranasal insulin (init)	1	NBK1198	
risperidone	1	NBK1198	
gov/books/n/gene/gr_3ms	1	NBK1481	
assessment of joint mobility by physical examination	1	NBK1481	
surgical bone lengthening may be an option for some	1	NBK1481	
adaptive aids for people with short stature are appropriate	1	NBK1481	
gov/books/n/gene/grin2a-dis	1	NBK385627	
consultation with a speech and language pathologist	1	NBK385627	
hearing testing	1	NBK385627	
speech/language deficits	1	NBK385627	
aeds are associated with possible adverse reactions (e	1	NBK385627	
developmental surveillance should be conducted in all affected children	1	NBK385627	
gov/books/n/gene/gsd1	1	NBK1312	
gly188arg pathogenic variant in g6pc	1	NBK1312	
evaluation of nutritional status	1	NBK1312	
liver imaging to evaluate for hepatomegaly	1	NBK1312	
kidney imaging to evaluate for renomegaly	1	NBK1312	
kidney function tests	1	NBK1312	
platelet function assay to evaluate platelet function	1	NBK1312	
measurement of bone density (after the first decade)	1	NBK1312	
screening to detect systemic and pulmonary hypertension	1	NBK1312	
metabolic specialist consultation	1	NBK1312	
metabolic specialist familiar with the multisystem nature of gsdi	1	NBK1312	
medical nutrition therapy goals	1	NBK1312	
maintain	1	NBK1312	
normal glucose levels and prevent hypoglycemia:	1	NBK1312	
frequent daytime feedings	1	NBK1312	
note: recommendations for uncooked cornstarch dosing are: 1	1	NBK1312	
provide	1	NBK1312	
optimal nutrition for growth and development:	1	NBK1312	
, protein low in fat)	1	NBK1312	
treatment of other manifestations	1	NBK1312	
sodium levels should also be monitored	1	NBK1312	
kidney transplantation can be performed for esrd	1	NBK1312	
liver transplantation can be considered when other interventions have failed	1	NBK1312	
g-csf should be administered subcutaneously starting at 1	1	NBK1312	
0 μg/kg given daily or every other day	1	NBK1312	
0 x 109/l is reached	1	NBK1312	
surveillance of the liver may include the following:	1	NBK1312	
when hepatic adenoma is detected	1	NBK1312	
any imaging performed for liver surveillance (e	1	NBK1312	
cardiovascular surveillance	1	NBK1312	
maintain a low-sucrose, low-fructose diet	1	NBK1312	
limit galactose and lactose intake to one serving per day	1	NBK1312	
baseline ultrasound of liver and kidneys prior to pregnancy	1	NBK1312	
consideration of referral to high-risk obstetrician	1	NBK1312	
metabolic control should be followed closely throughout the pregnancy	1	NBK1312	
abdominal ultrasound should be performed every six to 12 weeks	1	NBK1312	
gov/books/n/gene/gsd2	1	NBK1261	
see kishnani et al 2006b]	1	NBK1261	
chest radiography	1	NBK1261	
electrocardiography (ecg)	1	NBK1261	
in later stages, dilated cardiomyopathy may be seen	1	NBK1261	
most infants have varying degrees of respiratory insufficiency	1	NBK1261	
formal pulmonary function tests show pulmonary insufficiency	1	NBK1261	
assessment of growth (i	1	NBK1261	
all infants should be evaluated for gastroesophageal reflux disease	1	NBK1261	
assessment of nutritional status as baseline is recommended	1	NBK1261	
audiologic –	1	NBK1261	
baseline hearing evaluation including tympanometry is appropriate	1	NBK1261	
disability inventory –	1	NBK1261	
iopd and lopd	1	NBK1261	
assessment of risk for falls is recommended	1	NBK1261	
arteriopathy	1	NBK1261	
conduction disturbances	1	NBK1261	
muscle weakness	1	NBK1261	
respiratory insufficiency	1	NBK1261	
respiratory support including cpap and bipap may be required	1	NBK1261	
crim status	1	NBK1261	
age restrictions on lumizyme were removed in 2014	1	NBK1261	
many individuals are now treated with the higher dose	1	NBK1261	
complications of ert	1	NBK1261	
infusion-associated reactions	1	NBK1261	
prognosis	1	NBK1261	
the major morbidities are motor disability and respiratory insufficiency	1	NBK1261	
infections need to be aggressively managed	1	NBK1261	
immunizations need to be kept current	1	NBK1261	
patients and household members should receive annual influenza vaccinations	1	NBK1261	
close follow up is indicated	1	NBK1261	
chest x-rays at regular intervals	1	NBK1261	
yearly or more frequently as indicated	1	NBK1261	
this may include assessment for scoliosis and bone densitometry	1	NBK1261	
regular nutritional and feeding assessment	1	NBK1261	
periodic echocardiography	1	NBK1261	
hypotension and volume depletion should be avoided	1	NBK1261	
exposure to infectious agents is to be avoided	1	NBK1261	
gov/books/n/gene/gsd3	1	NBK26372	
baseline electrocardiogram and echocardiogram	1	NBK26372	
consultation with a biochemical geneticist	1	NBK26372	
special formulas are not required	1	NBK26372	
3 mmol/l)	1	NBK26372	
emergency protocol	1	NBK26372	
5 normal saline administered at 1	1	NBK26372	
osteoporosis may occur in adults with gsd iii	1	NBK26372	
bone mineralization is adversely affected in acidic environments	1	NBK26372	
the following are appropriate annually:	1	NBK26372	
measurement of height and weight to monitor growth	1	NBK26372	
laboratory studies: lfts, ck, lipid profile	1	NBK26372	
echocardiogram to monitor for cardiomyopathy	1	NBK26372	
bone density measurements are recommended after growth is complete	1	NBK26372	
long-term steroid usage itself can cause muscle weakness	1	NBK26372	
use the following with caution:	1	NBK26372	
statins for control of hyperlipidemia	1	NBK26372	
beta blockers as they can induce hypoglycemia	1	NBK26372	
gov/books/n/gene/gsd4	1	NBK115333	
abdominal ultrasound examination to assess liver size and texture	1	NBK115333	
neurodevelopmental evaluation	1	NBK115333	
medical or biochemical genetics consultation	1	NBK115333	
hepatic manifestations	1	NBK115333	
selecting appropriate candidates for liver transplantation can be complex	1	NBK115333	
nutritional deficiencies (e	1	NBK115333	
bleeding due to coagulopathy can occur especially with surgical procedures	1	NBK115333	
gov/books/n/gene/gsd5	1	NBK1344	
physical examination with emphasis on muscle strength/weakness	1	NBK1344	
basal serum ck activity	1	NBK1344	
aerobic training (on a regular diet)	1	NBK1344	
95% confidence intervals 20	1	NBK1344	
3 to 2496	1	NBK1344	
7) after controlling for age	1	NBK1344	
7 metabolic equivalents (mets, with 1met equaling 3	1	NBK1344	
5 ml o2/kg/min) necessary for independent living	1	NBK1344	
5mets higher than in those who were not active	1	NBK1344	
avoid a totally sedentary life, which induces deconditioning	1	NBK1344	
pharmacologic and nutritional treatments	1	NBK1344	
the authors' conclusions:	1	NBK1344	
this treatment does not influence sustained or unexpected exercise	1	NBK1344	
a carbohydrate-rich diet was of benefit	1	NBK1344	
pharmacologic treatments	1	NBK1344	
nutritional treatments	1	NBK1344	
see treatment of manifestations and agents/circumstances to avoid	1	NBK1344	
annual routine physical examination	1	NBK1344	
annual review of diet	1	NBK1344	
static muscle contractions (e	1	NBK1344	
, handgrip exercises)	1	NBK1344	
, weightlifting)	1	NBK1344	
dynamic exercises at a high-intensity level (e	1	NBK1344	
, competitive ball games)	1	NBK1344	
, jumps)	1	NBK1344	
very intense dynamic aerobic exercise (e	1	NBK1344	
general anesthetics	1	NBK1344	
lipid-lowering drugs	1	NBK1344	
arg50ter, p	1	NBK1344	
branched-chain amino acids (bca)	1	NBK1344	
gov/books/n/gene/gsd6	1	NBK5941	
height and weight should be measured annually to monitor growth	1	NBK5941	
bone density determinations are recommended after growth is complete	1	NBK5941	
gov/books/n/gene/gsd9	1	NBK55061	
elevated blood ketones (beta-hydroxybutyrate >1	1	NBK55061	
liver imaging, if not performed in the past year	1	NBK55061	
prothrombin time	1	NBK55061	
lipid panel (cholesterol and triglyceride concentrations)	1	NBK55061	
physical therapy evaluation	1	NBK55061	
serum creatine kinase measurement	1	NBK55061	
the dose of cornstarch can range from 0	1	NBK55061	
5 g/kg every six hours based on clinical symptoms	1	NBK55061	
for signs of	1	NBK55061	
some individuals may require cornstarch only before bedtime	1	NBK55061	
requirements for cornstarch tend to lessen with age	1	NBK55061	
however, regular moderate aerobic exercise may be beneficial	1	NBK55061	
abrupt discontinuation of fluids could result in hypoglycemia	1	NBK55061	
lipid-lowering drugs (e	1	NBK55061	
liver imaging	1	NBK55061	
follow-up echocardiogram	1	NBK55061	
no guidelines established	1	NBK55061	
affected individuals with should avoid the following:	1	NBK55061	
prolonged fasting	1	NBK55061	
the final decision is based on clinician judgment	1	NBK55061	
alcohol, as this may predispose to hypoglycemia	1	NBK55061	
affected individuals should avoid the following:	1	NBK55061	
vigorous exercise	1	NBK55061	
medications that can cause rhabdomyolysis (e	1	NBK55061	
, succinylcholine)	1	NBK55061	
gov/books/n/gene/hartsfield	1	NBK349073	
assess development including evidence of spasticity	1	NBK349073	
evaluate suspicious activity for evidence of seizures	1	NBK349073	
surgery may be required	1	NBK349073	
hypothalamic involvement	1	NBK349073	
central diabetes insipidus may require treatment with desmopressin	1	NBK349073	
temperature dysregulation can be managed by modifying the environment	1	NBK349073	
surgery of hand and foot defects can improve dexterity	1	NBK349073	
tethered cord may require surgical intervention	1	NBK349073	
some children may require a gastrostomy and/or tracheostomy	1	NBK349073	
gov/books/n/gene/hcp	1	NBK114807	
inquiry into possibility of seizures	1	NBK114807	
measurement of serum sodium concentration	1	NBK114807	
acute attacks	1	NBK114807	
in an individual presenting with acute abdominal symptoms:	1	NBK114807	
discontinue all nonessential medications	1	NBK114807	
provide glucose-containing iv solution to reverse the fasting state	1	NBK114807	
treat seizures with a short-acting benzodiazepine (e	1	NBK114807	
not yet approved in the us)	1	NBK114807	
some individuals recover with a glucose infusion only	1	NBK114807	
200 mg once daily is appropriate for most individuals	1	NBK114807	
the following responses to hematin infusion can be expected:	1	NBK114807	
chronic (cutaneous) manifestations	1	NBK114807	
grey or smoke colored filters provide only partial protection	1	NBK114807	
involves the following:	1	NBK114807	
selection of appropriate contraception for females	1	NBK114807	
a copper-eluting iud is theoretically the safest in porphyria	1	NBK114807	
however, little information exists	1	NBK114807	
suppression of menses using a gnrh agonist	1	NBK114807	
, propofol, ketamine, short-acting benzodiazepines)	1	NBK114807	
does not	1	NBK114807	
involve the following:	1	NBK114807	
use of glucose	1	NBK114807	
extreme diets (e	1	NBK114807	
extreme caloric deprivation (i	1	NBK114807	
, total fasting, gastric bypass surgery)	1	NBK114807	
female reproductive hormones	1	NBK114807	
birth-control pills are risky and not recommended	1	NBK114807	
some drugs are clearly unsafe for cpox heterozygotes	1	NBK114807	
porphyriafoundation	1	NBK114807	
com and www	1	NBK114807	
porphyria-europe	1	NBK114807	
the effect of pregnancy on inducing acute attacks is unpredictable	1	NBK114807	
in general, serious problems during pregnancy are unusual	1	NBK114807	
efforts to accomplish this are under way	1	NBK114807	
gov/books/n/gene/hd-l2	1	NBK1529	
pharmacologic agents may suppress abnormal movements	1	NBK1529	
tremor in one individual was suppressed with clonazepam	1	NBK1529	
no known treatment stops or slows the progression of hdl2	1	NBK1529	
nutrition and swallowing should be monitored	1	NBK1529	
any agents that increase ataxia should be used with caution	1	NBK1529	
gov/books/n/gene/hdls	1	NBK100239	
psychological and psychiatric assessments	1	NBK100239	
eeg or video eeg if a seizure disorder is suspected	1	NBK100239	
evaluation of the need for antiepileptic drugs	1	NBK100239	
no specific therapy is currently available for alsp	1	NBK100239	
other:	1	NBK100239	
onset of seizures and need for antiepileptic therapy	1	NBK100239	
need for physical therapy to minimize contractures and maintain locomotion	1	NBK100239	
gov/books/n/gene/hemo-a	1	NBK1404	
treatment should be coordinated through a hemophilia treatment center	1	NBK1404	
(individuals in the usa see national hemophilia foundation	1	NBK1404	
immunizations should be administered preferably subcutaneously	1	NBK1404	
ddavp®	1	NBK1404	
(desmopressin acetate)	1	NBK1404	
immune tolerance therapy	1	NBK1404	
5 to three years	1	NBK1404	
if the female is symptomatic (i	1	NBK1404	
others are in clinical trials	1	NBK1404	
these result in half-life extension by approximately 1	1	NBK1404	
5 fold	1	NBK1404	
products with greater half-life extension are under development	1	NBK1404	
gov/books/n/gene/hemo-b	1	NBK1495	
elsewhere worldwide: see world federation of hæmophilia)	1	NBK1495	
immunizations should be administered subcutaneously	1	NBK1495	
inhibitors	1	NBK1495	
, in individuals with atherosclerotic cardiovascular disease)	1	NBK1495	
range: 15%-50%)	1	NBK1495	
recombinant factor ix (fix) proteins with prolonged survival	1	NBK1495	
gene therapy for hemophilia b	1	NBK1495	
gov/books/n/gene/hemochromatosis	1	NBK1440	
for p	1	NBK1440	
cys282tyr homozygotes:	1	NBK1440	
clinical	1	NBK1440	
biochemical	1	NBK1440	
clinical hfe-hh	1	NBK1440	
this may be accompanied with measurement of alpha fetoprotein	1	NBK1440	
01 kpa [friedrich-rust et al 2008]	1	NBK1440	
biochemical hfe-hh	1	NBK1440	
alcohol consumption in those with hepatic involvement	1	NBK1440	
the following strategy is appropriate:	1	NBK1440	
perform iron studies (i	1	NBK1440	
no guidelines exist	1	NBK1440	
common practice is to withhold phlebotomy during pregnancy	1	NBK1440	
gov/books/n/gene/hep	1	NBK169003	
the following measures are recommended:	1	NBK169003	
avoidance of drugs and agents that induce the hepatic p450	1	NBK169003	
persons of all ages should avoid exposure to sunlight	1	NBK169003	
older individuals should avoid the known precipitating factors (e	1	NBK169003	
gov/books/n/gene/hepatic-fibrosis	1	NBK2701	
variceal bleeding	1	NBK2701	
transjugular intrahepatic portosystemic shunts (tips) are widely available	1	NBK2701	
hypersplenism	1	NBK2701	
hypersplenism usually does not result in clinically significant sequelae	1	NBK2701	
abnormalities of the biliary tree	1	NBK2701	
cholangitis is best treated with rapid institution of appropriate antibiotics	1	NBK2701	
biliary stones	1	NBK2701	
cholangiocarcinoma and hepatocellular carcinoma	1	NBK2701	
these should be managed by a multidisciplinary team	1	NBK2701	
patient education	1	NBK2701	
general health should be closely followed	1	NBK2701	
imaging allows:	1	NBK2701	
assessment of spleen size to indirectly follow ph	1	NBK2701	
visualization of bile duct abnormalities (e	1	NBK2701	
malnutrition	1	NBK2701	
infection with human immunodeficiency virus (hiv)	1	NBK2701	
immunosuppression (e	1	NBK2701	
, after renal transplantation)	1	NBK2701	
hepatotoxic medicines should be avoided	1	NBK2701	
gov/books/n/gene/hfg	1	NBK1423	
examination for upj obstruction	1	NBK1423	
urologic referral is indicated	1	NBK1423	
gynecologic referral is indicated	1	NBK1423	
hymenectomy may be necessary for tight constriction ring	1	NBK1423	
gynecologic examination prior to menstruation for small hymenal opening	1	NBK1423	
gov/books/n/gene/hfi	1	NBK333439	
biochemical geneticist or pediatrician with an interest in metabolic disorders	1	NBK333439	
dietician with experience in managing inherited metabolic diseases	1	NBK333439	
hepatologist	1	NBK333439	
nephrologist	1	NBK333439	
clinical geneticist and/or genetic counselor	1	NBK333439	
food category	1	NBK333439	
foods permitted	1	NBK333439	
foods prohibited	1	NBK333439	
dairy	1	NBK333439	
any milk, cheese, eggs	1	NBK333439	
meat	1	NBK333439	
beef, veal, lamb, pork	1	NBK333439	
ham, bacon, hot dogs, processed meats	1	NBK333439	
any other meat where sugar is used in processing	1	NBK333439	
fish	1	NBK333439	
all fish	1	NBK333439	
poultry	1	NBK333439	
chicken, turkey	1	NBK333439	
cereal	1	NBK333439	
sweetened/sugar-coated cereals	1	NBK333439	
fruit	1	NBK333439	
vegetables	1	NBK333439	
all other vegetables, including sweet potatoes	1	NBK333439	
bread	1	NBK333439	
soda crackers & saltines	1	NBK333439	
any breads or crackers prepared w/fructose/sucrose/sugar/sorbitol	1	NBK333439	
fat sources	1	NBK333439	
desserts and sweeteners	1	NBK333439	
dietetic jello, dietetic ice cream, dietetic puddings	1	NBK333439	
natural yogurt	1	NBK333439	
sugar, sucrose, sorbitol, fructose	1	NBK333439	
miscellaneous	1	NBK333439	
some sugar substitutes	1	NBK333439	
some dietetic beverages	1	NBK333439	
pasta	1	NBK333439	
rice	1	NBK333439	
cinnamon, garlic, poppy seeds	1	NBK333439	
peanut butter if prepared w/added sugars	1	NBK333439	
chewing gum w/sorbitol	1	NBK333439	
the following are recommendations:	1	NBK333439	
medicines	1	NBK333439	
not be given to neonates known to have hfi	1	NBK333439	
coli sepsis and pulmonary edema	1	NBK333439	
gov/books/n/gene/hfpoik-tmp	1	NBK390610	
blood tests:	1	NBK390610	
liver function: sgot, sgpt, alp, ggt	1	NBK390610	
fecal elastase level if steatorrhea is present	1	NBK390610	
ophthalmologic examination to evaluate for cataracts or other abnormalities	1	NBK390610	
however, no data on its use are available	1	NBK390610	
lymphedema management (manual lymphatic drainage, compression)	1	NBK390610	
muscle	1	NBK390610	
physical therapy and exercise to promote mobility and prevent contractures	1	NBK390610	
noninvasive ventilation if needed	1	NBK390610	
treatment of pancreatic exocrine insufficiency with pancreatic enzyme supplementation	1	NBK390610	
treatment of cholestasis with ursodeoxycholic acid	1	NBK390610	
enteral feeding as needed	1	NBK390610	
surgical removal of visually significant cataracts	1	NBK390610	
physical therapy assessment for muscle weakness or contractures	1	NBK390610	
blood test:	1	NBK390610	
excessive sun exposure, which may exacerbate the rash	1	NBK390610	
exposure to heat because of heat intolerance secondary to hypohidrosis	1	NBK390610	
gov/books/n/gene/hgc	1	NBK1139	
evaluation of cdh1 heterozygotes for h	1	NBK1139	
breast examination/mammography in females	1	NBK1139	
the primary curative treatment of gastric cancer is surgical resection	1	NBK1139	
biopsy-proven diffuse-type gastric carcinoma	1	NBK1139	
heterozygotes for a germline cdh1 pathogenic variant	1	NBK1139	
however, the morbidity from prophylactic gastrectomy is high	1	NBK1139	
the age-specific risks of gastric cancer	1	NBK1139	
gastric cancer	1	NBK1139	
several screening modalities have been tested:	1	NBK1139	
endoscopy	1	NBK1139	
endoscopy permits direct inspection and biopsy of suspicious areas	1	NBK1139	
the submucosal lesions are difficult to identify	1	NBK1139	
further research is needed to evaluate this possibility	1	NBK1139	
69 of 99 (70%) endoscopies were normal	1	NBK1139	
lobular breast cancer (lbc)	1	NBK1139	
lehman 2006	1	NBK1139	
schelfout, personal communication]	1	NBK1139	
testing of populations at risk	1	NBK1139	
gov/books/n/gene/hgps	1	NBK1121	
baseline electrocardiogram (ecg) and echocardiogram	1	NBK1121	
baseline mri/mra of the brain and neck	1	NBK1121	
standard goniometry to assess joint mobility	1	NBK1121	
physical therapy and occupational therapy assessments	1	NBK1121	
audiologic, ophthalmologic, and dental examinations	1	NBK1121	
frequent small meals tend to maximize caloric intake	1	NBK1121	
stiffened peripheral vasculature may be less tolerant to dehydration	1	NBK1121	
therefore maintaining optimal hydration orally is recommended	1	NBK1121	
infections are generally handled as for unaffected children	1	NBK1121	
anesthetics should be used with particular caution	1	NBK1121	
nitroglycerin is frequently of benefit if angina develops	1	NBK1121	
statins are recommended for their putative effect on farnesylation inhibition	1	NBK1121	
injuries	1	NBK1121	
wound healing is normal	1	NBK1121	
fracture rate is equivalent to the general pediatric population	1	NBK1121	
hips	1	NBK1121	
teeth	1	NBK1121	
, finger) joints	1	NBK1121	
eye care	1	NBK1121	
hearing aids can be used, when clinically necessary	1	NBK1121	
aspirin	1	NBK1121	
vitamin supplementation	1	NBK1121	
standard amounts of ordinary multiple vitamin tablets are appropriate	1	NBK1121	
fluoride supplements are recommended in areas where needed	1	NBK1121	
immunizations are generally handled as for unaffected children	1	NBK1121	
annually:	1	NBK1121	
lipid profiles	1	NBK1121	
dental examination, x-ray, and cleaning	1	NBK1121	
complete ophthalmologic examination with special attention to possible exposure keratopathy	1	NBK1121	
physical activity should be self-limited	1	NBK1121	
search hgps or progeria within clinicaltrials	1	NBK1121	
gov for access to information on clinical trials for hgps	1	NBK1121	
lonafarnib is an investigational farnesyltransferase inhibitor	1	NBK1121	
pravastatin inhibits hmg-coa reductase	1	NBK1121	
zoledronate is a bisphosphonate that inhibits farnesyl pyrophosphate synthase	1	NBK1121	
three clinical trials have been conducted: lonafarnib monotherapy	1	NBK1121	
lonafarnib in combination with pravastatin and zoledronate	1	NBK1121	
and pravastatin and zoledronate administered as combination therapy:	1	NBK1121	
trial results for pravastatin and zoledronate are not yet known	1	NBK1121	
gov/books/n/gene/hhhs	1	NBK97260	
neurocognitive evaluation of the affected individual including brain imaging	1	NBK97260	
evaluation of school performance with attention to possible learning disabilities	1	NBK97260	
treatment of acute hyperammonemic episodes	1	NBK97260	
, as part of nitrogen scavenging therapy)	1	NBK97260	
this approach also stops all protein intake	1	NBK97260	
infusion 1	1	NBK97260	
infants and children	1	NBK97260	
10% arginine hcl	1	NBK97260	
210 mg/kg/day	1	NBK97260	
drug	1	NBK97260	
action	1	NBK97260	
glucose	1	NBK97260	
arginine 1	1	NBK97260	
sodium benzoate 3	1	NBK97260	
sodium phenylacetate 3	1	NBK97260	
hemodialysis	1	NBK97260	
dialysis may be prolonged if the catabolic state persists	1	NBK97260	
note: non-essential amino acids (i	1	NBK97260	
citrulline supplementation at 0	1	NBK97260	
17 g/kg/day or 3	1	NBK97260	
lysine supplementation is indicated when plasma lysine concentrations are low	1	NBK97260	
liver transplantation is not indicated for persons with hhh syndrome	1	NBK97260	
excess dietary protein intake	1	NBK97260	
prolonged fasting during an illness or weight loss	1	NBK97260	
use of intravenous steroids	1	NBK97260	
valproic acid, which exacerbates hyperammonemia in urea cycle disorders	1	NBK97260	
exposure to communicable diseases	1	NBK97260	
gov/books/n/gene/hht	1	NBK1351	
polycythemia raises suspicion for pulmonary arteriovenous malformations	1	NBK1351	
nosebleeds	1	NBK1351	
oral drug therapy	1	NBK1351	
topical drug therapy	1	NBK1351	
, timolol 0	1	NBK1351	
gastrointestinal bleeding	1	NBK1351	
pulmonary avms	1	NBK1351	
hepatic avms	1	NBK1351	
cerebral avms	1	NBK1351	
cerebral avms greater than 1	1	NBK1351	
intestinal polyps	1	NBK1351	
reevaluation for cerebral avm	1	NBK1351	
childhood	1	NBK1351	
gov/books/n/gene/hi	1	NBK1375	
most investigators recommend maintaining all glucose levels above 3	1	NBK1375	
somatostatin analogs (e	1	NBK1375	
glucagon, which increases hepatic gluconeogenesis, helps prevents hypoglycemia	1	NBK1375	
however, therapeutic success has not been confirmed	1	NBK1375	
dietary intervention:	1	NBK1375	
night-time continuous gastric drip containing glucose or glucose polymer	1	NBK1375	
in such individuals, surgery must be considered	1	NBK1375	
aggressive treatment to prevent hypoglycemia helps avoid irreversible brain damage	1	NBK1375	
prolonged fasting of any sort should be avoided	1	NBK1375	
gov/books/n/gene/higes	1	NBK25507	
dermatologic examination	1	NBK25507	
chest imaging	1	NBK25507	
dental examination for possible retention of primary teeth	1	NBK25507	
if structural damage to the lungs (e	1	NBK25507	
, pseudomonas) or fungi (e	1	NBK25507	
, aspergillus)	1	NBK25507	
adequate skin lubrication is needed with frequent bleach baths	1	NBK25507	
osteoporosis and minimal trauma fractures are frequent findings	1	NBK25507	
, pneumatocoeles) have formed	1	NBK25507	
cessation of prophylactic antimicrobials is often advised during pregnancy	1	NBK25507	
gov/books/n/gene/hirschsprung-ov	1	NBK1439	
gov/books/n/gene/hlh	1	NBK1444	
hlh-1994	1	NBK1444	
hlh-2004	1	NBK1444	
in general, treatment involves the following:	1	NBK1444	
after achievement of clinical remission in simplex cases (i	1	NBK1444	
, a single occurrence in a family)	1	NBK1444	
the following are recommended annually after hct:	1	NBK1444	
neuropsychological evaluation	1	NBK1444	
live vaccinations	1	NBK1444	
exposure to infections	1	NBK1444	
gov/books/n/gene/hlrcc	1	NBK1252	
cutaneous lesions	1	NBK1252	
cutaneous leiomyomas should be examined by a dermatologist	1	NBK1252	
treatment of cutaneous leiomyomas is difficult:	1	NBK1252	
surgical excision may be performed for a solitary painful lesion	1	NBK1252	
lesions can be treated by cryoablation and/or lasers	1	NBK1252	
uterine fibroids should be evaluated by a gynecologist	1	NBK1252	
hysterectomy should be performed only when necessary	1	NBK1252	
renal tumors	1	NBK1252	
early detection of kidney tumor in hlrcc is important	1	NBK1252	
uterus	1	NBK1252	
caution: ultrasound examination alone is never sufficient	1	NBK1252	
gov/books/n/gene/hmdpc	1	NBK100241	
consultation with a hepatologist is advised	1	NBK100241	
establishment of whole blood manganese levels	1	NBK100241	
chelation therapy with disodium calcium edetate	1	NBK100241	
short term	1	NBK100241	
, >3 hours)	1	NBK100241	
long term	1	NBK100241	
chelation therapy should be continued lifelong	1	NBK100241	
iron therapy	1	NBK100241	
iron is a competitive inhibitor of intestinal manganese uptake	1	NBK100241	
dystonia can result in physical deformities and pain	1	NBK100241	
calcium, magnesium, and phosphate concentrations	1	NBK100241	
and iron status	1	NBK100241	
trace metal supplements are provided as needed	1	NBK100241	
white blood count <3	1	NBK100241	
5x10^9/l	1	NBK100241	
neutrophils <2	1	NBK100241	
0x10^9/l	1	NBK100241	
platelets <150x10^9/l	1	NBK100241	
toxicity of iron supplementation	1	NBK100241	
foods very high in manganese (cloves	1	NBK100241	
gov/books/n/gene/hmerf	1	NBK185330	
physiotherapy consultation to assess lower limb function and general mobility	1	NBK185330	
at present no disease-modifying therapy exists	1	NBK185330	
gov/books/n/gene/hna	1	NBK1395	
comprehensive neuromuscular evaluation	1	NBK1395	
bmj	1	NBK1395	
pain management is the primary goal of therapy:	1	NBK1395	
cleft palate is best managed by a local craniofacial team	1	NBK1395	
methylprednisolone, intravenous 30 mg/kg (or 1	1	NBK1395	
intravenous immune globulin, 0	1	NBK1395	
gov/books/n/gene/hnpcc	1	NBK1211	
management of colon cancer in a person with lynch syndrome	1	NBK1211	
endometrial cancer	1	NBK1211	
ovarian cancer	1	NBK1211	
gastric and duodenal cancers	1	NBK1211	
distal small bowel	1	NBK1211	
other cancers	1	NBK1211	
ideally cancer screening exams would be planned around a pregnancy	1	NBK1211	
chromoendoscopy and intensive colonoscopy	1	NBK1211	
chemoprevention research studies	1	NBK1211	
gov/books/n/gene/hnpp	1	NBK1392	
history of focal nerve symptoms	1	NBK1392	
electromyography / nerve conduction velocity (emg/ncv)	1	NBK1392	
gov/books/n/gene/homocystinuria	1	NBK1524	
complications should be managed appropriately (e	1	NBK1524	
betaine therapy is usually added to the therapeutic regimen	1	NBK1524	
details about each aspect of treatment follow	1	NBK1524	
vitamin b6 (pyridoxine) therapy	1	NBK1524	
dietary treatment	1	NBK1524	
this diet should be continued indefinitely	1	NBK1524	
folate and vitamin b12 supplementation	1	NBK1524	
betaine treatment	1	NBK1524	
side effects of betaine are few	1	NBK1524	
complications should be promptly addressed with appropriate therapy	1	NBK1524	
vitamin b12 and folate levels should be monitored	1	NBK1524	
5 n saline at 1	1	NBK1524	
if fluids at 1	1	NBK1524	
gov/books/n/gene/hops	1	NBK1150	
serum concentration of calcium, phosphorus, magnesium	1	NBK1150	
baseline dental evaluation	1	NBK1150	
baseline orthopedic evaluation	1	NBK1150	
multidisciplinary management at various ages may include:	1	NBK1150	
endocrinology to optimize bone homeostasis and avoid exacerbating treatments	1	NBK1150	
nephrology to monitor calcium homeostasis and examine for nephrocalcinosis	1	NBK1150	
neurology to prophylactically or prospectively treat seizures and manage myopathy	1	NBK1150	
neurosurgery or craniofacial team to manage pseudocraniosynostosis	1	NBK1150	
orthopedics to manage primary and secondary skeletal manifestations	1	NBK1150	
pain management	1	NBK1150	
pediatric and adult dentistry to manage tooth loss	1	NBK1150	
perinatal/infantile hpp study outcomes	1	NBK1150	
survival	1	NBK1150	
bone findings	1	NBK1150	
juvenile-onset hpp study outcomes	1	NBK1150	
age at treatment onset was six to 12 years	1	NBK1150	
perinatal types	1	NBK1150	
infantile type	1	NBK1150	
in the absence of ert, supportive management remains	1	NBK1150	
calcium homeostasis	1	NBK1150	
craniosynostosis in those with the infantile phenotype is variable	1	NBK1150	
childhood (juvenile) and adult hypophosphatasia	1	NBK1150	
osteoarthritis may respond to nsaids	1	NBK1150	
pseudofractures and stress fractures are difficult to manage	1	NBK1150	
biphosphonates are relatively contraindicated in hypophosphatasia	1	NBK1150	
it is contraindicated in children with hypophosphatasia	1	NBK1150	
gov/books/n/gene/hos	1	NBK1111	
limb involvement is determined by physical examination	1	NBK1111	
ecg is recommended for the detection of cardiac conduction disease	1	NBK1111	
gov/books/n/gene/hpe-overview	1	NBK1530	
cleft lip and/or palate	1	NBK1530	
hydrocephalus and/or features of hpe or other cortical anomalies	1	NBK1530	
growth deficiency	1	NBK1530	
pituitary dysfunction	1	NBK1530	
oral feeding and swallowing	1	NBK1530	
early surgical repair may improve feeding	1	NBK1530	
, illness, surgery)	1	NBK1530	
gov/books/n/gene/hpp	1	NBK1338	
during an acute paralytic attack:	1	NBK1338	
measurement of serum potassium concentration	1	NBK1338	
assessment for swallowing difficulty	1	NBK1338	
between attacks or in a currently asymptomatic individual:	1	NBK1338	
neurologic examination to assess muscle strength in the legs	1	NBK1338	
plasma thyroid-stimulating hormone (tsh)	1	NBK1338	
free thyroxine (ft4)	1	NBK1338	
free triiodothyronine (ft3)	1	NBK1338	
the principles of treatment are summarized in table 7	1	NBK1338	
goal	1	NBK1338	
means	1	NBK1338	
practical details	1	NBK1338	
to avoid triggering or aggravating factors for paralytic attacks	1	NBK1338	
strenuous effortprolonged immobilitycarbohydrate-rich diet	1	NBK1338	
treatment of paralytic attack:	1	NBK1338	
shorten/prevent aggravation of the weakness episodenormalize kalemia	1	NBK1338	
preventive treatment for paralytic attacks	1	NBK1338	
daily k+ supplementation	1	NBK1338	
slow-release forms of potassium may be used	1	NBK1338	
diamox (acetazolamide)	1	NBK1338	
k+-sparing diuretics	1	NBK1338	
preventive treatment for late-onset myopathy	1	NBK1338	
diamox (acetazolamide)?	1	NBK1338	
medical precautions	1	NBK1338	
other elements of management	1	NBK1338	
strenuous effort	1	NBK1338	
carbohydrate-rich diet	1	NBK1338	
provide dietary review/counseling	1	NBK1338	
shorten/prevent aggravation of the weakness episode	1	NBK1338	
normalize kalemia	1	NBK1338	
avoid glucose intake	1	NBK1338	
do not use slow-release forms of potassium	1	NBK1338	
oral potassium: initially, 1 meq/kg	1	NBK1338	
3 meq/kg after 30 minutes if no improvement	1	NBK1338	
iv potassium: 0	1	NBK1338	
avoid corticosteroids if possible	1	NBK1338	
kinesitherapy in case of permanent pelvic deficit	1	NBK1338	
paralytic crisis	1	NBK1338	
mild to moderate paralytic episodes	1	NBK1338	
aqueous potassium contained in vials may act more rapidly	1	NBK1338	
, 4	1	NBK1338	
3 meq/kg can be administered (20 meq	1	NBK1338	
, 1	1	NBK1338	
severe paralytic episodes	1	NBK1338	
note the following critical points:	1	NBK1338	
3 meq/kg/h of potassium (i	1	NBK1338	
some individuals exhibit serious arrhythmias with only mild hypokalemia	1	NBK1338	
they are associated with a risk for cardiac arrest	1	NBK1338	
attempting to abort paralytic attacks when they begin	1	NBK1338	
acetazolamide treatment:	1	NBK1338	
is beneficial in approximately 50% of individuals with hokpp	1	NBK1338	
has no effect in 30% of affected individuals	1	NBK1338	
alternatives to acetazolamide	1	NBK1338	
pinacidil [ligtenberg et al 1996]	1	NBK1338	
and bumetanide [wu et al 2013]	1	NBK1338	
pre- or postoperative paralysis	1	NBK1338	
general guidelines for perioperative care include the following:	1	NBK1338	
strict control of serum potassium concentration	1	NBK1338	
avoidance of large glucose and salt loads	1	NBK1338	
low-carbohydrate diet	1	NBK1338	
maintenance of body temperature and acid-base balance	1	NBK1338	
late-onset myopathy with fixed muscle weakness	1	NBK1338	
renal ultrasound should be performed annually	1	NBK1338	
unusually strenuous effort	1	NBK1338	
excess of carbohydrate-rich meals	1	NBK1338	
sweets	1	NBK1338	
gov/books/n/gene/hps	1	NBK1287	
complete ophthalmologic evaluation	1	NBK1287	
correction of these refractive errors can improve visual acuity	1	NBK1287	
the surgery is not always successful	1	NBK1287	
humidifiers may reduce the frequency of nosebleeds	1	NBK1287	
oral contraceptives can limit the duration of menstrual periods	1	NBK1287	
the authors know of several additional successful lung transplantations	1	NBK1287	
pulmonary function testing should be performed annually in adults	1	NBK1287	
colonoscopy is used to confirm the diagnosis	1	NBK1287	
gov/books/n/gene/hrpt2	1	NBK3789	
evaluation for renal lesions: renal ultrasound examination preferred	1	NBK3789	
ct and/or mri as clinically indicated	1	NBK3789	
consultation with a medical genetics professional (e	1	NBK3789	
, medical geneticist, genetic counselor): recommended	1	NBK3789	
primary hyperparathyroidism	1	NBK3789	
minimally invasive parathyroidectomy requires the use of:	1	NBK3789	
preoperative imaging (e	1	NBK3789	
jaw tumors	1	NBK3789	
uterine tumors	1	NBK3789	
, elevated serum alkaline phosphatase concentration)	1	NBK3789	
uterine tumors have only been reported in adults	1	NBK3789	
surveillance can begin at reproductive age	1	NBK3789	
gov/books/n/gene/hsan2	1	NBK49247	
a diabetic clinic is a good source of advice	1	NBK49247	
appropriate shoes and socks are recommended	1	NBK49247	
it is best to prevent callous formation in neuropathic skin	1	NBK49247	
gov/books/n/gene/hsan4	1	NBK1769	
hyperthermia or hypothermia	1	NBK1769	
hypothermia responds to warming by a blanket as necessary	1	NBK1769	
of note, longstanding infections require wide surgical debridement	1	NBK1769	
bone and joint deformities can be managed by corrective osteotomy	1	NBK1769	
joint dislocations are best treated conservatively	1	NBK1769	
the oral self-mutilation (i	1	NBK1769	
6-0	1	NBK1769	
dental care includes the following:	1	NBK1769	
inadequate sedation	1	NBK1769	
hyper- or hypothermia	1	NBK1769	
heating blankets should not be used	1	NBK1769	
hot or cold environments	1	NBK1769	
hot or cold foods	1	NBK1769	
hot showers or baths	1	NBK1769	
jumping or high-impact activities and sports	1	NBK1769	
hyperpyrexia and its potential complications, including febrile seizures	1	NBK1769	
, first 28 days of life)	1	NBK1769	
gov/books/n/gene/hsn1	1	NBK1390	
joints for evidence of charcot joints	1	NBK1390	
strength	1	NBK1390	
loss of sweating and compensatory patchy hyperhydrosis	1	NBK1390	
see warren & nade [1999]	1	NBK1390	
charcot joints may require arthrodesis	1	NBK1390	
opiates are contraindicated as hsn1a is a chronic disorder	1	NBK1390	
foot ulcers are frequently caused by breakdown of callus	1	NBK1390	
, during cooking)	1	NBK1390	
opiates are contraindicated as this is a chronic disorder	1	NBK1390	
gov/books/n/gene/hsp	1	NBK1509	
current recommendations:	1	NBK1509	
gov/books/n/gene/hunter	1	NBK1274	
sleep study if sleep apnea is a potential concern	1	NBK1274	
see prevention of secondary complications	1	NBK1274	
note: many of these assessments are age dependent	1	NBK1274	
commonly required interventions include the following:	1	NBK1274	
shunting for hydrocephalus	1	NBK1274	
tonsillectomy and adenoidectomy	1	NBK1274	
positive pressure ventilation (cpap or tracheostomy)	1	NBK1274	
carpal tunnel release	1	NBK1274	
cardiac valve replacement	1	NBK1274	
inguinal hernia repair	1	NBK1274	
hip replacement	1	NBK1274	
developmental, occupational, and physical therapy are often necessary	1	NBK1274	
5 mg/kg	1	NBK1274	
more recently, in a 3	1	NBK1274	
long-term use of ert was safe	1	NBK1274	
, infliximab)	1	NBK1274	
itching	1	NBK1274	
rash	1	NBK1274	
flushing	1	NBK1274	
and headache	1	NBK1274	
risks associated with general anesthesia include the following:	1	NBK1274	
nasopharyngeal intubation is often necessary	1	NBK1274	
the risk of airway complications may continue following successful surgery	1	NBK1274	
cardiology visit with echocardiogram	1	NBK1274	
pulmonary clinic visit with pulmonary function testing	1	NBK1274	
audiogram	1	NBK1274	
sleep study for obstructive sleep apnea	1	NBK1274	
ncv study for evidence of carpal tunnel syndrome	1	NBK1274	
head/neck mri to document ventricular size and cervicomedullary narrowing	1	NBK1274	
opening pressure on lumbar puncture	1	NBK1274	
orthopedic evaluation to monitor hip disease	1	NBK1274	
gov/books/n/gene/huntington	1	NBK1305	
significant secondary complications of hd include the following:	1	NBK1305	
the side effects associated with various pharmacologic treatments	1	NBK1305	
l-dopa-containing compounds may increase chorea	1	NBK1305	
alcohol and smoking are discouraged	1	NBK1305	
huntington-study-group	1	NBK1305	
for the most up-to-date information see hddrugworks	1	NBK1305	
gov/books/n/gene/husa	1	NBK1367	
creatinine clearance (i	1	NBK1367	
, glomerular filtration rate [gfr])	1	NBK1367	
serum concentration of creatinine resources	1	NBK1367	
hematologic status	1	NBK1367	
erythrocyte count	1	NBK1367	
search for schistocytes in the blood smear	1	NBK1367	
leukocyte count	1	NBK1367	
serum ldh concentration	1	NBK1367	
haptoglobin	1	NBK1367	
serum c3 and c4 concentrations	1	NBK1367	
plasma concentrations of bb and sc5b-9	1	NBK1367	
measure serum concentrations of cfh and cfi	1	NBK1367	
assessment of cd46 expression on leukocytes	1	NBK1367	
for further information about eculizumab, click here	1	NBK1367	
typically, plasma exchange is undertaken daily initially	1	NBK1367	
cfb	1	NBK1367	
cfh autoantibodies	1	NBK1367	
cfi	1	NBK1367	
, persistent severe thrombocytopenia and hemolytic anemia)	1	NBK1367	
molecular genetic testing can help to define graft prognosis	1	NBK1367	
c3, cfb, and cfi	1	NBK1367	
four individuals with isolated	1	NBK1367	
importantly, there were no ahus recurrences after transplantation	1	NBK1367	
individuals with known ahus	1	NBK1367	
note: individuals with esrd usually do not relapse	1	NBK1367	
fresh frozen plasma should be avoided (i	1	NBK1367	
some chemotherapeutic agents (e	1	NBK1367	
no monitoring is needed for:	1	NBK1367	
8%) and preeclampsia (7	1	NBK1367	
7%)	1	NBK1367	
for ahus associated with cfh pathogenic variants:	1	NBK1367	
plasma-resistant/plasma-dependent disease	1	NBK1367	
some individuals with ahus are plasma resistant (i	1	NBK1367	
gov/books/n/gene/hyper-card	1	NBK1768	
scd risk factors include:	1	NBK1768	
family history of scd	1	NBK1768	
extreme lvh (>30mm)	1	NBK1768	
hypotensive blood pressure response to exercise	1	NBK1768	
nonsustained ventricular tachycardia (vt) on ambulatory monitoring	1	NBK1768	
unexplained syncope	1	NBK1768	
echocardiogram to measure the degree of lvh	1	NBK1768	
exercise testing to assess blood pressure response to exercise	1	NBK1768	
ambulatory monitoring for significant ventricular ectopy	1	NBK1768	
l-type calcium channel blockers	1	NBK1768	
note: direct vasodilators (e	1	NBK1768	
for relatives at risk for hcm	1	NBK1768	
because penetrance of diagnostic features (i	1	NBK1768	
screening guideline	1	NBK1768	
<12 yrs	1	NBK1768	
optional unless any of the following are present:	1	NBK1768	
12-18 yrs	1	NBK1768	
repeat evaluation every 12-18 months	1	NBK1768	
>18-21 yrs	1	NBK1768	
competitive athlete in intense training program	1	NBK1768	
other clinical findings that suggest early lvh	1	NBK1768	
avoid exercise in extreme environmental conditions and maintain adequate hydration	1	NBK1768	
use jacuzzis, steam rooms, saunas with caution	1	NBK1768	
and avoid the following:	1	NBK1768	
medications that decrease afterload (e	1	NBK1768	
, ace inhibitors	1	NBK1768	
medications for erectile dysfunction (e	1	NBK1768	
, sildenafil, tadalafil)	1	NBK1768	
gov/books/n/gene/hyper-nfj2	1	NBK53700	
hemoglobin concentration to document the level of anemia	1	NBK53700	
dose is based on response to therapy	1	NBK53700	
gout typically responds well to prednisone or colchicine	1	NBK53700	
prednisone is the preferable alternative	1	NBK53700	
fludrocortisone treatment (0	1	NBK53700	
mineralocorticoid replacement	1	NBK53700	
kidney transplantation cures adtkd-ren	1	NBK53700	
treatment of hyperuricemia with allopurinol can prevent development of gout	1	NBK53700	
the use of other analgesics/antipyretics should be considered	1	NBK53700	
exertion under extreme conditions (e	1	NBK53700	
children because of their increased risk for anemia	1	NBK53700	
gov/books/n/gene/hyper-pp	1	NBK1496	
determine neurologic status	1	NBK1496	
edema should be extruded with long-term diuretics	1	NBK1496	
treatment for hyperpp is symptomatic and not curative	1	NBK1496	
, 2 g glucose per kg body weight)	1	NBK1496	
1 mg salbutamol	1	NBK1496	
calcium gluconate (0	1	NBK1496	
diet/environment	1	NBK1496	
potassium-rich medications and foods (e	1	NBK1496	
, fruits, fruit juices)	1	NBK1496	
strenuous work	1	NBK1496	
exposure to cold	1	NBK1496	
diuretics	1	NBK1496	
intubation and mechanical ventilation may be impaired	1	NBK1496	
permanent weakness requires continuous medication, eg	1	NBK1496	
the value should be between 3	1	NBK1496	
0 and 3	1	NBK1496	
5 mmol/l	1	NBK1496	
annual monitoring of thyroid function is appropriate	1	NBK1496	
see prevention of primary manifestations and prevention of secondary complications	1	NBK1496	
for results, see clinicaltrials	1	NBK1496	
gov/books/n/gene/hyperchol	1	NBK174884	
adults with fh	1	NBK174884	
risk factors (e	1	NBK174884	
4 mmol/l])	1	NBK174884	
risk factors:	1	NBK174884	
clinically evident cad or other atherosclerotic cardiovascular disease	1	NBK174884	
8 mmol/l)	1	NBK174884	
diabetes mellitus or metabolic syndrome	1	NBK174884	
women age <55 years)	1	NBK174884	
current smoking	1	NBK174884	
3 mmol/l] using an isoform insensitive assay)	1	NBK174884	
class	1	NBK174884	
ldl-lowering response	1	NBK174884	
statins	1	NBK174884	
↑ ldlr activity (1o)	1	NBK174884	
>35% 1, 2	1	NBK174884	
cholesterol absorption inhibitors (ezetimibe)	1	NBK174884	
mipomersen (apob antisense) 4	1	NBK174884	
blocks apob production in the liver	1	NBK174884	
mtp inhibitor(lomitapide) 4	1	NBK174884	
pcsk9 inhibitors(alirocumab, evolocumab)	1	NBK174884	
↓ ldl-receptor degradation	1	NBK174884	
50% 6	1	NBK174884	
bile acid sequestrants(cholestyramine, colesevelam)	1	NBK174884	
stanol esters	1	NBK174884	
10% 1, 3	1	NBK174884	
children with fh	1	NBK174884	
9 mmol/l)	1	NBK174884	
consultation or referral to a lipid specialist is recommended	1	NBK174884	
statins are the preferred initial pharmacologic treatment in children	1	NBK174884	
4 mmol/l)	1	NBK174884	
children and adults with homozygous fh (hofh)	1	NBK174884	
nla guidelines for homozygous fh (full text):	1	NBK174884	
referral to a lipid specialist is indicated	1	NBK174884	
early initiation of therapy and monitoring are recommended	1	NBK174884	
multiple drug therapy is usually needed	1	NBK174884	
many states do not have an apheresis center	1	NBK174884	
preventive measures include the following:	1	NBK174884	
statin-based therapy with addition of other medications as needed	1	NBK174884	
reduced intake of saturated fat	1	NBK174884	
increased intake of soluble fiber to 10-20 g/day	1	NBK174884	
increased physical activity	1	NBK174884	
not smoking	1	NBK174884	
1 mmol/l) is relatively specific for fh	1	NBK174884	
during treatment, individuals of any age with:	1	NBK174884	
fh should have lipid levels monitored as recommended	1	NBK174884	
high intake of saturated and trans unsaturated fat	1	NBK174884	
excessive intake of cholesterol	1	NBK174884	
sedentary lifestyle	1	NBK174884	
measurement of ldl-c level	1	NBK174884	
degree of relatedness to an affected individual	1	NBK174884	
first degree 1	1	NBK174884	
second degree 2	1	NBK174884	
third degree 3	1	NBK174884	
cholesterol levels	1	NBK174884	
total cholesterol (ldl cholesterol) in mg/dl	1	NBK174884	
<20	1	NBK174884	
220 (155)	1	NBK174884	
230 (165)	1	NBK174884	
20-29	1	NBK174884	
250 (180)	1	NBK174884	
260 (185)	1	NBK174884	
30-39	1	NBK174884	
270 (190)	1	NBK174884	
280 (200)	1	NBK174884	
290 (210)	1	NBK174884	
40+	1	NBK174884	
290 (205)	1	NBK174884	
300 (215)	1	NBK174884	
310 (225)	1	NBK174884	
statins are contraindicated during pregnancy	1	NBK174884	
statins are contraindicated in pregnancy due to concerns for teratogenicity	1	NBK174884	
nursing mothers should not take statins	1	NBK174884	
ldl apheresis is also occasionally used	1	NBK174884	
regarding other agents:	1	NBK174884	
pcsk9 inhibitors	1	NBK174884	
use during pregnancy has not been well studied	1	NBK174884	
use during human pregnancy has not been well studied	1	NBK174884	
niacin	1	NBK174884	
higher doses have been associated with toxicity	1	NBK174884	
cad outcome trials of pcsk9 inhibitors are currently underway	1	NBK174884	
gov/books/n/gene/hyperek	1	NBK1260	
evaluation for the head retraction reflex	1	NBK1260	
in adults the initial dose is 0	1	NBK1260	
5 mg twice a day	1	NBK1260	
the dose can be increased up to 2	1	NBK1260	
0 mg three times a day	1	NBK1260	
see treatment of manifestations, clonazepam	1	NBK1260	
gov/books/n/gene/hypo-mcc	1	NBK2587	
antiepileptic drugs if epileptic seizures are present	1	NBK2587	
a multidisciplinary approach is advisable to prevent:	1	NBK2587	
spasticity: pharmacologic agents, physical therapy	1	NBK2587	
ataxia: rehabilitation	1	NBK2587	
seizures: anticonvulsants	1	NBK2587	
feeding: swallowing surveillance and gastrostomy if needed	1	NBK2587	
surveillance includes periodic:	1	NBK2587	
neurologic evaluation to identify neurologic complications	1	NBK2587	
gov/books/n/gene/hypochondroplasia	1	NBK1477	
screening developmental assessment	1	NBK1477	
speech evaluation at diagnosis or by age two years	1	NBK1477	
the usual neurosurgical approach to spinal stenosis is laminectomy	1	NBK1477	
the l2-3 level most commonly required decompression	1	NBK1477	
seizure disorders should be treated in the standard manner	1	NBK1477	
standard management of frequent middle ear infections	1	NBK1477	
social adjustment should be monitored	1	NBK1477	
growth hormone therapy	1	NBK1477	
, those with fgfr3 mutations and those without)	1	NBK1477	
0+/-3	1	NBK1477	
their mean height increased 1	1	NBK1477	
32+/-1	1	NBK1477	
asn540lys substitution, mean age 2	1	NBK1477	
6+/-0	1	NBK1477	
their mean height sds increased by 1	1	NBK1477	
gov/books/n/gene/i-p	1	NBK1472	
management of blisters in a standard manner (i	1	NBK1472	
, not opening them, avoiding trauma)	1	NBK1472	
topical treatment (e	1	NBK1472	
, medications, oatmeal baths) to relieve discomfort	1	NBK1472	
significant skin involvement may benefit from dermatology management	1	NBK1472	
treatment of infections as for any other cellulitis	1	NBK1472	
standard treatment for retinal detachment	1	NBK1472	
head trauma may precipitate retinal detachment	1	NBK1472	
monthly until age three to four months	1	NBK1472	
every three months between ages four months and one year	1	NBK1472	
every six months between ages one and three years	1	NBK1472	
annually after age three years	1	NBK1472	
ongoing evaluation by a pedodontist or dentist is appropriate	1	NBK1472	
gov/books/n/gene/iahsp	1	NBK1243	
detailed dietary and feeding assessment as needed	1	NBK1243	
orthopedic and rehabilitation assessment as needed	1	NBK1243	
physical and occupational therapy to promote mobility and independence	1	NBK1243	
aids for mobility and limb function	1	NBK1243	
routine monitoring:	1	NBK1243	
gov/books/n/gene/ibm	1	NBK1262	
treatment is symptomatic only:	1	NBK1262	
annual routine follow-up with the multidisciplinary team is recommended	1	NBK1262	
several oral exogenous forms of sialic acid (e	1	NBK1262	
gov for details)	1	NBK1262	
gov/books/n/gene/ibmpfd	1	NBK1476	
assessment of muscle strength, muscle wasting and tendon reflexes	1	NBK1476	
emg and/or muscle biopsy may be necessary	1	NBK1476	
baseline pulmonary function studies	1	NBK1476	
cardiac evaluation by echocardiogram and ecg	1	NBK1476	
baseline neuropsychological studies of behavior and mental status	1	NBK1476	
management should be tailored to the individual	1	NBK1476	
paget disease of bone	1	NBK1476	
actonel®/risedronate	1	NBK1476	
fosamax®/alendronate	1	NBK1476	
aredia®/pamidronate	1	NBK1476	
at periodic intervals:	1	NBK1476	
echocardiogram and ekg to monitor for evidence of cardiomyopathy	1	NBK1476	
monitoring of behavior and mental status	1	NBK1476	
gov/books/n/gene/iiae3	1	NBK258641	
brain mri during a quiescent period	1	NBK258641	
rehabilitation/ot/pt consultation	1	NBK258641	
tnfα antagonists have also been used	1	NBK258641	
in intervals between ane events neurologic function is stable	1	NBK258641	
gov/books/n/gene/image	1	NBK190103	
serum and urine concentration of electrolytes	1	NBK190103	
serum concentration of glucose and acth	1	NBK190103	
assessment of arterial blood gases	1	NBK190103	
consultation with an endocrinologist	1	NBK190103	
growth hormone (gh) therapy	1	NBK190103	
risks during delivery include cephalopelvic disproportion	1	NBK190103	
gov/books/n/gene/inad	1	NBK1675	
thorough ophthalmologic examination to assess for optic atrophy	1	NBK1675	
eeg for the possibility of unrecognized seizure activity	1	NBK1675	
treatment by a psychiatrist for neuropsychiatric symptoms is indicated	1	NBK1675	
manju kurian, personal communication]	1	NBK1675	
paul kotzbauer, personal communication]	1	NBK1675	
gov/books/n/gene/ipa	1	NBK97965	
full text)	1	NBK97965	
thyrotropinoma (hyperthyroidism with non-suppressed tsh)	1	NBK97965	
measurement of parental heights	1	NBK97965	
visual field evaluation	1	NBK97965	
basal pituitary function including: spot gh, igf-1	1	NBK97965	
prolactin	1	NBK97965	
lh, fsh, testosterone/estradiol	1	NBK97965	
tsh, ft4	1	NBK97965	
9 a	1	NBK97965	
cortisol	1	NBK97965	
assess acth reserve if necessary	1	NBK97965	
consultation with specialists in endocrinology	1	NBK97965	
dopamine agonist therapy has been tried in some cases	1	NBK97965	
repeat pituitary mri	1	NBK97965	
persons with acromegaly	1	NBK97965	
persons with hypogonadism	1	NBK97965	
follow established guidelines	1	NBK97965	
recommendations follow	1	NBK97965	
more data are needed to develop appropriate future guidelines	1	NBK97965	
baseline	1	NBK97965	
thereafter	1	NBK97965	
perform annual clinical assessment and pituitary function tests	1	NBK97965	
yearly beginning at age four years	1	NBK97965	
measure height and weight with calculation of height velocity	1	NBK97965	
document pubertal development, tanner stages	1	NBK97965	
perform pituitary function tests (as for adults)	1	NBK97965	
perform baseline pituitary mri at about age ten years	1	NBK97965	
gov/books/n/gene/ipex	1	NBK1118	
complete blood count and differential, coombs test	1	NBK1118	
regulatory t cell numbers	1	NBK1118	
serum albumin and pre-albumin	1	NBK1118	
monitor fluid intake to assure adequate intravascular volume	1	NBK1118	
bmt is currently the only cure for ipex syndrome	1	NBK1118	
prevent disease	1	NBK1118	
gov/books/n/gene/iso-def	1	NBK453433	
complete neurologic assessment by a pediatric neurologist	1	NBK453433	
eeg/video eeg to monitor seizures	1	NBK453433	
assessment of feeding and nutrition and appropriate intervention	1	NBK453433	
appropriate medications for management of seizures and spasticity	1	NBK453433	
chest physiotherapy to prevent respiratory complications	1	NBK453433	
sleep studies to assess nocturnal hypoventilation and institute appropriate interventions	1	NBK453433	
assessment for scoliosis	1	NBK453433	
dietary	1	NBK453433	
medical	1	NBK453433	
degree of spasticity and related complications, including scoliosis	1	NBK453433	
periodic sleep studies	1	NBK453433	
gov/books/n/gene/issd	1	NBK1470	
biochemical genetics or neurogenetics consultation	1	NBK1470	
management focuses on rehabilitation to optimize mobility and communication	1	NBK1470	
treatment of seizures follows standard management principles	1	NBK1470	
gov/books/n/gene/jh	1	NBK1170	
serum iron status	1	NBK1170	
pituitary-gonadal axis	1	NBK1170	
pituitary mri may be considered in some cases	1	NBK1170	
affected joints	1	NBK1170	
radiographic evaluation	1	NBK1170	
dual photon absorptiometry of the lumbar spine	1	NBK1170	
ecg, transthoracic echocardiogram	1	NBK1170	
liver histology to determine the extent of liver damage	1	NBK1170	
treatment of iron overload	1	NBK1170	
it is simple, safe, and effective	1	NBK1170	
the hematocrit should be monitored prior to phlebotomy	1	NBK1170	
usually four to six phlebotomies annually are sufficient	1	NBK1170	
treatment of secondary complications	1	NBK1170	
transdermal preparations (i	1	NBK1170	
arthropathy is not modified by treatment	1	NBK1170	
cirrhosis is thought to be irreversible despite iron removal	1	NBK1170	
diabetes mellitus may require insulin administration	1	NBK1170	
treatment by phlebotomy in presymptomatic stages can prevent organ damage	1	NBK1170	
hrt prevents the development of osteoporosis	1	NBK1170	
iron-containing preparations and supplemental vitamin c	1	NBK1170	
gov/books/n/gene/jln	1	NBK1405	
formal audiology evaluation for extent of hearing loss	1	NBK1405	
cardiac examination including calculation of qtc	1	NBK1405	
complete blood count to screen for anemia	1	NBK1405	
cardiac issues	1	NBK1405	
even with additional therapies (e	1	NBK1405	
qtc interval >550 msec	1	NBK1405	
syncope before age five years	1	NBK1405	
left cardiac sympathetic denervation has been effective for some individuals	1	NBK1405	
iron deficiency anemia	1	NBK1405	
crediblemeds	1	NBK1405	
triggers for intense or sudden emotion	1	NBK1405	
competitive sports	1	NBK1405	
amusement park rides	1	NBK1405	
frightening movies	1	NBK1405	
jumping into cold water	1	NBK1405	
affected individuals should wear an id bracelet explaining their diagnosis	1	NBK1405	
gov/books/n/gene/joubert	1	NBK1325	
developmental assessment with age-appropriate tools	1	NBK1325	
, loss of corticomedullary differentiation)	1	NBK1325	
hypotonia and therapeutic interventions	1	NBK1325	
periodic neuropsychologic and developmental testing at appropriate ages	1	NBK1325	
other cns malformations	1	NBK1325	
posterior fossa cysts and fluid collections rarely require intervention	1	NBK1325	
encephalocele may require primary surgical closure	1	NBK1325	
corrective lenses for refractive errors	1	NBK1325	
consultation with a nephrologist is indicated	1	NBK1325	
hepatic fibrosis	1	NBK1325	
consultation with a gastroenterologist is indicated	1	NBK1325	
some individuals have needed orthotopic liver transplantation	1	NBK1325	
surgical treatment for polydactyly	1	NBK1325	
appropriate medical management by an orthopedic specialist for scoliosis	1	NBK1325	
orofacial clefting is treated by standard surgical interventions	1	NBK1325	
neuropsychological and developmental evaluation and testing, as appropriate	1	NBK1325	
individuals with liver impairment should avoid hepatotoxic medications	1	NBK1325	
gov/books/n/gene/jpd	1	NBK1478	
evaluate the degree of response to treatment	1	NBK1478	
assess for cognitive or behavioral problems	1	NBK1478	
consider clinical genetics consultation	1	NBK1478	
no specific guidelines are currently available	1	NBK1478	
pregnancy in women with parkinson disease is a rare event	1	NBK1478	
gov/books/n/gene/jps	1	NBK1469	
jps	1	NBK1469	
jps/hht	1	NBK1469	
treat manifestations of hht as needed	1	NBK1469	
see hereditary hemorrhagic telangiectasia	1	NBK1469	
these symptoms may warrant additional screening	1	NBK1469	
if negative, screening should be repeated in three years	1	NBK1469	
population	1	NBK1469	
see hereditary hemorrhagic telangiectasia, pregnancy management	1	NBK1469	
no known chemoprevention options are effective for juvenile polyps	1	NBK1469	
gov/books/n/gene/kabuki	1	NBK62111	
comprehensive management guidelines are also available online (pdf)	1	NBK62111	
monitoring for nocturnal lagophthalmos by parents or caregivers is recommended	1	NBK62111	
if present, evaluation by an ophthalmologist is indicated	1	NBK62111	
, dental work) that could lead to bacteremia	1	NBK62111	
the following are recommended for individuals with ks:	1	NBK62111	
evaluation of developmental milestones at each well child visit	1	NBK62111	
referral for formal developmental evaluation if delays are identified	1	NBK62111	
annual monitoring of vision	1	NBK62111	
expectant monitoring for otitis media in children	1	NBK62111	
gov/books/n/gene/kat6b-dis	1	NBK114806	
gps and sbbyss	1	NBK114806	
evaluation by developmental specialist	1	NBK114806	
feeding evaluation	1	NBK114806	
baseline hearing evaluation	1	NBK114806	
gps	1	NBK114806	
hip radiographs to evaluate for femoral head dislocation	1	NBK114806	
renal ultrasound examination for hydronephrosis and cysts	1	NBK114806	
sbbyss	1	NBK114806	
skeletal features	1	NBK114806	
early referral to physical therapy to help increase joint mobility	1	NBK114806	
orchiopexy in males with undescended testes	1	NBK114806	
anal anomalies	1	NBK114806	
referral to an urologist or nephrologist as indicated	1	NBK114806	
facial features	1	NBK114806	
hearing aids as needed for hearing loss	1	NBK114806	
the following should be assessed annually:	1	NBK114806	
thyroid function	1	NBK114806	
cardiac function if malformations are present	1	NBK114806	
renal function if hydronephrosis or multiple renal cysts are present	1	NBK114806	
gov/books/n/gene/kcnk9-is	1	NBK425128	
oropharynx	1	NBK425128	
feeding & swallowing evaluation	1	NBK425128	
polysomnogram if obstructive apnea is suspected	1	NBK425128	
evaluation for skeletal manifestations (i	1	NBK425128	
joint contractures, scoliosis)	1	NBK425128	
consider referral to an orthopedist, if indicated	1	NBK425128	
neurological	1	NBK425128	
assessment of strength & motor skills	1	NBK425128	
assessment for hypoglycemia during neonatal period & infancy	1	NBK425128	
misc/other	1	NBK425128	
no specific management guidelines have been developed	1	NBK425128	
management is mostly supportive	1	NBK425128	
lacrimal duct obstruction	1	NBK425128	
tear duct massage	1	NBK425128	
consider lacrimal duct stent placement	1	NBK425128	
cleft palate, bifid uvula, or velopharyngeal insufficiency	1	NBK425128	
management by a cleft/craniofacial team	1	NBK425128	
cpap or bipap	1	NBK425128	
ent evaluation for tonsillectomy/adenoidectomy	1	NBK425128	
pulmonary consultation	1	NBK425128	
feeding difficulties or signs of aspiration	1	NBK425128	
use of a special nipple or bottle with cleft palate	1	NBK425128	
short-term nasogastric feeding tube	1	NBK425128	
consideration of gastrostomy tube	1	NBK425128	
gastroesophageal reflux disease	1	NBK425128	
standard positioning & pharmacologic treatment	1	NBK425128	
musculoskeletal findings (i	1	NBK425128	
, contractures, scoliosis)	1	NBK425128	
ankle-foot orthoses or other assistive devices	1	NBK425128	
physical therapy and/or occupational therapy evaluation	1	NBK425128	
consultation w/an orthopedist	1	NBK425128	
seizure disorder	1	NBK425128	
evaluation of blood sugar & electrolytes	1	NBK425128	
standard treatment for seizures	1	NBK425128	
consider eeg and referral to a neurologist	1	NBK425128	
unexplained hypoglycemia or suspected hyperinsulinism	1	NBK425128	
consideration of diazoxide therapy	1	NBK425128	
consider referral to an endocrinologist	1	NBK425128	
consider referral to a neurodevelopmental specialist and/or neuropsychiatric testing	1	NBK425128	
evaluation of nutritional status & growth	1	NBK425128	
evaluation of feeding difficulties	1	NBK425128	
sleep study (if history of sleep disturbance)	1	NBK425128	
evaluate for scoliosis	1	NBK425128	
every 6 months until age 2 years	1	NBK425128	
1 or task3)	1	NBK425128	
the reduced outward current through abnormal p	1	NBK425128	
gov/books/n/gene/kcnq3-dis	1	NBK201978	
benign familial neonatal epilepsy (bfne)	1	NBK201978	
all but three had family histories of neonatal seizures	1	NBK201978	
pathogenic variants in kcnq3 were present in two	1	NBK201978	
earlier initiation of cbz was associated with shorter hospitalization	1	NBK201978	
no side effects of cbz were reported	1	NBK201978	
8 years)	1	NBK201978	
benign familial infantile epilepsy (bfie)	1	NBK201978	
bfne	1	NBK201978	
bfie	1	NBK201978	
the eeg at 36 months should be normal	1	NBK201978	
see mothertobaby for more information on medication use during pregnancy	1	NBK201978	
ezogabine has been commercially withdrawn as of june 2017	1	NBK201978	
gov/books/n/gene/kennedy	1	NBK1333	
assessment of/for:	1	NBK1333	
attention to distal muscle strength and deep tendon reflexes	1	NBK1333	
swallowing	1	NBK1333	
appropriate measures include:	1	NBK1333	
strength testing (annually)	1	NBK1333	
pulmonary function tests (annually in advanced cases)	1	NBK1333	
high-dose testosterone	1	NBK1333	
anti-androgen therapy	1	NBK1333	
creatine supplementation	1	NBK1333	
this remains to be tested	1	NBK1333	
experimental therapies in animal models	1	NBK1333	
reverses changes in muscle gene expression	1	NBK1333	
and extends the life span of mutant males	1	NBK1333	
gov/books/n/gene/kindler	1	NBK349072	
evaluation of nutritional status, diet, and oral intake	1	NBK349072	
no established treatment for kindler syndrome exists	1	NBK349072	
standard blister care in childhood	1	NBK349072	
antibiotics may be used to treat an infected blister	1	NBK349072	
use of moisturizers for dry, pruritic skin	1	NBK349072	
mucosal involvement	1	NBK349072	
mouth and periodontium	1	NBK349072	
esophageal dilatation may be indicated for those with dysphagia	1	NBK349072	
anal stenosis and bleeding requires regular laxatives	1	NBK349072	
severe colitis may require surgical bowel resection in some cases	1	NBK349072	
urethra	1	NBK349072	
meatal stenosis may require dilatation	1	NBK349072	
strictures may require stenting and/ or surgical intervention	1	NBK349072	
phimosis	1	NBK349072	
monitor for secondary iron-deficiency anemia	1	NBK349072	
gov/books/n/gene/kleefstra	1	NBK47079	
renal ultrasound examination to evaluate for possible renal/urologic anomalies	1	NBK47079	
speech/language evaluation including audiologic examination	1	NBK47079	
physical and/or occupational therapy assessment	1	NBK47079	
no well-controlled treatment trials have been reported	1	NBK47079	
cardiac and renal/urologic abnormalities should be monitored as needed	1	NBK47079	
gov/books/n/gene/kms	1	NBK1334	
males with igd age ≥18 years	1	NBK1334	
hormone replacement therapy for males not desiring fertility	1	NBK1334	
doses do vary with newer testosterone preparations	1	NBK1334	
if testosterone levels fall, therapy should be reinitiated	1	NBK1334	
human chorionic gonadotropin (hcg)	1	NBK1334	
male infants/adolescents with suspicion of igd	1	NBK1334	
if igd is clinically suspected (e	1	NBK1334	
fsh is added at doses ranging from 37	1	NBK1334	
5 to 75 iu as either hmg or recombinant formulation	1	NBK1334	
pulsatile gnrh stimulation vs	1	NBK1334	
females with igd	1	NBK1334	
hormone replacement therapy for females not desiring fertility	1	NBK1334	
many formulations of estrogens are available	1	NBK1334	
a suggested oral regimen is using premarin 0	1	NBK1334	
25 mg daily	1	NBK1334	
in vitro fertilization	1	NBK1334	
bone age determinations	1	NBK1334	
gov/books/n/gene/kos	1	NBK390670	
growth assessment, including assessment of feeding and nutrition	1	NBK390670	
ophthalmologic evaluation for microcornea, cataract, ptosis, coloboma	1	NBK390670	
hearing evaluation for sensorineural or mixed sensorineural/conductive hearing impairment	1	NBK390670	
renal ultrasound examination for structural renal abnormalities and vesicoureteral reflux	1	NBK390670	
hip ultrasound examination to evaluate for femoral head dislocation	1	NBK390670	
evaluation of thyroid function	1	NBK390670	
other hormone levels if clinically indicated	1	NBK390670	
the following treatment recommendations are appropriate:	1	NBK390670	
educational intervention and speech therapy beginning in infancy	1	NBK390670	
cataract and ptosis surgery if indicated	1	NBK390670	
hearing aids or cochlear implant if needed	1	NBK390670	
cardiac function assessment and treatment if needed	1	NBK390670	
orchidopexy in males with undescended testes	1	NBK390670	
treatment of vesicoureteral reflux if indicated	1	NBK390670	
other facial	1	NBK390670	
cleft palate repair if present	1	NBK390670	
the following should be assessed at least annually:	1	NBK390670	
vision, hearing	1	NBK390670	
gov/books/n/gene/krabbe	1	NBK1238	
brain mri and mrs	1	NBK1238	
treated individuals show improved and preserved cognitive function	1	NBK1238	
gov/books/n/gene/kss	1	NBK1203	
complete hematologic and gastroenterologic evaluations for pearson syndrome in infants	1	NBK1203	
placement of eyelid slings for severe ptosis	1	NBK1203	
cochlear implants and hearing aids for neurosensory hearing loss	1	NBK1203	
hormone replacement for endocrinopathies	1	NBK1203	
dilation of the upper esophageal sphincter to alleviate cricopharyngeal achalasia	1	NBK1203	
replacement of pancreatic enzymes in pearson syndrome	1	NBK1203	
treatment of depression	1	NBK1203	
ventilatory support for respiratory abnormalities in leigh syndrome	1	NBK1203	
yearly audiometry and endocrinologic evaluation	1	NBK1203	
medications to avoid:	1	NBK1203	
gov/books/n/gene/l1cam	1	NBK1484	
head imaging study	1	NBK1484	
surgical treatment should be performed as needed	1	NBK1484	
developmental progress should be monitored and stimulated	1	NBK1484	
adducted thumbs	1	NBK1484	
surgical intervention is not generally indicated	1	NBK1484	
a splint may help reduce the degree of adduction	1	NBK1484	
neurologic features should be monitored	1	NBK1484	
follow up and treatment is nonspecific	1	NBK1484	
physiotherapy is recommended	1	NBK1484	
evaluation by a child neurologist at regular intervals is appropriate	1	NBK1484	
gov/books/n/gene/lad-ad	1	NBK338165	
psychological evaluation and neuropsychological assessment	1	NBK338165	
assessment by rehabilitation specialists including equipment needs	1	NBK338165	
evaluation of swallowing function and communication	1	NBK338165	
gastroenterology evaluation for bowel dysfunction	1	NBK338165	
autonomic dysfunction	1	NBK338165	
neurogenic bladder:	1	NBK338165	
urinary urgency may require spasmolytics (e	1	NBK338165	
, solifenacine succinate)	1	NBK338165	
, docusate) or a laxative is needed	1	NBK338165	
sexual dysfunction can be alleviated with sildenafil	1	NBK338165	
anhidrosis is managed by avoiding overheating	1	NBK338165	
cognitive dysfunction can affect social interactions and financial management	1	NBK338165	
yearly influenza immunizations	1	NBK338165	
gov/books/n/gene/lafora	1	NBK1389	
valproic acid is the traditional antiepileptic treatment for ld	1	NBK1389	
carbamazepine [nanba & maegaki 1999]	1	NBK1389	
oxcarbazepine [kaddurah & holmes 2006]	1	NBK1389	
gov/books/n/gene/lal-def	1	NBK305870	
wolman disease	1	NBK305870	
malabsorption and malnutrition	1	NBK305870	
hepatomegaly and liver disease	1	NBK305870	
adrenal cortical insufficiency	1	NBK305870	
consider discussion of comfort care options	1	NBK305870	
cesd	1	NBK305870	
lipophilic vitamin supplementation may also be beneficial	1	NBK305870	
special attention should be paid to growth and nutritional status	1	NBK305870	
chronic diarrhea or failure to thrive could indicate malabsorption	1	NBK305870	
special attention should be paid to nutritional status	1	NBK305870	
chronic diarrhea or weight loss could indicate malabsorption	1	NBK305870	
both children and adults	1	NBK305870	
consensus on optimal screening protocols has not been published	1	NBK305870	
gov/books/n/gene/lbsl	1	NBK43417	
brain and spinal cord mri	1	NBK43417	
if possible, proton mrs of abnormal cerebral white matter	1	NBK43417	
the following as needed:	1	NBK43417	
lbsl is very slowly progressive in most cases	1	NBK43417	
annual clinical evaluations suffice	1	NBK43417	
gov/books/n/gene/lca	1	NBK1298	
rarely, vision appears to improve beyond expectations	1	NBK1298	
in such cases, a repeat erg is indicated	1	NBK1298	
gov/books/n/gene/lds	1	NBK1457	
recurrence is possible even with more definitive treatment	1	NBK1457	
surgery for ptosis if clinically indicated (e	1	NBK1457	
, obscured vision, cosmetic appearance)	1	NBK1457	
prophylactic antibiotics (e	1	NBK1457	
edema may be exacerbated during pregnancy	1	NBK1457	
diuretics are not effective in the treatment of lymphedema	1	NBK1457	
cosmetic surgery is often associated with disappointing results	1	NBK1457	
gov/books/n/gene/legius	1	NBK47312	
age-appropriate developmental assessment	1	NBK47312	
detailed dermatologic evaluation for supportive findings	1	NBK47312	
individualized education plans for learning disorders and school performance issues	1	NBK47312	
gov/books/n/gene/leigh-nucl-ov	1	NBK320989	
biotin-thiamine-responsive basal ganglia disease	1	NBK320989	
biotinidase deficiency	1	NBK320989	
(btd)	1	NBK320989	
coenzyme q10 biosynthesis deficiency	1	NBK320989	
(pdss2)	1	NBK320989	
thiamine transporter deficiency (mutation of slc19a3)	1	NBK320989	
biotinidase deficiency (btd)	1	NBK320989	
coenzyme q10 biosynthesis defect (pdss2)	1	NBK320989	
anesthesia can potentially aggravate respiratory symptoms and precipitate respiratory failure	1	NBK320989	
gov/books/n/gene/lenz	1	NBK1521	
consideration of hearing evaluation during infancy if:	1	NBK1521	
early intervention with special education maximizes cognitive development	1	NBK1521	
referral to services for the visually impaired is recommended	1	NBK1521	
no special preventative care is recommended	1	NBK1521	
gov/books/n/gene/leopard	1	NBK1383	
urinalysis if urinary tract abnormalities are identified	1	NBK1383	
treatment of hearing loss may include the following:	1	NBK1383	
if the ptpn11, raf1,	1	NBK1383	
gov/books/n/gene/leukodys-ov	1	NBK184570	
extrapyramidal manifestations	1	NBK184570	
dystonia and dyskinesias may cause significant disability	1	NBK184570	
pharmacologic treatment may result in significant functional improvement	1	NBK184570	
cognitive developmental delay/encephalopathy	1	NBK184570	
augmentative communication may be used to address speech deficits	1	NBK184570	
standard surveillance includes the following:	1	NBK184570	
routine history re signs and symptoms of seizures	1	NBK184570	
gov/books/n/gene/lgmd-overview	1	NBK1408	
referral to a cardiologist for standard supportive treatment of cardiomyopathy	1	NBK1408	
weight should be controlled to avoid obesity	1	NBK1408	
gov/books/n/gene/lgmd2a	1	NBK1313	
orthopedic examination when gait is severely impaired	1	NBK1313	
baseline cardiac evaluation including echocardiogram	1	NBK1313	
avoidance of prolonged immobility is recommended	1	NBK1313	
while the specific mechanism whereby cholesterol-lowering agents (e	1	NBK1313	
gov/books/n/gene/lhon	1	NBK1174	
measurement of best corrected visual acuity	1	NBK1174	
assessment of visual fields with static or kinetic perimetry	1	NBK1174	
idebenone	1	NBK1174	
3460g>a, m	1	NBK1174	
11778g>a, and m	1	NBK1174	
mitochondrial replacement	1	NBK1174	
gov/books/n/gene/li-ar	1	NBK1420	
examination for evidence of infection	1	NBK1420	
evaluation for problems relating to prematurity	1	NBK1420	
evaluation by a dermatologist familiar with congenital ichthyosis	1	NBK1420	
assessment of transepidermal water loss and hydration status	1	NBK1420	
assessment of corneal hydration in babies with ectropion	1	NBK1420	
assessment of feeding and nutrition status	1	NBK1420	
prevention of dehydration	1	NBK1420	
maintenance of body temperature	1	NBK1420	
prevention of overheating	1	NBK1420	
prevention of corneal drying	1	NBK1420	
high caloric diet	1	NBK1420	
frequency depends on the severity	1	NBK1420	
skin irritants and overheating should be avoided	1	NBK1420	
gov/books/n/gene/li-fraumeni	1	NBK1311	
the following is recommended:	1	NBK1311	
the following is suggested:	1	NBK1311	
gov/books/n/gene/lipoid-p	1	NBK338540	
consultation with a dermatologist (or pediatric dermatologist)	1	NBK338540	
evaluation for evidence of seizures if clinical findings are suggestive	1	NBK338540	
evaluation for neuropsychiatric manifestations	1	NBK338540	
there is no curative therapy for lp	1	NBK338540	
treatments of unproven efficacy	1	NBK338540	
click here (pdf) for further details	1	NBK338540	
monitoring of the airway and vocal cords by an otolaryngologist	1	NBK338540	
gov/books/n/gene/lms	1	NBK368476	
neurocognitive assessment	1	NBK368476	
assessment by general surgery for abdominal hernia repair	1	NBK368476	
assessment by orthopedic surgery for symptomatic skeletal deformities	1	NBK368476	
visualization of the aortic arch by echocardiogram or mri	1	NBK368476	
urologic assessment for cryptorchidism if present	1	NBK368476	
feeding assessment	1	NBK368476	
specific treatment for lms does not currently exist	1	NBK368476	
lateral spinal meningoceles	1	NBK368476	
symptomatic treatment of neurologic sequelae (e	1	NBK368476	
physiotherapy to reduce risk for joint subluxation and dislocation	1	NBK368476	
routine management of the following:	1	NBK368476	
congenital cardiac defects	1	NBK368476	
no surveillance guidelines for lms have been published	1	NBK368476	
gov/books/n/gene/lns	1	NBK1149	
complete blood count to evaluate for megaloblastic anemia	1	NBK1149	
chemistry screen for uric acid concentration	1	NBK1149	
developmental/behavioral assessments	1	NBK1149	
hyperuricemia	1	NBK1149	
allopurinol therapy results in the accumulation of hypoxanthine and xanthine	1	NBK1149	
xanthine may also form stones	1	NBK1149	
hypoxanthine is soluble	1	NBK1149	
neurologic dysfunction	1	NBK1149	
virtually any reduction of hyperuricemia will prevent urate nephropathy	1	NBK1149	
monitor plasma uric acid concentration and urinary excretion of oxypurines	1	NBK1149	
monitor affected individuals for early signs of self-injury	1	NBK1149	
some carrier females develop gout in later years	1	NBK1149	
deep brain stimulation must be considered experimental at present	1	NBK1149	
partial exchange transfusion in two individuals	1	NBK1149	
gov/books/n/gene/loeys-dietz	1	NBK1133	
, severe aortic dilatation)	1	NBK1133	
, severe scoliosis, cervical spine instability)	1	NBK1133	
craniofacial examination for evidence of cleft palate and craniosynostosis	1	NBK1133	
specific assessment for retinal detachment and blue sclerae	1	NBK1133	
two important considerations when managing cardiovascular features of lds:	1	NBK1133	
vascular disease is not limited to the aortic root	1	NBK1133	
0 cm and the excellent response to prophylactic surgery	1	NBK1133	
clubfeet require surgical correction by an orthopedic surgeon	1	NBK1133	
surgical intervention for protusio acetabulae is rarely indicated	1	NBK1133	
treatment focuses on pain control	1	NBK1133	
orthotics are only indicated for severe pes planus	1	NBK1133	
some individuals prefer use of arch supports	1	NBK1133	
others find them irritating	1	NBK1133	
surgical intervention is rarely indicated or successful	1	NBK1133	
if the causal tgfbr1,	1	NBK1133	
pregnancy can be dangerous for women with lds	1	NBK1133	
gov/books/n/gene/lowe	1	NBK1480	
plasma carnitinine may be measured to evaluate for carnintine deficiency	1	NBK1480	
developmental and behavioral evaluations should be completed	1	NBK1480	
cataract surgeons and glaucoma specialists may also be needed	1	NBK1480	
others require surgery	1	NBK1480	
most seizure disorders can be controlled with anticonvulsant therapy	1	NBK1480	
early childhood and preschool intervention programs, e	1	NBK1480	
kidney	1	NBK1480	
, with surgical procedures	1	NBK1480	
most undescended testes descend with time into the scrotum	1	NBK1480	
some require hormone therapy and/or surgical correction	1	NBK1480	
no formal guidelines exist	1	NBK1480	
corneal contact lenses	1	NBK1480	
artificial lens implants	1	NBK1480	
gov/books/n/gene/lpi	1	NBK1361	
neurologic evaluation to detect secondary neurologic damage	1	NBK1361	
evaluation and follow-up of growth parameters	1	NBK1361	
hematologic evaluation (bone marrow aspirate may be required)	1	NBK1361	
renal function studies	1	NBK1361	
bone density evaluation	1	NBK1361	
treatment of acute hyperammonemic crises	1	NBK1361	
pharmacologic management	1	NBK1361	
therapy with ondansetron can be started to decrease vomiting	1	NBK1361	
dietary protein restriction and citrulline supplementation	1	NBK1361	
current treatment consists of dietary protein restriction (0	1	NBK1361	
8-1	1	NBK1361	
5 g/kg/day in children and 0	1	NBK1361	
lysine supplementation	1	NBK1361	
carnitine supplemetation	1	NBK1361	
treatment of late complications	1	NBK1361	
however, relapses may require serial lavage	1	NBK1361	
monitoring should include the following:	1	NBK1361	
fasting and postprandial blood ammonia concentrations	1	NBK1361	
urinary orotic acid excretion	1	NBK1361	
attention to early clinical signs of lung involvement	1	NBK1361	
serum concentrations of ldh and ferritin	1	NBK1361	
no specific guidelines have been proposed	1	NBK1361	
large boluses of protein or amino acids should be avoided	1	NBK1361	
alendronate	1	NBK1361	
gov/books/n/gene/lpl	1	NBK1308	
medical nutrition therapy	1	NBK1308	
recurrent or persistent eruptive xanthomas indicate inadequate therapy	1	NBK1308	
fat malabsorption is very rare	1	NBK1308	
it is appropriate to evaluate at-risk sibs during infancy	1	NBK1308	
measurement of plasma triglyceride concentration	1	NBK1308	
1:p	1	NBK1308	
ser474ter (nm_000237	1	NBK1308	
2:c	1	NBK1308	
1421c>g)	1	NBK1308	
gov/books/n/gene/lrrk2	1	NBK1208	
tremor	1	NBK1208	
rigidity	1	NBK1208	
bradykinesia	1	NBK1208	
mental status	1	NBK1208	
a number of inhibitors are being developed	1	NBK1208	
gov/books/n/gene/ltbp4-cutis-laxa	1	NBK343782	
chest x-ray or high-resolution ct scan	1	NBK343782	
ultrasound examination of the genitourinary tract	1	NBK343782	
bladder ultrasound examination to diagnose multiple bladder diverticula	1	NBK343782	
physiotherapeutic evaluation (hypotonia, hyperlaxity)	1	NBK343782	
on clinical indication:	1	NBK343782	
bronchoscopy	1	NBK343782	
visualization of the gastrointestinal tract by gastrographin ingestion or enema	1	NBK343782	
intravenous pyelogram may be an alternative	1	NBK343782	
treatment is largely symptomatic	1	NBK343782	
oxygen supplementation if necessary	1	NBK343782	
education on complete bladder emptying when voiding	1	NBK343782	
medical treatment of pulmonary hypertension (e	1	NBK343782	
, by sildenafil)	1	NBK343782	
surgical treatment of congenital diaphragmatic hernia or severe hiatal hernia	1	NBK343782	
physical therapy for muscle strength and joint stability	1	NBK343782	
psychosocial support	1	NBK343782	
repeat imaging of:	1	NBK343782	
cardiovascular system	1	NBK343782	
positive pressure ventilation unless needed to treat life-threatening conditions	1	NBK343782	
people with respiratory infections	1	NBK343782	
affected mother	1	NBK343782	
affected fetus	1	NBK343782	
gov/books/n/gene/lwd	1	NBK1215	
height, arm span, and sitting height	1	NBK1215	
madelung deformity	1	NBK1215	
body mass index that is frequently above the mean	1	NBK1215	
mainly because of shortening of the legs	1	NBK1215	
painful bilateral madelung deformity (uncommon)	1	NBK1215	
gov/books/n/gene/m-hfm-ov	1	NBK5199	
upper airway obstruction	1	NBK5199	
clinical feeding and nutrition evaluation	1	NBK5199	
cervical spine films	1	NBK5199	
, torticollis)	1	NBK5199	
audiologist	1	NBK5199	
dietitian	1	NBK5199	
clinical geneticist and genetic counselor	1	NBK5199	
nurse coordinator	1	NBK5199	
oral and maxillofacial surgeon	1	NBK5199	
orthodontist	1	NBK5199	
orthopedist	1	NBK5199	
otolaryngologist	1	NBK5199	
pediatric dentist	1	NBK5199	
pediatrician	1	NBK5199	
plastic and reconstructive surgeon	1	NBK5199	
psychosocial professionals (psychologist, social worker)	1	NBK5199	
speech pathologist	1	NBK5199	
referral to a craniofacial center or otolaryngologist is recommended	1	NBK5199	
face	1	NBK5199	
jaw and teeth	1	NBK5199	
good oral hygiene is especially important for children with cfm	1	NBK5199	
children should have consistent primary preventative dental care	1	NBK5199	
early referral to an otolaryngologist is recommended	1	NBK5199	
this surgery typically occurs after age five years	1	NBK5199	
ears	1	NBK5199	
options for management of microtia include the following:	1	NBK5199	
no action	1	NBK5199	
prosthetic management, either adhesive or implant-retained	1	NBK5199	
family and social support	1	NBK5199	
individuals with any degree of hearing loss	1	NBK5199	
avoid exposure to ototoxic drugs	1	NBK5199	
individuals with cervical spine anomalies	1	NBK5199	
individuals with a single kidney	1	NBK5199	
manage diabetes mellitus to maintain good control and avoid hyperglycemia	1	NBK5199	
gov/books/n/gene/majeed	1	NBK1974	
skeletal radiographs, if not already performed	1	NBK1974	
cbc, if not already performed	1	NBK1974	
bone marrow biopsy if significant anemia is present	1	NBK1974	
examination of the skin	1	NBK1974	
crmo is treated as follows:	1	NBK1974	
thus, their efficacy in this disorder is unknown	1	NBK1974	
physical therapy to avoid disuse atrophy of muscles or contractures	1	NBK1974	
physical therapy can help to prevent contractures	1	NBK1974	
regular pediatric care	1	NBK1974	
gov/books/n/gene/maps	1	NBK107219	
colonoscopy and review of pathology	1	NBK107219	
upper endoscopy and review of pathology	1	NBK107219	
colon polyps and colon cancer	1	NBK107219	
colonoscopy is effective surveillance for colon cancer	1	NBK107219	
duodenal polyps	1	NBK107219	
management of polyps is similar to individuals with fap	1	NBK107219	
individuals with biallelic germline	1	NBK107219	
in europe:	1	NBK107219	
registration or institutional access required):	1	NBK107219	
pan colonoscopy beginning at age 18-20 years	1	NBK107219	
individuals heterozygous for a germline	1	NBK107219	
gov/books/n/gene/marfan	1	NBK1335	
specific assessment for glaucoma and cataract	1	NBK1335	
, severe scoliosis)	1	NBK1335	
click here	1	NBK1335	
protusio acetabulae can be associated with pain or functional limitations	1	NBK1335	
surgical intervention is rarely indicated	1	NBK1335	
orthotics are indicated only in severe cases	1	NBK1335	
surgical intervention is rarely indicated or fully successful	1	NBK1335	
pneumothorax can be a recurrent problem	1	NBK1335	
, prolonged lethargy, depression)	1	NBK1335	
caffeine can aggravate a tendency for arrhythmia	1	NBK1335	
agents that cause vasoconstriction, including triptans	1	NBK1335	
lasik correction of visual deficits	1	NBK1335	
at a root dimension <5	1	NBK1335	
0cm) before becoming pregnant	1	NBK1335	
gov/books/n/gene/mbd5-dis	1	NBK390803	
speech evaluation including feeding evaluation and nutrition consultation as needed	1	NBK390803	
school-age children benefit from an individualized educational program	1	NBK390803	
no information is available on response to specific aeds	1	NBK390803	
gov/books/n/gene/mcad	1	NBK1424	
plasma acylcarnitine analysis	1	NBK1424	
plasma free and total carnitine measurement	1	NBK1424	
urine acylglycine analysis	1	NBK1424	
urine organic acid analysis	1	NBK1424	
mcad activity assay in leukocytes (where available)	1	NBK1424	
blood glucose concentration	1	NBK1424	
blood gas analysis	1	NBK1424	
ammonia	1	NBK1424	
lactic acid	1	NBK1424	
blood cultures (in case of fever)	1	NBK1424	
up to ten hours during the second year of life	1	NBK1424	
up to 12 hours after age two years	1	NBK1424	
to avoid excessive fasting:	1	NBK1424	
infants require frequent feedings	1	NBK1424	
a relatively low-fat diet (e	1	NBK1424	
alcohol consumption, in particular acute alcohol intoxication (e	1	NBK1424	
pregnant women who have mcad deficiency must avoid catabolism	1	NBK1424	
gov/books/n/gene/mccune-albright	1	NBK274564	
the authors recommend the following studies:	1	NBK274564	
skeleton	1	NBK274564	
fd evaluation	1	NBK274564	
see fibrous dysplasia evaluation (pdf)	1	NBK274564	
see gonadal evaluation in girls (pdf)	1	NBK274564	
see gonadal evaluation in boys (pdf)	1	NBK274564	
growth hormone excess evaluation (pdf)	1	NBK274564	
see thyroid evaluation (pdf)	1	NBK274564	
adrenal evaluation (pdf)	1	NBK274564	
less common manifestations	1	NBK274564	
see gastrointestinal evaluation (pdf)	1	NBK274564	
the primary elements of management include the following	1	NBK274564	
see fibrous dysplasia management (pdf):	1	NBK274564	
see precocious puberty management in girls (pdf)	1	NBK274564	
see gonadal involvement management in boys (pdf)	1	NBK274564	
, letrozole) [boyce et al 2012]	1	NBK274564	
thyroid disease	1	NBK274564	
see hyperthyroidism management (pdf)	1	NBK274564	
methimazole is effective for management of hyperthyroidism	1	NBK274564	
the risk may potentially be enhanced by radiation exposure	1	NBK274564	
growth hormone (gh) excess	1	NBK274564	
see gh excess: management (pdf)	1	NBK274564	
medical therapy is the preferred first-line treatment	1	NBK274564	
see hypercortisolism management (pdf)	1	NBK274564	
definitive treatment includes surgical removal of the diseased adrenal glands	1	NBK274564	
see gonadal involvement management in boys	1	NBK274564	
growth hormone excess	1	NBK274564	
see growth hormone excess evaluation:	1	NBK274564	
all children should be monitored for growth acceleration	1	NBK274564	
routine biochemical surveillance is not indicated	1	NBK274564	
see gastrointestinal management (pdf)	1	NBK274564	
while a strong association between gsp mutations (i	1	NBK274564	
, radiation exposure) and encourage vigilance and monitoring	1	NBK274564	
gov/books/n/gene/mckd1	1	NBK153723	
referral to a nephrologist for further evaluation	1	NBK153723	
care by a nephrologist is recommended	1	NBK153723	
hemoglobin concentration	1	NBK153723	
serum concentrations of uric acid and creatinine	1	NBK153723	
for the purpose of early diagnosis and treatment	1	NBK153723	
for the purpose of kidney donation	1	NBK153723	
gov/books/n/gene/mckd2	1	NBK1356	
measurement of serum uric acid concentration	1	NBK1356	
gout prevention with allopurinol or probenecid should be considered	1	NBK1356	
kidney disease	1	NBK1356	
measurement of serum uric acid concentration at least annually	1	NBK1356	
drugs known to be nephrotoxic should be avoided	1	NBK1356	
however, patients should avoid chronic daily use	1	NBK1356	
no pregnancy issues are particular to adtkd-umod	1	NBK1356	
gov/books/n/gene/mcleod	1	NBK1354	
neurologic and neuropsychological examination	1	NBK1354	
serum ck concentration and liver function tests	1	NBK1354	
cerebral mri and electroencephalography	1	NBK1354	
treatment of psychiatric problems according to the clinical presentation	1	NBK1354	
antiepileptic drugs (aeds) for treatment of seizures	1	NBK1354	
carrier females with the mcleod blood group phenotype	1	NBK1354	
one individual with mls developed life-threatening rhabdomyolysis	1	NBK1354	
thus, no particular recommendations can be made	1	NBK1354	
no prenatal or perinatal neurologic manifestations of mls are known	1	NBK1354	
gov/books/n/gene/mdef-cmd	1	NBK97333	
physical therapy assessment of muscle strength and joint mobility	1	NBK97333	
neuropsychological testing if learning or behavioral deficiencies are identified	1	NBK97333	
evaluation by a cardiologist including electrocardiogram and echocardiogram	1	NBK97333	
evaluation of respite care services for caregivers	1	NBK97333	
early-onset	1	NBK97333	
nutrition/weight	1	NBK97333	
weight needs to increase annually by small increments	1	NBK97333	
gastroesophageal reflux is treated as needed	1	NBK97333	
respiratory function testing	1	NBK97333	
assistance with coughing	1	NBK97333	
noninvasive ventilation support is indicated in the setting of:	1	NBK97333	
daytime hypercapnea and/or nocturnal hypoventilation	1	NBK97333	
toddlers often fight the masks	1	NBK97333	
non-ambulant children require standing frames for postural support	1	NBK97333	
late-onset	1	NBK97333	
antiepileptic drugs should be used to treat seizures	1	NBK97333	
early-onset lama2 md	1	NBK97333	
annual measurement of fvc to allow trending of fvc	1	NBK97333	
at least annual evaluation of the spine by an orthopedist	1	NBK97333	
cardiac monitoring:	1	NBK97333	
late-onset lama2 md	1	NBK97333	
monitor for respiratory insufficiency with serial pulmonary function tests	1	NBK97333	
monitor to detect and treat seizures	1	NBK97333	
gov/books/n/gene/mdel15q13_3	1	NBK50780	
cognitive assessment including speech assessment	1	NBK50780	
eeg and neurologic examination if epilepsy is suspected	1	NBK50780	
cardiac ultrasound evaluation	1	NBK50780	
additional management in healthy adults who have the 15q13	1	NBK50780	
, schizophrenia)	1	NBK50780	
about 10% of the individuals with the 15q13	1	NBK50780	
3 microdeletion develop schizophrenia	1	NBK50780	
using genomic testing that will detect the 15q13	1	NBK50780	
gov/books/n/gene/mdel15q24	1	NBK84258	
formal audiology evaluation to assess for sensorineural hearing loss	1	NBK84258	
brain imaging in individuals with microcephaly and/or neurologic findings	1	NBK84258	
examination for genitourinary abnormalities (e	1	NBK84258	
, hypospadias or cryptorchidism in males)	1	NBK84258	
discussion of results with a clinical geneticist or genetic counselor	1	NBK84258	
routine treatment of ophthalmologic, cardiac, neurologic findings	1	NBK84258	
speech, occupational, and physical therapies	1	NBK84258	
routine developmental assessments	1	NBK84258	
monitoring of specific identified medical issues	1	NBK84258	
close monitoring for intrauterine growth retardation is warranted	1	NBK84258	
gov/books/n/gene/mdel16p12_2	1	NBK274565	
2 microdeletion, the following evaluations are recommended:	1	NBK274565	
broad review of all organ systems	1	NBK274565	
developmental assessment with cognitive and behavioral testing	1	NBK274565	
to consider:	1	NBK274565	
evaluation and echocardiogram by a cardiologist	1	NBK274565	
because manifestations of 16p12	1	NBK274565	
early diagnosis and treatment facilitate the best outcome	1	NBK274565	
developmental and cognitive delays	1	NBK274565	
initiate developmental therapies promptly when indicated	1	NBK274565	
individuals with 16p12	1	NBK274565	
psychiatric and/or behavior problems	1	NBK274565	
standard treatment should be provided for hearing loss	1	NBK274565	
other malformations	1	NBK274565	
periodic:	1	NBK274565	
gov/books/n/gene/mdel17q12	1	NBK401562	
urine magnesium and creatinine	1	NBK401562	
and consultation with a nephrologist	1	NBK401562	
liver function tests (ast, alt, ggtp)	1	NBK401562	
clinical assessment for congenital heart defects	1	NBK401562	
consultation with a cardiologist and echocardiography if warranted	1	NBK401562	
neurology consultation if seizure activity is suspected	1	NBK401562	
neurodevelopmental/neuropsychiatric disorders	1	NBK401562	
renal structure/function	1	NBK401562	
periodic monitoring of renal function	1	NBK401562	
serum concentration of magnesium, potassium, uric acid	1	NBK401562	
hgba1c annually	1	NBK401562	
routine monitoring through early childhood	1	NBK401562	
audiologic and ophthalmological evaluations on a regular basis	1	NBK401562	
gov/books/n/gene/mdel17q21_31	1	NBK24676	
multidisciplinary developmental evaluation, including feeding assessment	1	NBK24676	
comprehensive speech/language evaluation including audiologic examination	1	NBK24676	
a renal ultrasound examination	1	NBK24676	
brain imaging studies in individuals with microcephaly and/or seizures	1	NBK24676	
involvement of a clinical geneticist following the initial diagnosis	1	NBK24676	
routine medical care by a pediatrician or other primary physician	1	NBK24676	
speech therapy directed at improving verbal and nonverbal communication skills	1	NBK24676	
the seizures usually are easy to control with medication	1	NBK24676	
treatment for cryptorchidism if indicated	1	NBK24676	
ongoing pediatric care	1	NBK24676	
monitoring for spine deformities	1	NBK24676	
monitoring as needed of cardiac and renal/urologic abnormalities	1	NBK24676	
gov/books/n/gene/mdel1q21_1	1	NBK52787	
ophthalmologic examination if there are concerns about vision	1	NBK52787	
psychiatric evaluation if evidence of mental illness is present	1	NBK52787	
routine treatment of ophthalmologic, cardiac, and neurologic findings	1	NBK52787	
speech, occupational, and physical therapies, as appropriate	1	NBK52787	
routine developmental and learning assessments	1	NBK52787	
monitoring of any specific medical issues that are identified	1	NBK52787	
using genomic testing that will detect the 1q21	1	NBK52787	
gov/books/n/gene/mdel3q29	1	NBK385289	
assessment for feeding problems and nutrition	1	NBK385289	
consultation with pediatric feeding specialists as needed	1	NBK385289	
early consultation with a pediatric dentist	1	NBK385289	
evaluation in infancy for evidence of congenital heart disease	1	NBK385289	
early speech and language therapy to address speech delays	1	NBK385289	
individualized education program (iep) for school-age children	1	NBK385289	
applied behavioral analysis or other treatment for manifestations of asd	1	NBK385289	
continued assessment of:	1	NBK385289	
developmental milestones	1	NBK385289	
possible psychiatric manifestations	1	NBK385289	
gov/books/n/gene/mdel9q22_3	1	NBK61984	
brain imaging (not using ct) and neurologic evaluation	1	NBK61984	
familial genetic counseling	1	NBK61984	
3 microdeletion until disproven otherwise	1	NBK61984	
3 microdeletion	1	NBK61984	
gov/books/n/gene/me-ataxia	1	NBK9674	
evaluation of school performance and emotional status	1	NBK9674	
ataxia may require assistive devices or eventually wheelchair	1	NBK9674	
consultation with a speech pathologist may be helpful	1	NBK9674	
valproate levels are affected by a number of drugs	1	NBK9674	
phenytoin [eldridge et al 1983]	1	NBK9674	
gov/books/n/gene/mecp2-dup	1	NBK1284	
complete neurologic evaluation and eeg	1	NBK1284	
complete neuropsychological evaluation of intellectual level and behavioral problems	1	NBK1284	
assessment of feeding for swallowing difficulties in infants	1	NBK1284	
cognitive impairment	1	NBK1284	
developmental stimulation including speech therapy is appropriate	1	NBK1284	
treatment is nonspecific	1	NBK1284	
predisposition to infections	1	NBK1284	
all vaccines should be given	1	NBK1284	
gastrointestinal dysfunction	1	NBK1284	
respiratory problems require early intervention	1	NBK1284	
the following should be monitored from early childhood:	1	NBK1284	
onset and frequency of seizures and response to antiepileptic medications	1	NBK1284	
number and type of infections	1	NBK1284	
autistic-like features	1	NBK1284	
gastrointestinal symptoms	1	NBK1284	
gov/books/n/gene/megdel	1	NBK195853	
complete neurologic examination, including brain mri	1	NBK195853	
developmental assessment, iq testing	1	NBK195853	
for (progressive) spasticity	1	NBK195853	
for excessive drooling	1	NBK195853	
patients experienced great improvement (e	1	NBK195853	
for failure to thrive	1	NBK195853	
medications known to impair mitochondrial function (e	1	NBK195853	
, valproic acid) should be avoided	1	NBK195853	
gov/books/n/gene/melas	1	NBK1233	
no therapy is available for peo or retinopathy	1	NBK1233	
physical therapy should be implemented in individuals after strokes	1	NBK1233	
seizures respond to traditional anticonvulsant therapy	1	NBK1233	
standard analgesics can be used for migraine headaches	1	NBK1233	
cardiac manifestations can benefit from standard pharmacologic therapy	1	NBK1233	
no specific treatment for melas exists	1	NBK1233	
infertility may preclude pregnancy in some affected individuals	1	NBK1233	
double-blind studies are needed to confirm these data	1	NBK1233	
gov/books/n/gene/men1	1	NBK1538	
multiglandular parathyroid disease	1	NBK1538	
prolactinoma	1	NBK1538	
gastrinoma and other entero-pancreatic neuroendocrine tumors	1	NBK1538	
phpt	1	NBK1538	
subtotal parathyroidectomy (i	1	NBK1538	
removal of ≤3	1	NBK1538	
prl-secreting tumors (prolactinomas)	1	NBK1538	
growth hormone-secreting tumors	1	NBK1538	
acth-secreting tumors	1	NBK1538	
non-secreting pituitary adenomas	1	NBK1538	
gastrinoma	1	NBK1538	
pancreatic tumors	1	NBK1538	
the optimal therapy of gastrinoma is controversial	1	NBK1538	
occult metastatic disease (i	1	NBK1538	
carcinoid tumors	1	NBK1538	
adrenocortical tumors	1	NBK1538	
postoperative hypoparathyroidism	1	NBK1538	
intraoperative hypertensive crisis	1	NBK1538	
men1 minimal surveillance program	1	NBK1538	
fasting serum gastrin concentration from age 20 years 2	1	NBK1538	
every three to five years beginning at the specified age	1	NBK1538	
head mri from age five years 2	1	NBK1538	
abdominal ct or mri from age 20 years 2	1	NBK1538	
notes:	1	NBK1538	
serum concentration of prolactin from age five years	1	NBK1538	
primary hyperparathyroidism (phpt)	1	NBK1538	
a dose of 30 mg daily was well tolerated	1	NBK1538	
hypercalcemia and hypercalciuria normalized in 75% and 62	1	NBK1538	
5%, respectively	1	NBK1538	
these two studies mainly included individuals without men1	1	NBK1538	
gov/books/n/gene/men2	1	NBK1257	
biochemical evaluations	1	NBK1257	
plasma calcitonin	1	NBK1257	
plasma catecholamines and metanephrines	1	NBK1257	
serum calcium and parathyroid hormone	1	NBK1257	
workup to evaluate for metastatic disease in individuals with mtc	1	NBK1257	
ct with contrast for chest and abdomen	1	NBK1257	
medullary thyroid carcinoma (mtc)	1	NBK1257	
prophylactic thyroidectomy is safe for all age groups	1	NBK1257	
ata 1 risk level	1	NBK1257	
pathogenic variants 2, 3	1	NBK1257	
age of prophylactic surgery	1	NBK1257	
age to begin screening	1	NBK1257	
for pheo	1	NBK1257	
for hpt 4	1	NBK1257	
level d(highest risk)	1	NBK1257	
ala883phep	1	NBK1257	
met918thrp	1	NBK1257	
glu805lys 5p	1	NBK1257	
tyr806cys 5p	1	NBK1257	
ser904cys 5	1	NBK1257	
as soon as possible in 1st year of life	1	NBK1257	
level c	1	NBK1257	
cys634arg/gly/phe/ser/trp/tyr	1	NBK1257	
<5 yrs	1	NBK1257	
level b	1	NBK1257	
cys609phe/arg/gly/ser/tyrp	1	NBK1257	
cys611arg/gly/phe/ser/trp/tyrp	1	NBK1257	
cys618arg/gly/phe/ser/tyrp	1	NBK1257	
cys620arg/gly/phe/ser/trp/tyrp	1	NBK1257	
cys630arg/phe/ser/tyrp	1	NBK1257	
asp631tyrp	1	NBK1257	
633/9 bp dupp	1	NBK1257	
634/12 bp dupp	1	NBK1257	
val778ile 5	1	NBK1257	
consider <5 yrs	1	NBK1257	
may delay if criteria met 5	1	NBK1257	
level a	1	NBK1257	
arg321glyp	1	NBK1257	
531/9 bp dupp	1	NBK1257	
532 dupp	1	NBK1257	
cys515serp	1	NBK1257	
gly533cysp	1	NBK1257	
arg600glnp	1	NBK1257	
lys603glup	1	NBK1257	
tyr606cysp	1	NBK1257	
635/insert elcr	1	NBK1257	
thr636prop	1	NBK1257	
lys666glup	1	NBK1257	
glu768aspp	1	NBK1257	
asn777serp	1	NBK1257	
leu790phep	1	NBK1257	
val804leu/metp	1	NBK1257	
gly819lysp	1	NBK1257	
arg833cysp	1	NBK1257	
arg844glnp	1	NBK1257	
arg866trpp	1	NBK1257	
ser891alap	1	NBK1257	
arg912pro	1	NBK1257	
may delay beyond age 5 yrs if criteria met 6	1	NBK1257	
six months for children with men 2b	1	NBK1257	
mtc	1	NBK1257	
hypoparathyroidism	1	NBK1257	
parathyroid adenoma or hyperplasia	1	NBK1257	
dopamine d2 receptor antagonists (e	1	NBK1257	
other medications including monoamine oxidase inhibitors, sympathomimetics (e	1	NBK1257	
albumin-corrected calcium or ionized calcium for hyperparathyroidism	1	NBK1257	
gov/books/n/gene/menkes	1	NBK1413	
evaluation of feeding and nutrition	1	NBK1413	
assessment of bladder function	1	NBK1413	
bladder diverticula	1	NBK1413	
vascular tortuosity	1	NBK1413	
dysautonomia (chronic diarrhea, orthostatic hypotension)	1	NBK1413	
mild cognitive deficits	1	NBK1413	
emg with nerve conduction studies	1	NBK1413	
surgery for bladder diverticula that occur in classic menkes disease	1	NBK1413	
developmental intervention	1	NBK1413	
atp7a-related dmn	1	NBK1413	
physical therapy (strength and stretching exercises)	1	NBK1413	
occupational therapy	1	NBK1413	
ankle foot orthotics	1	NBK1413	
occipital horn syndrome	1	NBK1413	
antibiotic prophylaxis may be necessary to prevent bladder infection	1	NBK1413	
therapies proven to be ineffective include vitamin c	1	NBK1413	
gov/books/n/gene/merrf	1	NBK1520	
medical genetics consultation including genetic counseling	1	NBK1520	
the seizure disorder can be treated with conventional anticonvulsant therapy	1	NBK1520	
clonazepam can also reduce myoclonus	1	NBK1520	
physical therapy is helpful for any impaired motor abilities	1	NBK1520	
standard pharmacologic therapy is used to treat cardiac symptoms	1	NBK1520	
gov/books/n/gene/mf-dys-mic	1	NBK214367	
, skeletal x-ray for scoliosis)	1	NBK214367	
mandibulofacial dysostosis	1	NBK214367	
see esophageal atresia/tracheoesophageal fistula overview	1	NBK214367	
thumb anomalies	1	NBK214367	
other thumb anomalies are not generally functionally significant	1	NBK214367	
short stature is managed expectantly	1	NBK214367	
, cardiac and renal defects)	1	NBK214367	
gov/books/n/gene/mfm	1	NBK1499	
routine ecg to identify arrhythmias and cardiac conduction defects	1	NBK1499	
holter monitoring if symptoms suggest an intermittent arrhythmia	1	NBK1499	
echocardiogram if cardiac symptoms are present	1	NBK1499	
respiratory function tests if respiratory symptoms are present	1	NBK1499	
treatment of scoliosis by spinal fusion is appropriate	1	NBK1499	
orthoses are indicated for treatment of foot drop	1	NBK1499	
electrocardiogram and/or echocardiogram yearly for early detection of cardiomyopathy	1	NBK1499	
pulmonary function tests for individuals with exertional or nocturnal dyspnea	1	NBK1499	
the role of strengthening exercises has not been defined	1	NBK1499	
gov/books/n/gene/mga3	1	NBK1473	
developmental/educational assessment	1	NBK1473	
tobacco and alcohol use	1	NBK1473	
medications known to impair mitochondrial function	1	NBK1473	
gov/books/n/gene/mhs	1	NBK1146	
arterial blood gas analysis	1	NBK1146	
serum concentration of electrolytes, lactate, and ck	1	NBK1146	
coagulation studies	1	NBK1146	
continuous core temperature monitoring until the syndrome has resolved	1	NBK1146	
measurement of serum ck concentrations until normalized	1	NBK1146	
family history of anesthetic complications	1	NBK1146	
discontinue use of potent inhalation agents and succinylcholine	1	NBK1146	
increase minute ventilation to lower end-tidal co2	1	NBK1146	
get help	1	NBK1146	
prepare and administer dantrolene: 2	1	NBK1146	
5 mg/kg initial dose	1	NBK1146	
tachycardia, hypercarbia, and muscle rigidity respond rapidly	1	NBK1146	
multiple doses of dantrolene may be needed	1	NBK1146	
the suggested upper limit is 10 mg/kg	1	NBK1146	
however, more may be given as needed	1	NBK1146	
continue dantrolene at 1	1	NBK1146	
dantrolene may aggravate previously existing muscle weakness	1	NBK1146	
begin cooling measures	1	NBK1146	
stop cooling measures at core body temperature of 38	1	NBK1146	
5° c	1	NBK1146	
treat cardiac arrhythmias as needed	1	NBK1146	
do not use calcium channel blockers	1	NBK1146	
check values every six to 12 hours	1	NBK1146	
the earliest sign of rhabdomyolysis is myoglobinuria/myoglobinemia	1	NBK1146	
serum ck levels may not rise for several hours	1	NBK1146	
ensure urine output of 2	1	NBK1146	
evaluate need for invasive monitoring and continued mechanical ventilation	1	NBK1146	
myoglobinuria	1	NBK1146	
medicalert	1	NBK1146	
fetal monitoring should follow standard guidelines	1	NBK1146	
continuous epidural analgesia is highly recommended for labor and delivery	1	NBK1146	
therapies under investigations	1	NBK1146	
gov/books/n/gene/miccap-ms	1	NBK174452	
, physiotherapy, occupational therapy, communication assistance)	1	NBK174452	
pediatric neurology evaluation	1	NBK174452	
baseline echocardiogram and abdominal ultrasound examination	1	NBK174452	
pediatric palliative care consultation and psychosocial support for family	1	NBK174452	
physical habilitation	1	NBK174452	
standard care for other medical issues (e	1	NBK174452	
regular follow up with a child neurologist for seizure management	1	NBK174452	
gov/books/n/gene/microcephaly	1	NBK9587	
age-adapted psychomotor or neuropsychological evaluation	1	NBK9587	
therapy is supportive and involves the following:	1	NBK9587	
special education programs tailored to the needs of the individual	1	NBK9587	
speech and language therapy	1	NBK9587	
behavioral therapy as needed	1	NBK9587	
occupational therapy as needed	1	NBK9587	
community services that provide support for families	1	NBK9587	
ritalin® may be helpful to treat marked hyperkinesia	1	NBK9587	
objective efficiency of gh therapy has not been evaluated	1	NBK9587	
monitoring of head circumference and stature using standard growth charts	1	NBK9587	
gov/books/n/gene/microph-lsd	1	NBK7041	
dermatologic evaluation to look for skin lesions	1	NBK7041	
use of a prosthesis in severe microphthalmia and anophthalmia	1	NBK7041	
gov/books/n/gene/milroy	1	NBK1239	
referral to a lymphedema therapist	1	NBK1239	
lymphoscintigraphy	1	NBK1239	
, fitting stockings, massage) is important	1	NBK1239	
secondary cellulitis is prevented through the following measures:	1	NBK1239	
prompt treatment for early cellulitis with appropriate antibiotics	1	NBK1239	
prophylactic antibiotics in recurrent cases (e	1	NBK1239	
, penicillin v 500 mg daily)	1	NBK1239	
, on a long airplane flight)	1	NBK1239	
treatment with diuretics is of no proven benefit	1	NBK1239	
gov/books/n/gene/mirror	1	NBK279760	
a clinical genetics consultation may also be proposed	1	NBK279760	
adaptation of the school environment (e	1	NBK279760	
gov/books/n/gene/miyoshi	1	NBK1303	
especially calf muscle	1	NBK1303	
if needed, measurement of serum ck concentration	1	NBK1303	
no definitive treatments exist for the limb-girdle muscular dystrophies	1	NBK1303	
stretching exercises to prevent contractures are indicated	1	NBK1303	
the following surveillance is appropriate:	1	NBK1303	
control weight to avoid obesity	1	NBK1303	
muscle strength improved after the study drug was discontinued	1	NBK1303	
gov/books/n/gene/mkks	1	NBK1502	
skeletal radiographs to detect osseous polydactyly and syndactyly	1	NBK1502	
ecg and echocardiogram, to detect congenital heart defects	1	NBK1502	
standard treatment is indicated for the following:	1	NBK1502	
polydactyly and syndactyly	1	NBK1502	
anal anomalies and hirschsprung disease (surgical treatment)	1	NBK1502	
surveillance as appropriate for each individual is recommended	1	NBK1502	
gov/books/n/gene/ml2	1	NBK1828	
pulmonary radiographs	1	NBK1828	
joint	1	NBK1828	
intellectual impairment in ml ii is rarely severe	1	NBK1828	
severe gingival thickening can compromise routine dental cleaning	1	NBK1828	
otic	1	NBK1828	
extubation may also be challenging in ml ii	1	NBK1828	
ultrasound abnormalities are not present in all affected pregnancies	1	NBK1828	
gov/books/n/gene/ml3a	1	NBK1875	
the recommended dose is 1 mg/kg monthly	1	NBK1875	
bone density needs to be monitored closely	1	NBK1875	
the long-term effect(s) are unknown	1	NBK1875	
not all affected individuals benefit from bisphosphonate treatment	1	NBK1875	
the prevalence decreases with age	1	NBK1875	
however, such treatment is still considered investigational	1	NBK1875	
gov/books/n/gene/ml3c	1	NBK24701	
basic assessment	1	NBK24701	
pain assessment	1	NBK24701	
orthopedic and functional assessments	1	NBK24701	
skeletal survey	1	NBK24701	
medical genetics consultation for genetic counseling and reproductive decision making	1	NBK24701	
psychosocial support of patients and families is recommended	1	NBK24701	
management of pain in the hips is required	1	NBK24701	
jaw and neck movement can be limited	1	NBK24701	
annual ophthalmologic assessment should address possible ophthalmologic changes	1	NBK24701	
gov/books/n/gene/ml4	1	NBK1214	
ophthalmic examination	1	NBK1214	
iron studies	1	NBK1214	
neurologic evaluation, including eeg	1	NBK1214	
surgical correction of strabismus	1	NBK1214	
physical therapy and rehabilitation can help prevent permanent joint contractures	1	NBK1214	
annual follow up with a generalist is appropriate	1	NBK1214	
gov/books/n/gene/mlc	1	NBK1535	
assessment of cognitive dysfunction (neuropsychological testing)	1	NBK1535	
speech therapy as needed	1	NBK1535	
gov/books/n/gene/mld	1	NBK1130	
examination of the peripheral nervous system	1	NBK1130	
guidelines	1	NBK1130	
pulmonary function and vision may also need attention	1	NBK1130	
they reflect evolving pretreatment conditioning and improved donor matching	1	NBK1130	
hsct failures continue	1	NBK1130	
nevertheless, some improvement has been seen	1	NBK1130	
piguet et al [2009] investigate intracerebral aavrh	1	NBK1130	
10 as a possible gene therapy vector for mld	1	NBK1130	
mouse model of mld	1	NBK1130	
other studies	1	NBK1130	
capotondo et al [2007] evaluated overexpression of arsa	1	NBK1130	
gov/books/n/gene/mma	1	NBK1231	
arterial or venous blood gas	1	NBK1231	
plasma ammonium and lactic acid concentration	1	NBK1231	
formal urinalysis and ketone measurement	1	NBK1231	
quantitative plasma amino acids	1	NBK1231	
biochemical genetics consultation	1	NBK1231	
stabilization of critically ill individuals	1	NBK1231	
volume replacement with isotonic solutions	1	NBK1231	
adequate kcals must be delivered	1	NBK1231	
after stabilization, nutritional management is critical	1	NBK1231	
a propiogenic amino acid-deficient formula (e	1	NBK1231	
isolated valine or isoleucine supplementation should be avoided	1	NBK1231	
hydroxocobalamin injections	1	NBK1231	
antibiotics	1	NBK1231	
rotating antibiotic regimens may be considered in some persons	1	NBK1231	
a second patient developed progressive neurologic symptoms	1	NBK1231	
and two others developed metabolic decompensations post transplant	1	NBK1231	
plasma and urine mma levels	1	NBK1231	
serum acylcarnitines and free and total carnitine levels	1	NBK1231	
liver, kidney, and bone health	1	NBK1231	
bone marrow indices	1	NBK1231	
stress	1	NBK1231	
increased dietary protein	1	NBK1231	
gov/books/n/gene/mmd	1	NBK1290	
spinal x-rays to evaluate for presence of scoliosis	1	NBK1290	
physical examination for joint contractures	1	NBK1290	
cardiac evaluation for cardiomyopathy/cardiac involvement secondary to respiratory complications	1	NBK1290	
orthodontic evaluation for palatal anomalies	1	NBK1290	
annual influenza and other respiratory infection-related immunizations are advised	1	NBK1290	
aggressive treatment of lower respiratory infections is critical	1	NBK1290	
monitoring of respiratory function should include the following:	1	NBK1290	
lung function tests (fev1 and fvc)	1	NBK1290	
assessment of the need for intermittent or permanent ventilation	1	NBK1290	
growth should be assessed regularly	1	NBK1290	
regular neuromuscular evaluation to assess disease progress is indicated	1	NBK1290	
risk for malignant hyperthermia	1	NBK1290	
depolarizing muscle relaxants (e	1	NBK1290	
, succinylcholine) and inhalational agents (e	1	NBK1290	
abnormal presentation of an affected fetus may complicate delivery	1	NBK1290	
gov/books/n/gene/mngie	1	NBK1179	
emg/ncv	1	NBK1179	
ekg	1	NBK1179	
small bowel manometry shows reduced amplitude of contractions	1	NBK1179	
once symptoms appear, treatment is primarily supportive	1	NBK1179	
management of gi dysfunction can include the following:	1	NBK1179	
trial of dromperidone for nausea and vomiting	1	NBK1179	
celiac plexus block with bupivicaine	1	NBK1179	
physical therapy and occupational therapy to help preserve mobility	1	NBK1179	
activity as tolerated should be encouraged	1	NBK1179	
breath test to screen for bacterial overgrowth is recommended	1	NBK1179	
avoid drugs that interfere with mitochondrial function	1	NBK1179	
no change in blood nucleoside levels was observed	1	NBK1179	
gov/books/n/gene/mona	1	NBK373578	
cardiac evaluation, including echocardiogram	1	NBK373578	
osteopenia and osteolysis	1	NBK373578	
at present no specific therapy can alleviate the progressive osteopenia	1	NBK373578	
nonsteroidal anti-inflammatory drugs may not provide sufficient relief	1	NBK373578	
provide medical or surgical interventions as appropriate	1	NBK373578	
annual assessment of joints by a rheumatologist or orthopedic surgeon	1	NBK373578	
avoid physical trauma to reduce the risk of fractures	1	NBK373578	
no information on pregnancy management and outcomes is available	1	NBK373578	
gov/books/n/gene/mono7-mds	1	NBK45015	
monosomy 7 in children with de	1	NBK45015	
novo aml (i	1	NBK45015	
gov/books/n/gene/mota	1	NBK1728	
plastic surgery evaluation	1	NBK1728	
eye anomalies	1	NBK1728	
notched or bifid nose	1	NBK1728	
rhinoplasty may be performed for cosmetic purposes	1	NBK1728	
anal stenosis is generally managed by serial dilatations	1	NBK1728	
gov/books/n/gene/mpd1	1	NBK1433	
electromyography/nerve conduction studies	1	NBK1433	
the cardiomyopathy may respond to ace inhibitors or other medication	1	NBK1433	
cardiac consultation is recommended	1	NBK1433	
kyphoscoliosis may be treated with surgical stabilization of the spine	1	NBK1433	
there is no treatment for spinal rigidity	1	NBK1433	
additional recommendations include:	1	NBK1433	
repeat electrocardiogram and echocardiogram if symptoms of cardiac insufficiency occur	1	NBK1433	
gov/books/n/gene/mpgn	1	NBK1425	
screen cfh for pathogenic variants using bidirectional sequencing	1	NBK1425	
these agents are not widely used in children	1	NBK1425	
renal allografts	1	NBK1425	
001)	1	NBK1425	
005)	1	NBK1425	
allograft survival appears to be age-dependent in ddd	1	NBK1425	
penetrance rates, however, are not known	1	NBK1425	
the following treatment modalities are of unproven value:	1	NBK1425	
plasmapheresis to remove or suppress serum c3nef activity:	1	NBK1425	
calcineurin inhibitors	1	NBK1425	
bevacizumab	1	NBK1425	
an improvement in vision was noted	1	NBK1425	
gov/books/n/gene/mpph	1	NBK396098	
echocardiogram (to evaluate for structural cardiac defects)	1	NBK396098	
neurosurgical complications (hydrocephalus and cerebellar tonsillar ectopia)	1	NBK396098	
epilepsy may require long-term antiepileptic treatment	1	NBK396098	
developmental delays	1	NBK396098	
however, recommended surveillance includes the following:	1	NBK396098	
brain mri to detect hydrocephalus and/or cerebellar tonsillar ectopia	1	NBK396098	
gov/books/n/gene/mps1	1	NBK1162	
cardiac evaluation with echocardiography to assess ventricular size and function	1	NBK1162	
consideration of sleep study	1	NBK1162	
assessment of spinal cord and peripheral nerve involvement	1	NBK1162	
joint replacement and atlanto-occipital stabilization may be necessary	1	NBK1162	
repeated surgery may be required	1	NBK1162	
cardiac valve replacement should be considered early	1	NBK1162	
hearing aids should also be considered	1	NBK1162	
ent (otolaryngologic)	1	NBK1162	
gastrointestinal system	1	NBK1162	
hydrocephaly	1	NBK1162	
early surgical intervention may prevent severe complications	1	NBK1162	
adults have not undergone hsct	1	NBK1162	
all published reports indicate that ert is well tolerated	1	NBK1162	
hepatic volume normalized in 92%	1	NBK1162	
respiratory function either improved slightly or remained constant	1	NBK1162	
timed walk measurements remained largely constant	1	NBK1162	
growth resumed in approximately 70%	1	NBK1162	
the most common reactions were of an immune nature	1	NBK1162	
other studies have shown:	1	NBK1162	
5-4	1	NBK1162	
the following are important considerations:	1	NBK1162	
intubation may require fiber-optic laryngoscopy	1	NBK1162	
cardiac assessment including annual echocardiogram	1	NBK1162	
developmental assessment in all patients	1	NBK1162	
combined ert and hsct	1	NBK1162	
delivery of enzyme to the cns	1	NBK1162	
stabilization of mutated enzyme with substrate analogs	1	NBK1162	
substrate deprivation	1	NBK1162	
gene- and cell-based therapy	1	NBK1162	
gov/books/n/gene/mps4a	1	NBK148668	
plain radiographs	1	NBK148668	
baseline ap and lateral radiographs of the entire spine	1	NBK148668	
baseline ap and frog leg lateral radiographs of the pelvis	1	NBK148668	
baseline ap standing radiographs of the lower extremities	1	NBK148668	
evaluation by:	1	NBK148668	
a physiatrist (i	1	NBK148668	
electrocardiogram and echocardiogram	1	NBK148668	
ophthalmology evaluation to assess visual acuity and intraocular pressure	1	NBK148668	
slit lamp examination and posterior segment examination for retinopathy	1	NBK148668	
pain assessment and quality of life questionnaires	1	NBK148668	
physical therapist to optimize mobility	1	NBK148668	
occupational therapist to optimize autonomy	1	NBK148668	
psychological support to optimize coping skills and quality of life	1	NBK148668	
educational professions to optimize learning in a medically fragile individual	1	NBK148668	
home care for affected individuals with multiple medical equipment needs	1	NBK148668	
hospice for end-of-life care	1	NBK148668	
the recommendation dose is 2 mg/kg/week intravenous	1	NBK148668	
upper extremities	1	NBK148668	
knee and ankle valgus	1	NBK148668	
however, no absolute indications for intervention exist	1	NBK148668	
hip dysplasia	1	NBK148668	
affected individuals undergoing surgical fusion typically do well	1	NBK148668	
lumbar spine malalignment	1	NBK148668	
when kyphosis exceeds 45 degrees, progression is likely	1	NBK148668	
progressive thoracolumbar kyphosis greater than 70 degrees	1	NBK148668	
uncontrolled back pain	1	NBK148668	
neurologic changes related to spinal stenosis	1	NBK148668	
thus tachycardia treatment with beta blockers should be avoided	1	NBK148668	
restrictive lung disease is managed by supportive treatment	1	NBK148668	
learning environment	1	NBK148668	
cataract surgery may benefit those with cataracts	1	NBK148668	
orthodontic management to correct malocclusion may be necessary	1	NBK148668	
see treatment of manifestations for information regarding ert	1	NBK148668	
cardiac evaluation, including electrocardiogram and echocardiography	1	NBK148668	
evaluation of respiratory function (spirometry and polysomnography)	1	NBK148668	
postoperative narcotic management should be judicious	1	NBK148668	
individuals on ert	1	NBK148668	
physical and neurologic evaluation at least every six months	1	NBK148668	
optimize ambulation	1	NBK148668	
pain severity assessment every six months	1	NBK148668	
age-appropriate quality of life questionnaires every year	1	NBK148668	
upper and lower extremities	1	NBK148668	
, functional dexterity test) of the upper extremities	1	NBK148668	
, extremity weakness	1	NBK148668	
clumsiness	1	NBK148668	
unsteady, changing gait	1	NBK148668	
evaluate heart rate annually	1	NBK148668	
polysomnography every three years	1	NBK148668	
monitor for vision and ocular abnormalities at every visit	1	NBK148668	
refer to an ophthalmologist as needed	1	NBK148668	
evaluate every six to 12 months	1	NBK148668	
perform yearly audiogram	1	NBK148668	
hypersensitivity reactions occurred in 18	1	NBK148668	
7% of participants	1	NBK148668	
gov/books/n/gene/mpv17-mtdep	1	NBK92947	
alpha fetoprotein (afp) to screen for hepatocellular carcinoma	1	NBK92947	
hepatology/liver transplantation consultation	1	NBK92947	
neurologic consultation and comprehensive neurologic examination	1	NBK92947	
brain mri to assess white matter and other abnormalities	1	NBK92947	
nerve conduction velocity (ncv) to assess peripheral neuropathy	1	NBK92947	
plasma lactate and glucose concentration	1	NBK92947	
urinalysis and amino acids to assess for renal tubulopathy	1	NBK92947	
gastrointestinal consultation if gastrointestinal dysmotility is present	1	NBK92947	
prevention of hypoglycemia requires frequent feeds and avoidance of fasting	1	NBK92947	
hepatocellular carcinoma	1	NBK92947	
serum alpha fetoprotein (afp) concentration	1	NBK92947	
urinalysis and urine amino acids to assess for renal tubulopathy	1	NBK92947	
prolonged fasting can lead to hypoglycemia and should be avoided	1	NBK92947	
gov/books/n/gene/mss	1	NBK1192	
assessment of speech and feeding	1	NBK1192	
treatment of muscular manifestations is symptomatic	1	NBK1192	
cataracts are removed surgically during the first decade of life	1	NBK1192	
hypergonadotropic hypogonadism (i	1	NBK1192	
gov/books/n/gene/mstn	1	NBK1498	
gov/books/n/gene/msud	1	NBK1319	
86 and -0	1	NBK1319	
62, respectively	1	NBK1319	
p<0	1	NBK1319	
0001	1	NBK1319	
home therapy	1	NBK1319	
acute decompensation	1	NBK1319	
indication for hospitalization	1	NBK1319	
number	1	NBK1319	
vomiting and viral gastroenteritis	1	NBK1319	
viral bronchiolitis	1	NBK1319	
sinusitis	1	NBK1319	
neonatal encephalopathy	1	NBK1319	
urinary tract infection	1	NBK1319	
cellulitis	1	NBK1319	
influenza	1	NBK1319	
viral meningitis	1	NBK1319	
bacterial pharyngitis	1	NBK1319	
esophageal candidiasis	1	NBK1319	
appendicitis	1	NBK1319	
the primary goals of in-hospital therapy	1	NBK1319	
25 mosm/l per hour	1	NBK1319	
minimize exposure to hypotonic fluid sources	1	NBK1319	
the most commonly encountered are hypokalemia and hypophosphatemia	1	NBK1319	
methods of achieving these goals	1	NBK1319	
identify and treat precipitating conditions (e	1	NBK1319	
, infection, inflammation, and fever)	1	NBK1319	
administer antiemetics (e	1	NBK1319	
, odansetron 0	1	NBK1319	
15 mg/kg/dose) to control nausea and vomiting	1	NBK1319	
provide at least 1	1	NBK1319	
10 units/kg/hour and titrated to maintain euglycemia	1	NBK1319	
5 g/kg/day	1	NBK1319	
provide specific amino acid supplements during metabolic crisis:	1	NBK1319	
isoleucine and valine	1	NBK1319	
20-120 mg/kg/day each	1	NBK1319	
glutamine and alanine	1	NBK1319	
tyrosine	1	NBK1319	
strauss & morton, unpublished observation]	1	NBK1319	
nutrient	1	NBK1319	
age in months (# of persons)	1	NBK1319	
0-2 (31)	1	NBK1319	
3-5 (18)	1	NBK1319	
6-8 (21)	1	NBK1319	
9-12 (18)	1	NBK1319	
13-18 (21)	1	NBK1319	
19-24 (18)	1	NBK1319	
25-36 (32)	1	NBK1319	
leucine (mg)	1	NBK1319	
72(64-84)	1	NBK1319	
58(47-68)	1	NBK1319	
44(37-51)	1	NBK1319	
35(30-41)	1	NBK1319	
33(26-39)	1	NBK1319	
27(22-28)	1	NBK1319	
21(20-25)	1	NBK1319	
energy (kcal)	1	NBK1319	
111(103-119)	1	NBK1319	
99(94-107)	1	NBK1319	
89(82-99)	1	NBK1319	
78(71-87)	1	NBK1319	
67(55-77)	1	NBK1319	
57(49-71)	1	NBK1319	
38(39-51)	1	NBK1319	
total protein (g)	1	NBK1319	
1-2	1	NBK1319	
5(1	1	NBK1319	
isoleucine supplement (mg)	1	NBK1319	
4(0-7)	1	NBK1319	
3(0-3	1	NBK1319	
7(0-3	1	NBK1319	
6(0-3	1	NBK1319	
8(2	1	NBK1319	
1-5	1	NBK1319	
7(1	1	NBK1319	
5(3	1	NBK1319	
valine supplement (mg)	1	NBK1319	
5(9	1	NBK1319	
8-14	1	NBK1319	
4(9	1	NBK1319	
0-13	1	NBK1319	
0(9	1	NBK1319	
5-12	1	NBK1319	
1(6	1	NBK1319	
8(5	1	NBK1319	
4-10	1	NBK1319	
2(2	1	NBK1319	
8(4	1	NBK1319	
9-8	1	NBK1319	
alanine intake (mg)	1	NBK1319	
233(200-262)	1	NBK1319	
209(197-234)	1	NBK1319	
206(193-225)	1	NBK1319	
189(168-218)	1	NBK1319	
178(159-199)	1	NBK1319	
159(140-192)	1	NBK1319	
117(114-149)	1	NBK1319	
glutamine intake (mg)	1	NBK1319	
416(361-471)	1	NBK1319	
363(337-405)	1	NBK1319	
358(332-400)	1	NBK1319	
320(288-371)	1	NBK1319	
294(252-337)	1	NBK1319	
256(221-318)	1	NBK1319	
184(181-235)	1	NBK1319	
iron (mg)	1	NBK1319	
1(2	1	NBK1319	
6-2	1	NBK1319	
8(1	1	NBK1319	
zinc (mg)	1	NBK1319	
6(3	1	NBK1319	
1-4	1	NBK1319	
4-4	1	NBK1319	
9-4	1	NBK1319	
6(2	1	NBK1319	
6-3	1	NBK1319	
selenium (µg)	1	NBK1319	
0(5	1	NBK1319	
7-6	1	NBK1319	
7(4	1	NBK1319	
8-6	1	NBK1319	
7(5	1	NBK1319	
3-6	1	NBK1319	
3(4	1	NBK1319	
4-6	1	NBK1319	
0(4	1	NBK1319	
0-4	1	NBK1319	
378(307-401)	1	NBK1319	
330(307-378)	1	NBK1319	
330(307-354)	1	NBK1319	
307(260-354)	1	NBK1319	
307(283-330)	1	NBK1319	
283(236-330)	1	NBK1319	
212(212-260)	1	NBK1319	
leucine / energy ratio (mg/kcal)	1	NBK1319	
65(0	1	NBK1319	
57-0	1	NBK1319	
72)	1	NBK1319	
58(0	1	NBK1319	
48-0	1	NBK1319	
66)	1	NBK1319	
56)	1	NBK1319	
46(0	1	NBK1319	
37-0	1	NBK1319	
53)	1	NBK1319	
48(0	1	NBK1319	
38-0	1	NBK1319	
54(0	1	NBK1319	
44-0	1	NBK1319	
55)	1	NBK1319	
control of brain edema	1	NBK1319	
measure head circumference and fontanel size in neonates	1	NBK1319	
papilledema	1	NBK1319	
disorientation, combativeness	1	NBK1319	
depressed level of consciousness	1	NBK1319	
refractory vomiting	1	NBK1319	
extremity hyperreflexia	1	NBK1319	
bradycardic hypertension	1	NBK1319	
hyperactive gag	1	NBK1319	
pupillary asymmetry	1	NBK1319	
ophthalmoplegia	1	NBK1319	
decorticate posturing	1	NBK1319	
methods to minimize the possibility of brain swelling:	1	NBK1319	
elevate the individual's head	1	NBK1319	
note: give furosemide (0	1	NBK1319	
methods to manage brain swelling:	1	NBK1319	
furosemide: 0	1	NBK1319	
0 mg/kg, followed by	1	NBK1319	
mannitol: 0	1	NBK1319	
0 g/kg over 60 minutes, followed by	1	NBK1319	
hypertonic (3%-5%) saline: 2	1	NBK1319	
5 meq/kg over 60 minutes	1	NBK1319	
hemodialysis/hemofiltration	1	NBK1319	
other potential complications in hospitalized persons with msud:	1	NBK1319	
monitor for and promptly treat hospital-acquired infections	1	NBK1319	
superficial and invasive candida infections are common	1	NBK1319	
normal weight gain, linear growth, and head growth	1	NBK1319	
home formula supplies include bcaa-free powder	1	NBK1319	
normal age- and weight-adjusted energy intake	1	NBK1319	
appropriate leucine tolerance	1	NBK1319	
goals of laboratory monitoring:	1	NBK1319	
plasma isoleucine concentration approximately equal to plasma leucine concentration	1	NBK1319	
plasma valine concentration at least twofold plasma leucine concentration	1	NBK1319	
thiamine treatment	1	NBK1319	
9-20	1	NBK1319	
the post-partum period is dangerous for the mother	1	NBK1319	
gov/books/n/gene/msx2	1	NBK1128	
plain skull radiography	1	NBK1128	
3d ct scan of the head with bone windows	1	NBK1128	
brain imaging using ct or mri scanning, if appropriate	1	NBK1128	
the management of enlarged parietal foramina is generally conservative	1	NBK1128	
associated headaches or seizures should be treated symptomatically	1	NBK1128	
gov/books/n/gene/mt-deafness	1	NBK1422	
examination of the skin for evidence of keratoderma	1	NBK1422	
appropriate rehabilitation, e	1	NBK1422	
enrollment in educational programs appropriate for the hearing impaired	1	NBK1422	
for mild keratoderma, use of lotions and emollients	1	NBK1422	
for severe keratoderma, dermatologic evaluation	1	NBK1422	
mt-rnr1-related aminoglycoside-induced ototoxicity	1	NBK1422	
the following assessments are indicated:	1	NBK1422	
, palmoplantar keratosis)	1	NBK1422	
1555a>g	1	NBK1422	
mt-rnr1 pathogenic variant	1	NBK1422	
gov/books/n/gene/mt-mpan	1	NBK185329	
ophthalmologic examination to assess for optic atrophy	1	NBK185329	
treatment by a psychiatrist for those with significant neuropsychiatric symptoms	1	NBK185329	
tracheostomy as indicated for difficulty managing secretions	1	NBK185329	
annual ophthalmologic examination is recommended	1	NBK185329	
gov/books/n/gene/mt-overview	1	NBK1224	
prevention strategies under investigation	1	NBK1224	
gov/books/n/gene/mtm	1	NBK1432	
annual ophthalmologic exams for ophthalmoplegia, ptosis, and myopia	1	NBK1432	
potential screening tests include the following:	1	NBK1432	
annual blood counts [herman et al 1999]	1	NBK1432	
gov/books/n/gene/muenke	1	NBK1415	
assessment for hydrocephalus with brain ct or mri	1	NBK1415	
ophthalmologic assessment including screening for strabismus and vision	1	NBK1415	
other disciplines are involved as needed	1	NBK1415	
this procedure is usually transcranial (i	1	NBK1415	
severe initial clinical presentation requiring a staged repair	1	NBK1415	
postoperative increased icp	1	NBK1415	
recurrent deformity requiring a second transcranial repair:	1	NBK1415	
seven (24	1	NBK1415	
1%) of 29 individuals with the p	1	NBK1415	
3%) of 47 without the pathogenic variant	1	NBK1415	
048) [thomas et al 2005]	1	NBK1415	
15 were expected to undergo extracranial contouring	1	NBK1415	
note that none had increased icp	1	NBK1415	
hearing loss is often sensorineural	1	NBK1415	
strabismus surgery/correction is indicated to prevent amblyopia	1	NBK1415	
, behavioral changes)	1	NBK1415	
regular developmental assessments of affected children	1	NBK1415	
periodic repeat audiograms	1	NBK1415	
periodic assessment for strabismus	1	NBK1415	
evaluation includes targeted molecular genetic testing for the fgfr3 c	1	NBK1415	
749c>g pathogenic variant	1	NBK1415	
gov/books/n/gene/mws	1	NBK1412	
baseline echocardiogram	1	NBK1412	
baseline dental evaluation in early childhood	1	NBK1412	
baseline ophthalmology evaluation	1	NBK1412	
review history for evidence of chronic constipation	1	NBK1412	
review history for evidence of seizures	1	NBK1412	
renal ultrasound examination to assess for structural renal anomalies	1	NBK1412	
genitourinary evaluation, particularly for hypospadias and cryptorchidism in males	1	NBK1412	
physical examination for pectus anomalies and foot/ankle malpositioning	1	NBK1412	
evaluation for hscr and ultrashort hscr	1	NBK1412	
referral to a urologist or nephrologist as indicated	1	NBK1412	
monitoring for the development of otitis media (om)	1	NBK1412	
regular developmental assessments to plan and refine educational interventions	1	NBK1412	
gov/books/n/gene/myh9	1	NBK2689	
suturing for treatment of accidental or surgical wounds	1	NBK2689	
mouthwash with tranexamic acid may control gingival bleeding	1	NBK2689	
eltrombopag	1	NBK2689	
antifibrinolytic agents	1	NBK2689	
ten of them benefited from cochlear implants	1	NBK2689	
glomerular nephropathy	1	NBK2689	
dialysis or kidney transplantation is required in individuals with esrd	1	NBK2689	
cataract surgery remedies clouding of the lens	1	NBK2689	
elevation of liver enzymes does not require any specific treatment	1	NBK2689	
thrombocytopenia cannot be prevented	1	NBK2689	
oral contraceptives are often effective in preventing or controlling menorrhagia	1	NBK2689	
every six months	1	NBK2689	
every year	1	NBK2689	
measurement of serum concentration of creatinine	1	NBK2689	
every three years	1	NBK2689	
measurement of serum ast, alt and ggt	1	NBK2689	
drugs that inhibit platelet function or blood coagulation:	1	NBK2689	
other substances that interfere with platelet function including some antibiotics	1	NBK2689	
cardiovascular, psychotropic, and oncologic drugs	1	NBK2689	
drugs that affect platelet camp	1	NBK2689	
some anesthetics	1	NBK2689	
antihistamines	1	NBK2689	
ototoxic drugs (e	1	NBK2689	
exposure to hazardous noise	1	NBK2689	
, earplugs, headphones) to attenuate intense sound	1	NBK2689	
nephropathy	1	NBK2689	
elevation of liver enzymes	1	NBK2689	
gov/books/n/gene/myhre	1	NBK425723	
upper- and lower-extremity blood pressure measurements	1	NBK425723	
two-dimensional echocardiography with doppler	1	NBK425723	
treatment is largely symptomatic and may include the following	1	NBK425723	
elective tracheal surgery/intubation should be avoided	1	NBK425723	
symptomatic treatment of restrictive lung disease	1	NBK425723	
oxygen supplementation as necessary	1	NBK425723	
noninvasive 3d imaging may be preferred	1	NBK425723	
global developmental disability/intellectual disability educational issues	1	NBK425723	
persistent middle ear effusions	1	NBK425723	
myringotomy tubes as needed	1	NBK425723	
routine treatment of strabismus and refractive errors	1	NBK425723	
evaluation for upper airway stenosis (e	1	NBK425723	
annual ophthalmologic and audiology evaluations	1	NBK425723	
monitoring of physical skill development and joint mobility	1	NBK425723	
patients should be aggressively counseled not to smoke	1	NBK425723	
gov/books/n/gene/myo-dystonia	1	NBK1414	
all experienced substantial improvement of both myoclonus (61	1	NBK1414	
5%) and dystonia (48	1	NBK1414	
2%)	1	NBK1414	
no adverse effects on cognition or affect were noted	1	NBK1414	
the results of case studies are summarized below:	1	NBK1414	
gov/books/n/gene/myodef-sda	1	NBK5299	
no specific therapy currently exists for this disorder	1	NBK5299	
avoid sustained fatiguing physical exertion	1	NBK5299	
gov/books/n/gene/myotonia-c	1	NBK1355	
exercise temporarily alleviates myotonia (the warm-up effect)	1	NBK1355	
the effect has not been systematically studied	1	NBK1355	
a trial with lamotrigine is ongoing (nct01939561)	1	NBK1355	
gov/books/n/gene/myotonic-d	1	NBK1165	
assessment of thyroid function	1	NBK1165	
assessment of strength [whittaker et al 2006]	1	NBK1165	
fasting blood glucose determination	1	NBK1165	
assessment of motor skills	1	NBK1165	
baseline cardiac evaluation	1	NBK1165	
baseline endocrine evaluation	1	NBK1165	
special education evaluation is indicated for children with dm1	1	NBK1165	
statins)	1	NBK1165	
pain management can be an important part of dm1 treatment	1	NBK1165	
avoid using succinylcholine	1	NBK1165	
propofol-induced pain can induce myotonia	1	NBK1165	
sevoflurane has been used uneventfully	1	NBK1165	
gagnon et al [2010] provide guidelines for surveillance	1	NBK1165	
annual ecg to detect asymptomatic cardiac conduction defects	1	NBK1165	
ophthalmologic examination every two years to evaluate for cataract formation	1	NBK1165	
the overall frequency of complications was 8	1	NBK1165	
2% (18 of 219)	1	NBK1165	
evaluation for placenta previa	1	NBK1165	
gov/books/n/gene/myotonic-d2	1	NBK1466	
routine clinical evaluation of muscle strength and functional status	1	NBK1466	
initial cardiac evaluation including at minimum:	1	NBK1466	
ecg to establish a baseline record for future comparison	1	NBK1466	
thyroid studies	1	NBK1466	
treatment guidelines for dm2 have been published	1	NBK1466	
no one medication has been consistently effective	1	NBK1466	
anesthetic risk may be increased in those with dm2	1	NBK1466	
gov/books/n/gene/nail-ps	1	NBK1132	
history and physical examination to detect orthopedic problems	1	NBK1132	
history to identify gastrointestinal, neurologic, or vasomotor abnormalities	1	NBK1132	
history and examination to detect dental anomalies	1	NBK1132	
treatment as in the general population for:	1	NBK1132	
annual measurement of the following is appropriate:	1	NBK1132	
urine albumin:creatinine ratio on a first-morning urine	1	NBK1132	
dental examination is indicated at least every six months	1	NBK1132	
otherwise, monitor renal findings (i	1	NBK1132	
gov/books/n/gene/narp	1	NBK1173	
supportive management includes treatment of the following:	1	NBK1173	
neurologic, ophthalmologic, and cardiologic evaluations are recommended	1	NBK1173	
newer mitochondrial-targeted antioxidants (e	1	NBK1173	
findings have not yet been reported (clinicaltrials	1	NBK1173	
clinical trials have yet to be performed	1	NBK1173	
these findings are likely to prompt clinical trials	1	NBK1173	
8993t>g pathogenic variant [sgarbi et al 2009]	1	NBK1173	
rapamycin has a number of side effects (e	1	NBK1173	
gov/books/n/gene/nbia-ov	1	NBK121988	
consider consultation with a movement disorders specialist	1	NBK121988	
treatments for nbia are palliative	1	NBK121988	
botulinum toxin for those with focal dystonia	1	NBK121988	
l-dopa treatment, which is beneficial in rare cases	1	NBK121988	
some will develop prominent dyskinesias early in the treatment	1	NBK121988	
assessment of ambulation and speech abilities	1	NBK121988	
gov/books/n/gene/nbs	1	NBK321516	
dental evaluation if dental eruption is delayed	1	NBK321516	
ophthalmologic examination, including visual acuity and dilated fundus examination	1	NBK321516	
evaluation for cryptorchidism in males	1	NBK321516	
spectacles as needed to correct refractive errors	1	NBK321516	
orchiopexy as needed	1	NBK321516	
gov/books/n/gene/ncl	1	NBK1428	
developmental/cognitive and educational assessment	1	NBK1428	
trihexyphenydil improves dystonia and sialorrhea	1	NBK1428	
this may include clinical surveillance for the following:	1	NBK1428	
swallowing difficulties and recurrent aspiration	1	NBK1428	
x-ray surveillance of hip joints and spine	1	NBK1428	
lamotrigine may exacerbate seizures and myoclonus especially in cln2 disease	1	NBK1428	
czp is a sedative and can cause behavior disturbances	1	NBK1428	
the research is ongoing	1	NBK1428	
trials in humans have not yet started	1	NBK1428	
gov/books/n/gene/ndi	1	NBK1177	
general management	1	NBK1177	
thiazide diuretics (i	1	NBK1177	
emergency treatment for dehydration	1	NBK1177	
5% dextrose in water is the preferred solution	1	NBK1177	
if administration of iv fluids is required, 2	1	NBK1177	
special situations	1	NBK1177	
hydronephrosis, hydroureter, and megacystis	1	NBK1177	
treatment and monitoring may then start immediately	1	NBK1177	
monitoring of growth and development in infants and children	1	NBK1177	
water intake must not be restricted	1	NBK1177	
gov/books/n/gene/nem	1	NBK1288	
physical examination to evaluate for joint contractures	1	NBK1288	
orthodontic evaluation if palatal anomalies are present	1	NBK1288	
aggressive treatment of lower respiratory tract infections	1	NBK1288	
standard treatment of gastroesophageal reflux, if present	1	NBK1288	
physical therapy for maintenance/improvement of function and joint mobility	1	NBK1288	
speech therapy if dysarthria and/or hypernasal speech is present	1	NBK1288	
anesthetics are generally well tolerated in individuals with nm	1	NBK1288	
none developed malignant hyperthermia	1	NBK1288	
routine assessment for scoliosis and joint contractures	1	NBK1288	
l-tyrosine has been proposed as a potential therapy	1	NBK1288	
human data are lacking	1	NBK1288	
gov/books/n/gene/nephron-ov	1	NBK368475	
tests to evaluate the kidneys:	1	NBK368475	
complete blood count (cbc) to evaluate for anemia	1	NBK368475	
skeletal radiographs	1	NBK368475	
assessment of psychomotor development and/or behavior	1	NBK368475	
endocrine assessment	1	NBK368475	
currently no cure for nephronophthisis exists	1	NBK368475	
treatment of anemia, hypertension, and proteinuria if present	1	NBK368475	
dialysis or renal transplantation when patients reach esrd	1	NBK368475	
annual influenza vaccination is indicated for patients with ckd	1	NBK368475	
other vaccinations (e	1	NBK368475	
evaluations are recommended at least annually	1	NBK368475	
monitoring of blood pressure, growth parameters, and development	1	NBK368475	
urinalysis to monitor proteinuria	1	NBK368475	
nephrotoxic agents, e	1	NBK368475	
individuals with liver function impairment should avoid hepatotoxic medication	1	NBK368475	
gov/books/n/gene/neuroferritin	1	NBK1141	
psychometric assessment	1	NBK1141	
physiotherapy assessment	1	NBK1141	
speech therapy assessment	1	NBK1141	
botulinum toxin is helpful for painful focal dystonia	1	NBK1141	
dietary assessment is helpful	1	NBK1141	
affected individuals should maintain caloric intake	1	NBK1141	
physiotherapy helps to maintain mobility and prevent contractures	1	NBK1141	
current treatments under evaluation:	1	NBK1141	
venesection	1	NBK1141	
iron chelation with deferiprone	1	NBK1141	
coenzyme q10 (ubiquinone)	1	NBK1141	
gov/books/n/gene/nf1	1	NBK1109	
personal medical history with particular attention to features of nf1	1	NBK1109	
ophthalmologic evaluation including slit lamp examination of the irides	1	NBK1109	
further studies are in progress	1	NBK1109	
regular developmental assessment by screening questionnaire (in childhood)	1	NBK1109	
regular blood pressure monitoring	1	NBK1109	
other studies (e	1	NBK1109	
no limitations are necessary for most individuals with nf1	1	NBK1109	
note:	1	NBK1109	
nih clinicaltrials	1	NBK1109	
gov has a list of current clinical trials for nf1	1	NBK1109	
gov/books/n/gene/nf2	1	NBK1201	
hearing evaluation, including baer	1	NBK1201	
cutaneous examination	1	NBK1201	
for nf specialists see www	1	NBK1201	
ctf	1	NBK1201	
for nf2 service centers in uk see www	1	NBK1201	
nfauk	1	NBK1201	
vestibular schwannoma	1	NBK1201	
therapy remains primarily surgical	1	NBK1201	
small vestibular tumors (<1	1	NBK1201	
lip-reading skills may be enhanced by instruction	1	NBK1201	
ocular involvement	1	NBK1201	
treatment concentrates on prevention of secondary complications	1	NBK1201	
spinal tumors may make epidural analgesia difficult	1	NBK1201	
it is not clear if earlier surveillance (i	1	NBK1201	
gov/books/n/gene/nijmegen	1	NBK1176	
evaluation of immunologic status to include:	1	NBK1176	
proliferative response of peripheral blood mononuclear cells to stimuli	1	NBK1176	
evaluation for viruses with lymphotrotropic capacity (i	1	NBK1176	
, ebv and cmv)	1	NBK1176	
assessment of cognitive development and intellectual abilities	1	NBK1176	
infections	1	NBK1176	
the spectrum of recurrent infections in nbs is not opportunistic	1	NBK1176	
puberty and fertility	1	NBK1176	
females are infertile	1	NBK1176	
similarly, no male paternity has been reported	1	NBK1176	
breast self-examination and ultrasonographic evaluation recommended in affected females	1	NBK1176	
carriers (heterozygotes)	1	NBK1176	
parents	1	NBK1176	
at-risk sibs	1	NBK1176	
similarly, unnecessary exposure to ionizing radiation should be avoided	1	NBK1176	
gov/books/n/gene/nkh	1	NBK1357	
mri of the brain in neonates	1	NBK1357	
developmental assessment throughout the first years of life	1	NBK1357	
no effective treatment for severe glycine encephalopathy exists	1	NBK1357	
flusser et al 2005	1	NBK1357	
van hove et al, unpublished]	1	NBK1357	
it increases alertness	1	NBK1357	
nmda receptor site antagonists	1	NBK1357	
use of each has resulted in improved seizure control	1	NBK1357	
this may be different in mildly affected children	1	NBK1357	
blood concentration can be monitored	1	NBK1357	
seizure control is important for symptomatic benefit	1	NBK1357	
various antiepileptic drugs have been used with variable success	1	NBK1357	
most affected individuals need physical therapy	1	NBK1357	
scoliosis is managed with standard techniques	1	NBK1357	
patients on sodium benzoate should have plasma carnitine concentration monitored	1	NBK1357	
severely affected individuals should be monitored for scoliosis	1	NBK1357	
gov/books/n/gene/nkx2-1-dis	1	NBK185066	
for benign hereditary chorea*	1	NBK185066	
pulmonary consultation for further evaluation and treatment of pulmonary dysfunction	1	NBK185066	
endocrinology consultation for further evaluation and treatment of thyroid abnormalities	1	NBK185066	
chorea	1	NBK185066	
children: 0	1	NBK185066	
adults: 37	1	NBK185066	
5 mg/day starting dose divided in 2-3 doses	1	NBK185066	
of note:	1	NBK185066	
other neurologic manifestations	1	NBK185066	
pulmonary dysfunction	1	NBK185066	
treat asthma and interstitial lung disease as needed	1	NBK185066	
thyroid hormone replacement therapy is recommended	1	NBK185066	
gov/books/n/gene/noonan	1	NBK1124	
plotting of growth parameters on ns growth charts	1	NBK1124	
urinalysis if the urinary tract is anomalous	1	NBK1124	
there is substantial early mortality associated with hypertrophic cardiomyopathy	1	NBK1124	
significant short stature compared with normal peers	1	NBK1124	
documented response to gh treatment in studies	1	NBK1124	
no standard dose has been established	1	NBK1124	
the increase in height sd varies from 0	1	NBK1124	
6 to 1	1	NBK1124	
gov/books/n/gene/norrie	1	NBK1331	
behavioral evaluation as needed	1	NBK1331	
ophthalmologic evaluation is warranted	1	NBK1331	
at 23 months of life	1	NBK1331	
5 months) [walsh et al 2010]	1	NBK1331	
observation for clinical evidence of venous stasis or ulcer disease	1	NBK1331	
gov/books/n/gene/npab	1	NBK1370	
infants with npd-a	1	NBK1370	
ophthalmologic examination, if not yet performed	1	NBK1370	
comprehensive neurologic evaluation	1	NBK1370	
compete blood count	1	NBK1370	
serum chemistries including liver function tests	1	NBK1370	
dietary consultation	1	NBK1370	
occupational and physical therapy evaluations	1	NBK1370	
chest radiograph to assess the extent of interstitial lung disease	1	NBK1370	
bone age in children under age 18 years	1	NBK1370	
liver biopsy in individuals with evidence of deteriorating liver function	1	NBK1370	
severe neurodegenerative form (npd-a)	1	NBK1370	
progressive neurologic disease	1	NBK1370	
regular consultation with a dietician should be provided	1	NBK1370	
sleep disorder	1	NBK1370	
most affected individuals have thrombocytopenia	1	NBK1370	
individuals with symptomatic pulmonary disease may require supplemental oxygen	1	NBK1370	
variable results have been reported with hsct	1	NBK1370	
, statins for treatment of hypercholesterolemia)	1	NBK1370	
nutrition status	1	NBK1370	
occupational and physical therapy needs	1	NBK1370	
fatigue	1	NBK1370	
bleeding, shortness of breath	1	NBK1370	
extremity pain	1	NBK1370	
physical examination including assessment of neurologic function	1	NBK1370	
pulmonary function testing and chest radiograph	1	NBK1370	
individuals who have splenomegaly should avoid contact sports	1	NBK1370	
gov/books/n/gene/npc	1	NBK1296	
mri of the head	1	NBK1296	
no curative therapy for npc exists	1	NBK1296	
sleep disturbances are common in npc	1	NBK1296	
a clinical trial is being considered	1	NBK1296	
gov/books/n/gene/nsdhl-dis	1	NBK51754	
radiologic examination of trunk and extremities for skeletal malformations	1	NBK51754	
abdominal and pelvic ultrasounds examination to identify visceral malformations	1	NBK51754	
chest imaging to evaluate for lung hypoplasia	1	NBK51754	
echocardiogram to identify cardiac involvement	1	NBK51754	
magnetic resonance imaging to determine brain involvement	1	NBK51754	
evaluation of neurologic history and eeg for evidence of seizures	1	NBK51754	
psychoeducational evaluations to define delays and facilitate appropriate interventions	1	NBK51754	
orthopedic evaluation to determine the presence of scoliosis/kyphosis	1	NBK51754	
oral aromatic retinoids (etretinate) to ameliorate cutaneous symptoms	1	NBK51754	
topical statins	1	NBK51754	
dermatologic surgery	1	NBK51754	
other medical care as appropriate based on clinical findings	1	NBK51754	
antiepileptic drugs (aed) to control seizures	1	NBK51754	
ophthalmologic management of ocular abnormalities	1	NBK51754	
neurologic surveillance of seizures for readjustment of medications if necessary	1	NBK51754	
orthopedic surveillance for scoliosis/kyphosis	1	NBK51754	
gov/books/n/gene/oca1	1	NBK1166	
ophthalmologic care	1	NBK1166	
surgery may improve peripheral binocularity or appearance	1	NBK1166	
nystagmus surgery remains highly controversial	1	NBK1166	
additional classroom aids may include:	1	NBK1166	
high contrast reading materials (black on white)	1	NBK1166	
large font texts or xerographically enlarged worksheets	1	NBK1166	
computers and tablets with zoom-magnification text software	1	NBK1166	
skin that burns with sun exposure needs protection	1	NBK1166	
an early (pediatric) dermatologic consultation is warranted	1	NBK1166	
gov/books/n/gene/oca2	1	NBK1232	
skin cancer is treated as for the general population	1	NBK1232	
prolonged unprotected sun exposure should be avoided	1	NBK1232	
additional testing is not indicated	1	NBK1232	
gov/books/n/gene/oca4	1	NBK1510	
assessment for strabismus	1	NBK1510	
a hat with a brim (e	1	NBK1510	
avoid prolonged exposure of the skin to the sun	1	NBK1510	
gov/books/n/gene/ofd1	1	NBK1188	
formal, age-appropriate assessment of development and behavior	1	NBK1188	
evaluation of cns involvement	1	NBK1188	
blood pressure and serum creatinine concentration	1	NBK1188	
audiology evaluation if cleft palate is present	1	NBK1188	
removal of accessory teeth	1	NBK1188	
orthodontia for malocclusion	1	NBK1188	
surgery to repair syndactyly, if present	1	NBK1188	
routine management of seizures	1	NBK1188	
gov/books/n/gene/oi	1	NBK1295	
physical examination to assess deformities and presence of joint laxity	1	NBK1295	
hearing assessed through formal audiology	1	NBK1295	
physical medicine treatment	1	NBK1295	
avoid sudden acceleration/deceleration movements	1	NBK1295	
and avoid throwing a child in the air	1	NBK1295	
older children should not ride on amusement park rides	1	NBK1295	
physical activity serves a number of purposes	1	NBK1295	
analgesics can be used to control pain from fractures	1	NBK1295	
casts should be small and lightweight	1	NBK1295	
these studies are still ongoing	1	NBK1295	
a study comparing pamidronate to zoledronic acid was completed	1	NBK1295	
to date, the results have not been published	1	NBK1295	
basilar impression	1	NBK1295	
criteria for surgical intervention are not well defined	1	NBK1295	
plastic polymers are sometimes used to coat teeth	1	NBK1295	
outcome data are limited	1	NBK1295	
management of lethal oi	1	NBK1295	
contact sports should be avoided	1	NBK1295	
gov]	1	NBK1295	
gov/books/n/gene/ondine	1	NBK1427	
assessment in a pediatric respiratory physiology laboratory, with:	1	NBK1427	
neurocognitive assessment to determine baseline function	1	NBK1427	
see table 4 for additional details	1	NBK1427	
, pulse oximeter) and ventilation (i	1	NBK1427	
ongoing studies have not confirmed this report	1	NBK1427	
hirschsprung disease	1	NBK1427	
tumors of neural crest origin	1	NBK1427	
phox2b variant	1	NBK1427	
annual in-hospital comprehensive testing 1	1	NBK1427	
annual neurocognitive assessment	1	NBK1427	
annual 72-hr holter and ecg	1	NBK1427	
hirschsprung disease assessment	1	NBK1427	
tumors of neural crest origin assessment	1	NBK1427	
parm genotype:20/24, 20/25	1	NBK1427	
parm genotype: 20/26, 20/27	1	NBK1427	
parm genotype: 20/2820/33	1	NBK1427	
nparm	1	NBK1427	
x 3	1	NBK1427	
deletion/ duplication 4	1	NBK1427	
ideally, children with cchs should not go swimming	1	NBK1427	
gov/books/n/gene/opa	1	NBK1248	
no treatment for opa1 is of proven efficacy	1	NBK1248	
for treatment of ataxia, see ataxia overview	1	NBK1248	
individuals with an opa1 pathogenic variant are advised:	1	NBK1248	
not to smoke	1	NBK1248	
to moderate their alcohol intake	1	NBK1248	
to use sunglasses to limit uv exposure	1	NBK1248	
valerio carelli, university of bologna)	1	NBK1248	
gov/books/n/gene/opd	1	NBK1393	
full clinical examination	1	NBK1393	
full radiologic skeletal survey	1	NBK1393	
audiometry (see deafness and hereditary hearing loss overview)	1	NBK1393	
ear, nose, and throat examination	1	NBK1393	
renal tract ultrasound examination	1	NBK1393	
hand and foot malformations may also require surgery	1	NBK1393	
surgical correction of limb bowing has not been reported	1	NBK1393	
apnea prevention	1	NBK1393	
clinical evaluation for development of orthopedic manifestations (e	1	NBK1393	
gov/books/n/gene/opitz	1	NBK1327	
age-appropriate assessment of development and intellectual abilities	1	NBK1327	
assessment of anal position and patency	1	NBK1327	
cranial imaging	1	NBK1327	
treatment as needed by an ophthalmologist	1	NBK1327	
surgical intervention as needed for hypospadias	1	NBK1327	
surgical treatment of medically significant laryngotracheoesophageal (lte) abnormalities	1	NBK1327	
surgical management for cleft lip/palate and other craniofacial anomalies	1	NBK1327	
neuropsychological support	1	NBK1327	
surgical intervention for imperforate anus	1	NBK1327	
surgical repair as needed for heart defects	1	NBK1327	
all primary manifestations are present at birth	1	NBK1327	
cardiac follow-up for those with cardiac defects	1	NBK1327	
gov/books/n/gene/opmd	1	NBK1126	
ptosis	1	NBK1126	
however, the procedure requires general anesthesia	1	NBK1126	
food should be cut into small pieces	1	NBK1126	
to reduce the risk for these complications:	1	NBK1126	
annual flu vaccination is recommended for elderly affected individuals	1	NBK1126	
dietary supplements should be added if weight loss is significant	1	NBK1126	
gov/books/n/gene/otc-def	1	NBK154378	
plasma amino acid analysis	1	NBK154378	
laboratory values that reflect nutritional status (e	1	NBK154378	
pt/ptt and fibrinogen	1	NBK154378	
developmental/neuropsychological/psychological evaluation	1	NBK154378	
care of hyperammonemic coma	1	NBK154378	
rapid lowering of the plasma ammonia	1	NBK154378	
ammonia scavenger therapy	1	NBK154378	
citrulline is supplemented at 170 mg/kg/day or 3	1	NBK154378	
8g/m2/day (enterally)	1	NBK154378	
loading 1 and maintenance dose 2, 3	1	NBK154378	
sodium phenylacetate & sodium benzoate 4	1	NBK154378	
arginine hcl injection, 10%	1	NBK154378	
arginine hcl 5	1	NBK154378	
<25 kg	1	NBK154378	
undiluted: 2	1	NBK154378	
0 ml at 100 mg/ml	1	NBK154378	
≥25 kg	1	NBK154378	
40 ml at 100 mg/ml	1	NBK154378	
4,000 mg/m2	1	NBK154378	
protein intake	1	NBK154378	
recommendations for ammonia scavenger therapy:	1	NBK154378	
0 g/m2/day of sodium phenylbutyrate and 3	1	NBK154378	
it is typically performed by age six months	1	NBK154378	
attention deficit/hyperactivity disorder (adhd)	1	NBK154378	
seizure disorders	1	NBK154378	
learning disability/intellectual disability	1	NBK154378	
also see urea cycle disorders overview	1	NBK154378	
minimize risk of respiratory and gastrointestinal illnesses through hand hygiene	1	NBK154378	
provide multivitamin and vitamin d supplementation	1	NBK154378	
use antipyretics appropriately	1	NBK154378	
valproate	1	NBK154378	
haloperidol	1	NBK154378	
stress, especially physical stress	1	NBK154378	
potentially also psychological stress	1	NBK154378	
at the same time, preemptive measures (e	1	NBK154378	
gov, lichter-konecki et al 2013]	1	NBK154378	
current gene therapy approach	1	NBK154378	
gov/books/n/gene/pai-1-def	1	NBK447152	
questions to elicit a patient’s history of:	1	NBK447152	
epistaxis	1	NBK447152	
poor wound healing	1	NBK447152	
bleeding in association with injury or trauma	1	NBK447152	
bleeding with dental extractions	1	NBK447152	
additional oral bleeding	1	NBK447152	
post-surgical bleeding	1	NBK447152	
in females:	1	NBK447152	
heavy menstrual bleeding	1	NBK447152	
postpartum bleeding	1	NBK447152	
bleeding during pregnancy	1	NBK447152	
bleeding in association with ovulation	1	NBK447152	
evaluation by a hematologist with training in hemostasis	1	NBK447152	
for menstruating females:	1	NBK447152	
ghosh et al 2013	1	NBK447152	
high-risk activities such as contact sports	1	NBK447152	
the first pregnancy ended in miscarriage at 19 weeks	1	NBK447152	
gov/books/n/gene/pancreatitis-ov	1	NBK190101	
pancreatectomy	1	NBK190101	
issues to consider prior to referral for tpiat:	1	NBK190101	
the operation is irreversible	1	NBK190101	
pain relief is not universal	1	NBK190101	
chronic pancreatitis	1	NBK190101	
cholecystokinin (cck) and its analogs (e	1	NBK190101	
, mineral oil, olestra), or	1	NBK190101	
, orlistat), or	1	NBK190101	
routine screening of patients with chronic pancreatitis for glucose intolerance	1	NBK190101	
however, small meals may minimize pancreatic exocrine stimulation	1	NBK190101	
circumstances to avoid	1	NBK190101	
gov/books/n/gene/papr	1	NBK1451	
evaluation of renal structure by renal ultrasound examination	1	NBK1451	
urinalysis to evaluate for the presence of blood and protein	1	NBK1451	
esrd is treated with renal replacement therapy (i	1	NBK1451	
, dialysis and/or renal transplantation)	1	NBK1451	
no disease-specific guidelines have been developed	1	NBK1451	
follow up by an ophthalmologist to monitor vision	1	NBK1451	
audiometric evaluation with periodic follow up	1	NBK1451	
gov/books/n/gene/paragangliomas	1	NBK1548	
registration or institutional access required)	1	NBK1548	
most are benign and can be completely excised	1	NBK1548	
preoperative	1	NBK1548	
a liberal sodium diet	1	NBK1548	
, 3 days prior to surgery)	1	NBK1548	
postoperative	1	NBK1548	
sdhc, sdhd,	1	NBK1548	
in persons with sdhb pathogenic variants, periodic (e	1	NBK1548	
sdhc, sdhd, sdhaf2, or max	1	NBK1548	
, pre-eclampsia)	1	NBK1548	
gov/books/n/gene/parkinson-overview	1	NBK1223	
occupational, physical, and speech therapy are often helpful	1	NBK1223	
gov/books/n/gene/pbd	1	NBK1448	
vision (comprehensive ophthalmologic assessment)	1	NBK1448	
treatment focuses on symptomatic therapy	1	NBK1448	
no specific metabolic diet is recommended	1	NBK1448	
neurologic function	1	NBK1448	
early intervention services should be provided	1	NBK1448	
seizures are present in approximately one third of affected individuals	1	NBK1448	
standard antiepileptic drugs (aeds) may be used	1	NBK1448	
no type of aed is contraindicated	1	NBK1448	
no curative therapy is presently available for pbd, zss	1	NBK1448	
hearing should be evaluated annually	1	NBK1448	
annual ophthalmologic evaluation is indicated	1	NBK1448	
visual field testing is much more helpful	1	NBK1448	
coagulation factors and other synthetic liver functions should be monitored	1	NBK1448	
persons with overt hepatic dysfunction require more routine monitoring	1	NBK1448	
the use of routine neuroimaging is uncertain	1	NBK1448	
individuals with peroxisomal disorders may develop a progressive leukodystrophy	1	NBK1448	
gov/books/n/gene/pc-hypo-p	1	NBK9673	
pch2	1	NBK9673	
919g>t (p	1	NBK9673	
ala307ser)	1	NBK9673	
all other subtypes are very rare	1	NBK9673	
the main problems to manage:	1	NBK9673	
central visual impairment	1	NBK9673	
epilepsy, which is amenable to standard treatments	1	NBK9673	
physiotherapy can be helpful	1	NBK9673	
pch4 and pch5	1	NBK9673	
respiratory support is usually given for a limited time	1	NBK9673	
no treatment for the condition is available	1	NBK9673	
birth is usually normal and uncomplicated	1	NBK9673	
fetal akinesia often causes congenital contractures	1	NBK9673	
clonus persists after birth and is usually severe	1	NBK9673	
absence of respiratory movement necessitates mechanical support at birth	1	NBK9673	
gov/books/n/gene/pc	1	NBK1280	
thorough clinical examination to assess each affected area	1	NBK1280	
palmoplantar keratoderma	1	NBK1280	
however, trimming too aggressively can greatly increase pain	1	NBK1280	
topical therapies to remove the hyperkeratosis:	1	NBK1280	
occlusive ointments are often poorly tolerated	1	NBK1280	
nail dystrophy	1	NBK1280	
particularly troublesome nails can be successfully removed surgically	1	NBK1280	
oral leukokeratosis	1	NBK1280	
follicular hyperkeratosis	1	NBK1280	
leukokeratosis with laryngeal involvement	1	NBK1280	
cysts	1	NBK1280	
intralesional injection of steroid (e	1	NBK1280	
if necessary, cysts can be excised	1	NBK1280	
consistent, regular care of the conditions is necessary	1	NBK1280	
antibiotics may be indicated when infection occurs	1	NBK1280	
asn171lys mutated allele [leachman et al 2010]	1	NBK1280	
several persons have been treated with statins	1	NBK1280	
the results from studies are mixed	1	NBK1280	
gov/books/n/gene/pcd	1	NBK1122	
pulse oximetry, with overnight saturation studies if borderline	1	NBK1122	
nasal congestion and/or sinus symptoms	1	NBK1122	
chronic/recurrent ear infections	1	NBK1122	
at present, no specific therapies can correct ciliary dysfunction	1	NBK1122	
, vigorous exercise)	1	NBK1122	
routine immunizations to protect against respiratory pathogens:	1	NBK1122	
pertussis	1	NBK1122	
haemophilus influenzae type b	1	NBK1122	
pneumococcal vaccine	1	NBK1122	
annual influenza virus vaccine	1	NBK1122	
this approach, however, is controversial	1	NBK1122	
nasal congestion and sinus infections	1	NBK1122	
chronic/recurrent ear infection	1	NBK1122	
male infertility	1	NBK1122	
situs abnormalities	1	NBK1122	
appropriate preventive measures:	1	NBK1122	
gov/books/n/gene/pdc	1	NBK6852	
brain mri and mrs analysis	1	NBK6852	
minimize intercurrent infections as environmental stressors	1	NBK6852	
individuals with pc deficiency are very brittle metabolically	1	NBK6852	
monitor lactate levels regularly	1	NBK6852	
the ketogenic diet, which aggravates life-threatening metabolic acidosis	1	NBK6852	
the precise molecular diagnosis in these cases is uncertain	1	NBK6852	
gov/books/n/gene/pds	1	NBK1486	
special education programs should be offered	1	NBK1486	
5 mg for infants and 2 mg for adults	1	NBK1486	
studies have indicated that higher doses may enhance intellectual development	1	NBK1486	
such therapy is required for life	1	NBK1486	
regular assessments of intellectual function should be offered	1	NBK1486	
if not, treatment can be withdrawn	1	NBK1486	
specifically, the silent nucleotide change c	1	NBK1486	
gov/books/n/gene/peaf	1	NBK1537	
routine interictal eeg	1	NBK1537	
routine clinical imaging to rule out structural abnormalities	1	NBK1537	
, carbamazepine, phenytoin, valproate)	1	NBK1537	
, avoidance of unattended swimming)	1	NBK1537	
gov/books/n/gene/pendred	1	NBK1467	
vestibular function studies	1	NBK1467	
hearing habilitation (hearing aids as early as possible)	1	NBK1467	
educational programs designed for individuals with hearing impairment	1	NBK1467	
semiannual or annual examination by an endocrinologist familiar with pds	1	NBK1467	
gov/books/n/gene/perrault	1	NBK242617	
provision should be made for any special educational needs	1	NBK242617	
estrogen can be administered orally or topically	1	NBK242617	
before considering pregnancy, uterine size should be assessed	1	NBK242617	
for individuals with hearing loss:	1	NBK242617	
avoid ototoxic medication such as aminoglycosides if alternatives are available	1	NBK242617	
gov/books/n/gene/perry	1	NBK47027	
neurologic evaluation of motor function	1	NBK47027	
psychiatric evaluation and (if needed) neuropsychological examination	1	NBK47027	
weight loss	1	NBK47027	
adequate caloric intake must be ensured to prevent weight loss	1	NBK47027	
use of central respiratory depressants (e	1	NBK47027	
gov/books/n/gene/peters-plus	1	NBK1464	
echocardiography for congenital heart malformations	1	NBK1464	
abdominal ultrasound examination for renal anomalies	1	NBK1464	
additional management is symptomatic and expectant	1	NBK1464	
regular developmental assessments	1	NBK1464	
agents that increase risk of glaucoma (e	1	NBK1464	
, corticosteroids) are to be avoided	1	NBK1464	
gov/books/n/gene/pf	1	NBK1230	
clinical history	1	NBK1230	
chest radiograph	1	NBK1230	
thoracic society 2000, american thoracic	1	NBK1230	
society & european respiratory society 2002]	1	NBK1230	
transplantation are good candidates	1	NBK1230	
five-year survival rates post transplant in	1	NBK1230	
non-pharmologic treatments:	1	NBK1230	
oxygen therapy may improve exercise tolerance in patients with	1	NBK1230	
hypoxemia	1	NBK1230	
pulmonary rehabilitation is a recommended option for patients who would	1	NBK1230	
benefit	1	NBK1230	
ipf	1	NBK1230	
immunosuppressive/cytotoxic agents, and antifibrotic agents	1	NBK1230	
however, at least	1	NBK1230	
two antifibrotic pharmacologic interventions recently approved may be an option	1	NBK1230	
see therapies under	1	NBK1230	
investigation	1	NBK1230	
prevention and prompt treatment of acute exacerbations	1	NBK1230	
treatment of coexisting comorbidities if appropriate including:	1	NBK1230	
gastroesophageal reflux disease (gerd)	1	NBK1230	
pulmonary embolism	1	NBK1230	
lung cancer	1	NBK1230	
coronary artery disease	1	NBK1230	
pneumothorax	1	NBK1230	
aspiration	1	NBK1230	
the patient's individual diagnosis and status	1	NBK1230	
surveillance would follow the	1	NBK1230	
guidelines for ipf [raghu et	1	NBK1230	
al 2011] or the specific type of iip	1	NBK1230	
those who are stable may be	1	NBK1230	
pulmonary function studies including the following to serially monitor	1	NBK1230	
disease course [raghu	1	NBK1230	
et al 2011]:	1	NBK1230	
saturation change at baseline	1	NBK1230	
monitoring for progression of disease by hrct of the chest	1	NBK1230	
oxygen saturation by resting pulse oximetry	1	NBK1230	
suspected of an underlying possibility for ctd-related ild	1	NBK1230	
monitoring for any side effects known from pharmacologic treatments	1	NBK1230	
symptom control	1	NBK1230	
possible those who would benefit from initiation of treatment	1	NBK1230	
1994a, schwartz et al 1994b]	1	NBK1230	
it is recommended that every five years, asymptomatic	1	NBK1230	
standardized questionnaire to assess the presence of respiratory	1	NBK1230	
family members are considered to have a positive screening	1	NBK1230	
evaluation (i	1	NBK1230	
, to possibly have pulmonary fibrosis) if they	1	NBK1230	
family members	1	NBK1230	
radiologic and histopathologic abnormalities suggestive of possible	1	NBK1230	
early interstitial lung disease	1	NBK1230	
it is unknown if these findings would	1	NBK1230	
become symptomatic fpf in the subjects	1	NBK1230	
see genetic	1	NBK1230	
genetic counseling purposes	1	NBK1230	
several therapies remain under investigation for the treatment of ipf	1	NBK1230	
anticoagulation, and various chemokine and monoclonal antibodies among other	1	NBK1230	
targets remain under investigation as potential treatments	1	NBK1230	
two antifibrotic	1	NBK1230	
pirfenidone [king et al	1	NBK1230	
2014] and nintedanib [richeldi et al 2014]	1	NBK1230	
the former has	1	NBK1230	
gov for access to information	1	NBK1230	
gov/books/n/gene/pfcp	1	NBK395975	
recording of symptoms of hyperviscosity syndrome and their severity:	1	NBK395975	
hyperviscosity syndrome symptoms:	1	NBK395975	
headache	1	NBK395975	
dizziness	1	NBK395975	
altered mentation, sense of distance	1	NBK395975	
visual disturbances	1	NBK395975	
tinnitus	1	NBK395975	
paraesthesia	1	NBK395975	
low performance	1	NBK395975	
fatigue, lassitude	1	NBK395975	
myalgia, muscle weakness	1	NBK395975	
hyperviscosity syndrome severity:	1	NBK395975	
mild	1	NBK395975	
does not interfere with normal activities	1	NBK395975	
moderate	1	NBK395975	
interferes with some activities	1	NBK395975	
marked to severe	1	NBK395975	
interferes with most or all activities	1	NBK395975	
no management guidelines have been published	1	NBK395975	
the majority of individuals with pfcp require no regular treatment	1	NBK395975	
when symptoms of the hyperviscosity syndrome are evident	1	NBK395975	
hyperviscosity symptoms (see	1	NBK395975	
evaluations following initial diagnosis)	1	NBK395975	
in the presence of persistent symptoms perform phlebotomy	1	NBK395975	
consider additional aspirin treatment	1	NBK395975	
thromboembolic events	1	NBK395975	
provide acute treatment according to established practice for the event	1	NBK395975	
evaluate for other thrombophilic risk factors	1	NBK395975	
consider additional aspirin treatment in all patients	1	NBK395975	
consider life-long anticoagulation (e	1	NBK395975	
always maintain good hydration	1	NBK395975	
avoid activities that potentially increase blood viscosity (e	1	NBK395975	
, mountain climbing, scuba diving, smoking)	1	NBK395975	
any activity that would potentially increase blood viscosity	1	NBK395975	
if the epor pathogenic variant in the family is known	1	NBK395975	
if no pathogenic variant has been identified in the family	1	NBK395975	
gov/books/n/gene/pfic	1	NBK1297	
standard biochemical assays of hepatocellular function and of hepatobiliary injury	1	NBK1297	
pharmacologic therapy	1	NBK1297	
nutritional therapy and supplementation	1	NBK1297	
nasogastric tube feeding has been useful in some infants	1	NBK1297	
other approaches	1	NBK1297	
interruption of the enterohepatic circulation of bile acids	1	NBK1297	
the internal biliary bypass approach of cholecystojejunocolic anastomosis	1	NBK1297	
liver transplantation (ltx)	1	NBK1297	
steatohepatitis can be progressive and lead to cirrhosis	1	NBK1297	
extrahepatic manifestations	1	NBK1297	
periodic monitoring for fat-soluble vitamin deficiency is recommended	1	NBK1297	
gov/books/n/gene/ph1	1	NBK1283	
the following are recommended in all cases:	1	NBK1283	
for those with preserved renal function (i	1	NBK1283	
73 m2):	1	NBK1283	
baseline urinalysis (spot and 24 hour collection)	1	NBK1283	
for those with a gfr <60 ml/min/1	1	NBK1283	
73 m2	1	NBK1283	
for those with a gfr <30 ml/min/1	1	NBK1283	
in addition to the above evaluations:	1	NBK1283	
the general therapies for nephrolithiasis benefit all individuals with ph1	1	NBK1283	
patients should be advised to seek early medical attention	1	NBK1283	
alkalinzation of urine (ph 6	1	NBK1283	
2-6	1	NBK1283	
15 mg/kg or 0	1	NBK1283	
3-0	1	NBK1283	
treatment of kidney stones	1	NBK1283	
swl	1	NBK1283	
ureteroscopy	1	NBK1283	
percutaneous nephrolithotomy and ureteroscopy	1	NBK1283	
reduction of oxalate biosynthesis	1	NBK1283	
agt is a pyridoxal phosphate (plp)-dependent enzyme	1	NBK1283	
7 mmol/1	1	NBK1283	
phe152ile pathogenic allele	1	NBK1283	
73 m2/day)	1	NBK1283	
transplantation (tx) options:	1	NBK1283	
simultaneous liver - kidney	1	NBK1283	
sequential liver - kidney	1	NBK1283	
isolated kidney	1	NBK1283	
isolated liver	1	NBK1283	
hemodialysis (hd) strategy:	1	NBK1283	
perioperative ± postoperative based on pox & gfr	1	NBK1283	
preoperative & perioperative	1	NBK1283	
sometimes perioperative	1	NBK1283	
ckd category / residual gfr	1	NBK1283	
ckd category 3 (30<gfr<59)	1	NBK1283	
option in carefully selected patients	1	NBK1283	
ckd category 4 (15<gfr<29)	1	NBK1283	
option	1	NBK1283	
ckd category 5 (gfr <15)	1	NBK1283	
infantile form (esrd <2 yrs)	1	NBK1283	
use of deceased vs	1	NBK1283	
living donors for either or both organs	1	NBK1283	
, gfr >60 ml/min/1	1	NBK1283	
secondary complications may arise as a result of systemic oxalosis	1	NBK1283	
preserved renal function (i	1	NBK1283	
ongoing urinalysis (spot and 24-hour collections)	1	NBK1283	
gfr <60 ml/min/1	1	NBK1283	
gfr <30 ml/min/1	1	NBK1283	
intravascular volume depletion	1	NBK1283	
the importance of maintaining dilute urine cannot be overemphasized	1	NBK1283	
asymptomatic individuals:	1	NBK1283	
can be monitored periodically for renal function and urinary oxalate	1	NBK1283	
should maintain adequate hydration and avoid high-oxalate foods	1	NBK1283	
in addition:	1	NBK1283	
for those with the pathogenic variant p	1	NBK1283	
gly170arg or p	1	NBK1283	
phe152ile, pyridoxine should be supplemented	1	NBK1283	
several novel therapies are under investigation	1	NBK1283	
oxalate-degrading bacteria	1	NBK1283	
a human strain of o	1	NBK1283	
brevis, streptococcus thermophilus, and bifidobacterium infantis	1	NBK1283	
cerevisiae, and fructooligosaccharide	1	NBK1283	
longum, b	1	NBK1283	
infantis, lactobactillus acidophlus, l	1	NBK1283	
plantarum, l	1	NBK1283	
paracasei, and l	1	NBK1283	
this study must be validated in individuals with ph1	1	NBK1283	
in agxt-deficient mice colonized with o	1	NBK1283	
advances have been made to circumvent the colonization of o	1	NBK1283	
other bacterial species	1	NBK1283	
acidophilus, bifidobacgerium breve, and b	1	NBK1283	
longum	1	NBK1283	
hepatocyte transplantation	1	NBK1283	
the exact protocol is outlined in the paper	1	NBK1283	
pyridoxamine	1	NBK1283	
chemical chaperones	1	NBK1283	
gly170arg, p	1	NBK1283	
phe152ile,or p	1	NBK1283	
manipulation of the metabolic pathway	1	NBK1283	
auxiliary liver transplant	1	NBK1283	
gov/books/n/gene/ph2	1	NBK2692	
assessment of renal function	1	NBK2692	
bone x-rays to look for radiodense metaphyseal bands	1	NBK2692	
ophthalmic examination of the retina to look for oxalate crystals	1	NBK2692	
evaluation of cardiac function by echocardiography	1	NBK2692	
adequate fluid intake (>2	1	NBK2692	
5 l/m2 surface area/day)	1	NBK2692	
urinary inhibitors of calcium oxalate crystallization:	1	NBK2692	
potassium citrate (0	1	NBK2692	
frequency of testing depends on the center	1	NBK2692	
quarterly	1	NBK2692	
six monthly to annually	1	NBK2692	
excessive ascorbate (i	1	NBK2692	
, vitamin c	1	NBK2692	
>1000 mg/day)	1	NBK2692	
gov/books/n/gene/ph3	1	NBK316514	
assessment of kidney function by serum creatinine and egfr	1	NBK316514	
maintainance of high oral fluid intake (>2	1	NBK316514	
5 l/m2 bsa)	1	NBK316514	
oral administration of an inhibitor of calcium oxalate crystallization	1	NBK316514	
avoidance of supersaturation of calcium oxalate in the blood	1	NBK316514	
avoidance of marked dietary oxalate excess	1	NBK316514	
simple avoidance of marked dietary oxalate excess is recommended	1	NBK316514	
24 hour urine oxalate and supersaturation study	1	NBK316514	
delays in treatment of acute stone episodes	1	NBK316514	
nephrotoxic agents	1	NBK316514	
marked dietary oxalate excess	1	NBK316514	
high-dose ascorbic acid	1	NBK316514	
, heterozygous for one hoga1 pathogenic variant)	1	NBK316514	
adequate fluid intake should be maintained throughout the pregnancy	1	NBK316514	
humans cannot degrade oxalate	1	NBK316514	
preliminary studies suggest that oral administration of o	1	NBK316514	
formigenes could reduce oxalate excretion in individuals with ph	1	NBK316514	
gov/books/n/gene/pha2	1	NBK65707	
serum electrolyte analysis	1	NBK65707	
noninvasive blood pressure measurement	1	NBK65707	
metabolic abnormalities and hypertension generally improve within one week	1	NBK65707	
different thiazide diuretics exist, with different dosing regimens	1	NBK65707	
measurement of serum potassium concentration and blood pressure	1	NBK65707	
gov/books/n/gene/phs	1	NBK1465	
assessment for cortisol deficiency	1	NBK1465	
cranial mri to establish the location and extent of hamartoma	1	NBK1465	
visualization of the epiglottis by laryngoscopy	1	NBK1465	
limb radiographs to distinguish postaxial polydactyly from central polydactyly	1	NBK1465	
renal ultrasonography to evaluate for renal anomalies	1	NBK1465	
surgical consultation for imperforate anus or anal stenosis if present	1	NBK1465	
anal atresia or stenosis should be treated in standard fashion	1	NBK1465	
, hypothalamic hamartoma)	1	NBK1465	
during childhood:	1	NBK1465	
annual screening for developmental delay or learning disorders	1	NBK1465	
gov/books/n/gene/phts	1	NBK1488	
complete medical history and family history	1	NBK1488	
in children: consideration of neurodevelopmental evaluation	1	NBK1488	
urinalysis with cytospin	1	NBK1488	
for women age ≥30 years at diagnosis*:	1	NBK1488	
breast screening (at minimum mammogram	1	NBK1488	
mri may also be incorporated)	1	NBK1488	
transvaginal ultrasound or endometrial biopsy	1	NBK1488	
if asymptomatic, observation alone is prudent	1	NBK1488	
when symptomatic, topical agents (e	1	NBK1488	
current suggested screening by age follows:	1	NBK1488	
cowden syndrome	1	NBK1488	
pediatric (age <18 years)	1	NBK1488	
yearly skin check with physical examination	1	NBK1488	
adult	1	NBK1488	
yearly thyroid ultrasound** and dermatologic evaluation	1	NBK1488	
women beginning at age 30 years:	1	NBK1488	
monthly breast self-examination**	1	NBK1488	
yearly breast screening (at minimum mammogram)	1	NBK1488	
mri may also be incorporated	1	NBK1488	
yearly transvaginal ultrasound or endometrial biopsy**	1	NBK1488	
for men and women:	1	NBK1488	
colonoscopy beginning at age 35 years**	1	NBK1488	
frequency dependent on degree of polyposis identified	1	NBK1488	
bannayan-riley-ruvalcaba syndrome	1	NBK1488	
screening recommendations have not been established for brrs	1	NBK1488	
proteus syndrome/proteus-like syndrome	1	NBK1488	
, pain, deformity) are significant	1	NBK1488	
a clinical trial specifically directed at phts recently concluded	1	NBK1488	
gov/books/n/gene/pik3ca-overgrowth	1	NBK153722	
a baseline renal ultrasound to evaluate for structural renal abnormalities	1	NBK153722	
leg-length discrepancy secondary to segmental somatic overgrowth	1	NBK153722	
cardiac abnormalities (i	1	NBK153722	
, structural cardiovascular disease and arrhythmias)	1	NBK153722	
renal abnormalities	1	NBK153722	
speech, swallowing, and feeding difficulties	1	NBK153722	
neurologic and neurosurgical manifestations	1	NBK153722	
hmeg	1	NBK153722	
somatic overgrowth, vascular, lymphatic and musculoskeletal manifestations	1	NBK153722	
a medical history with attention to:	1	NBK153722	
childhood cancer	1	NBK153722	
breathing or sleep problems	1	NBK153722	
a detailed neurologic evaluation	1	NBK153722	
cloves syndrome	1	NBK153722	
therefore, diligent surgical care and monitoring are recommended	1	NBK153722	
fibroadipose hyperplasia	1	NBK153722	
gov/books/n/gene/pink1-pd	1	NBK26472	
assessment for cognitive or behavioral problems	1	NBK26472	
gov/books/n/gene/pitt-hopkins	1	NBK100240	
child behavior specialist to aid with behavioral concerns	1	NBK100240	
child neurology evaluation if there are concerns about seizure episodes	1	NBK100240	
gastroenterology evaluation to establish treatment regimen for chronic constipation	1	NBK100240	
infant feeding assessment to address early hypotonia as needed	1	NBK100240	
behavioral modification for self-injurious behavior or anxiety	1	NBK100240	
eyeglasses or surgery as needed for amblyopia	1	NBK100240	
orthopedic treatment of scoliosis as indicated	1	NBK100240	
standard care for other medical issues	1	NBK100240	
gov/books/n/gene/pjs	1	NBK1266	
colonoscopy beginning at age eight years	1	NBK1266	
polyps	1	NBK1266	
this strategy has two goals:	1	NBK1266	
from st	1	NBK1266	
intussusception should be treated in a standard manner	1	NBK1266	
malignancies should be treated in a standard manner	1	NBK1266	
site	1	NBK1266	
procedure	1	NBK1266	
age at initial screening (yrs)	1	NBK1266	
interval	1	NBK1266	
stomach	1	NBK1266	
upper endoscopy	1	NBK1266	
small intestine	1	NBK1266	
capsule endoscopy or mre 2	1	NBK1266	
8, 18 3	1	NBK1266	
large intestine	1	NBK1266	
colonoscopy	1	NBK1266	
breast	1	NBK1266	
breast self-examination	1	NBK1266	
clinical breast exam	1	NBK1266	
6 months	1	NBK1266	
breast mri or digital mammography 4, 5, 6	1	NBK1266	
ovary, cervix, uterus	1	NBK1266	
transvaginal ultrasound & serum ca 125	1	NBK1266	
pelvic exam w/pap smear 6	1	NBK1266	
18-20	1	NBK1266	
mri-mrcp or endoscopic ultrasound	1	NBK1266	
1-2 years	1	NBK1266	
testes	1	NBK1266	
testicular exam	1	NBK1266	
ultrasound if symptomatic or abnormality on exam	1	NBK1266	
birth to teenage years	1	NBK1266	
early diagnosis and treatment	1	NBK1266	
surveillance as outlined in surveillance	1	NBK1266	
gov/books/n/gene/pkan	1	NBK1490	
ophthalmologic assessment for evidence of retinopathy	1	NBK1490	
intramuscular botulinum toxin	1	NBK1490	
intrathecal and intraventricular baclofen	1	NBK1490	
ablative pallidotomy or thalmotomy	1	NBK1490	
referral for adaptive aids as needed (e	1	NBK1490	
, a walker or wheelchair for gait abnormalities)	1	NBK1490	
other manifestations	1	NBK1490	
treatment and interventions for retinopathy as per ophthalmology	1	NBK1490	
oral assessment for consequences of trauma	1	NBK1490	
swallowing evaluation and regular dietary assessments to assure adequate nutrition	1	NBK1490	
see related genetic counseling issues	1	NBK1490	
clinicians should check clinicaltrials	1	NBK1490	
gov regularly and maintain contact with pkan investigators	1	NBK1490	
pantothenate	1	NBK1490	
pantothenate has no known toxicity in humans	1	NBK1490	
docosahexanoic acid (dha)	1	NBK1490	
gov/books/n/gene/pkd-ad	1	NBK1246	
when "white coat" hypertension (i	1	NBK1246	
flank pain	1	NBK1246	
cyst hemorrhage and gross hematuria	1	NBK1246	
nephrolithiasis	1	NBK1246	
5), and administration of allopurinol	1	NBK1246	
cyst infection	1	NBK1246	
cyst infection is often difficult to treat	1	NBK1246	
therapeutic agents of choice include trimethoprim-sulfamethoxazole and fluoroquinolones	1	NBK1246	
chloramphenicol has shown therapeutic efficacy in otherwise refractory disease	1	NBK1246	
end-stage renal disease (esrd)	1	NBK1246	
females appear to do better than males	1	NBK1246	
complications directly related to adpkd are rare	1	NBK1246	
polycystic liver disease	1	NBK1246	
and the results are often short-lived	1	NBK1246	
ruptured or symptomatic intracranial aneurysm	1	NBK1246	
asymptomatic aneurysms	1	NBK1246	
those aneurysms measuring 5	1	NBK1246	
if the size increases, surgery is indicated	1	NBK1246	
the management of aneurysms 6	1	NBK1246	
0-9	1	NBK1246	
0 mm in size remains controversial	1	NBK1246	
surgical intervention is usually indicated for aneurysms larger than 10	1	NBK1246	
early detection of hypertension	1	NBK1246	
intracranial aneurysms	1	NBK1246	
cardiac valvular abnormalities	1	NBK1246	
colon diverticulosis	1	NBK1246	
presymptomatic diagnosis:	1	NBK1246	
permits early detection and treatment of complications and associated disorders	1	NBK1246	
reassures those found to be unaffected	1	NBK1246	
the literature on pregnancy and pkd is limited	1	NBK1246	
vasopressin v2 receptor antagonists	1	NBK1246	
8% per year compared to 5	1	NBK1246	
5% in the untreated group	1	NBK1246	
somatostatin analogs	1	NBK1246	
gov/books/n/gene/pkd-ar	1	NBK1326	
serum electrolyte concentrations to identify electrolyte abnormalities (e	1	NBK1326	
, hyponatremia, hyperkalemia)	1	NBK1326	
urinalysis to assess for the urinary concentration and proteinuria	1	NBK1326	
renal ultrasonography (consider high-resolution technology when available)	1	NBK1326	
early recognition and treatment of dehydration is critical	1	NBK1326	
and (2) the risk for ascending cholangitis	1	NBK1326	
administration of synthetic bile acids	1	NBK1326	
portosystemic shunting may be necessary to treat progressive portal hypertension	1	NBK1326	
dual-organ transplantation	1	NBK1326	
see table 2 (pdf) and figure 1	1	NBK1326	
feeding and growth	1	NBK1326	
influenza type b	1	NBK1326	
meningococcus) is indicated	1	NBK1326	
mineral balance, monitored by assessing calcium and phosphorous	1	NBK1326	
hydration status	1	NBK1326	
agents to avoid	1	NBK1326	
for affected individuals with hypertension, sympathomimetic agents	1	NBK1326	
potentially hepatotoxic agents (e	1	NBK1326	
gov/books/n/gene/pknd	1	NBK1460	
mri to rule out secondary causes of pkd	1	NBK1460	
clinical genetics consultation and testing for pathogenic variants in prrt2	1	NBK1460	
gov/books/n/gene/pku	1	NBK1504	
see acmg management guidelines for pku	1	NBK1504	
treatment of classic pku	1	NBK1504	
restriction of dietary phenylalanine	1	NBK1504	
maintain blood tyr in the normal range	1	NBK1504	
sapropterin (kuvan®)	1	NBK1504	
reviewed in ho & christodoulou [2014]	1	NBK1504	
large neutral amino acids (lnaa) transporters	1	NBK1504	
treatment for non-classic hyperphenylalaninemia	1	NBK1504	
neuropsychiatric testing may be considered to identify learning differences	1	NBK1504	
bone health assessment	1	NBK1504	
women with pah deficiency	1	NBK1504	
preconception	1	NBK1504	
assessment of early osteopenia risk	1	NBK1504	
discontinuation of lnaa treatment	1	NBK1504	
post partum	1	NBK1504	
provide coordinated care in the post-partum period	1	NBK1504	
enzyme substitution	1	NBK1504	
cell-directed therapies	1	NBK1504	
liver repopulation with pah-expressing cells is being investigated	1	NBK1504	
gene therapies	1	NBK1504	
gov/books/n/gene/plosl	1	NBK1197	
only symptomatic treatment is available	1	NBK1197	
epileptic seizures may worsen the individual's condition	1	NBK1197	
the effect of bisphosphonates has not been studied	1	NBK1197	
however, clinical trials have not been performed	1	NBK1197	
gov/books/n/gene/pmd	1	NBK1182	
probably reliable only after age four years	1	NBK1182	
family history to identify other affected or at-risk individuals	1	NBK1182	
those with severe dysphagia may require feeding by gastrostomy	1	NBK1182	
proper wheelchair seating and physical therapy may help prevent scoliosis	1	NBK1182	
gov/books/n/gene/pnknd	1	NBK1221	
mri to rule out secondary causes of pnkd	1	NBK1221	
response to pharmacologic treatment is poor	1	NBK1221	
however, clonazepam or diazepam can be effective	1	NBK1221	
no long-term sequelae are associated with pnkd	1	NBK1221	
monitoring medication requirements and dosage is appropriate	1	NBK1221	
gov/books/n/gene/pnpla6-dis	1	NBK247161	
no disease-modifying drug treatment exists for pnpla6-related disorders	1	NBK247161	
speech therapy [sapir et al 2003]	1	NBK247161	
swallowing therapy	1	NBK247161	
assistive walking devices and ankle-foot orthotics	1	NBK247161	
, baclofen [oral or intrathecal], tolperison	1	NBK247161	
botox® injections) and urinary urgency (e	1	NBK247161	
hypothyroidism is treated with thyroid hormone replacement (e	1	NBK247161	
, levothyroxine) at the time of diagnosis	1	NBK247161	
reduce spasticity	1	NBK247161	
and prevent contractures	1	NBK247161	
inactive, sedentary lifestyle	1	NBK247161	
exposure to medications or chemicals that exacerbate neuropathy	1	NBK247161	
spasticity generally does not change significantly with pregnancy	1	NBK247161	
gov/books/n/gene/pol3-leuk	1	NBK99167	
pediatric neurology consultation	1	NBK99167	
physiotherapy evaluation	1	NBK99167	
occupational therapy evaluation	1	NBK99167	
speech and language pathology assessment	1	NBK99167	
rehabilitation physician (i	1	NBK99167	
, physiatrist) consultation	1	NBK99167	
neuropsychology evaluation	1	NBK99167	
dentistry consultation	1	NBK99167	
endocrine consultation	1	NBK99167	
dysphagia management is therefore important	1	NBK99167	
hypersalivation is managed with the multidisciplinary team and an otolaryngologist	1	NBK99167	
treatment must be individualized	1	NBK99167	
therapies to consider include rehabilitation (e	1	NBK99167	
, oromotor therapy, behavioral therapy)	1	NBK99167	
medical therapy (e	1	NBK99167	
, anticholinergic medications, botulinum toxin injections)	1	NBK99167	
and, in severe cases, surgery (e	1	NBK99167	
learning difficulties are likely to progress slowly	1	NBK99167	
patients should be followed regularly by an endocrinologist	1	NBK99167	
patients need to be followed regularly by an ophthalmologist	1	NBK99167	
no general surveillance guidelines have been developed to date	1	NBK99167	
monitoring should be individualized	1	NBK99167	
foods that are likely to lead to choking	1	NBK99167	
medications acting on d2 receptor blockers (e	1	NBK99167	
gov/books/n/gene/poly	1	NBK1329	
speech evaluations for those with perisylvian polymicrogyria	1	NBK1329	
vision and hearing evaluation as clinically appropriate	1	NBK1329	
the following treatment is recommended:	1	NBK1329	
speech therapy for those with language impairment	1	NBK1329	
occupational therapy for those with language impairment	1	NBK1329	
education of parents about common seizure presentations	1	NBK1329	
gov/books/n/gene/pomc-def	1	NBK174451	
plasma acth concentration	1	NBK174451	
acth stimulation test	1	NBK174451	
severe obesity	1	NBK174451	
therefore, lifestyle measures should be instigated	1	NBK174451	
fair skin	1	NBK174451	
growth hormone (gh) deficiency	1	NBK174451	
gov/books/n/gene/porphyria-ct	1	NBK143129	
, hexachlorobenzene)	1	NBK143129	
evaluation for hepatitis c and/or human immunodeficiency virus infection	1	NBK143129	
treatment is highly effective	1	NBK143129	
iron reduction	1	NBK143129	
iron chelation therapy (e	1	NBK143129	
serum ferritin concentration should be measured before starting phlebotomy treatment	1	NBK143129	
for persons with the hfe genotypes p	1	NBK143129	
cys282tyr or p	1	NBK143129	
low-dose anti-malarial agents	1	NBK143129	
combining both treatment modalities (i	1	NBK143129	
pct may also improve after treatment of coexisting hepatitis c	1	NBK143129	
pct should be treated first in most individuals:	1	NBK143129	
vaccination against hepatitis a and b is appropriate	1	NBK143129	
surveillance is usually performed annually	1	NBK143129	
susceptibility factors (if known) (e	1	NBK143129	
exposure to sunlight in symptomatic phase	1	NBK143129	
pregnancy is generally not complicated by f-pct	1	NBK143129	
gov/books/n/gene/porphyria-var	1	NBK121283	
neurovisceral symptoms	1	NBK121283	
most acute neurovisceral attacks require hospital admission	1	NBK121283	
harmful medications should be discontinued	1	NBK121283	
cutaneous symptoms	1	NBK121283	
patients should wear protective clothing and avoid exposure to sunlight	1	NBK121283	
topical steroids are of little or no benefit	1	NBK121283	
acute attack	1	NBK121283	
weekly or biweekly hemin infusions may prevent frequent noncyclical attacks	1	NBK121283	
however, published experience is lacking	1	NBK121283	
photocutaneous	1	NBK121283	
gov/books/n/gene/potocki-lupski	1	NBK447920	
growth assessment for evidence of failure to thrive/short stature	1	NBK447920	
ophthalmologic evaluation for strabismus & refractive errors	1	NBK447920	
ent / dental	1	NBK447920	
audiology evaluation & assessment for sleep apnea	1	NBK447920	
sleep study if sleep apnea is suspected	1	NBK447920	
evaluation for dental crowding and/or malocclusion	1	NBK447920	
ecg & echocardiogram, incl aortic root measurements	1	NBK447920	
gastroenterology / nutrition	1	NBK447920	
if failure to thrive is present	1	NBK447920	
renal ultrasound to evaluate for structural anomalies	1	NBK447920	
developmental / psychiatric	1	NBK447920	
medical genetics	1	NBK447920	
strabismus and/or refractive errors	1	NBK447920	
standard treatment as recommended by ophthalmologist	1	NBK447920	
dental crowding / malocclusion	1	NBK447920	
evidence of sleep apnea	1	NBK447920	
standard treatment as indicated	1	NBK447920	
diet diary & calorie counts may be requested	1	NBK447920	
hypoglycemia, short stature, evidence of growth hormone deficiency	1	NBK447920	
standard treatment(s) as recommended by endocrinologist	1	NBK447920	
standard treatment as recommended by cardiologist	1	NBK447920	
renal anomaly and/or vesicoureteral reflux	1	NBK447920	
standard treatment as recommended by nephrologist/urologist	1	NBK447920	
enrollment in dda (developmental disabilities administration) is recommended	1	NBK447920	
consider:	1	NBK447920	
evaluation for alternative means of communication (e	1	NBK447920	
comments	1	NBK447920	
at every visit	1	NBK447920	
yearly	1	NBK447920	
newborn hearing screen, then as indicated for speech delay	1	NBK447920	
every 6 months starting in early childhood	1	NBK447920	
echocardiogram w/attention to aortic root dimension & ecg	1	NBK447920	
every 3 yrs, if initial evaluations were normal	1	NBK447920	
otherwise, as directed by cardiologist	1	NBK447920	
monitoring for development of scoliosis	1	NBK447920	
clinical examination at every visit	1	NBK447920	
scoliosis survey if scoliosis is clinically suspected	1	NBK447920	
referral to orthopedist if indicated	1	NBK447920	
screen for behavior problems at every visit	1	NBK447920	
developmental monitoring by a developmental specialist	1	NBK447920	
annually, or at frequency directed by developmental specialist	1	NBK447920	
for short stature: consider endocrinology evaluation	1	NBK447920	
gov/books/n/gene/pp-blastoma	1	NBK196157	
the presence of other synchronous dicer1-related conditions	1	NBK196157	
extent of disease spread (staging)	1	NBK196157	
pleuropulmonary blastoma types i and ir	1	NBK196157	
no metastatic potential is associated with this type	1	NBK196157	
pleuropulmonary blastoma types ii and iii	1	NBK196157	
brain mri to evaluate for metastatic disease	1	NBK196157	
rarely, spine mri for a paraspinal or intraspinal extension	1	NBK196157	
ct of the abdomen to assess for liver metastases	1	NBK196157	
ciliary body medulloepithelioma	1	NBK196157	
evaluations for synchronous	1	NBK196157	
pleuropulmonary blastoma (ppb)	1	NBK196157	
individuals receiving neoadjuvant chemotherapy may have marked tumor reduction	1	NBK196157	
chemotherapy alone is insufficient to eradicate solid ppb	1	NBK196157	
pleural effusions	1	NBK196157	
drainage of pleural effusions should be approached with caution	1	NBK196157	
surgery for metastases	1	NBK196157	
therapeutic resection of bone and liver metastases is rarely indicated	1	NBK196157	
type i ppb	1	NBK196157	
types ii and iii ppb	1	NBK196157	
aggressive chemotherapy is necessary	1	NBK196157	
ppbregistry	1	NBK196157	
radiation therapy	1	NBK196157	
treatment failure	1	NBK196157	
sertoli-leydig cell tumor	1	NBK196157	
juvenile granulosa cell tumor (jgct)	1	NBK196157	
hyperthermic chemotherapy has been used by some investigators	1	NBK196157	
gynandroblastoma	1	NBK196157	
the malignant potential of gynandroblastoma is not yet clear	1	NBK196157	
cystic nephroma	1	NBK196157	
multinodular goiter (mng) and thyroid cancer	1	NBK196157	
observation with or without biopsy	1	NBK196157	
ciliary body medulloepithelioma (cbme)	1	NBK196157	
the four management options include:	1	NBK196157	
observation	1	NBK196157	
local resection	1	NBK196157	
however, many of these tumors will progress	1	NBK196157	
enucleation	1	NBK196157	
long-term survival is common after this definitive therapy	1	NBK196157	
orbital exenteration	1	NBK196157	
nasal chondromesenchymal hamartoma (ncmh)	1	NBK196157	
however, complete extirpation is preferred	1	NBK196157	
immediate management issues may include interventions for obstructive hydrocephalus	1	NBK196157	
an aggressive surgical approach is associated with prolonged survival	1	NBK196157	
ppb	1	NBK196157	
thyroid gland neoplasia	1	NBK196157	
thyroid physical examination in a patient of any age	1	NBK196157	
ovarian stromal tumors	1	NBK196157	
cbme	1	NBK196157	
visual inspection of the eye and orbit	1	NBK196157	
botryoid erms	1	NBK196157	
ncmh	1	NBK196157	
nasal endoscopy as warranted by ophthalmologic signs (e	1	NBK196157	
gov/books/n/gene/pph	1	NBK1485	
a medical genetics consultation is recommended	1	NBK1485	
medications in use for pah include the following:	1	NBK1485	
endothelin blockers (oral)bosentanambrisenanmacitentan	1	NBK1485	
phosphodiesterase inhibitors (oral)sildenafiltadalafil	1	NBK1485	
guanylate cyclase stimulator (oral)riociguat	1	NBK1485	
calcium channel blockers	1	NBK1485	
adjunctive agents	1	NBK1485	
mean survival after lung transplantation is about five years	1	NBK1485	
fluid balance	1	NBK1485	
exercise regimen	1	NBK1485	
nutrition management	1	NBK1485	
infusion pump management	1	NBK1485	
central venous catheter	1	NBK1485	
appetite-suppressant medications (e	1	NBK1485	
hypoxia	1	NBK1485	
newer effective therapies may decrease the risk	1	NBK1485	
antiangiogenesis strategies	1	NBK1485	
growth factor inhibitors	1	NBK1485	
endothelial progenitor cells/stem cells in lung repair	1	NBK1485	
developing therapies against right-ventricle remodeling	1	NBK1485	
gov/books/n/gene/ppr-dysp	1	NBK327267	
no specific therapy for ppd is available	1	NBK327267	
pain due to secondary osteoarthritis may respond to nsaids	1	NBK327267	
physical therapy may help preserve joint mobility	1	NBK327267	
immobilization (e	1	NBK327267	
, casting) should be avoided	1	NBK327267	
angular deformities of lower limbs	1	NBK327267	
progressive joint stiffness	1	NBK327267	
, hip and knee replacement)	1	NBK327267	
progressive stiffness and deformities of the spine	1	NBK327267	
scoliosis and mild kyphosis can be managed with bracing	1	NBK327267	
no specific guidelines for surveillance have been published	1	NBK327267	
recommendations include the following:	1	NBK327267	
avoid immobilization (e	1	NBK327267	
, casting)	1	NBK327267	
gov/books/n/gene/prion	1	NBK1229	
therapy is aimed at controlling symptoms that may cause discomfort	1	NBK1229	
myoclonus can sometimes be mitigated by clonazepam	1	NBK1229	
issues related to dysphagia are often difficult to resolve	1	NBK1229	
however, no successful clinical results have been reported	1	NBK1229	
gov/books/n/gene/prolidase-def	1	NBK299584	
physical examination to evaluate for splenomegaly	1	NBK299584	
complete blood count to evaluate for anemia and thrombocytopenia	1	NBK299584	
consultation with a wound care specialist	1	NBK299584	
no curative treatment is available	1	NBK299584	
care is preferably provided by a multidisciplinary team	1	NBK299584	
antibiotic prophylaxis should also be considered in the appropriate setting	1	NBK299584	
abdominal ultrasound examination to assess liver and spleen size	1	NBK299584	
follow up as recommended by a pulmonologist and immunologist	1	NBK299584	
adenovirus-mediated gene transfer	1	NBK299584	
intracellular delivery of liposome-encapsulated prolidase	1	NBK299584	
gov/books/n/gene/prop1	1	NBK1347	
am cortisol can be used to evaluate adrenal hormone production	1	NBK1347	
growth hormone	1	NBK1347	
, recombinant) gh	1	NBK1347	
tsh	1	NBK1347	
lh and fsh	1	NBK1347	
usually sex steroids are used to maintain secondary sex characteristics	1	NBK1347	
acth	1	NBK1347	
growth should be carefully monitored	1	NBK1347	
gov/books/n/gene/propionic-a	1	NBK92946	
complete blood count to evaluate for cytopenias	1	NBK92946	
amylase and lipase to evaluate for pancreatitis	1	NBK92946	
immunology consult	1	NBK92946	
neonatal/acute decompensation	1	NBK92946	
in-patient management	1	NBK92946	
assess and manage ventilation and circulation as necessary	1	NBK92946	
determine the need for sepsis workup and antibiotics	1	NBK92946	
reverse catabolism by giving intravenous glucose and lipids	1	NBK92946	
dextrose solutions exceeding the concentration of 12	1	NBK92946	
5% require a central line placement	1	NBK92946	
additional calories can be provided using parenteral lipid emulsion	1	NBK92946	
manage protein intake to reduce propiogenic precursors	1	NBK92946	
remove toxic compounds	1	NBK92946	
pharmacologic detoxification:	1	NBK92946	
oral n-carbamoylglutamate (carglumic acid	1	NBK92946	
manage pancreatitis using standard practices	1	NBK92946	
home management of metabolic status	1	NBK92946	
at-home detection and monitoring of urine ketones	1	NBK92946	
diet modification under the direction of the metabolic team	1	NBK92946	
management of arrhythmias is similar to that from other causes	1	NBK92946	
dermatologic manifestations (e	1	NBK92946	
pre-prandial plasma essential amino acids	1	NBK92946	
plasma albumin	1	NBK92946	
prealbumin	1	NBK92946	
hemoglobin	1	NBK92946	
plasma ammonia	1	NBK92946	
plasma vitamin d	1	NBK92946	
essential fatty acid profile	1	NBK92946	
additional calories can be provided using protein-free formulas	1	NBK92946	
the optimal dose of levocarnitine has not been established	1	NBK92946	
levocarnitine can be given enterally and intravenously	1	NBK92946	
antimicrobial therapy	1	NBK92946	
biotin supplementation	1	NBK92946	
management during episodes of metabolic decompensation includes:	1	NBK92946	
avoidance of fasting (e	1	NBK92946	
, using intravenous dextrose)	1	NBK92946	
increasing calorie intake to prevent catabolism (e	1	NBK92946	
, intravenous fat emulsion)	1	NBK92946	
olt in patients with pa is not curative	1	NBK92946	
sedation and perioperative management	1	NBK92946	
emergency situations	1	NBK92946	
clinical evaluation should include assessment of the following:	1	NBK92946	
interval assessment for the need of g-tube	1	NBK92946	
neurologic evaluation including survey for seizures and movement disorders	1	NBK92946	
interval ophthalmologic evaluation including dilated eye examination	1	NBK92946	
evaluation for clinical signs of cardiomyopathy (e	1	NBK92946	
laboratory evaluation should include the following:	1	NBK92946	
complete blood count and differential to monitor for cytopenias	1	NBK92946	
renal function tests	1	NBK92946	
amylase and lipase as needed to evaluate for pancreatitis	1	NBK92946	
other evaluations:	1	NBK92946	
dexa scan	1	NBK92946	
brain mri, mrs, and eeg as clinically indicated	1	NBK92946	
neuroleptic antiemetics (e	1	NBK92946	
gov/books/n/gene/proteus	1	NBK99495	
evaluation for dvts	1	NBK99495	
evaluation of pe	1	NBK99495	
bullous pulmonary disease	1	NBK99495	
psychosocial issues	1	NBK99495	
gov/books/n/gene/prs	1	NBK1973	
juvenile/adult onset	1	NBK1973	
serum uric acid concentration	1	NBK1973	
joint examination for evidence of gout	1	NBK1973	
assessment of renal function and renal structural integrity (e	1	NBK1973	
, renal ultrasound examination)	1	NBK1973	
infantile onset	1	NBK1973	
0 mg/dl (360 μmol/l)	1	NBK1973	
febuxostat, a newer urate-lowering xanthine oxidase inhibitor	1	NBK1973	
note: excretion of >1	1	NBK1973	
high daily fluid intake (i	1	NBK1973	
, ≥2 l/day in the adult)	1	NBK1973	
xanthinuria does not respond to urinary alkalinization	1	NBK1973	
360 μmol/l)	1	NBK1973	
plasma xanthine is cleared efficiently and does not accumulate	1	NBK1973	
anchovies, sardines) in excess	1	NBK1973	
and an audiology evaluation	1	NBK1973	
however slight deterioration in their vision was noted	1	NBK1973	
gov/books/n/gene/prss1-hp	1	NBK84399	
several expert groups (e	1	NBK84399	
giessen, germany)	1	NBK84399	
burtonsville, md)	1	NBK84399	
cholecystokinin (cck) and its analogues (e	1	NBK84399	
13c-mixed triglyceride breath test	1	NBK84399	
72-hour fecal fat	1	NBK84399	
sudan stain	1	NBK84399	
, mineral oil, olestra)	1	NBK84399	
, orlistat)	1	NBK84399	
chronic pancreatitis is associated with a gradual loss of function	1	NBK84399	
prevention of primary manifestations in hereditary pancreatitis is limited	1	NBK84399	
however, this treatment cannot yet be recommended	1	NBK84399	
gov/books/n/gene/psach	1	NBK1487	
surgical methods are standard	1	NBK1487	
symptomatic lower limb malalignment	1	NBK1487	
evidence of kyphoscoliosis	1	NBK1487	
symptoms related to joint hypermobility	1	NBK1487	
gov/books/n/gene/ptt	1	NBK1148	
evaluation of high-risk individuals (i	1	NBK1148	
a target inr of 2	1	NBK1148	
5 (therapeutic range: 2	1	NBK1148	
anticoagulation is recommended:	1	NBK1148	
indefinitely for those with recurrent idiopathic vte	1	NBK1148	
(see prevention of primary manifestations	1	NBK1148	
f2 20210g>a heterozygotes:	1	NBK1148	
is recommended for all women:	1	NBK1148	
should be considered for:	1	NBK1148	
all women received a course of postpartum anticoagulation	1	NBK1148	
all asymptomatic homozygous women	1	NBK1148	
trialregister	1	NBK1148	
nl, ntr 3361)	1	NBK1148	
studies suggesting that prophylactic anticoagulation improves pregnancy outcome:	1	NBK1148	
5% and 15	1	NBK1148	
gov/books/n/gene/pura-dis	1	NBK426063	
ophthalmology examination	1	NBK426063	
electrodiagnostic tests may be indicated in some cases	1	NBK426063	
consider echocardiogram	1	NBK426063	
assessment of pulmonary function	1	NBK426063	
consider ultrasound of the urinary tract	1	NBK426063	
appropriate radiographs	1	NBK426063	
if hip dysplasia and/or scoliosis is suspected	1	NBK426063	
assessment of serum vitamin d levels	1	NBK426063	
assessment of bone density	1	NBK426063	
if osteoporosis or osteopenia is suspected	1	NBK426063	
evaluation of anterior pituitary hormones	1	NBK426063	
if necessary	1	NBK426063	
miscellaneous/other	1	NBK426063	
cognitive/developmental delay	1	NBK426063	
see global developmental disability/ intellectual disability educational issues	1	NBK426063	
management by a neurologist	1	NBK426063	
, dystonia, dyskinesia, dysconjugate eye movements)	1	NBK426063	
vision deficits	1	NBK426063	
correction of refractive errors	1	NBK426063	
vision support	1	NBK426063	
standard treatment for strabismus & exophoria	1	NBK426063	
supplementary oxygen (at night) & rarely tracheostomy	1	NBK426063	
ambulatory peripheral saturation monitoring may be required	1	NBK426063	
congenital heart defect	1	NBK426063	
frequent aspiration (or high risk of aspiration)	1	NBK426063	
a percutaneous endoscopic gastrostomy tube may be considered	1	NBK426063	
medical management	1	NBK426063	
referral to a gastroenterologist may be required in severe cases	1	NBK426063	
congenital urogenital defect	1	NBK426063	
management as per current practice for the specific urogenital defect	1	NBK426063	
progressive neuropathic scoliosis may require spinal fusion	1	NBK426063	
osteoporosis/osteopenia	1	NBK426063	
instability in standing position	1	NBK426063	
neuropathic hip dysplasia, progressive subluxation, & dislocation	1	NBK426063	
consideration of hip reconstructions w/varus derotational proximal femoral osteotomies	1	NBK426063	
vitamin d deficiency	1	NBK426063	
vitamin d supplementation	1	NBK426063	
anterior pituitary hormone deficiencies	1	NBK426063	
standard treatment as directed by an endocrinologist	1	NBK426063	
global developmental disability/ intellectual disability educational issues	1	NBK426063	
, scoliosis, hip dislocation)	1	NBK426063	
, feeding, grooming, dressing)	1	NBK426063	
monitoring by developmental pediatrics	1	NBK426063	
long-term	1	NBK426063	
eeg & video eeg monitoring	1	NBK426063	
ophthalmologic & vision evaluations	1	NBK426063	
monitoring for dysphagia & constipation	1	NBK426063	
monitoring for musculoskeletal complications including hip dysplasia & scoliosis	1	NBK426063	
gov/books/n/gene/pws	1	NBK1330	
endocrinology consultation	1	NBK1330	
nutritional consultation	1	NBK1330	
x-rays are necessary to establish the diagnosis	1	NBK1330	
feeding, hyperphagia, and obesity	1	NBK1330	
therapies, education and behavior management	1	NBK1330	
initiate appropriate educational programming in children:	1	NBK1330	
social skills training groups have been beneficial	1	NBK1330	
however, preservation of fertility is not an issue	1	NBK1330	
standard treatment is appropriate	1	NBK1330	
angulo & miller, unpublished data]	1	NBK1330	
schulze et al 2001	1	NBK1330	
vats & cassidy, unpublished data]	1	NBK1330	
sleep issues	1	NBK1330	
skin picking	1	NBK1330	
management of strabismus is as for any infant	1	NBK1330	
adulthood	1	NBK1330	
affected individuals generally require a sheltered employment environment	1	NBK1330	
diabetes mellitus rarely occurs in the absence of obesity	1	NBK1330	
if osteoporosis develops, consider treatment with a bisphosphonate	1	NBK1330	
starting with lower doses is recommended	1	NBK1330	
every month in infancy	1	NBK1330	
every six months in the first decade of life	1	NBK1330	
at least annually thereafter	1	NBK1330	
cryptorchidism can recur after orchidopexy	1	NBK1330	
therefore, testicular position should be monitored	1	NBK1330	
obtain history of any sleep disturbance	1	NBK1330	
if present, obtain a sleep study	1	NBK1330	
obtain history for behavioral and psychiatric disturbance at least annually	1	NBK1330	
gov/books/n/gene/pxe	1	NBK1113	
cardiac stress testing	1	NBK1113	
doppler evaluation of peripheral vasculature	1	NBK1113	
no specific treatment for pxe exists	1	NBK1113	
regular examination by an ophthalmologist with expertise in retinal disease	1	NBK1113	
regular physical examination with specific attention to the cardiovascular system	1	NBK1113	
monitoring by the affected individual for black tarry stool	1	NBK1113	
periodic monitoring of serum lipid concentrations	1	NBK1113	
participation in such activities should be discouraged	1	NBK1113	
gov/books/n/gene/rapid-odp	1	NBK1115	
rapid-onset dystonia-parkinsonism (rdp)	1	NBK1115	
neuropsychological testing to evaluate cognitive or memory problems	1	NBK1115	
alternating hemiplegia of childhood (ahc)	1	NBK1115	
brain imaging to evaluate the cerebellum	1	NBK1115	
audiogram and hearing specialist consultation to evaluate sensorineural hearing loss	1	NBK1115	
for all phenotypes	1	NBK1115	
occupational therapy to maximize motor function	1	NBK1115	
speech therapy for dysarthria	1	NBK1115	
standard therapies for the following are appropriate:	1	NBK1115	
episode prophylaxis (avoiding triggers	1	NBK1115	
prophylactic medications	1	NBK1115	
flunarizine	1	NBK1115	
chloral hydrate	1	NBK1115	
other sleep inducers	1	NBK1115	
epilepsy management utilizes existing anticonvulsants	1	NBK1115	
symptomatic treatment includes hearing and visual aids	1	NBK1115	
there is no known reason to avoid vaccinations	1	NBK1115	
fever	1	NBK1115	
excessive exercise (such as running track)	1	NBK1115	
emotional excitement	1	NBK1115	
excessive or atypically strenuous exercise (e	1	NBK1115	
illness	1	NBK1115	
irregular sleep, missing a nap, delayed bedtime	1	NBK1115	
gov/books/n/gene/rasa1-rel-dis	1	NBK52764	
consideration of spine imaging to identify and characterize avms/avfs	1	NBK52764	
capillary malformations (cms)	1	NBK52764	
avms/avfs	1	NBK52764	
, embolization vs	1	NBK52764	
surgery)	1	NBK52764	
cardiac overload	1	NBK52764	
hemihyperplasia and/or leg length discrepancy	1	NBK52764	
lymphangiography to evaluate for lymphatic malformations may be considered	1	NBK52764	
gov/books/n/gene/rbs	1	NBK1153	
ultrasound evaluation of the kidneys for cysts	1	NBK1153	
prostheses	1	NBK1153	
intervention and/or special education if developmental delays are detected	1	NBK1153	
annual screening for developmental delays or learning disorders	1	NBK1153	
gov/books/n/gene/rcdp	1	NBK1270	
mr imaging of brain (with mr spectroscopy)	1	NBK1270	
cataract extraction may preserve some vision	1	NBK1270	
orthopedic procedures have improved function in some individuals	1	NBK1270	
note: improved nutrition does not enhance linear growth	1	NBK1270	
influenza vaccine and rsv monoclonal antibody should be provided	1	NBK1270	
dha can be measured in plasma	1	NBK1270	
oral supplementation should be provided if levels are low	1	NBK1270	
leu292ter allele [dranchak et al 2011]	1	NBK1270	
gov/books/n/gene/refsum	1	NBK1353	
neurology	1	NBK1353	
ataxia, neuropathy, myography, and electrophysiologic assessment	1	NBK1353	
radiology	1	NBK1353	
physical examination of hands, feet, and knees	1	NBK1353	
radiologic assessment of hands and feet	1	NBK1353	
cardiology	1	NBK1353	
dietary restriction of phytanic acid intake	1	NBK1353	
avoidance of sudden weight loss	1	NBK1353	
lifelong treatment with hydrating creams	1	NBK1353	
treatment of acute presentation	1	NBK1353	
no curative therapy currently exists for refsum disease	1	NBK1353	
annual cardiac examination to identify cardiomyopathy and concomitant arrhythmias	1	NBK1353	
gov/books/n/gene/retinoblastoma	1	NBK1452	
treatment options for the eye include enucleation	1	NBK1452	
cryotherapy	1	NBK1452	
radiation therapy using episcleral plaques	1	NBK1452	
detection of subsequent rb after initial diagnosis	1	NBK1452	
detection of second non-ocular tumors in individuals with retinoblastoma	1	NBK1452	
young or uncooperative children may require examination under anesthesia	1	NBK1452	
gov/books/n/gene/retinoschisis	1	NBK1222	
visual acuity	1	NBK1222	
goldmann visual field	1	NBK1222	
optical coherence tomography	1	NBK1222	
legal use of telescopic lenses may vary by locale	1	NBK1222	
retinoschisis affects primarily the inner retinal layers	1	NBK1222	
older children and adults need less frequent monitoring	1	NBK1222	
possible drawbacks of using viral vectors (e	1	NBK1222	
gov/books/n/gene/rett	1	NBK1497	
history of sleep and/or breathing problems	1	NBK1497	
screening for prolonged qtc by ecg and holter monitoring	1	NBK1497	
examination for scoliosis	1	NBK1497	
psychosocial support for families is an integral part of management	1	NBK1497	
they are tolerated better than milk of magnesia	1	NBK1497	
periodic ecg to screen for prolonged qtc	1	NBK1497	
examination at regular intervals for the progression of scoliosis	1	NBK1497	
prokinetic agents (e	1	NBK1497	
, cisapride)	1	NBK1497	
antipsychotics (e	1	NBK1497	
, thioridazine), tricyclic antidepressants (e	1	NBK1497	
, imipramine)	1	NBK1497	
antiarrhythmics (e	1	NBK1497	
, quinidine, sotolol, amiodarone)	1	NBK1497	
anesthetic agents (e	1	NBK1497	
, thiopental, succinylcholine)	1	NBK1497	
antibiotics (e	1	NBK1497	
, erythromycin, ketoconazole)	1	NBK1497	
l-carnitine was tested in a double-blind trial	1	NBK1497	
a statistical increase in global dna methylation was seen	1	NBK1497	
gov/books/n/gene/riboflavin-tn	1	NBK299312	
sleep study and pulmonary consultation	1	NBK299312	
other consultations depending on clinical problems	1	NBK299312	
consultation with a medical geneticist/genetic counselor	1	NBK299312	
high dose supplementation	1	NBK299312	
supportive care	1	NBK299312	
respiratory support	1	NBK299312	
physiotherapy to avoid contractures	1	NBK299312	
occupational therapy for support in activities of daily living	1	NBK299312	
orthotics for limb and trunk bracing	1	NBK299312	
speech and language therapy to avoid choking and respiratory problems	1	NBK299312	
wheel chair as needed	1	NBK299312	
low vision aids for those with decreased visual acuity	1	NBK299312	
routine management of scoliosis to avoid long term respiratory problems	1	NBK299312	
routine management of depression	1	NBK299312	
general examination	1	NBK299312	
discussion of any problems with riboflavin supplementation	1	NBK299312	
avoid dietary restriction of riboflavin	1	NBK299312	
recommended doses during pregnancy are 10 mg/kg/day	1	NBK299312	
gov/books/n/gene/rickets-xlh	1	NBK83985	
bone age measurement to evaluate growth potential	1	NBK83985	
craniofacial examination for signs of craniosynostosis	1	NBK83985	
individuals of any age	1	NBK83985	
evaluation of those with headache and vertigo for chiari malformation	1	NBK83985	
pharmacologic treatment focuses on improving pain and correcting bone deformation	1	NBK83985	
low dose	1	NBK83985	
high dose	1	NBK83985	
50 to 0	1	NBK83985	
75 µg daily	1	NBK83985	
in these individuals, surgical treatment is frequently pursued	1	NBK83985	
the literature consists of case series	1	NBK83985	
craniofacial treatment	1	NBK83985	
sensorineural hearing loss has been reported in persons with xlh	1	NBK83985	
see hereditary hearing loss and deafness overview, management	1	NBK83985	
see treatment of manifestations, pharmacologic treatment	1	NBK83985	
hyperparathyroidism is associated with treatment for xlh	1	NBK83985	
no long-term studies have been conducted	1	NBK83985	
if tertiary hyperparathyroidism is identified, surgical evaluation is warranted	1	NBK83985	
alkaline phosphatase level	1	NBK83985	
intact parathyroid hormone level	1	NBK83985	
renal ultrasound examination to assess for nephrocalcinosis	1	NBK83985	
evaluation can be accomplished by:	1	NBK83985	
gov/books/n/gene/rob-ad	1	NBK268648	
assessment for possible cryptorchidism	1	NBK268648	
abdominal ultrasound examination for investigation of renal anomalies	1	NBK268648	
echocardiogram to evaluate for a cardiac defect	1	NBK268648	
formal cognitive assessment if developmental delay is present	1	NBK268648	
corrective surgeries may be required for repair of:	1	NBK268648	
abnormal penile insertion/penoscrotal position	1	NBK268648	
hormone therapy may be helpful for males with micropenis	1	NBK268648	
orthodontic treatment is typically required	1	NBK268648	
pregnancy in affected women appears to be generally uncomplicated	1	NBK268648	
gov/books/n/gene/rob	1	NBK1240	
dental assessment for misaligned, crowded teeth	1	NBK1240	
radiographic documentation of the forearm shortening and hand anomalies	1	NBK1240	
and (2) growth hormone deficiency	1	NBK1240	
echocardiogram to evaluate for structural heart defects	1	NBK1240	
corrective surgeries may be required for the following:	1	NBK1240	
syndactyly repair	1	NBK1240	
severe scoliosis secondary to hemivertebrae and rib abnormalities	1	NBK1240	
cleft lip and cleft palate repair	1	NBK1240	
hormone therapy should be monitored by a pediatric endocrinologist	1	NBK1240	
orthodontic treatment is usually required	1	NBK1240	
preoperative cardiac evaluation for the presence of congenital heart defects	1	NBK1240	
gov/books/n/gene/rotor	1	NBK114805	
no treatment is required	1	NBK114805	
no adverse drug effects have been documented in rotor syndrome	1	NBK114805	
the list includes:	1	NBK114805	
anticancer drugs - methotrexate and irinotecan	1	NBK114805	
sartans – olmesartan and valsartan	1	NBK114805	
rifampicin	1	NBK114805	
mycophenolic acid	1	NBK114805	
torsemide	1	NBK114805	
thiazolidine diones – pioglitazone and rosiglitazone	1	NBK114805	
glinides – nateglinide and repaglinide	1	NBK114805	
lopinavir	1	NBK114805	
fexofenadine	1	NBK114805	
gov/books/n/gene/rp-overview	1	NBK1417	
management of nonsyndromic retinitis pigmentosa	1	NBK1417	
cystoid macular edema (cme)	1	NBK1417	
optical aids	1	NBK1417	
however, its current cost limits widespread use	1	NBK1417	
retinal prostheses	1	NBK1417	
agencies for the visually impaired	1	NBK1417	
vitamin e may adversely affect the course of rp	1	NBK1417	
, 400 iu/d) [berson 2000]	1	NBK1417	
supplementation	1	NBK1417	
vitamin a	1	NBK1417	
docosahexaenoic acid (dha)	1	NBK1417	
lutein	1	NBK1417	
stem cells	1	NBK1417	
triamcinolone injection	1	NBK1417	
intravitreal vegf inhibitors bevacizumab and ranibizumab	1	NBK1417	
gov/books/n/gene/rrm2b-mtddepl	1	NBK195854	
speech and language assessment	1	NBK195854	
occupational therapy assessment	1	NBK195854	
general management guidelines for those with systemic involvement:	1	NBK195854	
nutritional support (e	1	NBK195854	
management may include consideration of tracheostomy and artificial ventilation	1	NBK195854	
referral to a pediatric neurologist for seizure management	1	NBK195854	
of note, seizures may be refractory to treatment	1	NBK195854	
aggressive management of fever and infection	1	NBK195854	
the following evaluations should be considered:	1	NBK195854	
regular assessments of neurodevelopment, speech, and language	1	NBK195854	
rrm2b-related mitochondrial dna depletion syndrome and mitochondrial neurogastrointestinal encephalopathy	1	NBK195854	
rrm2b-related multiple mtdna deletions with external ophthalmoplegia	1	NBK195854	
care will be directed by clinical findings	1	NBK195854	
the following general evaluations are recommended:	1	NBK195854	
ecg advised biannually (kss phenotype)	1	NBK195854	
gov/books/n/gene/rss	1	NBK1324	
assessment and plotting of growth curves	1	NBK1324	
for north american children, see the magic foundation	1	NBK1324	
for children with diaphoresis, evaluation for hypoglycemia	1	NBK1324	
5 epimutations possibly because children with 11p15	1	NBK1324	
initial treatment is use of a shoe lift	1	NBK1324	
neurodevelopment	1	NBK1324	
gastrointestinal disorders should be aggressively managed	1	NBK1324	
craniofacial anomalies	1	NBK1324	
orthognathic surgery is rarely required	1	NBK1324	
referral of males with cryptorchidism to a urologist	1	NBK1324	
referral of males with micropenis to an endocrinologist	1	NBK1324	
androgenic hormone therapy as indicated	1	NBK1324	
neoplasia	1	NBK1324	
monitoring of growth with special attention to growth velocity	1	NBK1324	
close monitoring of speech and language development	1	NBK1324	
gov/books/n/gene/rsts	1	NBK1526	
dental and orthodontic evaluations	1	NBK1526	
echocardiogram or evaluation by cardiologist for structural heart defects	1	NBK1526	
assessment for gastroesophageal reflux as warranted	1	NBK1526	
assessment for presence of cryptorchidism in males	1	NBK1526	
orthopedic assessment of thumbs and halluces, joints and spine	1	NBK1526	
standard treatment for hearing loss if identified	1	NBK1526	
standard treatment for cardiac defects if identified	1	NBK1526	
aggressive management of gastroesophageal reflux and constipation	1	NBK1526	
standard treatment for cryptorchidism if identified	1	NBK1526	
surgical repair of significantly angulated thumbs or duplicated halluces	1	NBK1526	
appropriate treatment for sleep apnea if identified	1	NBK1526	
annual follow-up evaluation for ophthalmologic abnormalities	1	NBK1526	
yearly audiologic screens	1	NBK1526	
monitoring as per routine for cardiac or renal anomalies	1	NBK1526	
regular dental and orthodontic follow up	1	NBK1526	
gov/books/n/gene/rts	1	NBK1237	
ophthalmologic examination to evaluate for cataracts	1	NBK1237	
visually significant cataracts require surgical removal	1	NBK1237	
annual evaluation by a physician familiar with rts	1	NBK1237	
monitoring of growth	1	NBK1237	
gov/books/n/gene/rws	1	NBK1129	
ecg evaluation	1	NBK1129	
complete cessation of symptoms is the goal	1	NBK1129	
it is therefore important that:	1	NBK1129	
icd	1	NBK1129	
doses should be altered as needed	1	NBK1129	
lifestyle modifications are advised based on genotype	1	NBK1129	
that has documented lqts	1	NBK1129	
in which evaluation for lqts has not been performed	1	NBK1129	
or both of the following:	1	NBK1129	
follow-up experience with these drugs is still limited	1	NBK1129	
most affected individuals live normal lifestyles	1	NBK1129	
gov/books/n/gene/salih-myo	1	NBK83297	
adequate posture should be maintained when lying prone and sitting	1	NBK83297	
monitor as follows:	1	NBK83297	
ibuprofen (brufen®):	1	NBK83297	
give with care in those with evidence of cardiomyopathy	1	NBK83297	
avoid in those with congestive heart failure	1	NBK83297	
gov/books/n/gene/samd9l-ap	1	NBK435692	
medical history and physical examination including neurologic examination	1	NBK435692	
brain mri examination and referral to a neurologist	1	NBK435692	
referral to a hematologist/oncologist	1	NBK435692	
hematologic manifestations	1	NBK435692	
complete blood count annually	1	NBK435692	
annual evaluation of gait, coordination, and speech	1	NBK435692	
gov/books/n/gene/sca-io	1	NBK3795	
neurologic examination to evaluate the grade of ataxia and neuropathy	1	NBK3795	
neurophysiologic examinations	1	NBK3795	
enmg (electroneuromyography)	1	NBK3795	
sep (somatosensory evoked potentials)	1	NBK3795	
vep (visual evoked potentials)	1	NBK3795	
treatment is symptomatic:	1	NBK3795	
sensory axonal neuropathy	1	NBK3795	
physiotherapy and orthoses to prevent foot and spine deformity	1	NBK3795	
supportive shoes, splints, and braces	1	NBK3795	
foot care to treat calluses and ulcerations	1	NBK3795	
a walker, wheelchair, physiotherapy, occupational therapy	1	NBK3795	
some patients have benefited from lamotrigine or levetiracetam	1	NBK3795	
small children	1	NBK3795	
neurophysiologic studies when clinically indicated	1	NBK3795	
brain mri every three to five years	1	NBK3795	
neurologic examination annually	1	NBK3795	
audiologic and ophthalmologic examinations every one to two years	1	NBK3795	
eeg and brain mri at least during status epilepticus	1	NBK3795	
gov/books/n/gene/sca1	1	NBK1184	
neurologic evaluation every three to six months is appropriate	1	NBK1184	
, diphenylhydantoin)	1	NBK1184	
results have not been published (nct00683943)	1	NBK1184	
gov/books/n/gene/sca10	1	NBK1175	
nerve conduction tests	1	NBK1175	
neuropsychological tests	1	NBK1175	
canes and walkers help prevent falling	1	NBK1175	
no dietary factor that curtails symptoms has been documented	1	NBK1175	
gov/books/n/gene/sca11	1	NBK1757	
general and neurologic examination	1	NBK1757	
nerve conduction studies	1	NBK1757	
medical genetics or neurogenetics consultation	1	NBK1757	
occupational therapy, including home adaptations	1	NBK1757	
physiotherapy and assessment for cane and wheelchair	1	NBK1757	
ankle-foot orthotics (afos) for those with neuropathy	1	NBK1757	
weight control can help to facilitate ambulation	1	NBK1757	
gov/books/n/gene/sca12	1	NBK1202	
tremor rating and gait ataxia assessment	1	NBK1202	
evaluation for peripheral neuropathy and autonomic dysfunction	1	NBK1202	
modest success has been observed in some affected individuals	1	NBK1202	
supplements of antioxidants, which may have some beneficial effects	1	NBK1202	
treatment of psychiatric syndromes as needed	1	NBK1202	
technical assistance with writing and other fine-motor tasks	1	NBK1202	
recommended:	1	NBK1202	
education of affected individuals and their families	1	NBK1202	
gov/books/n/gene/sca13	1	NBK1225	
epileptic seizures can be improved by treatment with anticonvulsive medications	1	NBK1225	
alcohol and sedating drugs can exacerbate ataxia	1	NBK1225	
weight gain during pregnancy can further impair gait ataxia	1	NBK1225	
gov/books/n/gene/sca14	1	NBK1399	
gait, coordination, and speech should be evaluated annually	1	NBK1399	
alcohol and sedation may make gait and coordination worse	1	NBK1399	
gov/books/n/gene/sca15	1	NBK1362	
treatment of symptomatic tremor has not been reported in sca15	1	NBK1362	
gov/books/n/gene/sca17	1	NBK1438	
neuropsychological testing to evaluate for dementia and/or psychiatric disturbance	1	NBK1438	
brain mri to evaluate areas and degree of atrophy	1	NBK1438	
neurology consultation, if not completed prior to initial diagnosis	1	NBK1438	
treatment of seizures with antiepileptic drugs (aeds)	1	NBK1438	
treatment of dystonia with local injections of botulinum toxin	1	NBK1438	
the side effects of psychotropic medications and aeds (e	1	NBK1438	
affected women may be on medications (e	1	NBK1438	
, antiepileptics) to control the symptoms of sca17	1	NBK1438	
gov/books/n/gene/sca2	1	NBK1275	
baseline assessment of cognition	1	NBK1275	
gov/books/n/gene/sca20	1	NBK1471	
careful clinical and neurologic evaluation	1	NBK1471	
periodic speech assessment if dysphagia becomes a problem	1	NBK1471	
, isoniazid)	1	NBK1471	
gov/books/n/gene/sca28	1	NBK54582	
evaluation of cognitive abilities	1	NBK54582	
at present, only symptomatic treatments are available	1	NBK54582	
these include the following:	1	NBK54582	
crutches (less often canes) and walkers	1	NBK54582	
speech/language therapy for dysarthria and swallowing difficulties	1	NBK54582	
surgical intervention as needed for severe ptosis	1	NBK54582	
weight control can facilitate ambulation	1	NBK54582	
monitoring of speech and swallowing difficulties is recommended	1	NBK54582	
gov/books/n/gene/sca3	1	NBK1196	
gait assessment	1	NBK1196	
symptoms of restless legs syndrome may respond to these agents	1	NBK1196	
non-pharmacologic therapy is important in sca3:	1	NBK1196	
general anesthesia may be problematic	1	NBK1196	
gov/books/n/gene/sca36	1	NBK231880	
neurologic examination with appropriate scoring protocols:	1	NBK231880	
clinical genetics consultation and genetic counseling	1	NBK231880	
specific treatment for sca36 is currently not available	1	NBK231880	
walking aids to facilitate ambulation and mobility	1	NBK231880	
the use of a wheelchair is rare	1	NBK231880	
speech therapy and communication devices for those with dysarthria	1	NBK231880	
the utility of cochlear implants in sca36 is unknown	1	NBK231880	
surveillance of speech and ambulation	1	NBK231880	
, salicilates)	1	NBK231880	
environmental noise at work and in everyday life (e	1	NBK231880	
gov/books/n/gene/sca6	1	NBK1140	
medical, neurologic, family and social history	1	NBK1140	
swallow evaluation for aspiration risk and counseling	1	NBK1140	
vestibular suppressants may reduce vertigo and/or osscilopsia	1	NBK1140	
canes, walking sticks, and walkers help prevent falling	1	NBK1140	
note: rbd is rare in individuals with sca6	1	NBK1140	
continuous positive airway pressure may be used for sleep apnea	1	NBK1140	
driving ability should be assessed by professionals periodically	1	NBK1140	
gov/books/n/gene/sca7	1	NBK1256	
cerebellar ataxia	1	NBK1256	
gov/books/n/gene/sca8	1	NBK1268	
use of canes and walkers helps prevent falls	1	NBK1268	
affected individuals should get plenty of rest	1	NBK1268	
symptoms are often aggravated by fatigue	1	NBK1268	
gov/books/n/gene/scad	1	NBK63582	
carnitine levels	1	NBK63582	
compound heterozygous for pathogenic variant and a susceptibility variant	1	NBK63582	
free carnitine levels were normal in all individuals	1	NBK63582	
gov/books/n/gene/scan1	1	NBK1105	
routine visits to a neurologist are appropriate	1	NBK1105	
gov/books/n/gene/scn8a-ee	1	NBK379665	
brain mri if not previously performed	1	NBK379665	
cognitive and behavioral neuropsychological evaluation	1	NBK379665	
no published treatment guidelines exist	1	NBK379665	
, dravet syndrome	1	NBK379665	
see scn1a-related seizure disorders and differential diagnosis)	1	NBK379665	
sodium channel blockers	1	NBK379665	
other aeds	1	NBK379665	
vagus nerve stimulator	1	NBK379665	
cannabinoids	1	NBK379665	
sleep hygiene	1	NBK379665	
monitor with eeg and other modalities (e	1	NBK379665	
gov/books/n/gene/scs	1	NBK1189	
audiologic screening for hearing loss	1	NBK1189	
examination for cleft palate	1	NBK1189	
examination of upper and lower extremities for anomalies	1	NBK1189	
measurement of height and growth velocity	1	NBK1189	
it prevents the following:	1	NBK1189	
in most cases, cranioplasty precedes palatal repair	1	NBK1189	
ophthalmologic abnormalities are treated in a standard fashion	1	NBK1189	
, gymnastics, football, soccer)	1	NBK1189	
, headache, reduced school performance) are identified	1	NBK1189	
audiologic screening throughout childhood is indicated	1	NBK1189	
screen for sleep-disordered breathing at all visits	1	NBK1189	
gov/books/n/gene/sds	1	NBK1756	
discussions to update recommendations are ongoing	1	NBK1756	
pancreatic imaging by ultrasound	1	NBK1756	
bone densitometry as clinically indicated	1	NBK1756	
assessment of serum aminotransferase levels	1	NBK1756	
routine monitoring (see surveillance) is recommended	1	NBK1756	
hematologic abnormalities	1	NBK1756	
note: discussions to update and maintain recommendations are ongoing	1	NBK1756	
some drugs (e	1	NBK1756	
gov/books/n/gene/sedt	1	NBK1145	
gov/books/n/gene/sft	1	NBK1164	
cbc with differential to evaluate for microcytic anemia	1	NBK1164	
measurement of serum bilirubin concentration to evaluate for jaundice	1	NBK1164	
skeletal survey to evaluate for dysostosis multiplex	1	NBK1164	
eeg when relevant	1	NBK1164	
gov/books/n/gene/sgbs	1	NBK1219	
assessment for upper airway sufficiency if macroglossia is present	1	NBK1219	
renal ultrasound examination to evaluate for genitourinary malformations	1	NBK1219	
abdominal/pelvic ultrasound examination to evaluate for intra-abdominal tumors	1	NBK1219	
abdominal ultrasound examination to evaluate for visceral anomalies	1	NBK1219	
further studies (e	1	NBK1219	
, mri) if findings are suspicious	1	NBK1219	
examination for evidence of skeletal anomalies requiring intervention (e	1	NBK1219	
, scoliosis during period of rapid growth rate)	1	NBK1219	
development assessment including speech and language assessment	1	NBK1219	
prompt treatment of hypoglycemia if present	1	NBK1219	
ophthalmologist for management of vision problems	1	NBK1219	
neurologist if seizures are present	1	NBK1219	
oncologist if a tumor is identified	1	NBK1219	
for males with sgbs1:	1	NBK1219	
monitoring for hypoglycemia in the newborn period	1	NBK1219	
radiographs as needed	1	NBK1219	
monitoring of renal function if renal anomalies are present	1	NBK1219	
every three months until age four years	1	NBK1219	
every four months from age four to seven years	1	NBK1219	
biannually after age seven years	1	NBK1219	
the following screening recommendations require further study to determine benefit	1	NBK1219	
gonadoblastoma or hepatocellular carcinoma	1	NBK1219	
every six months between ages four and seven years	1	NBK1219	
neuroblastoma	1	NBK1219	
every six months from age four to seven years	1	NBK1219	
gov/books/n/gene/sgs	1	NBK1277	
severe scoliosis, c1/c2 abnormality)	1	NBK1277	
surgical evaluation for hernia repair, if indicated	1	NBK1277	
surgical intervention for aneurysms may be indicated	1	NBK1277	
surgical repair of abdominal hernias may be indicated	1	NBK1277	
cleft palate and craniosynostosis require management by a craniofacial team	1	NBK1277	
surgical fixation of cervical spine instability may be necessary	1	NBK1277	
clubfoot deformity may require surgical correction	1	NBK1277	
pectus excavatum may be severe	1	NBK1277	
rarely, surgical correction is indicated for medical reasons	1	NBK1277	
physiotherapy	1	NBK1277	
physiotherapy may help increase mobility in individuals with joint contractures	1	NBK1277	
activities that cause joint pain or injury	1	NBK1277	
gov/books/n/gene/short	1	NBK201365	
for infants just diagnosed with short syndrome:	1	NBK201365	
measurement of length and weight	1	NBK201365	
assessment for evidence of insulin resistance/diabetes mellitus	1	NBK201365	
axenfeld-rieger anomaly or related anterior chamber ocular anomalies	1	NBK201365	
dental anomalies	1	NBK201365	
insulin resistance/diabetes mellitus	1	NBK201365	
periodic hearing assessments in childhood	1	NBK201365	
successful pregnancies have occurred in women with short syndrome	1	NBK201365	
if present, diabetes mellitus is managed as appropriate	1	NBK201365	
gov/books/n/gene/sickle	1	NBK1377	
hematology consultation	1	NBK1377	
infants	1	NBK1377	
cbc and reticulocyte count	1	NBK1377	
measurement of hbf (%)	1	NBK1377	
baseline vitamin d	1	NBK1377	
renal and liver function tests	1	NBK1377	
older individuals	1	NBK1377	
see surveillance	1	NBK1377	
a systematic approach to pain management should be reviewed regularly	1	NBK1377	
vaso-occlusive pain episodes (including dactylitis)	1	NBK1377	
, cold, dehydration)	1	NBK1377	
nsaids (e	1	NBK1377	
fever/suspected infection	1	NBK1377	
individuals with temperature greater than 38	1	NBK1377	
rapid triage and physical assessment	1	NBK1377	
urgent cbc and reticulocyte count	1	NBK1377	
acute chest syndrome (acs)	1	NBK1377	
perform chest x-ray examination	1	NBK1377	
incentive spirometry should be encouraged	1	NBK1377	
aplastic crisis	1	NBK1377	
blood transfusion may be necessary	1	NBK1377	
splenic sequestration	1	NBK1377	
the following general approach is reasonable:	1	NBK1377	
, thrombotic disease, obstructive sleep apnea)	1	NBK1377	
optimization of scd-related therapy to stop progression (e	1	NBK1377	
stroke	1	NBK1377	
cerebral hemorrhage requires immediate neurosurgical consultation	1	NBK1377	
chronic transfusion has been shown to reduce silent infarcts	1	NBK1377	
priapism	1	NBK1377	
ongoing education is essential to help minimize morbidity and mortality	1	NBK1377	
maintaining hydration and avoiding extremes of climate	1	NBK1377	
monitoring for signs and symptoms requiring acute medical intervention	1	NBK1377	
early detection of chronic complications	1	NBK1377	
updates on new therapies	1	NBK1377	
chronic red blood cell transfusion therapy	1	NBK1377	
prevention of stroke recurrence	1	NBK1377	
treatment of chronic pain refractory to other therapies	1	NBK1377	
chronic renal failure	1	NBK1377	
recurrent episodes of acs	1	NBK1377	
severe end-organ damage	1	NBK1377	
metabolism into nitric oxide, a potent vasodilator	1	NBK1377	
overall improvement in blood flow	1	NBK1377	
reduction of vascular inflammation	1	NBK1377	
hydroxyurea can have potentially significant toxicity, including myelosuppression	1	NBK1377	
gov/ct2/show/nct01179217)	1	NBK1377	
timely administration of vaccines is essential	1	NBK1377	
iron overload	1	NBK1377	
the following are general guidelines compiled from several sources	1	NBK1377	
comprehensive medical and social evaluation	1	NBK1377	
routine dental care is recommended	1	NBK1377	
mental health and neurocognitive assessment	1	NBK1377	
annual laboratory assessment should include the following:	1	NBK1377	
cbc with differential and reticulocyte count	1	NBK1377	
ldh as a marker of hemolysis	1	NBK1377	
vitamin d level	1	NBK1377	
assessment of stroke risk	1	NBK1377	
end-organ evaluation	1	NBK1377	
chest x-ray examination	1	NBK1377	
pulmonary function tests (pfts)	1	NBK1377	
six-minute walk test	1	NBK1377	
sleep study (to assess nighttime hypoxemia)	1	NBK1377	
iron overload by mri	1	NBK1377	
environmental controls include avoiding the following:	1	NBK1377	
extremes of temperature (e	1	NBK1377	
physical exhaustion	1	NBK1377	
extremely high altitude without oxygen supplementation	1	NBK1377	
cocaine	1	NBK1377	
the field is changing rapidly	1	NBK1377	
gov for the status of current studies	1	NBK1377	
prevention of hbs polymerization	1	NBK1377	
decreasing adhesion to the endothelium	1	NBK1377	
modifying inflammatory responses	1	NBK1377	
antioxidants therapy	1	NBK1377	
multiple antioxidants are being studied	1	NBK1377	
rejuvenation of nitric oxide (no) stores	1	NBK1377	
induction of fetal hemoglobin	1	NBK1377	
glu6val) with a normal allele	1	NBK1377	
this leaves the endogenous sickle allele intact	1	NBK1377	
the status of these trials is changing rapidly	1	NBK1377	
gov for the most up-to-date information	1	NBK1377	
gov/books/n/gene/sider-anemia	1	NBK1321	
brain ct or mri	1	NBK1321	
psychological testing if indicated	1	NBK1321	
there is no effective treatment for xlsa/a	1	NBK1321	
weighted eating utensils may help promote independent skills in childhood	1	NBK1321	
speech therapy may improve intelligibility problems resulting from dysarthria	1	NBK1321	
hepatic and systemic iron overload does not occur	1	NBK1321	
gov/books/n/gene/siod	1	NBK1376	
referral to a nephrologist for evaluation	1	NBK1376	
dental evaluation after teeth are present	1	NBK1376	
detailed history for headaches or neurologic abnormalities	1	NBK1376	
assessment for osteopenia	1	NBK1376	
orthopedic manifestations	1	NBK1376	
treatment of scoliosis and/or kyphosis is standard	1	NBK1376	
immunologic manifestations	1	NBK1376	
individuals with autoimmune problems have had variable responses to treatment	1	NBK1376	
infectious disease manifestations	1	NBK1376	
hypothyroidism can be treated with levothyroxine supplementation	1	NBK1376	
regular monitoring of the hips	1	NBK1376	
annual monitoring of renal, immune, and hematologic status	1	NBK1376	
heat, stress, and lack of sleep	1	NBK1376	
vaccinations with live vaccines	1	NBK1376	
anti-cancer therapies	1	NBK1376	
individuals with siod usually have normal growth hormone studies	1	NBK1376	
gov/books/n/gene/slc39a14-def	1	NBK431123	
assessment of liver function	1	NBK431123	
white blood count is <3	1	NBK431123	
5x109/l	1	NBK431123	
neutrophil count is <2	1	NBK431123	
0x109/l	1	NBK431123	
platelet count is <150x109/l	1	NBK431123	
routine monitoring of:	1	NBK431123	
height and weight using age and gender appropriate growth charts	1	NBK431123	
swallowing and diet to assure adequate nutrition	1	NBK431123	
ambulation and speech	1	NBK431123	
environmental manganese exposure (i	1	NBK431123	
high manganese content of total parenteral nutrition	1	NBK431123	
foods very high in manganese, including: cloves	1	NBK431123	
and pumpkin, sesame, and sunflower seeds	1	NBK431123	
gov/books/n/gene/slc6a3-dtds	1	NBK442323	
neurologic assessment of the movement disorder	1	NBK442323	
ophthalmology assessment of vision and eye movements	1	NBK442323	
evaluation of caloric intake and feeding by a nutritionist	1	NBK442323	
speech and language therapy assessment of communication and swallowing	1	NBK442323	
physiotherapy evaluation of postural issues and tone	1	NBK442323	
orthopedic review of any fixed contractures / joint dislocations	1	NBK442323	
although the role of atypical tranquilizers (e	1	NBK442323	
treatment of status dystonicus	1	NBK442323	
standard protocols are used in an intensive care setting	1	NBK442323	
regular swallowing assessment to evaluate risk for aspiration	1	NBK442323	
drugs with anti-dopaminergic side effects (e	1	NBK442323	
gov/books/n/gene/slo	1	NBK1143	
cardiac evaluation (ecg and echocardiogram) for congenital defects	1	NBK1143	
nutritional assessment for feeding problems and poor weight gain	1	NBK1143	
renal ultrasound evaluation for renal anomalies	1	NBK1143	
hearing evaluation for either sensorineural or conductive hearing loss	1	NBK1143	
cholesterol supplementation	1	NBK1143	
dental management can be challenging	1	NBK1143	
recurrent otitis media may require tympanostomy tube placement	1	NBK1143	
airway management during anesthesia may be challenging	1	NBK1143	
gov/books/n/gene/sma-xli	1	NBK2594	
determine if caloric intake is adequate	1	NBK2594	
determine if gastrostomy tube placement and fundoplication are indicated	1	NBK2594	
orthopedic evaluation to assess contractures	1	NBK2594	
see spinal muscular atrophy	1	NBK2594	
feeding/growth	1	NBK2594	
manage gastroesophageal reflux disorder in the standard manner	1	NBK2594	
use oral suctioning as needed	1	NBK2594	
in some cases artificial ventilation and tracheostomy may be employed	1	NBK2594	
manage accordingly	1	NBK2594	
standard precautions against infection are appropriate	1	NBK2594	
, a clinical geneticist)	1	NBK2594	
affected children frequently die in infancy or early childhood	1	NBK2594	
the following are indicated on a routine basis:	1	NBK2594	
monitoring for scoliosis and kyphosis	1	NBK2594	
gov/books/n/gene/sma	1	NBK1352	
nutrition/feeding assessment	1	NBK1352	
time required to complete a feeding	1	NBK1352	
evidence of fatigue during a feeding/meal	1	NBK1352	
weight plotted on standard growth curves	1	NBK1352	
respiratory function assessment	1	NBK1352	
normal breathing pattern versus abdominal breathing pattern	1	NBK1352	
sleep assessment	1	NBK1352	
activities of daily living	1	NBK1352	
health issues specific to sma	1	NBK1352	
scoliosis occurs frequently in individuals with sma ii	1	NBK1352	
no surgical complications were identified	1	NBK1352	
hip dislocation is another orthopedic concern in sma	1	NBK1352	
individuals with sma are evaluated at least every six months	1	NBK1352	
weaker children are evaluated more frequently	1	NBK1352	
small-molecule therapy approaches	1	NBK1352	
increasing smn protein production	1	NBK1352	
neuroprotective and other approaches	1	NBK1352	
rna-based therapy approaches	1	NBK1352	
subcutaneous injections extended the median life span 25-fold	1	NBK1352	
gov/books/n/gene/sms	1	NBK1310	
complete review of systems at the time of diagnosis	1	NBK1310	
comprehensive speech/language pathology evaluation	1	NBK1310	
early evaluation by physical and/or occupational therapists	1	NBK1310	
a change in behavior or attention warrants reevaluation	1	NBK1310	
specific screening for adrenal function	1	NBK1310	
[hildenbrand & smith 2012]	1	NBK1310	
no well-controlled treatment trials have been reported:	1	NBK1310	
thus, dosages may not be exact	1	NBK1310	
enclosed bed system for containment during sleep	1	NBK1310	
treatment with diet or medication as indicated	1	NBK1310	
treatment with corrective lenses as indicated for ophthalmologic abnormalities	1	NBK1310	
treatment of recurrent otitis media with tympanostomy tubes as needed	1	NBK1310	
recommended annually:	1	NBK1310	
thyroid function, including free t4 and tsh	1	NBK1310	
fasting lipid profile	1	NBK1310	
routine urinalysis to evaluate for occult urinary tract infections	1	NBK1310	
monitoring for scoliosis	1	NBK1310	
significant changes in her sleep pattern were also documented	1	NBK1310	
gov/books/n/gene/snyder-robinson	1	NBK144284	
assessment of seizures, including eeg if seizures are suspected	1	NBK144284	
gov/books/n/gene/sost	1	NBK1228	
formal audiologic evaluation	1	NBK1228	
neurologic evaluation for consequences of cranial nerve entrapment	1	NBK1228	
radiographic and imaging studies	1	NBK1228	
the bones in sclerosteosis are thick and dense	1	NBK1228	
surgical intervention may be difficult and prolonged	1	NBK1228	
standard neurosurgical instruments may not be sufficient (i	1	NBK1228	
tooth extraction may be difficult	1	NBK1228	
management by an orthodontic or craniofacial team is recommended	1	NBK1228	
annually from infancy onwards for the following:	1	NBK1228	
assessment for increased intracranial pressure and medullary compression	1	NBK1228	
neurologic and otologic examination for consequences of cranial nerve entrapment	1	NBK1228	
clinical appraisal and lateral skull radiograph as indicated	1	NBK1228	
gov/books/n/gene/sotos	1	NBK1479	
referral for audiologic assessment	1	NBK1479	
thus, the threshold for referral should be low	1	NBK1479	
when clinical problems (e	1	NBK1479	
antibiotic prophylaxis is indicated in individuals with vesicoureteral reflux	1	NBK1479	
the following are appropriate at the clinical evaluation:	1	NBK1479	
thorough history to identify known clinical sequelae of sotos syndrome	1	NBK1479	
cardiac auscultation	1	NBK1479	
examination for curvature of the spine	1	NBK1479	
urine dipstick to assess for quiescent urine infection	1	NBK1479	
referral to the appropriate clinical specialist if problems are identified	1	NBK1479	
note: cancer screening is not recommended	1	NBK1479	
gov/books/n/gene/sox2	1	NBK1300	
examination by an experienced pediatric ophthalmologist	1	NBK1300	
baseline neurodevelopmental assessment	1	NBK1300	
care includes:	1	NBK1300	
early referral to an experienced multidisciplinary team	1	NBK1300	
referral to special educational services for visually impaired infants	1	NBK1300	
referral to endocrinologist for growth or hypogonadism concerns	1	NBK1300	
referral to physiotherapist if any evidence of motor impairment exists	1	NBK1300	
referral to special educational services for neurodevelopmental problems as needed	1	NBK1300	
parent/caregiver training in seizure management	1	NBK1300	
the following measures are suggested:	1	NBK1300	
annual hearing test	1	NBK1300	
neurodevelopmental assessment annually for the first five years of life	1	NBK1300	
gov/books/n/gene/spg11	1	NBK1210	
neuropsychological testing to assess the cognitive impairment and decline	1	NBK1210	
neuro-urologic examination for those with sphincter disturbance	1	NBK1210	
electrophysiologic investigations (e	1	NBK1210	
, enmg, vep, sep)	1	NBK1210	
no specific drug treatment or cures exist for spg11	1	NBK1210	
physiotherapy for stretching of the spastic muscles to prevent contractures	1	NBK1210	
anti-spastic drugs such as baclofen and tizanidine	1	NBK1210	
anticholinergic drugs are indicated for urinary urgency	1	NBK1210	
psychiatric manifestations should be treated in accordance with standard practice	1	NBK1210	
early regular physiotherapy helps to prevent contractures	1	NBK1210	
regular electrophysiologic investigations (e	1	NBK1210	
gov/books/n/gene/spg17	1	NBK1307	
physiotherapy is appropriate	1	NBK1307	
foot deformities are corrected by surgical treatment	1	NBK1307	
gov/books/n/gene/spg20	1	NBK1382	
occipitofrontal circumference (ofc)	1	NBK1382	
gross motor and fine motor skills	1	NBK1382	
school performance	1	NBK1382	
emotional status, including presence or absence of emotional lability	1	NBK1382	
skeletal abnormalities and skeletal x-rays as needed	1	NBK1382	
improve muscle strength (through resistance exercise)	1	NBK1382	
improve cardiovascular fitness	1	NBK1382	
oxybutynin is helpful in reducing urinary urgency	1	NBK1382	
see also hereditary spastic paraplegia overview	1	NBK1382	
provide good nursing care and physiotherapy during disease progression	1	NBK1382	
monitor for dysphagia to reduce risk of aspiration	1	NBK1382	
cognitive testing	1	NBK1382	
repeat skeletal survey	1	NBK1382	
gov/books/n/gene/spg3a	1	NBK45978	
urologic evaluation in persons with prominent urinary bladder hyperactivity	1	NBK45978	
spasticity can be treated with:	1	NBK45978	
oral baclofen or tizanidine	1	NBK45978	
chemodenervation with botulinum a or b toxins	1	NBK45978	
see also prevention of secondary complications	1	NBK45978	
referral to orthotic services may be helpful	1	NBK45978	
urinary urgency can be treated with anticholinergic antispasmodic drugs	1	NBK45978	
gov/books/n/gene/spg4	1	NBK1160	
symptomatic treatment includes use of the following:	1	NBK1160	
antispastic drugs for leg spasticity	1	NBK1160	
anticholinergic antispasmodic drugs for urinary urgency	1	NBK1160	
regular physiotherapy for stretching of spastic muscles	1	NBK1160	
gov/books/n/gene/spg7	1	NBK1107	
no specific drug treatments or cures exist for spg7	1	NBK1107	
this approach may offer hope for future treatment strategies	1	NBK1107	
gov/books/n/gene/spg8	1	NBK1827	
urodynamic evaluation	1	NBK1827	
antispasmodic drugs (e	1	NBK1827	
no significant toxicity limits their use	1	NBK1827	
gov/books/n/gene/spondylocostal-d	1	NBK8828	
evaluation for other (e	1	NBK8828	
, renal and cardiac) anomalies	1	NBK8828	
routine treatment of inguinal herniae	1	NBK8828	
surgical intervention as needed if scoliosis is significant	1	NBK8828	
expert management of these clinical problems is indicated	1	NBK8828	
gov/books/n/gene/spr-def	1	NBK304122	
neurologic consultation	1	NBK304122	
neuropsychological evaluation depending on the severity of manifestations	1	NBK304122	
social services consultation depending on the severity of manifestations	1	NBK304122	
l-dopa (0	1	NBK304122	
optimal therapeutic level is determined by clinical response	1	NBK304122	
tetrahydrobiopterin (bh4	1	NBK304122	
monoamine oxidase inhibitors (selegeline)	1	NBK304122	
serotonin reuptake inhibitors (sertraline)	1	NBK304122	
melatonin	1	NBK304122	
dopamine agonists (bromocriptine, pramipexole)	1	NBK304122	
anticholinergics	1	NBK304122	
methylphenidate	1	NBK304122	
neuroleptics and other dopamine antagonists (e	1	NBK304122	
, metoclopramide)	1	NBK304122	
gov/books/n/gene/ssadh	1	NBK1195	
neuroimaging (mri)	1	NBK1195	
5 years [escalera et al 2010]	1	NBK1195	
and speech therapy [gropman 2003]	1	NBK1195	
regular neurologic and developmental assessments are indicated	1	NBK1195	
the refractory epilepsy was finally controlled with magnesium valproate	1	NBK1195	
in addition, the eeg demonstrated improved background organization	1	NBK1195	
gov/books/n/gene/stickler	1	NBK1302	
evaluation of palate by a craniofacial specialist	1	NBK1302	
baseline audiogram	1	NBK1302	
refractive errors should be corrected with spectacles	1	NBK1302	
myringotomy tubes are often required	1	NBK1302	
annual examination by a vitreoretinal specialist is appropriate	1	NBK1302	
more advanced testing (e	1	NBK1302	
gov/books/n/gene/stsl	1	NBK131810	
evaluation for possible hemolysis/ hemolytic anemia	1	NBK131810	
monitoring liver function (e	1	NBK131810	
evaluation for arthralgias and/or arthritis	1	NBK131810	
some of these treatments have only been partially effective	1	NBK131810	
current treatment therapies focus on the following:	1	NBK131810	
treatments should begin at the time of diagnosis	1	NBK131810	
often existing xanthomas regress	1	NBK131810	
partial ileal bypass surgery (i	1	NBK131810	
sitosterolemia does not respond to standard statin treatment	1	NBK131810	
margarines and other products containing stanols (e	1	NBK131810	
gov/books/n/gene/stxbp1-ee	1	NBK396561	
global developmental delay, cognitive dysfunction and intellectual disability	1	NBK396561	
seizure management is symptomatic	1	NBK396561	
other neurologic findings	1	NBK396561	
gov/books/n/gene/sucla2-def	1	NBK6803	
emg to assess myopathy	1	NBK6803	
bracing for scoliosis and kyphosis	1	NBK6803	
blepharoplasty for significant ptosis	1	NBK6803	
hearing aids and/or cochlear implantation for sensorineural hearing loss	1	NBK6803	
routine developmental and neurologic assessment	1	NBK6803	
periodic nutritional and growth assessment	1	NBK6803	
periodic hearing evaluation	1	NBK6803	
periodic ophthalmologic examination	1	NBK6803	
gov/books/n/gene/suclg1-mtddepl	1	NBK425223	
echocardiogram to assess for cardiomyopathy	1	NBK425223	
ophthalmologic examination for evidence of ptosis and/or strabismus	1	NBK425223	
nutritional and growth assessment	1	NBK425223	
gov/books/n/gene/syne1ca-ar	1	NBK1379	
brain mri to assess for cerebellar atrophy	1	NBK1379	
nerve conduction studies to rule out a peripheral neuropathy	1	NBK1379	
no pregnancy complications have been reported	1	NBK1379	
gov/books/n/gene/sys-h	1	NBK1525	
complete nutritional evaluation, including evaluation for intestinal malabsorption	1	NBK1525	
evaluation for immune deficiency	1	NBK1525	
agents such as gabapentin should be considered	1	NBK1525	
gentle handling may reduce pain that is worsened with movement	1	NBK1525	
splinting of affected joints may provide comfort	1	NBK1525	
consultation with a pain management specialist may be helpful	1	NBK1525	
palliative care may be an option in severe cases	1	NBK1525	
a nutritionist should follow affected individuals	1	NBK1525	
protein-losing enteropathy	1	NBK1525	
an effective long-term treatment is lacking	1	NBK1525	
dermatitis	1	NBK1525	
perianal masses may be excised, but may recur	1	NBK1525	
contractures are typically progressive	1	NBK1525	
immune system/infections	1	NBK1525	
routine nutritional assessment is appropriate	1	NBK1525	
gov/books/n/gene/taa	1	NBK1120	
risk assessment for thoracic aortic aneurysm and dissection	1	NBK1120	
echocardiography is used to detect aortic root dilation	1	NBK1120	
surveillance for thoracic aortic disease	1	NBK1120	
proband	1	NBK1120	
first-degree relatives (i	1	NBK1120	
recommendations for medical/surgical management of thoracic aortic disease	1	NBK1120	
prophylactic surgical repair of the aorta	1	NBK1120	
5 to 6	1	NBK1120	
when the specific cause of htad has been identified	1	NBK1120	
gene-specific recommendations exist for the four following genes	1	NBK1120	
data are limited on other genes	1	NBK1120	
5 cm	1	NBK1120	
[regalado et al 2015]	1	NBK1120	
, greater than 0	1	NBK1120	
consider repair at aortic diameters <5	1	NBK1120	
rapid enlargement (>0	1	NBK1120	
5 cm per year)	1	NBK1120	
a family history of aortic dissections at diameters <5	1	NBK1120	
significant aortic regurgitation	1	NBK1120	
gov/books/n/gene/tar	1	NBK23758	
platelet count if this has not been completed	1	NBK23758	
orthopedic evaluation of both upper and lower limbs	1	NBK23758	
echocardiography to assess for cardiac anomalies	1	NBK23758	
evaluation of renal structure and function	1	NBK23758	
the treatment for thrombocytopenia is platelet transfusion as needed	1	NBK23758	
almost all develop thrombocytopenia during pregnancy	1	NBK23758	
gov/books/n/gene/tardbp-als	1	NBK5942	
emg/ncs to document the regions of involvement	1	NBK5942	
screening for depression and need for psychosocial support	1	NBK5942	
routine screening for depression at clinic visits is appropriate	1	NBK5942	
gov/books/n/gene/tay-sachs	1	NBK1218	
complete history and physical examination, including ophthalmologic examination	1	NBK1218	
family history, including ethnicity	1	NBK1218	
referral to a pediatric neurologist and/or ophthalmologist	1	NBK1218	
but the clinical response is unpredictable and generally poor	1	NBK1218	
none has been successful	1	NBK1218	
gov/books/n/gene/tbc1d24-dis	1	NBK274566	
doors syndrome	1	NBK274566	
clinical genetics consultation, including dysmorphology examination	1	NBK274566	
audiology consultation	1	NBK274566	
otolaryngology consultation	1	NBK274566	
ophthalmology consultation	1	NBK274566	
dental consultation	1	NBK274566	
heart ultrasound	1	NBK274566	
the management of epilepsy in many genetic epilepsies is complex	1	NBK274566	
refer to an urologist or nephrologist as indicated	1	NBK274566	
manage according to the anomalies detected	1	NBK274566	
yearly dental evaluation is appropriate	1	NBK274566	
gov/books/n/gene/tbs	1	NBK1445	
baseline evaluation by a cardiologist including an echocardiogram	1	NBK1445	
imperforate anus	1	NBK1445	
immediate surgical intervention is required	1	NBK1445	
thumb malformations	1	NBK1445	
, removal of additional thumbs)	1	NBK1445	
annual hearing evaluation is indicated	1	NBK1445	
medications that cause renal or otic toxicity should be avoided	1	NBK1445	
gov/books/n/gene/tcs	1	NBK1532	
the palate for clefts	1	NBK1532	
swallowing function	1	NBK1532	
birth to 2 years: airway and feeding difficulties	1	NBK1532	
13 years to 18 years: orthognathic surgery	1	NBK1532	
generally, bone reconstruction precedes soft tissue corrections	1	NBK1532	
reconstruction can prevent the progression of facial asymmetry	1	NBK1532	
maxillomandibular reconstruction	1	NBK1532	
orthognathic procedures are typically indicated before age 16 years	1	NBK1532	
misaligned teeth often require orthodonture	1	NBK1532	
nasal reconstruction, if needed, should follow orthognathic surgeries	1	NBK1532	
gov/books/n/gene/td	1	NBK1366	
assessment of respiratory status by respiratory rate and skin color	1	NBK1366	
medical genetics consultation and genetic counseling	1	NBK1366	
other measures:	1	NBK1366	
medication to control seizures, as in the general population	1	NBK1366	
shunt placement, when hydrocephaly is identified	1	NBK1366	
suboccipital decompression for relief of craniocervical junction constriction	1	NBK1366	
hearing aids, when hearing loss is identified	1	NBK1366	
routine assessment of neurologic status on physical examination	1	NBK1366	
audiology assessment	1	NBK1366	
eeg for seizure activity	1	NBK1366	
it can be addressed on three levels:	1	NBK1366	
maternal	1	NBK1366	
avoidance of emergency c-section for fetal distress	1	NBK1366	
fetal	1	NBK1366	
familial	1	NBK1366	
gov/books/n/gene/tef-ov	1	NBK5192	
x-ray evaluation for vertebral anomalies	1	NBK5192	
supplemental oxygen should be administered as needed	1	NBK5192	
gov/books/n/gene/tetra-amelia	1	NBK1276	
tetra-amelia syndrome is usually diagnosed prenatally	1	NBK1276	
other individualized ambulatory devices may be indicated	1	NBK1276	
gov/books/n/gene/tfap	1	NBK1194	
complete neurologic assessment including baseline nerve conduction studies	1	NBK1194	
evaluation of the heart:	1	NBK1194	
carpal tunnel release surgery for carpal tunnel syndrome	1	NBK1194	
vitrectomy for vitreous involvement	1	NBK1194	
orthotopic liver transplantation (oltx)	1	NBK1194	
age younger than 60 years	1	NBK1194	
disease duration less than five years	1	NBK1194	
no significant cardiac or renal dysfunction	1	NBK1194	
fapwtr	1	NBK1194	
org/ram_fap	1	NBK1194	
severe polyneuropathy (norris score <55/81)	1	NBK1194	
permanent urinary incontinence	1	NBK1194	
marked postural hypotension	1	NBK1194	
a fixed pulse rate	1	NBK1194	
inhibition of synthesis of variant ttr	1	NBK1194	
stabilization of variant ttr	1	NBK1194	
inhibition of aggregation of amyloidogenic intermediates	1	NBK1194	
disruption of insoluble amyloid fibrils	1	NBK1194	
this study is currently fully enrolled	1	NBK1194	
results are anticipated in december, 2012	1	NBK1194	
however, no obvious benefit could be detected	1	NBK1194	
gov/books/n/gene/tfr2	1	NBK1349	
serum concentration of testosterone to assess testicular function	1	NBK1349	
serum concentration of estradiol to assess ovarian function	1	NBK1349	
therapeutic phlebotomy	1	NBK1349	
periodic phlebotomy (i	1	NBK1349	
the usual therapy is weekly phlebotomy	1	NBK1349	
camaschella & roetto, unpublished observation]	1	NBK1349	
treatment of clinical complications	1	NBK1349	
in some cases, joint replacement has been performed	1	NBK1349	
diabetes mellitus may require lifelong insulin treatment	1	NBK1349	
medicinal iron	1	NBK1349	
mineral supplements	1	NBK1349	
excess vitamin c	1	NBK1349	
gov/books/n/gene/thctd	1	NBK26373	
neurologic evaluation and eeg to assess possible seizures	1	NBK26373	
glycopyrolate or scopolamine to improve drooling	1	NBK26373	
standard anticonvulsant medication to control seizures, if present	1	NBK26373	
placement of permanent feeding tube to avert malnutrition	1	NBK26373	
diet restrictions to prevent aspiration	1	NBK26373	
regular orthopedic evaluations to monitor scoliosis or joint problems	1	NBK26373	
aspiration of food should be avoided to prevent pneumonia	1	NBK26373	
gov/books/n/gene/thdrd	1	NBK1437	
clinical examination to assess the severity of motor disturbances	1	NBK1437	
evaluation for associated psychiatric symptoms or cognitive impairments	1	NBK1437	
, 0	1	NBK1437	
mild form (th-deficient drd)	1	NBK1437	
individuals demonstrate complete responsiveness of symptoms to levodopa treatment	1	NBK1437	
individuals show a marked response to levodopa	1	NBK1437	
very severe form (th-deficient progressive infantile encephalopathy)	1	NBK1437	
individuals are extremely sensitive to levodopa	1	NBK1437	
2 to 1	1	NBK1437	
gov/books/n/gene/timothy	1	NBK1403	
orthopedist consulation for skeletal abnormalities	1	NBK1403	
long qt interval	1	NBK1403	
beta-blockers	1	NBK1403	
pacemaker	1	NBK1403	
implants	1	NBK1403	
the possibility of reduced immune response should be considered	1	NBK1403	
surgical release of syndactyly	1	NBK1403	
drugs and dietary practices that could lead to hypoglycemia	1	NBK1403	
gov/books/n/gene/tk2-mtddepl	1	NBK114628	
neurology consultation with comprehensive neurologic examination	1	NBK114628	
consultation with a pediatric pulmonologist to evaluate pulmonary function	1	NBK114628	
brain mri in patients with encephalopathy or seizures	1	NBK114628	
currently there is no definitive treatment	1	NBK114628	
management should involve a multidisciplinary team	1	NBK114628	
soon after diagnosis is established:	1	NBK114628	
gov/books/n/gene/tps	1	NBK425926	
measurement of height	1	NBK425926	
at an older age, only for trps ii	1	NBK425926	
dental examination for supernumerary teeth	1	NBK425926	
cardiac evaluation (once)	1	NBK425926	
management of trps is principally supportive	1	NBK425926	
ectodermal features	1	NBK425926	
hair	1	NBK425926	
however, reported results vary	1	NBK425926	
hands	1	NBK425926	
regular simple analgesia (e	1	NBK425926	
physiotherapy may aid mobility	1	NBK425926	
exostoses	1	NBK425926	
monitor linear growth in childhood	1	NBK425926	
routine developmental assessments in childhood	1	NBK425926	
gov/books/n/gene/trimethylaminuria	1	NBK1103	
ratios of 70%-89% are classified as mild	1	NBK1103	
ratios lower than 70% are classified as severe	1	NBK1103	
restriction of dietary trimethylamine and its precursors	1	NBK1103	
choline	1	NBK1103	
dietary choline is absorbed through the small intestine	1	NBK1103	
trimethylamine n-oxide	1	NBK1103	
intake of such vegetables should be restricted	1	NBK1103	
use of acid soaps and body lotions	1	NBK1103	
trimethylamine is a strong base (pka 9	1	NBK1103	
thus, at ph 6	1	NBK1103	
0, less than 0	1	NBK1103	
02% of trimethylamine exists as the volatile free base	1	NBK1103	
sequestering of trimethylamine produced in the gut	1	NBK1103	
suppression of intestinal production of trimethylamine	1	NBK1103	
enhancement of residual fmo3 enzyme activity	1	NBK1103	
counseling	1	NBK1103	
affected individuals and their families benefit from counseling	1	NBK1103	
avoid or eat in moderation	1	NBK1103	
drugs that are metabolized by the fmo3 enzyme	1	NBK1103	
for example, the antipsychotic clozapine	1	NBK1103	
the monoamine oxidase b inhibitor deprenyl	1	NBK1103	
the anti-histamine ranitidine	1	NBK1103	
the anti-estrogen tamoxifen	1	NBK1103	
these compete for residual fmo3 activity	1	NBK1103	
gov/books/n/gene/trio-id	1	NBK447257	
evaluation for dental crowding and/or failed/delayed tooth eruption	1	NBK447257	
consider referral to dentist or orthodontist	1	NBK447257	
gastroenterology / feeding	1	NBK447257	
refer to feeding therapist if feeding problems are identified	1	NBK447257	
clinical evaluation for scoliosis and/or kyphosis	1	NBK447257	
consider referral to orthopedic surgeon if scoliosis is present	1	NBK447257	
psychiatric / behavioral	1	NBK447257	
refer to developmental pediatrician and/or developmental psychologist	1	NBK447257	
review of medical history for recurrent infections	1	NBK447257	
if present, consider referral to immunologist	1	NBK447257	
see table 3	1	NBK447257	
dental crowding /	1	NBK447257	
malocclusion	1	NBK447257	
dietary diary & calorie counts may be requested	1	NBK447257	
gerd and/or constipation	1	NBK447257	
standard treatment(s)	1	NBK447257	
standard treatment(s) as recommended by neurologist	1	NBK447257	
scoliosis / kyphosis	1	NBK447257	
standard treatment as recommended by orthopedist	1	NBK447257	
effectiveness should be evaluated on an individual basis	1	NBK447257	
regular dietary evaluation in infancy to ensure optimal nutritional status	1	NBK447257	
monitoring of developmental progress and educational needs	1	NBK447257	
monitoring for spine deformities beginning in early childhood	1	NBK447257	
regular evaluation of teeth	1	NBK447257	
frequency determined by a dentist based on dental condition	1	NBK447257	
gov/books/n/gene/trma	1	NBK1282	
neuroimaging including brain mri when clinically indicated	1	NBK1282	
high-dose thiamine supplementation:	1	NBK1282	
invariably improves the hematologic picture	1	NBK1282	
additional treatment	1	NBK1282	
red blood cell transfusion for severe anemia is indicated	1	NBK1282	
treatment has included cochlear implant [hagr 2014]	1	NBK1282	
ongoing management of the primary disease is essential	1	NBK1282	
hematologic tests (cbc, reticulocyte count)	1	NBK1282	
gov/books/n/gene/tubb4a-leuk	1	NBK395611	
assessment of developmental milestones and cognitive function	1	NBK395611	
assessment of functional disability and equipment needs by a physiotherapist	1	NBK395611	
in some instances intrathecal baclofen pumps can be considered	1	NBK395611	
dystonia can be managed with:	1	NBK395611	
baclofen or intramuscular botulinum toxin when associated with spasticity	1	NBK395611	
trihexyphenidyl or tetrabenazine	1	NBK395611	
dysarthria may warrant augmentative communication tools	1	NBK395611	
anticonvulsant medications should be used when seizures are present	1	NBK395611	
calcium and vitamin d supplementation as required to prevent osteoporosis	1	NBK395611	
annual flu vaccination	1	NBK395611	
fall prevention strategies, adaptive equipment (e	1	NBK395611	
at least yearly:	1	NBK395611	
medical evaluation including physical examination to assess weight and medications	1	NBK395611	
evaluation by orthopedists to assess for scoliosis and joint dislocation	1	NBK395611	
annual neurologic evaluation to assess symptoms and any emerging complications	1	NBK395611	
gov/books/n/gene/tuberous-sclerosis	1	NBK1220	
detailed dermatologic inspection/exam	1	NBK1220	
detailed clinical dental inspection/exam	1	NBK1220	
screening for hypertension by obtaining an accurate blood pressure measurement	1	NBK1220	
baseline routine electroencephalogram (eeg)	1	NBK1220	
evaluation for tsc-associated neuropsychiatric disorder (tand)	1	NBK1220	
subependymal giant cell astrocytomas (segas)	1	NBK1220	
additional trials are underway to confirm these preliminary findings	1	NBK1220	
renal angiomyolipoma	1	NBK1220	
facial angiofibromas	1	NBK1220	
cardiac rhabdomyomas	1	NBK1220	
, outflow tract obstruction) was surgery	1	NBK1220	
however, response to treatment is highly individual	1	NBK1220	
oxygen therapy is necessary with impaired lung function	1	NBK1220	
persons with severe disease require lung transplantation	1	NBK1220	
perform screening for tand features at least annually	1	NBK1220	
perform detailed clinical dermatologic inspection/exam annually	1	NBK1220	
avoid the following	1	NBK1220	
estrogen use in adolescent and adult females	1	NBK1220	
nephrectomy (see treatment of manifestations, renal angiomyolipoma)	1	NBK1220	
gov/books/n/gene/tubulin-ov	1	NBK350554	
growth, feeding, and nutrition	1	NBK350554	
gov/books/n/gene/tyrosinemia	1	NBK1515	
cbc with platelet count	1	NBK1515	
serum concentration of electrolytes	1	NBK1515	
clinical genetics consultation is indicated for all affected individuals	1	NBK1515	
management guidelines have been published	1	NBK1515	
acute management of liver failure	1	NBK1515	
nitisinone (orfadin®)	1	NBK1515	
nitisinone is generally prescribed at 1	1	NBK1515	
0 mg/kg/day	1	NBK1515	
individual requirements may vary	1	NBK1515	
nitisinone is typically given in two divided doses	1	NBK1515	
low-tyrosine diet	1	NBK1515	
3 mg/dl)	1	NBK1515	
transplant recipients require long-term immunosuppression	1	NBK1515	
transplant recipients may also benefit from low-dose (0	1	NBK1515	
initiation of therapy (baseline)	1	NBK1515	
first 6 months:	1	NBK1515	
after 6 months of rx: every 6-12 months	1	NBK1515	
after 2 years of rx: every 6-12 months	1	NBK1515	
as clinically indicated	1	NBK1515	
every 3 months	1	NBK1515	
tyrosinemia type i markers	1	NBK1515	
plasma concentration of methionine, phenylalanine, tyrosine	1	NBK1515	
blood / urine succinylacetone	1	NBK1515	
x(urine)	1	NBK1515	
blood nitisinone concentration	1	NBK1515	
hemoglobin, hematocrit, wbc, platelet count	1	NBK1515	
liver evaluation	1	NBK1515	
serum afp concentration	1	NBK1515	
pt/ptt	1	NBK1515	
bilirubin	1	NBK1515	
alt/ast/ggt	1	NBK1515	
alkaline phosphatase	1	NBK1515	
ct or mri 1	1	NBK1515	
renal studies	1	NBK1515	
bun / creatinine	1	NBK1515	
urine: po4, ca, prot/cr ratio	1	NBK1515	
skeletal evaluation	1	NBK1515	
x-ray of wrist (for rickets)	1	NBK1515	
avoid inappropriate protein intake	1	NBK1515	
org for more information on medication exposure during pregnancy	1	NBK1515	
average survival was less than age ten years	1	NBK1515	
gov/books/n/gene/ucd-overview	1	NBK1217	
acute management of a urea cycle disorder	1	NBK1217	
see:	1	NBK1217	
ornithine transcarbamylase deficiency (otc deficiency)	1	NBK1217	
citrullinemia type i (ass1 deficiency)	1	NBK1217	
argininosuccinic aciduria (asl deficiency)	1	NBK1217	
arginase deficiency (hyperargininemia, arg1 deficiency)	1	NBK1217	
citrin deficiency	1	NBK1217	
treatment of acute manifestations	1	NBK1217	
rapidly return plasma ammonia concentrations to normal physiologic levels	1	NBK1217	
clearance with peritoneal dialysis is substantially lower than with hemodialysis	1	NBK1217	
however, published outcome data are limited	1	NBK1217	
however, central access is preferred	1	NBK1217	
the only form currently available is an oral preparation	1	NBK1217	
deficiency	1	NBK1217	
dosage provided	1	NBK1217	
administration	1	NBK1217	
sodium phenylacetate& sodium benzoate 1, 2	1	NBK1217	
arginine hcl injection, 10% 2	1	NBK1217	
sodium phenyl-acetate	1	NBK1217	
arginine hcl	1	NBK1217	
0-20 kg	1	NBK1217	
loading 3maintenance 4	1	NBK1217	
600 mg/kg	1	NBK1217	
>20 kg	1	NBK1217	
4000 mg/m2	1	NBK1217	
12000 mg/m2	1	NBK1217	
enteral nutrition is preferred	1	NBK1217	
reduce the risk for neurologic damage	1	NBK1217	
use cardiac pressors as necessary while avoiding overhydration	1	NBK1217	
gov/books/n/gene/udd	1	NBK1323	
ct and mri identify affected muscles with high specificity	1	NBK1323	
heavy muscle force training of weak muscles should be avoided	1	NBK1323	
gov/books/n/gene/unc80-def	1	NBK453434	
organ system	1	NBK453434	
constitutional	1	NBK453434	
ophthalmologic eval	1	NBK453434	
feeding eval	1	NBK453434	
orthopedic eval	1	NBK453434	
if club feet and/or scoliosis is present	1	NBK453434	
if neurologic history suggests presence of seizures	1	NBK453434	
psychiatric eval	1	NBK453434	
if behavioral problems are present	1	NBK453434	
ocular abnormalities (nystagmus/strabismus)	1	NBK453434	
ophthalmologic management	1	NBK453434	
oral feeding difficulties	1	NBK453434	
g-tube feeding	1	NBK453434	
braces and/or corrective surgery	1	NBK453434	
self-injurious behavior	1	NBK453434	
behavior modification therapy	1	NBK453434	
hypo/hypertonia, gross motor delays, sensory processing difficulties	1	NBK453434	
physical therapy, occupational therapy	1	NBK453434	
absent speech	1	NBK453434	
sign language instruction	1	NBK453434	
consider alternate forms of communication	1	NBK453434	
annual evaluation with the following specialists is appropriate:	1	NBK453434	
pediatrician for growth assessment	1	NBK453434	
neurologist to identify and manage seizures	1	NBK453434	
orthopedist for evaluation of contractures and back examination for scoliosis	1	NBK453434	
ophthalmologist for ocular manifestations and corrective therapy if needed	1	NBK453434	
gov/books/n/gene/urofacial	1	NBK154138	
urinalysis and urine culture for occult or chronic infection	1	NBK154138	
urinary tract ultrasound examination	1	NBK154138	
micturating cystourethrogram	1	NBK154138	
uroflowmetry or urodynamic testing	1	NBK154138	
assessment of bowel voiding	1	NBK154138	
urinary tract infections warrant rapid and complete treatment	1	NBK154138	
antibiotic prophylaxis may also be considered	1	NBK154138	
bowel	1	NBK154138	
constipation is managed as for the general population	1	NBK154138	
gov/books/n/gene/usher1	1	NBK1265	
clinical genetics	1	NBK1265	
consultation with a clincial geneticist and/or genetic counselor	1	NBK1265	
balance	1	NBK1265	
they should therefore exercise caution while swimming	1	NBK1265	
gov/books/n/gene/usher2	1	NBK1341	
hearing aids are helpful	1	NBK1341	
environmental trauma (e	1	NBK1341	
, noise) or a genetic susceptibility (e	1	NBK1341	
in such individuals, cochlear implantation may be warranted	1	NBK1341	
abr, dpoae	1	NBK1341	
gov/books/n/gene/vhl	1	NBK1463	
ophthalmologic evaluation for retinal hemangioblastomas	1	NBK1463	
abdominal ultrasound examination after age 16 years	1	NBK1463	
audiologic evaluation for hearing loss associated with endolymphatic sac tumors	1	NBK1463	
no guidelines exist for the management of vhl lesions	1	NBK1463	
cns hemangioblastoma	1	NBK1463	
two patients required additional surgery	1	NBK1463	
retinal hemangioblastoma	1	NBK1463	
3% and 4	1	NBK1463	
3%, respectively [young et al 2012]	1	NBK1463	
pheochromocytomas	1	NBK1463	
pheochromocytomas should be surgically removed	1	NBK1463	
laparoscopic approaches have been shown to be effective	1	NBK1463	
partial adrenalectomy could be considered	1	NBK1463	
one long-term follow-up study (9	1	NBK1463	
partial adrenalectomy is also therapy of choice in children	1	NBK1463	
in 10 vhl patients 18 successful operations were performed	1	NBK1463	
after follow up (median 7	1	NBK1463	
pancreatic cysts and neuroendocrine tumors	1	NBK1463	
a tumor of ≥3 cm	1	NBK1463	
a pathogenic variant in exon 3	1	NBK1463	
a tumor with a doubling rate <500 days	1	NBK1463	
twenty-nine patients were symptomatic	1	NBK1463	
epididymal or broad ligament papillary cyst adenomas	1	NBK1463	
annual blood pressure monitoring starting at age one year	1	NBK1463	
monitoring for complications is as follows:	1	NBK1463	
cns lesions	1	NBK1463	
visceral lesions	1	NBK1463	
annual abdominal ultrasound	1	NBK1463	
retinal angiomas	1	NBK1463	
the best way to detect elst is unknown	1	NBK1463	
other guidelines originate from denmark and the netherlands	1	NBK1463	
two recent studies evaluated tumor progression	1	NBK1463	
such test results need to be interpreted with caution	1	NBK1463	
, vhl syndrome or other hereditary disorder)	1	NBK1463	
many experimental therapies target these misregulated signaling pathways	1	NBK1463	
preclinical investigation of ptc124 effects on vhl is ongoing	1	NBK1463	
gov/books/n/gene/vlcad	1	NBK6816	
measurement of baseline liver transaminases	1	NBK6816	
cardiac echocardiography	1	NBK6816	
[behrend et al 2012]	1	NBK6816	
however, the efficacy remains controversial	1	NBK6816	
severe exercise (e	1	NBK6816	
myocardial irritation (e	1	NBK6816	
, cardiac catheterization)	1	NBK6816	
dehydration (risk for acute tubular necrosis)	1	NBK6816	
gov/books/n/gene/vldlr-ch	1	NBK1874	
formal testing of cognitive function	1	NBK1874	
physical therapy to promote ambulation	1	NBK1874	
gov/books/n/gene/vmcm	1	NBK1967	
biopsy is usually not necessary for diagnosis	1	NBK1967	
treatment is required for any symptomatic vmcm lesion	1	NBK1967	
during pregnancy, affected women may develop small new lesions	1	NBK1967	
gov/books/n/gene/vodi	1	NBK1271	
an appropriate dose is 0	1	NBK1271	
625 ml/kg) or 150 mg/m2 (3	1	NBK1271	
75 ml/m2)	1	NBK1271	
measurement of immunoglobulin concentrations prior to ivig infusions	1	NBK1271	
broncho-alveolar lavage to diagnose pneumocystis jirovecii infection	1	NBK1271	
viral cultures or lung function studies as needed	1	NBK1271	
cerebrospinal imaging to diagnose leukodystrophy when clinically indicated	1	NBK1271	
agents known to predispose to hvod (e	1	NBK1271	
penetrance is complete (i	1	NBK1271	
defibrotide was prophylactically continued until two months post transplant	1	NBK1271	
a homozygous sp110 pathogenic variant (c	1	NBK1271	
642delc) was identified on molecular genetic testing	1	NBK1271	
defibrotide was given as hvod prophylaxis	1	NBK1271	
defibrotide was able to be discontinued at day 60	1	NBK1271	
seventy days following hsct he developed seizures	1	NBK1271	
ct showed widespread calcifications	1	NBK1271	
gov/books/n/gene/von-willebrand	1	NBK7014	
desmopressin	1	NBK7014	
intranasal preparations are also available	1	NBK7014	
intravenous infusion of vwf/fviii clotting factor concentrates	1	NBK7014	
in those who are non-responsive to desmopressin (i	1	NBK7014	
virus inactivation procedures eliminate potential pathogens	1	NBK7014	
indirect treatments	1	NBK7014	
fibrinolytic inhibitors (i	1	NBK7014	
hormonal treatments (i	1	NBK7014	
treatment by vwd type	1	NBK7014	
type 1 vwd	1	NBK7014	
treatments that directly increase vwf levels (e	1	NBK7014	
indirect treatment with fibrinolytic inhibitors or hormones is often effective	1	NBK7014	
type 2a vwd	1	NBK7014	
indirect treatments can be beneficial	1	NBK7014	
type 2b vwd	1	NBK7014	
[federici et al 2009]	1	NBK7014	
indirect treatments (i	1	NBK7014	
, fibrinolytic inhibitors) can be useful	1	NBK7014	
type 2m vwd	1	NBK7014	
type 2n vwd	1	NBK7014	
type 3 vwd	1	NBK7014	
desmopressin is not effective in type 3 vwd	1	NBK7014	
indirect treatments may also be beneficial	1	NBK7014	
vwf levels are higher in the neonatal period	1	NBK7014	
delayed, secondary postpartum bleeding may be a problem	1	NBK7014	
gov/books/n/gene/vps35-pd	1	NBK447258	
, orthostasis)	1	NBK447258	
assess cognitive function and psychiatric manifestations (e	1	NBK447258	
evaluate levodopa response	1	NBK447258	
pharmacotherapy	1	NBK447258	
to reduce or delay side effects (e	1	NBK447258	
patients treated with ergot-derived dopamine agonists require periodic echocardiograms	1	NBK447258	
droxidopa may be used to treat orthostasis	1	NBK447258	
gov/books/n/gene/vws	1	NBK1407	
plastic surgery	1	NBK1407	
feeding and hearing evaluation	1	NBK1407	
management is supportive/symptomatic	1	NBK1407	
cleft lip	1	NBK1407	
management is surgical, dental, and orthodontic	1	NBK1407	
lip pits	1	NBK1407	
popliteal pterygium	1	NBK1407	
syndactyly may require surgery	1	NBK1407	
the genital anomalies may result in infertility	1	NBK1407	
some individuals may have pressure-equalizing tubes placed	1	NBK1407	
neonatal period and infancy	1	NBK1407	
assessment of prelinguistic speech-language development	1	NBK1407	
longitudinal evaluation and treatment	1	NBK1407	
evaluations should be carried out routinely through adolescence	1	NBK1407	
routine dental evaluation should continue throughout life	1	NBK1407	
these evaluations should continue throughout adolescence	1	NBK1407	
gov/books/n/gene/wagner	1	NBK3821	
visual field examination	1	NBK3821	
photographic fundus documentation	1	NBK3821	
optical coherence tomography (oct), if available	1	NBK3821	
orthoptic assessment	1	NBK3821	
refractive error is corrected by spectacles or contact lenses	1	NBK3821	
visually disabling cataract is treated by cataract surgery	1	NBK3821	
annual ophthalmologic examination by a vitreoretinal specialist is indicated	1	NBK3821	
gov/books/n/gene/was	1	NBK1178	
referral to immunologist for management	1	NBK1178	
platelet count and size	1	NBK1178	
t-cell subsets	1	NBK1178	
immunoglobulin levels	1	NBK1178	
wiskott-aldrich syndrome	1	NBK1178	
[buchbinder et al 2014]	1	NBK1178	
hematopoietic cell transplantation (hct)	1	NBK1178	
eczema	1	NBK1178	
topical steroids are the mainstay of therapy	1	NBK1178	
autoimmune disease	1	NBK1178	
x-linked thrombocytopenia (xlt)	1	NBK1178	
, risk of secondary malignancy, infertility)	1	NBK1178	
x-linked neutropenia (xln)	1	NBK1178	
intravenous immune globulin	1	NBK1178	
routine childhood immunizations	1	NBK1178	
live vaccines should be avoided	1	NBK1178	
splenectomy	1	NBK1178	
platelet transfusions	1	NBK1178	
platelet transfusions should be administered judiciously (e	1	NBK1178	
, for significant bleeding and surgical procedures)	1	NBK1178	
gov/books/n/gene/weaver	1	NBK148820	
thorough history to identify clinical features associated with weaver syndrome	1	NBK148820	
the presence of an abdominal mass warrants immediate investigation	1	NBK148820	
where possible, measurement of parental heights	1	NBK148820	
camptodactyly	1	NBK148820	
occasionally toe camptodactyly may require surgical intervention	1	NBK148820	
physiotherapy may also be beneficial	1	NBK148820	
ligamentous laxity	1	NBK148820	
gov/books/n/gene/weill-ms	1	NBK1114	
evaluation by a medical geneticist	1	NBK1114	
cardiac echocardiogram	1	NBK1114	
gov/books/n/gene/werner	1	NBK1514	
physical examination for cancers common in werner syndrome (e	1	NBK1514	
, thyroid nodules, skin tumors)	1	NBK1514	
ophthalmologic examination including slit lamp examination	1	NBK1514	
assessment of coping and psychological fitness in light of prognosis	1	NBK1514	
infants with werner syndrome are unaffected at birth	1	NBK1514	
control of type 2 diabetes mellitus	1	NBK1514	
use of cholesterol-lowering drugs if lipid profile is abnormal	1	NBK1514	
muscle atrophy is a potential complication	1	NBK1514	
surgical treatment of ocular cataracts	1	NBK1514	
treatment of malignancies in a standard fashion	1	NBK1514	
screening for type 2 diabetes mellitus at least annually	1	NBK1514	
annual lipid profile	1	NBK1514	
annual ophthalmologic examination for cataracts	1	NBK1514	
smoking and excess weight increase the risk of atherosclerosis	1	NBK1514	
trauma to the extremities should be avoided	1	NBK1514	
gov/books/n/gene/wfs	1	NBK4144	
wolfram syndrome and wolfram-like syndrome	1	NBK4144	
glucose tolerance test (if not already performed)	1	NBK4144	
neuroimaging with mri	1	NBK4144	
baseline psychologic assessment	1	NBK4144	
treatment follows routine practices for insulin-dependent diabetes mellitus	1	NBK4144	
wfs	1	NBK4144	
psychiatric difficulties	1	NBK4144	
neurogenic bladder	1	NBK4144	
treatment of central diabetes insipidus follows routine practices	1	NBK4144	
treatment of gastroparesis and celiac disease follows routine practices	1	NBK4144	
(see celiac disease	1	NBK4144	
diabetes mellitus: tests of glucose tolerance	1	NBK4144	
optic atrophy: ophthalmologic examination	1	NBK4144	
sensorineural hearing loss: audiologic examination including speech discrimination testing	1	NBK4144	
diabetes insipidus: assessment of concentrating ability of the urine	1	NBK4144	
puberty: monitoring for signs of onset of puberty	1	NBK4144	
diabetic retinopathy	1	NBK4144	
microalbuminuria	1	NBK4144	
regular audiologic examination including speech discrimination testing is appropriate	1	NBK4144	
gov/books/n/gene/whs	1	NBK1183	
measurement of growth parameters and plotting on growth charts	1	NBK1183	
, clubfoot, scoliosis, kyphosis)	1	NBK1183	
complete blood count to evaluate for hematopoietic dysfunction	1	NBK1183	
baseline liver ultrasound to evaluate for hepatic adenoma	1	NBK1183	
sleeping problems	1	NBK1183	
if no medical factors (e	1	NBK1183	
hepatic adenomas	1	NBK1183	
other structural anomalies (e	1	NBK1183	
antibiotic prophylaxis is indicated for vesicoureteral reflux	1	NBK1183	
complete blood count annually to evaluate for hematopoietic dysfunction	1	NBK1183	
and creatinine clearance test	1	NBK1183	
consideration of routine liver ultrasonography to evaluate for liver adenomas	1	NBK1183	
gov/books/n/gene/williams	1	NBK1249	
plotting of growth parameters on williams syndrome growth charts	1	NBK1249	
measurement of blood pressure in all four limbs	1	NBK1249	
echocardiogram, including doppler flow studies	1	NBK1249	
urinary system evaluation	1	NBK1249	
ultrasound examination of the bladder and kidneys	1	NBK1249	
calcium determinations	1	NBK1249	
serum concentration of calcium or ionized calcium	1	NBK1249	
cognitive/behavioral	1	NBK1249	
self-calming techniques can help manage anxiety	1	NBK1249	
hypertension is usually treated medically	1	NBK1249	
hypercalcemia	1	NBK1249	
management of hypercalcemia involves the following:	1	NBK1249	
hydration status should be assessed	1	NBK1249	
increase water intake as indicated	1	NBK1249	
but the serum concentration of calcium must be monitored	1	NBK1249	
vitamin supplements containing vitamin d should be avoided	1	NBK1249	
refractory hypercalcemia may be treated with oral steroids	1	NBK1249	
eye, ear, nose, and throat	1	NBK1249	
hyperopia is treated with corrective lenses	1	NBK1249	
dacrostenosis is treated as in the general population	1	NBK1249	
recurrent otitis media may be treated with tympanotomy tubes	1	NBK1249	
dental care may require assistance with daily brushing and flossing	1	NBK1249	
orthodontic referral should be considered for treatment of malocclusion	1	NBK1249	
infants often benefit from feeding therapy	1	NBK1249	
urinary tract abnormalities	1	NBK1249	
hypothyroidism is treated with oral thyroxine therapy	1	NBK1249	
range of motion exercises to prevent or ameliorate joint contractures	1	NBK1249	
electrocardiogram prior to surgery	1	NBK1249	
awareness of the risk for myocardial insufficiency and cardiac arrest	1	NBK1249	
interval / age	1	NBK1249	
in infants – toddlers	1	NBK1249	
annual / all ages 1	1	NBK1249	
every 2 years	1	NBK1249	
serum concentration of calciumthyroid function and tsh level	1	NBK1249	
every 10 years	1	NBK1249	
in adults	1	NBK1249	
thyroid function test yearly until age 3 years	1	NBK1249	
medical evaluation	1	NBK1249	
vision screening to monitor for refractive errors and strabismus	1	NBK1249	
monitoring of blood pressure in both arms	1	NBK1249	
serum concentration of calcium	1	NBK1249	
thyroid function and tsh level	1	NBK1249	
evaluation for cataracts	1	NBK1249	
pregnancies in women with ws are high risk	1	NBK1249	
gov/books/n/gene/wilms-ov	1	NBK1294	
general considerations	1	NBK1294	
individuals with a germline wt1 pathogenic variant	1	NBK1294	
individuals with an 11p15	1	NBK1294	
5 alteration,	1	NBK1294	
beckwith-wiedemann syndrome	1	NBK1294	
wilms tumor was not observed in children with:	1	NBK1294	
wilms tumor was observed in children with:	1	NBK1294	
surveillance for relatives at risk for wilms tumor predisposition	1	NBK1294	
gov/books/n/gene/wilson	1	NBK1512	
upper gi endoscopy to exclude or confirm esophageal varices	1	NBK1512	
detailed clinical neurologic assessment	1	NBK1512	
brain mri to assess for structural alteration	1	NBK1512	
assessment of kidney function	1	NBK1512	
treatment is life long, including during pregnancy	1	NBK1512	
d-penicillamine (chelator)	1	NBK1512	
pyridoxine must be given along with d-penicillamine	1	NBK1512	
zinc (metallothionein inducer)	1	NBK1512	
, vegetarians) consult with a trained dietitian	1	NBK1512	
zinc has been used effectively during pregnancy	1	NBK1512	
org for more information on medication use during pregnancy	1	NBK1512	
curcumin	1	NBK1512	
gov/books/n/gene/ws1	1	NBK1531	
the hearing loss in ws1 is typically non-progressive	1	NBK1531	
hence, repeat audiogram would usually not be necessary	1	NBK1531	
gov/books/n/gene/wss	1	NBK378974	
assessment of scalp hair	1	NBK378974	
speech and language assessment of dysarthria and dysphagia	1	NBK378974	
no specific treatment exists for wss	1	NBK378974	
all treatment is symptomatic	1	NBK378974	
note: standard replacement hormonal treatment will not promote fertility	1	NBK378974	
low igf-1	1	NBK378974	
standard treatment	1	NBK378974	
l-thyroxine replacement therapy	1	NBK378974	
treatment is symptomatic and cosmetic only	1	NBK378974	
movement disorders	1	NBK378974	
benzodiazepines, especially clonazepam	1	NBK378974	
its use in wss has not been documented	1	NBK378974	
dysarthria	1	NBK378974	
consultation with a speech therapist may be helpful	1	NBK378974	
nutritional management by a knowledgeable nutritionist is helpful	1	NBK378974	
monitor for endocrine abnormalities:	1	NBK378974	
hypogonadism at age 12-14 years	1	NBK378974	
diabetes mellitus in the teens and later	1	NBK378974	
hypothyroidism in the teens and later	1	NBK378974	
dystonia may require monitoring by a neurologist	1	NBK378974	
monitor hearing annually	1	NBK378974	
gov/books/n/gene/x-ald	1	NBK1315	
adrenal function tests [dubey et al 2005]	1	NBK1315	
gov/books/n/gene/x-dcdp	1	NBK55062	
pulmonary evaluation, if scoliosis compromises respiratory function	1	NBK55062	
dermatologic evaluation to exclude other causes of the phenotype	1	NBK55062	
ophthalmologic evaluation for congenital cataracts and other eye abnormalities	1	NBK55062	
developmental assessment (after the newborn period)	1	NBK55062	
renal ultrasound examination for possible kidney anomalies	1	NBK55062	
hearing evaluation to detect hearing loss	1	NBK55062	
treatment is symptomatic and should be tailored to each patient	1	NBK55062	
orthopedic management of leg length discrepancy	1	NBK55062	
surgical correction of polydactyly	1	NBK55062	
cataract extraction and correction of vision	1	NBK55062	
dermatologic management of skin lesions	1	NBK55062	
regular follow-up of ophthalmologic abnormalities	1	NBK55062	
ongoing follow-up with dermatologist	1	NBK55062	
routine monitoring of any existing cardiac and/or renal abnormalities	1	NBK55062	
regular hearing evaluations	1	NBK55062	
gov/books/n/gene/x-hed	1	NBK1112	
a dental evaluation by age one year is recommended	1	NBK1112	
hypohidrosis	1	NBK1112	
some individuals may benefit from "cooling vests	1	NBK1112	
hypodontia	1	NBK1112	
orthodontics may be necessary	1	NBK1112	
dental implants in adults can support aesthetic and functional dentition	1	NBK1112	
lubrication eye drops can be helpful for dry eyes	1	NBK1112	
individuals with severe hypohidrosis can have marked heat intolerance	1	NBK1112	
there are no other special recommendations for pregnancy management	1	NBK1112	
the results of the study were inconclusive	1	NBK1112	
for additional information on the clinical trial click here	1	NBK1112	
gov/books/n/gene/x-lpd	1	NBK1406	
no formal management guidelines exist	1	NBK1406	
the following are general considerations	1	NBK1406	
hypogammaglobulinemia is treated with ivig	1	NBK1406	
no formal surveillance guidelines exist	1	NBK1406	
the following are general considerations:	1	NBK1406	
gov/books/n/gene/x-oa	1	NBK1343	
a complete ophthalmologic evaluation	1	NBK1343	
gov/books/n/gene/x-pvh	1	NBK1213	
evaluation by a neurologist	1	NBK1213	
evaluation by an epileptologist if seizures are present	1	NBK1213	
evaluation by a hematologist if findings suggest a bleeding diathesis	1	NBK1213	
treatment with antiepileptic agents	1	NBK1213	
many individuals with periventricular nodular heterotopia have dyslexia	1	NBK1213	
gov/books/n/gene/x-scid	1	NBK1410	
consultation with a specialist in immunodeficiency	1	NBK1410	
hla-matched bone marrow transplantation from a relative is preferred	1	NBK1410	
cord blood from normal infants is now being banked	1	NBK1410	
bmt after age 3	1	NBK1410	
administration of immunoglobulin	1	NBK1410	
live vaccines	1	NBK1410	
transfusion of non-irradiated blood products	1	NBK1410	
the following investigations are underway:	1	NBK1410	
gov/books/n/gene/xdp	1	NBK1489	
assessment of speech	1	NBK1489	
assessment of swallowing	1	NBK1489	
surface electromyography (emg) study	1	NBK1489	
pharmacologic treatment of dystonia	1	NBK1489	
anticholinergic agents and benzodiazepines	1	NBK1489	
the benzodiazepine associated with the best response is clonazepam	1	NBK1489	
zolpidem	1	NBK1489	
risperidone seems less effective than haloperidol in controlling dystonia	1	NBK1489	
pharmacologic treatment of parkinsonism	1	NBK1489	
surgical treatment of dystonia and parkinsonism	1	NBK1489	
gov/books/n/gene/xl-nystag	1	NBK3822	
recording eye movements to evaluate the nystagmus waveform:	1	NBK3822	
amplitude, frequency, and conjugacy	1	NBK3822	
foveation dynamics	1	NBK3822	
null point width determination	1	NBK3822	
optical devices	1	NBK3822	
pharmacologic	1	NBK3822	
gov/books/n/gene/xla	1	NBK1453	
a complete blood count with differential	1	NBK1453	
baseline chest and sinus x-rays	1	NBK1453	
bacterial infections	1	NBK1453	
both routes provide good therapeutic concentrations of serum igg	1	NBK1453	
a variety of brands of gammaglobulin are available	1	NBK1453	
such reactions may disappear over time	1	NBK1453	
at least once a year:	1	NBK1453	
chest x-rays or cts and sinus films	1	NBK1453	
gov/books/n/gene/xlhi	1	NBK1402	
total parenteral nutrition may be required	1	NBK1402	
institute appropriate antimicrobial therapy for infections	1	NBK1402	
treat lymphomas and gi cancer	1	NBK1402	
the following methods are used to prevent infection:	1	NBK1402	
intravenous immune globulin (ivig)	1	NBK1402	
monitor and treat pulmonary complications:	1	NBK1402	
bronchoscopic evaluations as indicated	1	NBK1402	
perform annual endoscopic evaluation	1	NBK1402	
at routine visits, monitor for the following:	1	NBK1402	
chronic neutropenia	1	NBK1402	
chronic diarrhea and resulting malnutrition	1	NBK1402	
if present, screen for ova and parasites	1	NBK1402	
autoimmune disorders with history, physical examination, and cbc	1	NBK1402	
gov/books/n/gene/xlmr	1	NBK1449	
review of medical history for developmental progress and seizures	1	NBK1449	
assessment of growth in infants and children	1	NBK1449	
assessment of cognitive and adaptive functions by neuropsychological testing	1	NBK1449	
auscultation of the heart for evidence of structural defect	1	NBK1449	
examination of the genitalia for cryptorchidism and other anomalies	1	NBK1449	
the following treatments are recommended:	1	NBK1449	
early intervention programs and special education for developmental delays	1	NBK1449	
(syndrome-specific growth charts are not available	1	NBK1449	
developmental progress should be monitored throughout infancy and childhood	1	NBK1449	
gov/books/n/gene/xp	1	NBK1397	
use the schirmer test to detect dry eyes	1	NBK1397	
deep tendon reflex testing	1	NBK1397	
auditory	1	NBK1397	
premalignant lesions (e	1	NBK1397	
this involves electrodesiccation/curettage or surgical excision	1	NBK1397	
calcification of ligaments and tendons	1	NBK1397	
however, no controlled studies have been reported	1	NBK1397	
author, personal communication]	1	NBK1397	
periodic audiograms	1	NBK1397	
artificial sources of uv	1	NBK1397	
certain light sources (e	1	NBK1397	
cigarette smoke	1	NBK1397	
regular monitoring with pregnancy tests is indicated	1	NBK1397	
gov/books/n/gene/xq28-dup	1	NBK349624	
psychiatric evaluation if psychiatric illness is suspected	1	NBK349624	
spine x-ray and orthopedic evaluation if kyphoscoliosis is present	1	NBK349624	
nutritional evaluation and counseling if obesity is present	1	NBK349624	
recurrent bacterial infections are treated with standard antibiotics	1	NBK349624	
standard management is recommended for the following:	1	NBK349624	
behavioral and psychiatric problems	1	NBK349624	
kyphoscoliosis	1	NBK349624	
eye problems	1	NBK349624	
the following routine monitoring is recommended:	1	NBK349624	
assessment of developmental progress and cognitive abilities	1	NBK349624	
screening for behavioral and psychiatric problems	1	NBK349624	
gov/books/n/gene/xxms	1	NBK1416	
dexascan to evaluate for osteopenia	1	NBK1416	
testosterone-replacement therapy	1	NBK1416	
regression of gynecomastia may occur with testosterone replacement therapy	1	NBK1416	
monitoring during testosterone replacement therapy should include the following:	1	NBK1416	
such testing should then be performed annually	1	NBK1416	
ongoing psychosocial support	1	NBK1416	
gov/books/n/gene/yci	1	NBK1339	
gov/books/n/gene/zap70-scid	1	NBK20221	
consultation with a clinical immunologist	1	NBK20221	
consultation for hematopoietic stem cell transplantation	1	NBK20221	
outcomes are the best with hla-matched, related donors	1	NBK20221	
matched unrelated donor	1	NBK20221	
umbilical cord blood donor	1	NBK20221	
all individuals were alive at a median of 13	1	NBK20221	
5 years of follow up	1	NBK20221	
two individuals receiving myeloablative conditioning have developed premature ovarian failure	1	NBK20221	
delay of immunizations until immune reconstitution	1	NBK20221	
complete blood counts	1	NBK20221	
liver and renal function	1	NBK20221	
immune status	1	NBK20221	
donor and recipient chimerism	1	NBK20221	
individuals with zap70-related cid should avoid the following:	1	NBK20221	
non-irradiated blood products	1	NBK20221	
live virus vaccinations	1	NBK20221	
contaminated water sources	1	NBK20221	
exposure to fungus-enriched environments (e	1	NBK20221	
nonviral transfer methods (e	1	NBK20221	
